Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AC008397.2		ENSG00000285188	"Novel protein"		19	18207961-18255419	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"stomach 1: 3.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 2.0;Alveolar cells type 1: 9.6;Alveolar cells type 2: 10.6;Breast glandular cells: 2.2;Breast myoepithelial cells: 4.6"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.2"									"HPA048975, HPA054218"	Uncertain		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA					"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "																		0.1	0.0	1.8	0.1	2.3	0.0	0.0	1.2	2.3	0.3	1.2	1.2	0.8	0.7	1.9	0.1	0.7	0.3	0.5	2.1	1.5	0.4	0.0	1.2	0.0	1.3	1.5	0.2	0.4	0.0		0.6	1.4	0.2	1.0	0.0	0.0	0.7	2.4	0.0	0.5	0.5	1.3	0.4	3.6	0.3	1.6	0.0	0.0	2.6	0.0	0.1		1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.3	1.2	2.3	2.1	1.5	1.3	1.5	1.4	1.3	1.6	1.6	2.0	9.6	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC013489.1		ENSG00000173867	"Novel transcript"		15	88459501-88546585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"granulocytes: 1.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (3.32e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	0.4	0.4	0.6	0.2	0.6	0.4	1.1	0.7	0.7	0.4	0.9	0.5	0.3	2.2	1.0	0.3	1.0	0.5	0.8	0.5	0.9	0.7	0.8	0.5	0.4	0.6	0.6	2.2	1.0	0.7		0.5	0.7	0.6	0.6	1.3	0.4	0.7	1.4	0.3	0.4	0.9	0.6	0.7	0.4	0.4	0.7	0.5	0.7	1.2	0.5	0.3		0.8	0.3	0.6	0.5	0.8	1.2	0.6	0.6	1.0	0.7	1.0	0.7	0.6	1.1	0.9	0.7	1.2	0.7	0.6	2.1	0.6	0.9	0.3	1.0	1.0	0.5	0.8	0.4	0.8	0.7	1.0	1.1	0.7	0.8	0.4	0.5	1.2	1.0	0.9	0.1	0.4	1.0	0.5	0.6	0.7	0.2	0.4	0.7	1.2	0.6	0.8	0.6	0.4	0.9	0.4	1.4	1.0	0.7	1.5	0.8	0.7	0.5	0.9	0.9	0.5	0.9	0.6	0.9	0.7	0.5	0.0	0.5	0.3	0.7	0.9	0.8	0.9	0.9	0.8	0.8	0.7	1.0	1.1	0.0	0.9	0.6	0.6	0.8	0.9	0.6	0.6	0.7	0.7	0.5	0.9	0.6	0.6	0.7	0.6	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC026464.4		ENSG00000260914	"Novel protein"		16	69299682-69322700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060092			Approved	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Midbody		"HPA060092: AB_2684203"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-1)"			"unprognostic (7.34e-2)"	"unprognostic (8.50e-2)"		"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"		"unprognostic (3.50e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.51e-4)"	"unprognostic (1.69e-1)"		"unprognostic (2.76e-1)"	"unprognostic (5.11e-2)"	44.1	30.4	24.3	29.1	27.0	28.6	31.8	26.0	37.3	28.4	14.9	36.4	30.5	32.6	12.3	41.7	29.4	22.0	43.2	28.4	27.4	30.3	20.7	28.8	28.0	28.5	25.1	33.7	47.2	47.6	16.1	29.4	29.1	27.7	26.4	35.4	36.1	26.6	156.6	34.6	35.1	31.7	25.2	29.9	31.7	18.7	27.4	26.2	30.3	97.2	30.0	32.2	28.3	30.1	64.9	56.5	65.5	62.3	48.9	51.3	36.9	80.1	53.7	83.6	54.6	72.3	35.1	61.6	81.7	64.5	42.9	49.7	62.2	54.6	52.9	38.2	30.0	48.9	30.1	37.3	61.5	62.3	49.8	43.7	73.8	69.2	75.7	47.9	70.0	52.4	63.2	29.6	68.7	84.5	62.1	30.8	53.1	42.7	27.0	94.3	37.4	82.1	38.7	41.2	67.7	38.1	107.8	35.6	47.7	39.9	50.7	43.0	74.0	77.7	55.5	67.8	61.3	101.4	78.6	147.0	78.7	23.3	94.8	16.1	25.4	36.1	31.0	20.7	28.4	23.0	27.4	36.9	26.8	20.2	27.7	27.4	17.1	22.5	28.3	18.5	28.5	33.7	24.3	27.0	26.0	37.3	28.4	27.4	28.5	25.1	29.1	25.2	27.4	30.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC092143.1		ENSG00000198211	"Novel protein (MC1R-TUBB3 readthrough)"		16	89919165-89936092	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	12	"testis: 6.6"	"Cell type enriched"	"Detected in single"	15	"Fibroblasts: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 10.7"									"CAB011512, HPA043640, HPA046280"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612"					"unprognostic (2.90e-4)"				"unprognostic (6.87e-2)"									0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 100.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	2.7	100.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.5	0.3	0.5	0.3	0.3	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656448	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;pituitary gland: 15.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.0;Excitatory neurons: 22.1;Horizontal cells: 6.7;Inhibitory neurons: 19.0"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	76	"SCLC-21H: 28.5;SH-SY5Y: 28.7"	"Low region specificity"	"Detected in all"							HPA045126	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli rim, Mitotic chromosome"		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	0.0	1.8	13.8	0.0	14.5	0.0	0.0	9.4	20.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.9	8.5	0.0	0.0	0.0	0.0	4.4	1.8	0.0	0.8	0.1	15.3	0.0	4.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.5	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.5	9.4	20.7	14.9	8.5	4.4	1.8	4.3	1.7	3.9	11.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	8.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	22.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	19.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	0.0	1.2	0.0	3.5	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;ovary: 10.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 7.3;Excitatory neurons: 44.7;Fibroblasts: 13.7;Granulosa cells: 22.2;Theca cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.9;SuSa: 3.5;U-2197: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	5.4	0.2	1.4	0.4	1.9	0.5	0.7	17.0	2.6	1.4	0.0	0.7	0.6	1.3	1.6	1.5	0.7	6.4	0.2	3.4	0.0	3.5	0.4	0.7	0.2	0.2	0.2	10.4	4.5	0.1	0.0	0.2	0.7	0.1	0.3	1.2	0.2	0.5	0.2	0.4	0.5	1.1	0.0	0.2	0.2	0.4	0.0	0.2	0.3	0.2	0.1	1.0	0.6	1.8	1.7	1.7	1.7	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.5	0.0	1.4	0.1	2.1	0.0	3.0	0.1	0.0	0.0	0.4	0.1	0.9	0.3	2.8	0.0	0.0	0.2	0.0	0.0	0.0	3.9	0.1	0.5	0.0	0.3	0.6	0.4	0.7	0.0	0.4	0.2	1.1	0.0	1.6	0.4	2.2	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	3.5	0.1	0.1	0.1	2.1	3.0	5.8	1.4	0.9	0.3	0.1	3.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	1.9	17.0	2.6	3.4	0.0	0.2	0.2	0.7	0.0	0.0	1.8	0.7	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.6	2.0	0.7	0.4	0.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	5.0	0.1	0.0	0.0	44.7	0.0	0.0	13.7	0.5	0.5	0.0	22.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	6.9	1.6	0.1	0.0	0.0	0.0	0.0	0.1	15.9	0.0	0.0
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435034	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.0;placenta: 20.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 36.8;Granulosa cells: 15.0;Muller glia cells: 13.7;Oligodendrocytes: 16.9;Rod photoreceptor cells: 7.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.6;HUVEC TERT2: 8.0;SuSa: 10.6;TIME: 2.5;U-87 MG: 4.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.3"	"Low region specificity"	"Detected in all"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	3.1	0.1	1.3	0.3	3.0	0.0	2.9	11.0	2.5	1.2	0.5	0.0	0.1	0.8	0.0	0.1	0.2	0.6	0.0	1.8	2.7	0.2	0.0	0.1	0.1	4.3	2.4	0.1	0.3	0.0	0.8	20.6	3.7	0.4	0.0	2.0	1.3	0.1	0.6	0.1	0.0	0.6	1.7	0.0	0.0	0.2	2.4	0.9	0.0	0.0	0.0	0.9	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.6	0.0	0.5	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.0	11.0	2.5	1.8	2.7	4.3	2.4	3.7	1.7	2.4	5.9	36.8	0.0	0.0	4.6	0.1	0.1	0.1	0.0	0.0	1.8	1.5	4.3	0.6	0.0	0.0	1.8	2.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.6	0.0	0.1	1.2	0.0	0.3	0.0	15.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.1	0.2	0.6	0.0	0.1	0.3	0.0	0.1	0.0	0.0
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"		5	129460281-129738683	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	10	"brain: 3.3;cervix: 10.2;endometrium 1: 9.8;placenta: 3.7;smooth muscle: 5.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7;testis cancer: 1.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 15.9;SH-SY5Y: 34.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.0	0.6	1.0	0.0	3.3	0.0	0.0	0.0	1.5	10.2	0.1	0.2	0.1	9.8	0.0	0.2	0.2	0.0	0.2	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	3.7	0.0	0.1	0.3	0.5	0.3	0.0	0.5	0.0	0.1	5.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	15.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	34.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.3	0.0	1.5	0.8	0.2	0.0	0.5	0.0	0.0	0.3	0.6	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.4	0.0	0.0	1.8	0.0	15.6	0.0	0.3	0.0	0.0	1.5	0.5	8.9	0.2	0.0	0.0	82.6	0.2	0.7	1.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	79.7	0.1	0.0	0.0	0.3	0.7	0.0	0.1	0.0	1.0	0.0	1.1	0.0	12.5	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.1	0.1	0.0	5.2	0.1	0.1	0.3	0.0
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 219.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 219.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	6.3	2.5	85.4	10.0	69.0	14.5	1.8	0.6	219.9	0.8	0.0	2.2	2.9	2.0	0.3	2.3	1.0	4.3	23.5	162.1	0.0	0.8	1.1	3.4	16.9	0.0	0.0	1.5	3.7	1.8	7.5	2.5	0.0	1.9	1.5	4.6	2.3	0.8	15.1	3.2	5.8	1.0	0.0	11.4	3.3	1.0	0.0	15.0	2.5	9.9	11.3	3.2	1.0	38.7	7.3	10.5	19.8	5.8	0.0	0.0	11.3	4.8	0.9	0.1	0.5	1.2	6.6	18.4	1.5	0.0	3.6	4.4	0.1	0.2	0.0	20.3	3.1	20.5	1.6	3.4	0.1	21.2	40.3	0.0	0.0	0.1	0.1	8.4	0.0	21.3	0.0	39.8	0.0	12.6	37.4	13.5	3.2	2.3	10.6	15.5	98.8	13.4	0.0	6.0	5.6	20.5	2.6	3.6	4.3	0.1	2.6	14.8	11.2	5.5	9.0	10.5	3.6	16.8	10.9	9.4	9.8	13.9	9.4	3.8	0.5	0.6	2.7	0.8	2.9	1.2	2.8	3.0	0.8	0.8	1.1	1.7	3.8	1.4	0.4	0.8	4.2	1.1	85.4	69.0	0.6	219.9	162.1	0.0	0.0	0.0	0.0	0.0	0.0	38.7	3.6	3.2	1.1	0.0	5.7	0.0	0.3	0.0	0.0	10.0	0.8	0.5	5.8	1.5	0.6	0.0	0.0	0.1	16.4	0.2	0.0	0.1	0.4	0.1	0.7	4.2	0.0	2.1	22.2	0.0	0.2	0.9	2.0	0.2	2.5	0.0	1.1	0.1	1.3	8.4	12.3	0.5	0.0	2.2	1.1	1.1	0.0	3.0	0.0	1.9	3.9	0.5	17.5	5.0	1.2	0.1	0.1	0.7	11.4	0.3	0.3	0.1	0.0	2.3	32.9	2.2	16.2	0.8	0.4	0.2	0.4	0.0	16.4	0.3	0.2	0.0
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"parathyroid gland: 49.9;testis: 192.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 302.7;Late spermatids: 338.0;Spermatocytes: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	8.8	16.7	8.4	8.0	7.4	13.6	12.4	7.8	8.2	14.4	9.5	16.2	8.8	14.0	26.0	18.3	20.8	14.3	12.7	7.3	11.3	22.5	7.2	11.2	10.7	8.3	7.8	14.4	15.0	49.9	12.5	11.2	8.9	15.2	11.5	16.3	21.2	16.5	7.1	20.5	9.9	14.6	6.1	8.5	11.8	192.9	9.1	15.6	28.5	6.5	8.6	14.9	7.3	7.5	55.0	34.7	55.4	37.2	11.6	23.0	62.9	10.9	23.5	30.9	31.9	30.2	40.5	30.3	34.0	18.9	43.4	24.6	44.8	49.4	33.9	25.9	66.8	44.5	42.0	65.7	23.6	21.6	14.4	24.4	36.7	27.1	22.0	46.9	32.8	43.5	38.9	23.8	30.3	21.5	63.2	32.3	39.4	39.4	23.7	64.5	62.9	48.0	31.9	13.6	37.1	53.6	21.5	16.7	35.0	53.9	24.9	16.3	16.4	28.6	39.2	13.8	23.9	47.7	27.2	62.4	31.8	24.4	26.1	8.8	1.8	4.5	3.3	1.1	2.5	4.6	4.1	4.6	4.1	2.3	3.6	2.2	1.1	8.5	0.7	2.3	2.8	3.8	8.4	7.4	7.8	8.2	7.3	11.3	8.3	7.8	8.9	6.1	9.1	7.5	3.6	0.0	10.1	5.2	6.3	3.3	8.3	7.2	13.6	5.7	8.6	6.7	6.7	10.0	6.8	9.2	0.0	14.7	1.8	5.9	19.6	8.3	302.7	13.0	3.9	4.9	2.4	11.6	7.9	6.0	7.9	6.4	5.6	5.8	1.3	14.1	6.4	4.1	5.2	0.0	9.1	8.4	6.1	3.1	3.5	338.0	10.5	8.0	7.2	6.5	4.9	6.8	0.0	10.1	10.1	5.0	7.6	11.3	17.1	6.0	6.3	25.0	10.7	10.0	0.0	4.2	7.0	156.8	41.2	16.3	2.7	8.3	5.0	9.4	8.6	10.5
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	72.3	36.1	53.6	39.1	63.8	21.9	40.2	57.1	66.5	47.8	47.1	50.0	25.3	36.1	56.1	45.2	31.3	40.8	45.8	51.7	62.0	39.3	49.0	46.2	51.2	63.0	58.4	40.6	32.5	32.5	21.4	47.8	62.8	35.1	36.1	19.4	28.0	42.1	28.4	26.6	28.9	54.2	58.9	37.4	28.2	44.3	58.5	33.8	37.5	49.7	52.9	47.2	31.2	69.6	74.3	56.2	65.5	70.4	181.2	169.9	71.4	135.7	145.0	95.1	87.0	64.3	62.0	39.5	67.2	161.7	73.4	44.8	81.4	89.9	115.4	59.6	30.0	50.4	64.2	61.9	95.2	62.5	28.4	104.0	78.9	113.4	108.9	102.4	117.8	49.6	77.1	54.3	180.8	27.6	40.9	38.4	163.6	83.9	118.8	43.8	183.9	57.9	110.9	49.7	43.1	72.1	91.0	53.4	83.8	100.3	43.5	38.5	94.1	127.4	62.9	124.9	162.7	40.3	80.4	35.2	118.1	38.7	128.0	5.7	2.8	2.9	5.7	4.4	4.8	14.2	7.2	6.2	2.5	13.8	7.4	5.8	1.6	3.5	5.0	7.2	10.2	4.1	53.6	63.8	57.1	66.5	51.7	62.0	63.0	58.4	62.8	58.9	58.5	69.6	80.2	22.4	49.9	6.5	57.9	32.5	36.2	19.8	20.5	18.8	20.8	18.0	8.6	27.1	18.7	33.1	33.3	20.6	46.5	19.0	29.4	38.6	20.4	27.1	48.9	52.4	36.1	46.7	8.9	37.9	55.0	52.6	12.8	46.6	3.8	32.4	43.9	36.9	31.5	23.5	11.1	22.4	22.4	37.8	40.2	23.8	60.3	42.5	37.4	30.9	58.9	32.1	38.1	10.6	10.0	51.1	19.8	50.8	32.1	61.2	24.4	54.4	32.8	13.8	32.9	66.1	43.9	35.3	17.9	26.6	30.3	9.0	28.0	32.0	17.8	33.7
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108963484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 4.8"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;hTCEpi: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.7	0.0	0.0	1.6	0.0	1.5	0.1	0.0	1.8	2.5	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	80.6	0.3	5.1	1.4	0.0	0.0	1.0	0.2	0.8	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.7	0.0	0.0	0.3	17.8	2.5	0.1	1.8	0.0	0.0	0.4	0.0	3.5	3.1	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.9	0.6	1.4	0.1	0.1	0.7	0.1	0.7	0.5	0.0
AL031681.2		ENSG00000288000	"Novel protein"		20	43458054-43541881	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059648			Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA							Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL592490.1		ENSG00000197991	"Novel protein"		13	61409858-61427849	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062669			Approved	"Vesicles,Cytokinetic bridge"		Yes	NA						"Cluster 11: Alveolar cells - Smell perception"	Vesicles	"Cytokinetic bridge"	"HPA062669: AB_2732687"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3018.1"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.6	3.0	3.6	6.0	3.5	1.0	37.8	3.5	4.9	38.2	5.6	32.6	23.2	23.4	17.9	9.8	30.5	28.5	16.9	3.6	4.9	18.4	3018.1	18.5	3.5	4.5	4.2	58.1	30.8	5.3	5.0	3.8	4.3	32.7	45.7	2.2	52.6	13.3	6.2	27.4	27.1	10.4	4.5	7.4	58.2	10.2	3.7	1.5	8.8	10.5	4.1	24.8	31.4	4.8	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.5	3.5	4.9	3.6	4.9	4.5	4.2	4.3	4.5	3.7	4.8	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
ANKRD54	LIAR	ENSG00000100124	"Ankyrin repeat domain 54"	Q6NXT1	22	37830855-37849327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071287	Approved		Approved	Nucleoplasm,Microtubules,Midbody		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Microtubules, Midbody"	Nucleoplasm	"HPA071287: AB_2686380"	"unprognostic (5.36e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.38e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-3)"	8.6	18.7	22.4	5.9	20.8	6.9	9.1	22.6	23.3	13.0	28.7	16.4	7.1	12.9	7.8	14.0	23.8	6.3	12.4	23.0	26.2	14.9	15.6	8.4	6.4	22.6	24.7	17.8	18.1	11.7	19.2	5.4	21.6	13.7	6.6	6.3	13.9	11.0	12.6	11.3	8.9	9.5	22.0	9.2	10.9	30.9	26.1	10.4	13.8	8.7	7.2	14.0	10.9	20.3	18.5	18.6	15.4	23.0	19.9	11.3	8.1	24.8	19.2	41.1	25.2	11.8	7.3	17.8	10.1	16.5	13.3	16.4	19.5	14.1	19.9	14.2	39.5	9.3	17.3	28.3	17.7	17.8	20.8	10.1	14.2	22.6	13.3	10.3	25.5	13.1	11.9	12.7	19.1	19.8	17.6	21.1	4.4	24.5	16.5	20.2	18.3	11.3	23.2	6.4	26.4	14.1	20.7	18.8	30.8	7.0	19.3	28.0	15.1	24.5	25.6	12.9	18.6	13.3	11.7	14.3	20.1	15.1	17.9	3.5	4.5	2.2	5.4	5.5	5.4	3.9	5.1	4.0	5.7	5.2	5.3	2.6	2.7	10.2	9.3	5.3	2.4	3.3	22.4	20.8	22.6	23.3	23.0	26.2	22.6	24.7	21.6	22.0	26.1	20.3	8.4	12.8	14.5	11.8	14.4	15.8	11.0	12.4	12.0	18.3	16.9	15.6	8.1	24.3	12.2	18.4	29.2	20.9	14.0	19.9	39.2	17.1	6.4	47.8	12.6	10.9	9.0	12.8	9.4	14.7	17.7	12.3	12.2	8.5	9.5	23.3	13.6	12.0	13.2	26.9	9.4	14.3	12.2	12.5	10.7	7.7	18.0	8.8	10.6	2.8	9.2	18.5	17.5	13.6	8.6	11.3	15.3	21.4	8.4	11.4	19.2	22.0	48.2	23.2	6.6	13.1	13.4	65.6	42.1	12.7	17.6	16.8	13.3	25.4	20.7	9.9
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389821-36453791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 266.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 156.4;Oligodendrocytes: 441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 655.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.2	0.7	59.8	5.2	134.5	36.4	2.0	125.1	72.7	1.8	18.4	6.0	4.4	1.8	0.2	10.4	0.9	2.1	0.8	59.3	83.6	0.4	1.2	1.4	6.7	162.3	106.5	0.9	0.6	0.2	0.2	8.9	160.2	0.9	8.0	0.3	1.7	0.4	0.3	13.6	4.3	14.9	99.2	1.2	4.8	12.4	102.3	16.0	0.8	0.3	9.5	3.2	3.2	266.0	476.1	96.5	79.3	61.0	10.7	26.9	85.6	292.5	169.3	344.4	256.0	66.4	142.7	23.9	82.1	148.6	182.8	237.0	63.4	170.7	655.4	16.1	46.0	32.7	104.8	55.8	1.7	47.3	36.7	6.0	7.7	225.3	147.2	40.8	109.3	31.2	69.6	48.8	284.4	71.0	40.0	54.8	88.5	71.9	102.3	29.1	238.2	15.9	76.5	76.5	33.5	39.5	154.1	175.8	26.1	109.6	119.0	53.6	104.5	214.2	239.0	127.6	346.6	20.1	34.2	43.2	72.9	74.9	460.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	59.8	134.5	125.1	72.7	59.3	83.6	162.3	106.5	160.2	99.2	102.3	266.0	0.4	0.0	1.1	2.3	1.0	14.1	1.9	8.3	7.4	0.0	1.9	2.0	0.6	0.0	3.2	0.0	0.0	13.8	1.1	2.8	0.0	0.7	156.4	18.9	3.2	1.9	0.0	35.3	3.4	0.2	23.2	6.9	10.2	12.8	0.0	15.4	1.1	0.5	9.8	0.0	5.7	3.4	6.1	1.6	5.9	53.3	1.2	2.7	0.0	0.0	0.0	0.0	0.0	1.5	441.3	0.6	0.1	0.0	8.8	1.6	0.8	0.3	10.4	0.0	0.0	0.4	5.2	20.0	17.7	27.1	9.2	2.9	2.6	1.7	6.0	3.3
AP002495.1		ENSG00000254469	"XRCC1 N-terminal domain containing 1-like"	Q6ZNB5	11	71865504-71928665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	1.9	2.1	1.9	2.2	2.8	4.7	3.2	4.3	2.6	2.8	2.8	2.2	2.6	3.7	5.3	2.6	2.4	2.1	2.1	1.7	2.2	2.9	2.2	1.8	4.2	2.5	1.5	4.6	3.1	2.9	2.5	2.0	2.4	3.1	3.5	7.3	2.2	2.8	1.6	4.2	2.6	2.4	0.6	2.9	2.4	3.3	2.8	3.2	3.2	1.5	3.4	2.3	2.2	5.0	2.6	6.2	4.7	4.5	1.8	1.6	3.1	2.9	2.3	3.1	3.0	6.5	6.4	5.8	2.6	2.0	3.9	8.4	4.9	3.3	3.2	8.4	4.5	9.4	7.7	4.2	1.1	4.2	3.1	2.2	1.6	5.2	3.6	2.6	4.9	8.0	6.3	7.6	3.0	4.9	4.8	3.5	4.9	9.6	4.5	3.6	16.3	4.0	3.5	3.1	6.9	6.6	4.6	4.1	9.2	3.3	5.1	2.3	4.6	2.5	4.1	4.9	1.9	5.5	8.4	7.0	4.0	4.6	3.7	2.7	1.9	1.7	2.9	3.0	1.7	2.5	5.1	3.8	2.2	3.3	4.8	4.1	2.0	1.2	1.9	4.8	4.9	1.9	1.9	2.8	4.3	2.6	1.7	2.2	2.5	1.5	2.4	0.6	2.8	5.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0
AP002748.5		ENSG00000256349	"Novel protein"		11	66509079-66533613	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 2.9;choroid plexus: 1.9;retina: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 9.7;THP-1: 2.8"									HPA058283	Uncertain		Approved	Midbody		Yes	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"		Midbody		"HPA058283: AB_2683667"																		0.0	0.1	2.1	0.0	2.2	0.0	0.2	1.9	2.9	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.0	2.3	0.4	0.2	0.2	0.2	2.3	2.1	0.0	0.9	0.2	0.0	0.2	2.3	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.2	2.3	0.1	0.1	0.0	2.4	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.6	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.4	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.0	0.1	1.1	0.1	0.0	1.3	0.1	0.4	0.0	0.6	0.3	0.6	9.7	0.8	0.0	0.8	0.0	0.0	0.7	1.4	0.2	0.1	0.2	0.5	0.4	0.2	0.9	2.8	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	2.2	1.9	2.9	2.0	2.3	2.3	2.1	2.3	2.3	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APC2	APCL	ENSG00000115266	"APC regulator of WNT signaling pathway 2"	O95996	19	1446302-1473244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 64.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 142.4;Bipolar cells: 50.4;Excitatory neurons: 26.8;Horizontal cells: 45.4;Inhibitory neurons: 27.5;Muller glia cells: 29.4;Oligodendrocyte precursor cells: 28.1"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.8;SCLC-21H: 9.3;SH-SY5Y: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"		Yes	No				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: AB_2686874"	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	0.1	2.4	41.5	0.0	27.3	0.0	0.0	41.4	42.4	0.1	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.3	37.1	20.8	0.0	0.0	0.0	0.0	64.5	42.3	0.0	0.3	0.0	6.2	0.0	54.9	0.1	0.0	2.7	0.2	0.0	0.2	0.1	0.4	0.1	38.3	0.0	0.3	1.0	54.6	0.0	0.1	0.0	0.0	0.1	0.2	49.0	0.2	0.6	7.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.0	9.3	31.7	1.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.6	0.1	0.1	1.7	0.5	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	27.3	41.4	42.4	37.1	20.8	64.5	42.3	54.9	38.3	54.6	49.0	0.3	0.0	0.0	142.4	0.3	0.0	0.2	0.2	1.2	50.4	0.4	0.4	3.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.5	0.5	0.5	0.0	0.0	26.8	0.0	0.1	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.1	45.4	27.5	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	29.4	2.1	28.1	17.8	0.0	0.0	0.7	0.0	0.1	0.2	0.2	0.0	11.1	0.0	0.6	0.4	0.4	0.7	2.4	0.0	0.0	0.3	0.2	0.1	0.2
ARHGAP39	"CrGAP, KIAA1688, Vilse"	ENSG00000147799	"Rho GTPase activating protein 39"	Q9C0H5	8	144529179-144605816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.3;Endometrial ciliated cells: 31.4;Excitatory neurons: 41.7;Inhibitory neurons: 33.1;Oligodendrocytes: 30.8;Respiratory ciliated cells: 27.6;Rod photoreceptor cells: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044491			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Nucleoplasm, Microtubules, Cytokinetic bridge"	"HPA044491: AB_10794775"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-7)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.97e-2)"	1.6	3.9	4.3	0.8	5.2	0.0	3.4	2.3	9.4	4.9	1.2	4.5	1.7	2.8	0.8	5.0	8.2	0.7	1.9	8.5	2.3	4.9	1.6	2.7	0.3	8.4	5.9	2.6	5.2	1.3	9.9	0.7	5.5	4.2	0.6	3.1	3.5	1.4	0.7	5.2	2.7	0.5	4.7	1.3	2.0	21.8	3.5	0.7	7.5	0.1	0.1	1.9	3.1	9.5	8.3	8.1	3.8	5.8	0.7	0.6	7.2	2.1	0.7	2.6	1.6	5.2	4.8	0.8	5.4	0.8	2.7	7.0	1.8	2.0	0.5	0.0	7.2	0.1	5.8	3.4	1.3	0.0	0.8	0.5	3.2	3.3	1.4	1.3	0.8	0.4	7.7	0.0	1.1	13.4	4.6	0.0	4.0	3.4	11.4	4.3	3.0	3.2	2.1	4.1	10.9	7.7	6.2	2.1	3.8	1.4	9.0	1.2	2.0	1.9	0.1	6.6	4.5	0.0	0.1	0.3	3.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.2	2.3	9.4	8.5	2.3	8.4	5.9	5.5	4.7	3.5	9.5	0.8	3.2	2.3	34.3	0.6	3.7	0.6	1.9	2.2	7.2	5.0	3.3	1.6	0.0	2.8	3.7	20.9	0.6	0.1	7.5	0.0	2.4	3.9	31.4	2.8	1.1	0.0	0.0	41.7	2.5	0.9	1.2	1.1	6.0	0.0	6.0	0.7	1.4	0.5	3.3	33.1	4.2	4.1	0.0	0.4	3.1	2.1	0.2	5.4	1.0	0.0	3.6	0.0	15.6	30.8	1.4	7.9	8.2	0.0	1.0	3.3	1.5	27.6	24.5	6.6	2.5	2.1	8.5	11.2	2.1	3.0	0.5	0.3	3.1	5.2	0.7
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase and isoaspartyl peptidase 1"	Q7L266	11	62337448-62393412	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.7;cervix: 121.7;testis: 100.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 277.9;eosinophil: 269.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 277.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	13.8	3.7	94.2	6.5	95.4	14.4	12.0	92.5	103.5	121.7	71.7	14.2	6.8	26.4	3.1	2.1	68.1	11.2	6.2	87.1	93.3	42.5	10.2	25.8	5.6	87.5	102.7	1.8	13.4	2.3	21.2	3.2	87.6	23.8	17.1	17.8	13.2	7.2	7.3	2.9	9.5	4.4	83.4	4.7	15.1	100.5	112.7	10.3	6.7	3.0	4.7	4.3	2.0	90.0	2.4	19.5	20.9	27.2	0.1	0.0	16.4	2.3	0.8	3.6	3.5	32.0	8.5	1.9	85.2	0.3	9.3	1.8	83.9	0.7	4.2	2.6	34.4	1.2	28.1	23.5	0.6	24.0	30.8	0.8	0.2	1.6	0.4	1.3	39.4	47.8	24.5	21.5	0.9	37.5	65.3	15.9	28.5	13.6	15.2	26.1	12.5	11.8	73.3	5.9	112.3	16.1	16.4	28.2	14.4	21.2	15.0	12.1	2.0	0.4	15.4	1.2	9.5	32.8	33.6	3.0	0.8	12.3	9.7	277.9	68.6	269.5	2.8	50.8	1.9	2.4	1.0	3.3	39.7	1.5	2.3	3.4	16.3	11.5	38.5	7.2	0.8	24.2	94.2	95.4	92.5	103.5	87.1	93.3	87.5	102.7	87.6	83.4	112.7	90.0	29.2	6.4	27.8	56.8	5.2	3.4	2.5	2.2	0.6	24.4	13.8	6.6	2.4	42.9	4.1	22.0	33.3	2.3	3.2	14.0	133.1	30.3	372.5	414.6	39.9	31.2	47.2	14.1	13.9	22.3	2.4	4.0	19.9	437.1	80.9	16.6	49.2	3.7	25.0	16.8	18.6	67.4	6.1	11.4	6.4	597.6	8.7	26.9	1.8	9.4	10.5	80.8	4.1	15.1	22.0	7.8	7.5	7.2	13.9	35.4	2.9	214.1	5.4	37.1	13.1	7.7	6.1	534.3	48.6	0.1	1.3	0.8	7.8	10.8	36.0	15.9
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family AAA domain containing 5"	Q96QE3	17	30831966-30895869	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Spermatocytes: 73.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"	Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	0.7	0.4	0.3	2.1	0.2	12.3	1.2	2.6	0.5	0.8	0.1	1.2	1.4	1.0	0.4	1.3	0.7	0.5	0.4	0.3	0.2	0.4	0.5	0.8	3.6	0.2	0.1	0.9	0.5	0.3	0.5	1.4	0.3	0.6	1.6	2.5	0.7	0.4	0.4	2.5	1.4	0.6	0.1	1.4	1.1	2.0	0.3	5.3	0.6	0.1	2.9	0.6	0.9	0.6	7.2	6.0	14.0	13.3	0.3	1.4	5.5	6.3	3.2	6.9	9.8	6.6	5.1	19.5	5.9	2.9	4.7	13.0	9.1	4.7	12.4	4.4	7.9	11.7	8.0	4.6	0.2	23.1	9.2	0.6	0.6	10.1	3.5	1.4	3.6	18.7	18.7	15.9	4.6	4.2	26.1	11.5	8.2	5.3	2.9	17.6	26.4	9.3	1.8	7.6	8.1	7.2	7.0	4.0	3.7	7.6	7.6	10.2	2.8	8.3	11.3	12.0	11.4	5.2	5.9	24.0	3.6	10.7	8.4	0.4	0.2	0.3	0.3	0.3	0.2	0.3	0.1	0.2	0.1	0.4	0.2	0.2	0.6	0.6	0.1	0.5	0.3	0.1	0.3	0.2	2.6	0.5	0.3	0.2	0.2	0.1	0.3	0.1	0.3	0.6	4.3	3.2	4.1	6.8	9.9	4.7	3.1	2.6	3.4	19.3	4.7	5.1	2.7	0.0	2.6	3.7	0.0	21.7	10.7	6.6	0.0	4.1	13.9	4.4	8.5	5.4	0.0	59.3	20.4	2.9	21.1	5.4	9.7	5.1	3.8	32.6	2.9	0.7	8.7	11.8	17.4	8.6	2.0	2.8	7.4	7.8	3.7	5.7	7.2	11.2	10.0	2.9	12.3	16.6	14.9	4.0	2.4	2.2	24.4	2.4	2.3	0.5	2.7	21.3	0.0	7.4	6.5	73.3	34.5	9.3	4.5	7.9	10.5	8.4	13.0	2.3
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.1;testis: 30.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 81.6;Extravillous trophoblasts: 67.1;granulocytes: 54.1;Spermatocytes: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB001454, HPA002636"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"	"Mitotic spindle, Cytosol"	"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	1.3	2.3	1.3	10.4	1.6	15.3	2.2	2.4	1.4	1.4	0.6	10.8	11.7	1.5	0.8	7.5	1.2	2.0	5.3	0.8	1.0	2.3	5.0	2.2	20.9	1.7	1.2	8.4	2.0	1.8	0.6	8.1	1.4	1.1	12.9	3.0	1.9	1.3	8.7	3.5	9.3	4.9	1.3	5.2	4.9	30.8	1.6	20.2	1.4	8.2	22.1	2.9	2.6	1.3	179.9	127.2	84.5	61.2	4.9	10.8	106.3	145.2	66.8	339.7	142.9	361.4	124.8	58.4	96.2	59.2	176.2	142.2	152.4	96.4	360.0	52.4	57.5	102.6	128.9	229.8	2.8	140.4	140.4	5.1	10.1	117.3	104.5	26.7	80.7	93.2	121.8	45.3	146.9	182.1	85.3	108.9	78.3	145.6	129.8	62.9	163.4	65.9	56.0	46.8	73.9	39.6	200.5	228.8	94.2	77.3	137.9	86.1	47.1	149.7	145.3	83.0	208.6	62.3	78.9	100.5	80.5	80.9	127.0	0.2	3.5	4.3	1.2	5.9	1.8	2.5	2.0	1.1	3.7	0.8	0.9	0.9	2.3	1.4	3.4	0.8	4.7	1.7	1.3	1.6	2.4	1.4	0.8	1.0	1.7	1.2	1.4	1.3	1.6	1.3	2.5	0.0	2.8	0.3	7.4	1.1	1.2	5.6	0.6	1.0	4.3	6.2	5.6	1.5	2.3	3.7	2.1	34.5	8.3	8.3	1.9	4.0	33.9	2.0	2.3	3.1	6.0	81.6	1.1	4.9	67.1	7.0	13.7	3.4	54.1	12.3	3.6	2.6	17.5	1.7	1.5	10.8	2.0	3.5	7.6	16.3	1.5	11.7	0.0	1.0	12.0	3.7	3.1	1.0	2.0	5.2	2.8	0.4	10.1	2.0	5.1	4.2	1.5	2.7	6.6	2.2	7.7	168.2	30.8	8.3	1.1	8.2	8.0	8.7	15.5	1.5
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395710-231401164	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 272.8;Intestinal goblet cells: 145.2;Paneth cells: 126.4;Undifferentiated cells: 354.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.5;HEL: 15.6;THP-1: 14.0;WM-115: 23.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA013881, HPA035625, HPA035626"	Enhanced		Approved	"Golgi apparatus,Mitotic spindle,Cytosol"	"Intracellular and membrane"	Yes	NA		3600000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	"Mitotic spindle, Cytosol"	"HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (3.57e-1)"	3.1	12.9	5.9	2.8	5.1	14.2	3.8	4.0	5.8	2.5	4.6	56.2	25.2	1.9	6.8	2.9	4.6	14.0	4.7	5.6	6.5	2.2	1.2	15.3	1.6	6.0	7.0	16.7	25.4	14.3	8.8	5.4	5.3	3.2	71.2	2.1	7.5	4.4	0.4	5.0	28.4	2.3	4.3	5.1	35.6	1.3	7.3	2.4	8.4	0.3	1.5	3.7	0.6	5.4	0.7	2.8	0.3	0.6	0.1	0.2	1.0	0.2	1.1	0.1	0.1	1.4	19.5	2.2	5.8	0.3	0.2	5.1	0.2	0.0	0.1	0.3	0.5	15.6	0.5	0.9	0.1	0.1	0.8	0.1	1.4	0.2	0.3	1.1	0.2	0.4	0.5	0.4	0.1	0.9	0.2	0.7	6.3	7.7	3.3	0.3	0.1	0.4	0.6	1.7	0.5	0.8	0.3	1.7	0.7	6.9	0.6	14.0	0.2	0.4	0.4	0.2	0.2	2.3	0.9	0.7	0.3	0.2	23.7	0.7	0.1	0.7	2.9	0.5	0.5	9.9	0.1	0.4	6.5	7.0	0.1	0.7	0.2	32.1	0.6	3.1	0.2	1.0	5.9	5.1	4.0	5.8	5.6	6.5	6.0	7.0	5.3	4.3	7.3	5.4	0.9	41.7	30.2	0.3	8.7	2.3	1.7	8.7	0.0	0.4	5.2	2.5	1.1	95.8	29.7	1.8	2.1	0.6	61.7	272.8	0.0	16.1	0.4	13.3	2.2	4.7	103.0	0.4	0.5	84.3	64.9	2.3	51.5	18.5	9.5	17.3	3.3	0.2	11.2	0.0	0.4	145.2	18.3	10.1	38.6	1.2	1.5	9.7	3.6	0.0	2.9	0.5	10.3	55.3	0.2	69.8	126.4	8.2	5.5	11.6	93.2	0.4	82.2	1.8	0.0	0.5	2.3	0.9	1.4	0.0	2.7	2.1	10.0	0.4	354.6	16.2
BBS1	FLJ23590	ENSG00000174483	"Bardet-Biedl syndrome 1"	Q8NFJ9	11	66510606-66533613	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Olfaction, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.9;Excitatory neurons: 28.5;Inhibitory neurons: 28.4;Microglial cells: 14.0;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058283	Uncertain		Uncertain	Midbody		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Midbody		"HPA058283: AB_2683667"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.61e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.87e-4)"	10.5	15.2	11.5	4.9	13.0	2.9	11.9	10.8	17.8	18.9	13.9	18.0	6.5	20.7	17.7	9.0	28.0	12.6	10.1	11.6	12.7	24.2	7.0	10.4	5.1	10.2	13.5	27.5	13.5	38.0	17.9	8.2	10.1	15.8	7.3	21.4	16.8	22.0	8.1	9.6	9.4	14.1	10.5	6.0	13.8	10.5	13.3	8.0	27.1	8.2	5.0	15.4	10.9	10.7	5.7	6.0	13.7	5.4	24.9	17.2	6.3	4.8	9.6	6.3	6.0	9.5	10.1	0.8	10.0	11.5	5.6	10.6	10.1	10.6	6.8	5.2	5.8	2.5	8.9	5.3	11.7	4.7	1.8	17.7	9.7	9.7	7.1	17.8	8.9	8.5	5.5	4.3	7.8	5.1	3.7	4.1	10.4	18.0	10.5	9.2	9.0	7.4	19.3	6.4	14.0	9.3	8.1	8.7	18.6	6.6	18.7	2.5	8.7	5.0	5.7	6.0	1.6	3.1	1.5	1.4	16.3	1.3	5.4	0.0	1.5	0.2	1.8	1.6	2.6	2.2	2.5	2.0	1.2	1.1	1.7	2.2	0.9	3.1	3.0	0.5	0.8	1.9	11.5	13.0	10.8	17.8	11.6	12.7	10.2	13.5	10.1	10.5	13.3	10.7	0.5	0.0	2.2	19.9	2.5	0.5	1.3	1.6	0.6	3.9	0.9	1.0	0.5	1.5	1.1	0.0	8.4	1.6	0.5	0.6	0.0	0.8	4.1	2.3	1.8	1.3	1.2	3.0	28.5	0.4	0.6	3.1	7.1	0.9	0.0	2.9	0.7	0.3	0.6	0.0	28.4	0.7	2.0	0.9	0.7	2.6	0.9	0.5	0.0	14.0	0.8	1.7	1.0	13.6	9.0	0.4	0.5	1.5	2.5	0.8	0.4	1.7	9.2	10.8	0.0	1.5	1.6	4.9	2.6	2.2	1.0	1.0	1.4	2.0	0.9	0.9
BCL3	"BCL4, D19S37"	ENSG00000069399	"BCL3 transcription coactivator"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 172.4;Squamous epithelial cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.5;neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.3;Karpas-707: 54.1;SiHa: 69.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: AB_2680074"	"prognostic favorable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	65.1	43.6	6.7	25.0	6.3	54.0	37.2	6.4	7.8	26.8	7.9	39.7	32.2	26.8	1.7	67.5	35.9	13.4	36.3	5.9	7.2	56.6	161.8	87.3	11.6	11.6	7.8	23.7	37.4	3.1	25.2	7.9	8.1	43.4	9.3	1.3	40.9	8.9	17.8	28.3	44.2	11.7	8.0	58.7	35.9	9.6	8.5	6.6	36.8	4.9	12.7	37.6	37.7	6.4	9.8	33.5	0.7	17.5	6.1	12.6	1.7	5.8	6.3	3.7	5.3	6.9	17.8	9.5	13.4	11.5	18.5	10.5	2.4	9.9	2.3	67.3	0.6	1.1	18.9	9.3	14.6	0.7	28.2	22.5	7.8	8.1	9.9	16.6	10.0	0.0	1.2	54.1	2.2	8.4	0.0	7.4	0.9	15.1	12.8	4.3	6.5	3.4	16.5	19.9	0.0	0.9	69.7	35.7	1.9	1.1	12.7	7.6	16.8	11.8	11.6	18.5	2.2	50.1	21.4	10.1	22.1	1.2	9.2	0.4	2.7	5.5	0.8	1.8	1.1	1.5	1.0	1.3	2.6	1.3	0.5	0.7	19.8	2.3	1.1	3.1	1.7	1.0	6.7	6.3	6.4	7.8	5.9	7.2	11.6	7.8	8.1	8.0	8.5	6.4	56.3	19.2	51.3	2.6	43.9	46.7	38.8	22.4	172.4	2.3	106.8	62.0	3.0	42.9	28.6	12.9	0.0	0.6	33.4	60.6	9.8	31.8	11.8	49.4	34.2	76.3	21.5	4.2	0.5	68.7	6.8	47.8	128.0	70.0	38.0	1.4	38.9	35.5	16.1	8.4	0.8	56.2	8.2	30.5	110.8	2.7	13.4	86.6	40.9	1.0	28.4	2.2	2.1	0.0	0.1	43.0	40.0	4.5	100.4	58.9	56.6	17.7	20.5	0.6	6.6	43.3	40.1	0.5	2.0	146.0	61.1	1.4	46.2	0.3	34.5	51.2
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Protease inhibitor, Repressor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;lymphoid tissue: 41.0;testis: 19.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.7;Early spermatids: 94.1;Erythroid cells: 166.7;Extravillous trophoblasts: 162.0;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 14.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.28e-6)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	0.9	1.1	0.3	8.5	0.5	37.9	5.1	0.6	0.6	1.9	0.4	6.7	7.9	1.6	0.0	12.8	0.6	1.1	0.5	0.4	0.4	0.7	2.1	1.9	16.2	0.6	0.6	0.4	0.6	0.2	0.2	6.1	0.5	0.6	8.0	0.1	1.8	0.2	1.1	5.8	7.6	4.3	0.4	5.8	3.7	19.6	1.0	41.0	0.4	0.1	16.3	2.6	3.2	0.8	139.1	126.2	111.3	121.5	6.7	11.3	41.0	103.6	57.5	144.0	94.2	104.0	52.9	140.7	41.5	60.5	108.7	71.9	113.6	66.6	125.2	48.2	157.5	93.2	71.4	123.1	0.8	90.8	67.0	3.9	4.5	79.8	59.2	21.0	103.5	104.3	118.8	116.0	112.6	79.7	195.5	86.2	83.4	96.3	218.0	100.5	180.2	108.4	34.5	50.2	136.8	94.8	80.3	88.6	71.7	54.1	117.5	84.8	39.5	173.1	152.6	76.0	150.4	83.3	72.2	163.3	63.3	37.8	154.4	0.0	0.0	0.0	0.7	0.0	0.1	2.4	4.1	2.8	0.8	0.2	0.0	0.4	0.5	2.4	0.0	0.2	14.1	3.1	0.3	0.5	0.6	0.6	0.4	0.4	0.6	0.6	0.5	0.4	1.0	0.8	1.2	0.0	20.0	0.0	15.9	8.2	3.7	12.2	2.8	0.7	7.7	8.6	2.3	2.8	10.8	0.0	0.0	74.7	3.3	10.7	0.0	2.0	94.1	5.4	5.1	8.8	3.0	166.7	0.4	0.0	162.0	15.1	8.6	6.9	9.5	42.7	12.8	2.7	52.1	0.0	0.2	17.1	10.2	13.7	13.8	68.4	3.1	9.6	1.8	0.0	0.6	0.4	7.2	0.0	0.3	0.4	2.5	0.7	50.2	2.8	3.2	0.1	2.6	0.5	6.6	0.9	15.2	191.1	58.2	31.3	6.5	19.2	10.1	3.4	38.8	6.3
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	4.6	4.7	3.1	6.7	9.7	11.3	8.9	13.9	5.7	7.7	6.3	7.6	5.0	6.8	5.2	5.3	6.2	5.8	4.9	4.6	3.7	7.6	8.9	5.4	9.6	6.4	5.5	12.0	14.7	10.9	2.9	6.9	7.3	6.2	7.5	15.5	5.5	5.9	6.1	6.7	5.4	6.1	4.4	8.5	7.1	6.8	5.6	14.7	11.4	8.8	9.7	7.2	3.1	16.3	21.7	17.8	16.1	7.9	14.9	19.1	11.3	10.8	14.1	11.0	11.3	14.2	5.7	23.6	7.3	19.7	13.2	10.1	22.9	15.1	13.9	18.8	10.5	31.2	11.3	10.7	7.9	32.4	11.9	12.4	6.9	18.0	16.2	10.1	17.7	5.4	25.6	10.0	11.9	9.3	15.5	7.5	11.7	9.2	10.5	14.6	26.6	8.2	9.2	23.4	11.7	18.4	18.6	10.8	8.2	12.5	6.4	11.5	28.7	13.0	13.3	9.1	15.3	13.9	20.0	30.6	10.1	15.1	8.7	9.7	0.9	0.6	1.3	0.7	1.8	0.8	1.0	1.2	0.7	1.8	1.1	1.4	1.5	1.6	1.5	1.6	1.0	0.5	3.1	9.7	13.9	5.7	4.6	3.7	6.4	5.5	7.3	4.4	5.6	16.3	53.9	32.1	30.5	239.3	74.8	46.0	28.6	34.7	41.5	60.8	40.0	23.4	45.8	38.6	42.7	36.8	191.8	35.0	93.4	70.1	1.9	26.9	45.9	39.3	58.0	49.8	32.5	34.3	272.0	31.2	22.0	39.7	68.3	63.1	29.9	52.1	45.7	47.5	29.8	69.0	291.3	43.3	26.4	54.7	60.0	17.6	45.4	59.1	23.2	202.4	67.2	34.9	64.9	231.8	361.3	34.3	30.3	59.0	70.9	46.4	48.5	22.6	30.6	88.2	39.5	56.0	49.1	53.7	46.2	49.7	54.8	38.0	72.4	52.8	45.3	44.0
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1 ribosome biogenesis factor"	Q14692	10	42782795-42834937	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Mitotic chromosome"		"HPA036589: AB_10601460, HPA043081: AB_2678305"	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	8.1	8.3	6.5	8.9	7.2	10.7	8.5	8.6	8.2	8.2	8.5	7.7	6.3	8.2	6.8	9.6	7.3	5.1	9.0	6.1	7.8	8.1	8.1	7.6	10.0	7.4	7.8	8.4	8.8	11.4	7.6	8.2	7.7	7.3	7.9	6.5	8.8	6.9	17.7	10.2	7.8	7.7	6.5	8.7	7.4	8.1	7.0	9.6	7.2	13.4	10.8	10.1	8.3	7.2	32.0	26.7	25.3	29.0	18.8	15.5	24.5	26.1	27.5	30.3	25.9	37.1	24.4	16.9	18.1	22.7	17.0	27.3	42.0	33.8	39.4	24.7	29.3	22.7	20.7	31.9	16.2	61.7	20.4	13.9	16.9	32.7	31.5	16.9	23.2	19.4	40.4	17.7	21.8	27.1	34.6	20.3	32.3	22.0	28.0	31.3	26.7	18.1	16.8	27.7	19.3	20.4	22.9	25.1	21.7	26.2	30.6	17.6	28.3	14.0	50.7	28.4	43.2	14.1	18.7	48.5	20.5	44.9	11.0	3.8	4.6	2.7	7.2	8.2	8.5	8.7	8.9	7.9	7.5	6.1	9.6	8.3	0.6	6.1	7.1	3.9	6.9	5.3	6.5	7.2	8.6	8.2	6.1	7.8	7.4	7.8	7.7	6.5	7.0	7.2	25.6	32.1	33.1	19.6	29.7	22.9	33.9	28.4	14.2	20.7	18.8	17.1	48.0	20.0	37.4	23.9	10.4	27.7	23.6	10.2	21.5	32.3	14.6	28.8	34.5	31.3	16.8	19.5	31.4	34.9	30.0	26.4	16.3	30.0	22.1	36.8	21.4	18.6	19.7	21.9	28.8	11.5	22.4	15.3	22.6	12.1	23.6	19.9	33.8	10.3	35.2	12.8	24.7	20.1	24.0	38.2	8.9	16.6	31.3	32.2	8.8	30.1	49.5	28.7	19.7	35.3	31.4	40.3	56.1	17.1	25.4	24.9	25.3	33.5	18.7	41.4
BOP1	KIAA0124	ENSG00000261236	"BOP1 ribosomal biogenesis factor"	Q14137	8	144262045-144291438	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 223.5"	"Low region specificity"	"Detected in all"							"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	18.1	17.8	6.8	8.8	6.9	9.7	16.3	7.7	10.9	16.1	3.5	17.3	5.6	18.2	1.0	26.0	13.2	2.8	24.4	7.6	5.5	16.7	21.5	13.3	8.0	7.1	6.0	11.1	32.0	5.6	16.9	3.7	6.5	15.3	1.9	1.1	13.2	3.1	76.6	21.4	14.9	3.1	4.7	20.4	15.4	20.1	6.2	5.4	17.0	8.1	3.6	19.3	16.5	6.1	45.0	87.4	11.8	50.6	6.4	7.7	41.4	30.5	6.5	30.3	19.1	66.3	25.4	54.1	50.1	11.6	11.5	34.9	21.2	36.2	6.9	47.8	82.5	68.4	54.4	49.7	15.1	30.8	35.6	15.5	17.0	25.2	22.1	5.7	18.8	48.3	70.1	18.1	11.9	112.8	82.4	37.6	28.3	45.1	223.5	61.4	17.6	82.2	12.5	30.1	64.7	25.8	32.5	41.9	20.3	5.5	30.6	27.7	36.6	27.8	83.3	37.1	88.5	16.5	11.7	45.6	20.3	48.6	36.7	0.0	2.2	1.3	1.9	2.3	2.1	2.5	2.2	2.5	3.0	1.8	2.0	1.8	0.1	1.8	2.0	2.0	2.0	1.2	6.8	6.9	7.7	10.9	7.6	5.5	7.1	6.0	6.5	4.7	6.2	6.1	12.8	9.6	5.1	3.9	16.7	0.5	18.7	0.0	13.1	9.8	12.7	13.8	7.2	10.0	3.7	11.0	0.0	25.2	20.9	18.7	5.9	25.8	11.2	7.5	10.7	12.0	26.9	22.1	4.4	21.7	45.3	13.2	17.3	8.3	10.2	13.5	4.6	14.8	21.5	15.2	3.5	11.5	0.0	11.1	0.0	24.3	10.5	12.8	0.0	1.0	16.2	16.7	18.6	5.0	2.8	26.4	11.3	9.8	25.4	39.5	11.3	17.2	1.5	4.6	13.1	12.9	15.1	13.9	53.4	25.7	0.1	17.8	11.8	29.6	31.8	14.3
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"Biogenesis of ribosomes BRX1"	Q8TDN6	5	34915677-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039614			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Mitotic chromosome"		"HPA039614: AB_10963698"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.6	17.1	13.3	17.6	13.8	37.1	24.7	15.2	18.7	15.1	12.8	15.6	12.9	17.4	17.8	17.7	16.1	12.2	14.7	13.2	14.1	15.1	18.5	13.0	26.4	13.7	13.6	18.5	13.7	18.2	9.5	25.7	13.8	15.7	17.1	11.6	12.9	14.5	10.4	14.6	12.8	16.1	13.9	14.3	13.1	13.9	13.5	20.7	15.8	12.2	25.8	30.1	12.3	15.2	66.1	57.0	64.2	87.1	26.0	37.8	121.6	74.9	52.7	100.0	63.5	74.5	81.0	138.8	38.7	45.5	113.5	52.1	108.5	79.8	117.3	75.1	101.3	93.9	125.7	71.9	67.4	150.8	63.8	44.4	49.8	93.3	85.9	31.0	48.5	72.9	158.4	43.8	66.2	63.6	108.3	163.9	101.0	75.2	86.8	94.6	112.5	60.5	59.3	70.7	75.1	68.8	157.6	109.7	76.1	50.0	66.4	92.7	28.4	78.7	87.5	58.1	151.0	39.3	87.7	177.6	66.3	171.3	100.3	15.0	21.4	10.0	34.5	21.0	50.1	63.7	43.2	44.3	27.8	49.9	53.3	46.6	1.2	43.7	30.6	37.5	43.5	44.6	13.3	13.8	15.2	18.7	13.2	14.1	13.7	13.6	13.8	13.9	13.5	15.2	35.5	28.9	30.7	8.5	40.0	108.7	114.3	110.2	55.2	20.8	27.3	41.3	23.2	25.8	63.0	23.9	12.5	127.1	37.0	13.5	49.0	52.5	24.8	29.9	45.1	40.6	21.0	45.2	11.9	42.7	100.6	44.4	19.4	31.6	20.2	30.0	20.0	11.9	42.7	21.9	13.4	19.0	63.1	10.7	20.1	8.4	39.4	18.4	32.0	4.7	31.1	22.3	21.6	10.6	13.6	44.7	13.1	29.0	21.4	70.9	9.9	37.9	45.8	37.2	6.6	54.3	55.7	59.9	77.6	46.0	95.8	126.1	37.1	31.7	31.9	85.1
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921499-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	10.7	10.1	6.0	8.2	6.1	7.4	8.8	5.7	6.2	6.4	5.8	6.8	4.7	8.2	5.4	9.2	8.5	5.4	7.2	6.1	6.7	6.5	10.7	5.1	8.4	6.0	6.7	8.1	11.6	6.5	3.6	10.0	6.9	6.8	7.0	2.5	4.8	6.5	20.1	8.0	4.0	11.9	5.9	5.8	5.5	7.9	6.6	12.2	5.2	10.8	13.2	15.4	5.9	6.2	50.6	52.1	30.2	54.2	21.8	25.5	59.7	44.0	21.6	66.7	48.9	72.1	15.7	78.2	43.9	32.9	51.9	34.3	91.6	61.0	58.0	30.1	89.2	72.7	37.3	81.5	38.6	58.8	36.0	30.1	39.5	67.2	62.1	16.9	50.5	47.3	96.1	26.0	48.7	70.8	74.2	68.3	29.0	162.4	50.9	77.9	38.2	57.3	45.2	37.9	65.6	37.4	30.0	37.8	58.2	26.3	38.0	58.6	39.3	49.0	53.5	31.4	77.2	24.6	33.0	185.8	14.5	57.9	49.9	0.0	3.8	0.7	4.3	3.9	5.9	3.8	2.5	3.5	6.0	5.5	1.6	3.3	0.5	6.1	3.0	9.2	3.3	2.3	6.0	6.1	5.7	6.2	6.1	6.7	6.0	6.7	6.9	5.9	6.6	6.2	6.4	0.0	3.9	0.7	6.7	31.0	34.5	19.2	8.6	2.8	8.6	8.5	2.8	5.7	9.5	1.8	4.2	22.1	4.8	4.6	3.9	21.4	10.4	7.9	12.1	10.9	5.4	6.3	2.8	17.5	24.4	11.4	4.6	9.8	2.5	11.4	3.9	6.8	12.0	0.0	2.5	6.5	12.2	1.0	7.3	6.8	8.1	5.1	8.8	1.9	6.6	4.4	9.2	4.0	2.8	23.5	2.9	7.2	4.9	26.2	2.2	10.5	5.1	3.4	6.6	16.1	13.8	10.8	25.7	14.0	25.3	29.1	4.1	18.2	11.4	32.2
C12orf66	FLJ32549	ENSG00000174206	"Chromosome 12 open reading frame 66"	Q96MD2	12	64186316-64222296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046743, HPA052855"	Uncertain		Supported	"Lysosomes,Cytokinetic bridge"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	Lysosomes	"Cytokinetic bridge"	"HPA046743: AB_2679782, HPA052855: AB_2681973"	"unprognostic (7.44e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.07e-2)"	2.9	4.2	3.6	3.4	5.3	1.7	5.4	4.0	4.8	2.8	1.9	2.8	3.1	2.6	4.8	4.2	3.9	2.5	2.3	3.5	4.3	5.5	8.6	2.8	4.9	4.0	4.4	3.9	5.2	5.7	2.6	2.1	4.5	2.3	3.1	1.6	2.9	2.3	4.4	5.6	2.5	2.3	3.7	5.0	3.0	3.4	4.3	3.3	5.6	3.2	4.8	2.6	3.0	6.8	5.5	8.7	1.6	4.7	4.3	7.2	4.5	3.0	3.7	4.4	2.7	2.7	4.3	17.4	4.1	2.4	7.1	6.3	6.9	5.3	4.7	13.3	4.6	6.3	2.1	2.5	5.6	6.9	3.6	5.6	9.0	5.7	10.3	5.0	3.2	12.0	8.8	11.3	4.4	10.6	7.9	6.0	7.7	6.5	6.8	4.0	4.9	13.4	6.6	6.4	3.8	3.8	4.9	6.7	4.8	4.2	10.8	4.4	2.5	4.4	2.9	4.4	2.9	14.9	13.2	9.7	6.6	5.9	5.0	0.5	2.6	0.2	3.3	2.6	5.7	8.5	6.4	5.0	4.3	7.2	8.7	8.4	0.2	4.0	1.8	3.1	10.8	4.2	3.6	5.3	4.0	4.8	3.5	4.3	4.0	4.4	4.5	3.7	4.3	6.8	3.4	3.2	2.7	5.5	9.3	2.4	8.8	3.4	7.4	2.1	5.9	4.1	2.7	7.2	5.5	9.2	2.1	6.3	4.0	1.9	9.8	4.1	9.2	3.3	4.0	3.9	4.2	3.4	7.1	5.2	3.9	3.5	7.1	3.6	1.3	3.6	1.8	10.8	4.9	0.0	5.5	2.7	4.1	6.3	2.6	7.3	4.7	4.3	1.8	1.0	2.1	2.5	1.0	3.5	17.4	2.6	2.6	1.9	2.8	4.7	2.1	12.9	2.4	1.6	0.0	7.4	2.8	4.4	8.8	6.9	4.3	1.8	5.8	4.3	3.7	4.3
C17orf100	LOC388327	ENSG00000256806	"Chromosome 17 open reading frame 100"	A8MU93	17	6651762-6693202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.9;Late spermatids: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.0;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA046824			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA046824: AB_2679825"	"unprognostic (9.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.65e-2)"	0.9	1.6	4.1	1.7	4.9	0.5	1.5	3.3	4.8	1.9	2.2	1.6	3.0	1.6	2.2	4.3	2.0	1.1	0.6	3.5	4.5	2.4	3.6	1.2	3.2	3.2	3.7	1.3	4.5	3.5	9.5	0.8	3.2	2.5	1.5	5.3	2.8	1.0	0.6	7.3	3.0	0.8	3.4	2.9	2.4	5.5	4.1	1.7	3.3	0.8	1.2	1.9	2.3	3.9	1.1	2.1	4.6	1.5	0.7	1.3	2.2	0.6	3.4	1.4	2.7	3.2	1.5	1.3	2.3	1.1	3.6	4.1	0.9	2.2	2.0	5.6	6.3	1.2	2.4	10.0	1.6	0.2	3.2	1.8	2.1	0.7	1.5	4.1	0.8	6.7	1.6	1.2	1.8	2.4	1.4	2.1	0.6	1.9	1.4	2.6	0.8	2.0	2.9	1.0	4.8	9.4	2.9	0.3	3.4	1.4	2.5	0.3	1.3	1.3	2.6	0.8	1.1	1.7	1.2	0.8	1.1	0.4	3.1	3.9	0.9	4.0	1.2	1.3	1.6	2.3	2.2	1.4	1.6	2.5	2.5	1.4	0.8	1.4	1.3	0.5	1.5	0.9	4.1	4.9	3.3	4.8	3.5	4.5	3.2	3.7	3.2	3.4	4.1	3.9	1.7	0.0	1.7	0.0	3.2	2.8	5.4	4.8	8.0	3.8	4.9	5.0	0.4	0.0	4.9	0.0	2.1	1.7	0.6	3.8	1.9	4.1	32.9	3.0	3.0	1.8	7.7	1.3	1.4	3.2	1.8	1.6	4.1	2.9	8.9	4.7	0.0	0.0	1.2	1.7	1.4	7.1	10.2	0.0	1.3	48.7	0.9	0.7	1.8	1.0	1.2	5.1	1.0	1.5	2.2	3.3	2.6	1.9	0.9	4.5	9.0	2.1	2.4	5.8	6.6	1.9	3.0	16.4	4.6	7.0	3.0	1.5	1.7	3.8	3.9	5.1
C1orf159	FLJ20584	ENSG00000131591	"Chromosome 1 open reading frame 159"	Q96HA4	1	1081818-1116361	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.9;Late spermatids: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010019, HPA075399"	Approved		Approved	"Nucleoli rim,Mitotic chromosome,Intermediate filaments"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim, Mitotic chromosome"	"Intermediate filaments"	"HPA010019: AB_1078885, HPA075399: "	"unprognostic (2.79e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (1.34e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.62e-4)"	4.0	4.8	9.6	1.6	8.0	2.4	3.8	0.9	10.4	5.3	3.2	6.1	1.8	4.2	1.1	8.6	4.8	2.2	4.3	9.4	1.0	7.7	6.7	3.9	1.8	6.3	2.7	4.3	3.7	0.7	5.3	1.4	2.8	6.9	0.6	1.6	4.6	2.3	2.2	5.0	4.1	0.5	0.7	5.5	6.0	22.9	5.4	1.8	4.5	0.3	0.9	5.5	5.9	6.9	15.7	12.0	5.6	10.0	1.5	1.6	13.3	9.0	2.1	7.8	5.1	6.5	14.7	4.3	10.8	2.8	6.4	12.2	2.5	7.1	2.2	8.6	18.2	3.1	19.6	7.0	3.6	5.5	7.3	3.2	2.8	3.3	1.6	2.3	3.8	6.4	18.6	3.1	2.8	11.9	10.2	13.2	4.7	5.9	19.7	12.0	6.7	8.5	4.7	4.7	11.8	16.1	6.8	12.2	7.6	1.6	7.8	6.5	5.2	8.3	8.8	11.9	9.2	5.6	8.3	7.8	6.8	14.9	6.5	8.1	2.6	1.4	2.6	2.6	2.8	2.5	2.5	3.0	1.7	2.2	2.5	2.6	0.5	2.7	1.8	2.2	0.9	2.3	9.6	8.0	0.9	10.4	9.4	1.0	6.3	2.7	2.8	0.7	5.4	6.9	6.3	0.0	7.7	20.2	3.4	7.5	3.6	6.2	4.6	5.9	8.9	6.6	2.3	5.7	7.1	9.2	4.2	5.0	4.9	13.6	1.9	8.2	60.9	8.6	8.2	4.4	4.2	5.2	26.5	7.0	14.0	4.2	20.4	9.0	5.7	9.0	3.3	5.3	3.9	13.5	21.8	7.4	6.1	1.0	4.8	124.1	2.8	3.9	3.6	2.8	6.0	3.2	9.2	10.6	24.5	7.8	3.5	1.5	6.9	5.1	3.4	1.8	10.4	8.2	0.0	3.5	4.8	18.3	6.8	4.2	7.0	4.9	4.6	4.4	9.4	4.9
C21orf91	"C21orf14, C21orf38, CSSG1, EURL, YG81"	ENSG00000154642	"Chromosome 21 open reading frame 91"	Q9NYK6	21	17788974-17819386	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 345.8;Late spermatids: 98.6;Oligodendrocytes: 103.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 111.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018288, HPA049030"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Microtubules	"Cytokinetic bridge"	"HPA018288: AB_1845710, HPA049030: AB_2680605"	"unprognostic (3.28e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.51e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.90e-3)"	6.3	4.8	11.5	9.8	26.7	8.2	8.2	22.0	16.3	6.2	4.4	4.7	5.1	9.2	4.3	8.3	6.7	6.0	5.4	13.3	15.5	5.3	8.7	7.9	15.4	26.0	21.2	8.0	2.8	4.9	2.7	13.5	26.6	5.3	5.2	5.7	5.0	3.6	2.7	18.9	5.5	7.6	20.9	9.8	6.3	24.4	20.7	19.2	5.7	5.5	13.0	8.3	4.1	59.0	7.2	1.2	15.6	0.1	3.9	7.3	6.9	10.4	18.6	10.1	8.9	6.5	3.7	25.2	5.1	4.2	14.1	5.7	17.1	13.4	8.7	27.5	9.2	16.9	13.2	4.1	8.8	20.6	9.2	5.3	14.6	13.3	21.5	7.1	2.8	10.3	12.1	107.9	7.7	4.5	28.8	6.1	16.4	1.7	5.7	21.9	29.9	10.2	6.8	12.0	6.2	14.4	13.1	10.1	47.2	7.0	6.1	11.6	4.8	44.2	13.8	0.2	6.8	28.6	37.7	21.5	3.5	18.9	17.3	111.1	11.2	56.8	20.9	11.9	29.8	14.0	19.3	22.7	13.9	11.7	14.9	19.7	24.9	20.7	12.2	3.5	36.9	12.0	11.5	26.7	22.0	16.3	13.3	15.5	26.0	21.2	26.6	20.9	20.7	59.0	20.2	19.2	11.1	1.6	26.4	27.9	10.1	57.9	63.2	12.6	14.4	10.4	7.4	4.3	27.1	5.5	16.7	17.3	18.8	4.4	1.9	4.8	345.8	14.5	13.8	21.3	10.7	5.5	0.8	6.9	12.2	12.0	9.2	14.4	39.9	11.3	7.5	6.8	5.8	15.2	0.8	5.0	18.3	7.2	14.0	98.6	23.6	9.7	21.4	3.7	30.7	3.5	48.4	7.5	103.4	4.4	5.9	17.0	27.6	11.0	3.4	6.4	19.3	13.0	6.6	20.1	12.1	38.7	24.1	21.4	27.6	80.2	38.9	22.1	3.8	7.7
C9orf72	"DENND9, DENNL72, MGC23980"	ENSG00000147894	"C9orf72-SMCR8 complex subunit"	Q96LT7	9	27535640-27573866	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 24.3;classical monocyte: 32.0;intermediate monocyte: 44.7;myeloid DC: 25.2;neutrophil: 34.3;non-classical monocyte: 36.9"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.2;granulocytes: 34.3;monocytes: 44.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Intracellular and membrane"	Yes	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	11.7	12.1	9.5	16.6	9.5	25.3	9.4	21.0	12.5	9.8	12.4	8.8	6.8	12.0	11.3	7.6	16.0	10.2	9.3	9.7	13.5	7.0	16.0	17.7	9.2	14.6	11.9	24.2	9.6	6.9	16.2	12.1	12.5	14.2	7.8	31.3	6.7	5.8	14.9	8.8	8.3	8.6	12.4	16.8	7.8	17.6	11.3	11.1	13.1	9.9	8.8	9.2	8.5	14.5	4.4	3.7	28.7	4.4	5.7	7.0	4.4	5.9	4.9	3.5	1.8	0.4	1.4	10.2	3.7	5.3	7.5	3.1	9.4	7.2	2.5	19.8	3.6	4.9	11.0	3.0	8.9	3.4	5.2	7.3	8.6	0.8	16.1	3.5	7.6	11.1	9.8	18.6	4.3	0.8	6.6	5.0	14.2	6.8	16.0	2.4	9.5	5.1	2.8	3.3	9.9	24.4	4.0	4.4	3.7	10.9	3.7	2.9	6.6	0.0	14.5	8.6	4.0	4.8	15.8	6.8	11.4	11.0	3.8	24.3	32.0	2.4	1.9	44.7	3.3	3.4	2.7	2.5	25.2	2.5	4.6	2.9	34.3	4.3	36.9	3.9	4.0	10.0	9.5	9.5	21.0	12.5	9.7	13.5	14.6	11.9	12.5	12.4	11.3	14.5	15.4	16.0	14.7	19.2	43.2	35.9	50.7	15.0	26.2	22.1	7.2	6.6	15.6	4.3	15.2	7.3	20.9	21.2	11.7	5.0	1.9	8.4	2.6	94.4	11.8	15.0	11.4	3.0	53.0	9.3	7.3	18.7	16.8	57.6	16.5	18.4	8.2	9.3	25.8	11.8	58.9	12.5	10.2	71.9	127.8	4.2	6.2	94.8	19.6	42.2	58.2	45.2	3.1	30.2	60.9	8.6	11.1	3.8	10.7	30.0	4.1	5.4	80.7	27.5	0.0	17.5	20.6	29.2	20.9	15.2	29.1	34.6	18.2	7.9	5.1	37.6
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49869935	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 91.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.2;Early spermatids: 6.3;Excitatory neurons: 32.7;Inhibitory neurons: 27.0;Late spermatids: 7.8"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.6;CACO-2: 6.1;HAP1: 10.3;NTERA-2: 34.1;RPMI-8226: 6.9;SCLC-21H: 17.7;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	0.0	0.8	66.5	0.0	91.8	0.0	0.0	0.0	84.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	19.0	0.1	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	0.1	0.0	12.9	0.0	0.1	2.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.2	7.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	0.1	0.9	0.2	34.1	0.0	0.2	1.3	0.0	6.9	0.0	0.0	17.7	8.3	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.5	91.8	0.0	84.9	73.3	19.0	0.2	8.7	0.0	12.9	37.2	39.2	0.0	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	12.2	0.1	0.1	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.2	0.0	32.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	27.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	4.7	0.0	0.2	0.0	2.5	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.3	0.0	0.0	0.1	0.0
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 105.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 339.9;Rod photoreceptor cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favorable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	6.7	7.4	12.5	5.5	12.7	10.3	5.4	12.7	12.6	9.2	2.5	7.4	3.2	7.5	5.2	20.0	7.7	5.2	7.8	14.1	9.8	5.1	4.3	6.8	5.8	8.3	9.3	10.7	7.9	6.1	8.7	5.2	8.8	6.2	3.5	105.5	7.5	6.5	32.8	10.4	4.4	6.9	5.6	5.3	5.0	18.1	11.5	11.1	4.4	17.5	6.9	7.4	11.7	11.6	15.4	22.3	36.0	25.5	8.2	7.1	17.6	12.2	10.2	13.0	9.8	19.7	13.2	7.1	17.0	15.4	16.7	30.8	19.0	13.2	9.7	24.0	10.5	10.3	24.9	9.9	12.4	18.0	14.8	9.5	16.3	16.6	22.6	12.3	14.8	15.5	21.4	15.0	17.1	27.5	16.8	11.0	20.4	18.2	15.8	32.5	29.7	17.4	12.8	18.7	39.1	38.2	15.6	11.2	17.0	11.7	15.9	14.6	18.3	24.6	19.0	18.3	20.9	7.3	14.7	19.2	16.0	12.0	14.5	1.5	0.3	0.0	0.2	0.4	0.4	0.6	0.4	0.3	0.2	0.1	0.3	0.4	0.1	0.2	0.3	0.2	0.3	0.3	12.5	12.7	12.7	12.6	14.1	9.8	8.3	9.3	8.8	5.6	11.5	11.6	6.3	6.4	3.9	31.6	5.5	22.7	17.4	10.8	9.6	34.4	11.8	9.8	14.0	4.3	15.7	3.7	339.9	12.6	5.8	4.5	0.0	11.8	13.1	41.5	13.2	8.8	12.6	6.6	37.7	8.9	3.5	6.6	8.2	32.4	6.3	20.4	7.5	8.2	10.3	16.8	34.1	4.4	10.2	8.1	13.5	15.8	5.9	11.7	12.4	25.3	12.2	19.2	4.1	27.2	35.9	15.7	3.0	6.0	11.9	14.2	2.7	4.3	37.1	236.1	13.1	16.8	11.7	24.4	34.4	35.2	31.7	5.6	6.5	15.6	4.5	24.8
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666737-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA052637: AB_2681894, HPA053914: AB_2682306"	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	8.2	9.5	13.8	12.3	13.7	17.7	7.6	13.5	17.5	10.7	14.2	9.3	11.4	7.5	5.5	23.1	7.8	6.1	6.5	13.7	13.8	10.2	10.8	7.7	16.3	14.4	14.3	6.7	8.2	7.0	6.2	7.7	14.7	11.7	5.8	2.8	9.9	6.4	7.7	22.8	10.7	6.0	13.4	15.6	8.8	10.4	14.5	11.8	7.8	4.5	11.5	9.8	13.8	14.3	38.0	62.8	21.5	35.3	13.9	13.1	35.2	41.6	19.7	53.0	30.6	55.1	22.8	33.8	22.4	21.2	36.6	47.9	34.5	43.8	30.6	19.4	51.7	51.6	30.1	48.0	20.7	46.6	37.5	19.8	26.3	47.6	26.3	14.6	37.4	41.1	53.3	19.1	28.3	34.5	45.7	56.6	46.9	32.9	59.8	55.4	34.6	24.1	19.8	29.6	45.1	57.7	41.1	87.8	37.1	28.9	58.8	48.3	27.8	82.0	53.5	34.9	65.9	53.1	28.7	36.8	30.8	42.9	48.8	2.2	7.7	11.7	11.5	9.6	6.3	10.4	8.7	8.8	7.5	13.2	9.2	8.8	3.3	13.1	11.9	12.9	9.8	5.9	13.8	13.7	13.5	17.5	13.7	13.8	14.4	14.3	14.7	13.4	14.5	14.3	17.9	22.4	17.0	5.9	29.8	31.7	22.8	19.7	74.6	6.8	17.4	13.7	6.7	15.7	20.9	12.9	2.1	25.7	31.5	19.7	19.6	25.2	1.7	26.5	32.9	20.3	7.2	37.5	4.5	21.4	41.0	16.5	29.0	29.4	19.6	28.1	15.4	11.8	24.3	18.5	4.6	17.0	14.2	12.9	11.5	1.7	13.7	16.8	16.0	4.7	24.2	13.8	37.0	4.0	5.0	35.2	16.0	13.5	25.7	40.0	12.4	15.9	21.6	9.1	6.6	13.7	22.3	30.8	44.9	57.0	34.4	20.8	29.7	22.8	22.4	24.2
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621837	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	2.7	3.1	3.8	3.6	3.7	3.0	5.2	3.7	4.3	4.8	4.2	4.0	3.0	4.1	5.3	2.5	5.7	3.4	2.9	3.7	4.2	4.1	2.0	3.6	4.9	3.8	3.7	6.0	3.3	5.4	4.5	3.3	3.9	4.0	4.1	7.8	3.3	3.6	4.5	2.5	2.8	4.9	3.8	4.3	3.2	3.7	3.7	5.1	4.9	2.6	4.9	3.7	3.1	3.8	5.6	2.0	5.8	3.7	8.9	5.2	4.6	6.8	6.4	9.1	7.8	4.3	4.3	15.6	1.6	3.8	5.8	2.8	3.4	6.5	10.1	5.6	4.0	9.5	9.0	4.6	6.2	12.8	3.3	4.9	8.8	7.7	5.1	8.0	6.0	7.7	9.3	2.4	7.2	4.7	10.0	7.5	9.7	4.8	7.5	3.4	5.2	8.6	5.3	1.9	2.2	4.2	8.7	5.5	5.2	4.9	1.9	5.2	3.1	6.6	5.2	6.3	9.9	4.7	5.3	8.0	4.9	14.3	5.5	10.0	1.5	3.5	4.1	2.0	5.4	2.7	7.0	5.0	1.1	1.6	8.0	5.8	0.3	5.1	2.4	1.0	14.8	2.6	3.8	3.7	3.7	4.3	3.7	4.2	3.8	3.7	3.9	3.8	3.7	3.8	39.7	22.4	22.6	42.7	41.3	28.2	20.1	30.5	15.9	68.5	18.5	21.0	30.5	30.0	29.0	22.0	108.4	23.0	51.5	7.7	29.4	23.7	202.5	58.1	33.5	28.8	21.0	40.8	93.2	10.5	14.6	29.9	18.8	13.9	34.2	38.3	37.9	8.5	18.4	52.2	95.8	11.4	22.4	35.8	27.9	109.6	54.0	20.7	26.6	51.5	56.1	36.8	105.0	70.9	96.7	14.1	9.8	47.8	28.1	25.5	11.5	20.3	51.5	111.5	32.9	38.6	30.9	55.8	46.8	12.1	29.5	16.4	51.7	33.6	14.5	11.4
CCDC7	"BIOT2, C10orf68, FLJ13031, FLJ32762"	ENSG00000216937	"Coiled-coil domain containing 7"	Q96M83	10	32446140-32882874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"brain: 28.1;testis: 78.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 489.6;Late spermatids: 914.3;Oligodendrocytes: 161.0;Spermatocytes: 176.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA075536			Approved	"Nucleoli,Mitotic spindle,Cytosol"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli	"Mitotic spindle, Cytosol"	"HPA075536: AB_2686755"	"unprognostic (3.43e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.65e-5)"	"unprognostic (6.95e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.95e-5)"	"unprognostic (7.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	1.0	1.2	10.9	0.9	20.3	2.4	1.3	28.1	14.5	1.4	0.0	1.1	1.2	1.3	1.5	1.2	0.8	1.1	1.1	3.1	8.9	1.1	0.7	1.2	1.6	13.7	9.1	1.5	1.5	0.8	1.7	0.9	17.0	1.1	1.5	3.0	0.8	1.3	0.7	0.7	1.0	1.2	10.7	1.1	1.2	78.0	15.6	0.8	1.9	0.6	1.4	0.8	1.0	23.7	1.4	1.5	0.4	1.8	1.2	0.9	0.6	1.2	0.4	0.4	1.2	0.3	2.0	1.0	0.6	0.8	1.1	0.6	0.7	0.7	1.6	3.6	0.2	0.5	1.3	0.4	2.1	0.6	0.9	0.8	0.3	0.8	0.3	0.8	0.5	1.6	0.8	3.4	1.5	0.2	0.4	0.3	0.4	0.7	1.4	0.9	1.9	0.1	1.2	0.3	0.9	1.0	0.2	0.2	0.9	0.5	1.0	0.8	2.0	1.0	1.2	1.3	0.7	1.1	0.8	1.0	1.3	4.0	0.6	0.0	0.3	0.0	1.7	0.2	1.7	1.2	2.7	1.5	0.1	0.6	2.9	2.0	0.0	1.8	0.1	1.0	2.0	0.3	10.9	20.3	28.1	14.5	3.1	8.9	13.7	9.1	17.0	10.7	15.6	23.7	7.4	6.4	8.6	87.8	4.8	1.9	1.1	0.5	2.2	8.9	4.1	3.9	7.2	0.0	3.0	1.8	4.2	0.7	6.2	2.0	1.9	4.6	489.6	5.0	6.1	3.5	3.0	2.1	84.3	3.4	1.1	3.7	4.1	5.4	12.6	7.0	0.0	0.0	1.7	0.0	103.3	2.8	0.0	0.0	1.2	914.3	9.6	3.1	1.8	93.7	2.4	3.5	4.1	96.0	161.0	2.8	0.5	7.2	3.8	0.5	2.4	1.1	1.1	23.1	13.1	6.0	3.6	176.0	9.4	1.3	1.1	0.1	8.6	4.6	2.1	0.6
CCDC85C		ENSG00000205476	"Coiled-coil domain containing 85C"	A6NKD9	14	99500190-99604207	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058346, HPA061922"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Cell Junctions"	"Nucleoplasm, Nuclear bodies, Mitotic chromosome"	"HPA058346: AB_2683686, HPA061922: "	"unprognostic (7.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (5.70e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.68e-3)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.14e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.81e-3)"	5.2	22.0	26.4	4.3	32.9	9.7	7.1	72.9	27.1	5.8	20.6	31.3	18.7	15.4	14.3	28.3	11.3	5.4	19.6	24.8	20.9	14.4	18.2	8.1	2.5	30.8	24.1	5.1	18.5	16.4	17.0	8.6	27.0	15.0	11.1	34.7	26.4	16.2	20.7	19.4	17.7	13.1	24.5	3.6	19.2	8.5	28.6	5.0	9.3	5.6	7.5	16.1	8.9	21.0	48.4	43.4	52.7	31.7	0.7	0.2	48.9	16.0	16.2	31.4	18.1	52.9	49.8	0.3	61.7	18.2	8.6	63.3	39.2	38.4	19.5	79.2	23.3	2.5	43.6	36.1	4.2	0.5	4.9	0.1	19.9	9.0	25.9	18.6	9.9	27.9	11.8	7.2	3.9	80.3	21.8	6.6	19.3	55.4	44.7	32.1	22.1	10.8	22.3	18.8	26.0	32.6	40.7	21.5	9.5	19.9	46.9	9.8	22.6	6.2	51.5	22.4	16.2	11.2	15.8	0.4	1.0	4.3	4.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.4	0.1	26.4	32.9	72.9	27.1	24.8	20.9	30.8	24.1	27.0	24.5	28.6	21.0	8.5	22.4	5.6	15.7	6.7	8.8	8.7	4.0	13.6	35.2	12.1	9.3	3.0	5.7	7.3	1.8	62.6	6.3	3.9	21.2	0.0	7.6	3.1	18.8	8.1	9.2	9.6	3.4	2.8	9.4	4.5	6.2	17.3	35.6	6.3	14.1	5.3	16.7	1.8	1.7	5.4	9.6	6.1	1.6	1.2	2.1	0.6	5.0	8.8	4.7	0.4	30.6	1.0	1.5	11.7	17.4	13.2	0.7	10.4	11.0	23.3	6.5	3.0	51.7	0.0	5.7	4.1	1.4	3.5	20.4	14.1	4.9	8.3	2.3	13.0	12.0
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842113-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 377.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	25.6	26.7	12.0	14.3	13.3	10.2	20.8	13.1	14.2	12.9	11.2	14.1	11.4	16.7	3.5	19.4	15.2	6.9	16.0	12.7	13.5	19.2	13.7	11.8	11.6	13.2	13.5	13.8	23.9	377.6	24.9	11.6	13.7	23.9	5.8	8.2	12.2	8.6	34.7	22.7	12.3	10.4	12.3	12.7	16.4	48.9	12.7	8.8	12.9	13.7	8.5	20.2	14.5	14.1	83.4	110.2	26.5	76.1	21.8	35.7	36.3	54.3	42.4	98.1	52.4	95.0	53.7	98.9	100.7	31.0	69.7	73.3	94.2	65.7	48.2	35.7	101.3	51.0	45.8	133.2	70.7	80.7	82.6	39.5	48.7	90.2	61.8	14.3	75.8	53.5	166.0	46.9	50.3	97.3	125.2	122.6	107.0	48.6	156.3	81.4	39.6	253.5	37.2	33.8	59.9	38.9	34.7	79.5	64.6	17.6	80.8	30.3	45.9	93.6	59.6	131.6	118.2	41.0	66.5	109.2	78.2	86.0	118.6	1.7	13.5	4.2	9.1	29.4	9.7	9.4	9.6	8.3	29.8	9.0	11.5	10.2	1.0	6.9	9.3	16.6	9.7	10.1	12.0	13.3	13.1	14.2	12.7	13.5	13.2	13.5	13.7	12.3	12.7	14.1	9.3	0.0	2.2	2.0	8.9	37.0	22.2	5.7	28.5	12.1	9.9	10.3	0.6	4.3	4.0	1.8	8.4	17.2	5.7	5.3	7.9	18.6	25.6	6.8	9.4	12.7	7.2	8.8	2.0	12.2	20.4	10.2	9.7	7.7	5.1	7.9	3.6	3.1	18.4	3.3	1.7	5.7	6.1	2.5	16.5	15.0	11.5	7.3	16.0	1.0	5.3	3.9	4.1	1.0	1.3	19.2	3.6	6.0	8.6	24.0	4.4	7.3	1.3	8.3	19.7	10.7	19.1	74.6	18.8	21.2	31.0	8.2	7.0	12.5	11.3	18.8
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 53.6;Hofbauer cells: 78.6;Kupffer cells: 23.5;Macrophages: 17.5;monocytes: 13.8;Plasma cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 77.0;naive B-cell: 78.9"	"Group enriched"	"Detected in many"	25	"B-cells: 78.9;dendritic cells: 23.5;monocytes: 34.5"	"Group enriched"	"Detected in some"	10	"Daudi: 45.2;Karpas-707: 41.1;U-266/70: 33.1;U-266/84: 49.0;U-698: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle"		Yes	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nucleoli, Mitotic spindle"	"HPA003740: AB_1078450"	"unprognostic (9.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.85e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	1.6	0.7	0.7	9.7	0.7	2.4	6.7	0.6	1.2	0.5	0.4	2.1	2.0	0.5	0.2	0.4	0.4	1.6	0.4	0.8	0.7	0.3	2.5	1.6	23.2	1.5	1.5	0.2	0.3	0.2	0.1	3.2	2.0	0.5	2.7	0.3	1.1	0.4	0.1	0.2	3.9	1.8	1.0	12.9	2.2	0.4	1.8	2.5	0.3	0.2	23.3	3.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.2	33.1	49.0	12.3	0.0	2.7	0.0	0.3	11.8	0.9	0.0	20.4	0.0	77.0	0.1	0.1	22.1	78.9	0.0	0.0	0.9	1.8	34.5	23.5	0.1	8.5	0.7	0.7	0.6	1.2	0.8	0.7	1.5	1.5	2.0	1.0	1.8	2.1	0.1	0.0	0.5	0.3	53.6	0.4	0.1	0.0	0.0	0.1	1.8	1.1	0.7	1.5	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	2.2	0.1	0.0	0.6	0.0	1.7	0.0	0.2	0.3	0.4	0.0	0.1	2.5	0.0	0.0	0.3	78.6	0.0	0.0	0.0	0.0	23.5	8.0	1.0	0.0	17.5	0.0	1.9	13.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	39.6	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	2.2	0.0	0.1	0.1
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 7.2;NK-cells: 18.1;T-cells: 28.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	29.2	15.6	30.5	28.8	32.4	29.4	25.1	39.2	33.2	41.7	23.2	37.6	14.4	35.0	9.4	27.1	31.5	17.9	16.3	27.6	32.5	31.3	24.8	78.4	47.6	31.3	29.9	37.4	12.8	3.8	45.7	31.1	30.2	25.4	11.3	7.8	16.7	8.9	10.5	21.8	41.2	14.2	27.4	56.1	30.1	12.4	30.9	44.7	41.8	6.3	32.8	35.8	30.2	35.8	129.6	273.2	36.5	60.0	43.8	43.0	19.3	63.3	95.3	103.1	75.9	49.2	182.9	91.3	27.5	65.4	253.5	183.5	50.6	105.8	50.2	36.2	54.4	49.4	88.5	59.6	178.4	38.6	25.0	41.1	85.0	95.4	115.7	35.6	58.4	44.2	33.3	232.7	63.1	105.5	119.0	57.7	27.3	90.9	116.9	62.0	102.6	67.5	73.2	12.2	25.8	56.9	148.6	140.8	78.1	31.7	48.1	20.4	48.6	55.1	66.2	101.5	85.0	57.8	97.8	36.8	28.1	38.0	54.6	3.9	2.4	0.0	22.7	3.4	21.3	5.8	22.6	23.3	2.4	7.2	18.6	21.6	0.3	18.1	1.7	1.3	28.2	11.2	30.5	32.4	39.2	33.2	27.6	32.5	31.3	29.9	30.2	27.4	30.9	35.8	14.0	9.6	21.7	18.6	21.7	11.2	6.0	10.9	7.4	14.4	4.8	5.5	8.6	8.6	4.5	7.3	2.1	11.9	30.6	5.8	0.0	9.9	0.7	2.7	20.6	27.1	7.8	32.6	39.2	4.8	17.7	15.7	17.3	5.4	1.3	11.5	14.3	13.7	30.4	3.3	38.0	10.4	12.2	14.8	9.4	1.1	7.2	12.4	17.8	6.5	8.8	8.3	44.3	22.6	13.2	15.0	4.3	9.1	49.6	6.0	5.5	11.1	3.7	2.6	0.0	26.5	14.0	2.3	12.3	10.3	11.2	3.6	36.4	7.1	10.9	4.4
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22025511-22101360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	No		2700000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: AB_2732138"	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	177.4	116.1	91.7	160.2	96.5	402.9	142.7	100.1	113.8	128.6	98.4	198.2	142.3	131.3	99.8	162.3	124.8	131.7	117.0	95.2	108.8	158.8	153.5	154.1	167.9	115.5	103.7	105.9	82.5	128.4	59.6	170.3	108.4	108.3	185.4	95.9	103.8	107.5	119.9	132.0	156.9	175.0	107.4	157.5	159.9	64.2	102.2	157.7	110.6	120.9	216.8	194.8	114.9	127.1	341.9	146.4	272.2	222.0	295.0	306.4	274.2	347.3	318.8	365.5	336.2	178.0	374.5	253.1	272.8	416.7	136.2	210.7	241.1	369.3	431.1	332.4	180.1	438.1	184.5	225.4	259.1	388.5	350.5	285.6	396.6	341.0	195.2	234.7	535.6	157.8	250.8	273.4	430.2	135.6	242.9	307.5	170.2	242.9	179.3	199.6	297.6	243.3	316.2	301.3	183.4	175.8	293.4	228.7	263.4	296.3	242.3	219.1	466.3	265.3	265.2	349.3	207.8	148.6	355.9	305.8	234.5	419.3	277.6	244.3	200.6	255.1	142.4	282.3	144.3	108.0	152.0	146.7	162.3	103.4	109.5	143.5	308.3	145.0	352.2	107.2	157.4	244.8	91.7	96.5	100.1	113.8	95.2	108.8	115.5	103.7	108.4	107.4	102.2	127.1	502.1	60.9	51.8	20.9	301.0	450.6	385.5	266.0	136.1	119.1	281.1	179.6	86.9	231.6	168.0	312.6	18.8	349.6	470.1	434.9	375.6	441.3	38.0	350.5	356.5	307.7	300.4	243.0	58.5	441.9	499.6	225.2	152.4	425.8	163.6	138.2	277.0	230.9	439.2	106.0	71.0	315.4	187.2	585.4	875.2	41.3	157.8	443.4	423.4	53.4	654.9	102.5	286.3	41.7	72.9	570.5	369.7	177.1	192.9	323.1	283.1	578.2	176.2	65.2	236.7	174.2	308.3	155.3	116.2	176.6	556.6	551.6	379.2	178.6	286.7	469.6
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287879-40304657	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2;lymphoid tissue: 17.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 500.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	2.1	1.9	0.5	13.7	0.8	27.2	3.4	0.2	1.9	3.2	0.0	8.4	7.5	2.2	1.1	5.7	1.0	2.8	0.6	1.1	0.1	0.5	3.0	1.4	16.4	0.1	0.0	0.9	1.9	0.8	0.5	9.3	0.3	1.1	8.7	0.5	1.3	1.2	0.3	2.8	6.7	3.7	0.0	3.7	3.6	10.1	0.2	16.7	1.7	0.5	17.1	4.3	1.8	0.6	155.1	119.0	115.1	86.5	6.7	12.7	118.0	159.9	49.0	149.2	166.5	135.8	64.9	123.9	99.6	35.9	85.9	214.0	112.2	76.2	148.9	64.5	98.4	96.2	122.3	134.6	4.4	133.3	55.1	4.7	8.1	156.4	107.1	14.8	46.9	84.2	183.0	109.0	71.9	95.8	199.3	43.3	101.6	96.9	48.7	145.0	286.8	119.9	30.3	184.8	85.6	76.9	146.9	500.3	55.4	100.3	100.8	120.0	34.7	95.5	146.3	170.8	196.1	46.1	103.6	222.8	84.6	93.9	109.2	0.1	0.1	0.0	0.8	0.0	0.5	0.4	0.6	1.1	0.7	0.3	0.4	1.1	0.1	1.5	0.0	3.6	2.4	0.6	0.5	0.8	0.2	1.9	1.1	0.1	0.1	0.0	0.3	0.0	0.2	0.6	2.2	0.0	2.0	0.7	4.9	4.2	1.1	3.7	3.4	0.2	2.1	2.2	0.9	1.5	1.3	0.0	0.0	23.2	2.3	7.8	0.0	1.3	2.2	1.3	2.9	2.1	0.0	37.2	2.0	0.6	34.6	5.6	3.6	5.1	0.0	8.1	1.1	0.9	8.3	0.0	0.7	6.1	0.0	1.3	2.1	1.0	2.8	1.5	0.0	0.0	0.0	0.4	2.1	0.0	0.2	1.5	3.0	0.7	31.6	1.3	0.8	0.2	0.2	0.3	13.1	0.6	4.6	69.5	57.2	9.1	1.6	16.7	3.3	1.9	9.3	2.4
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500851-91525764	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.8;Erythroid cells: 23.1;Spermatocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: AB_2674807"	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	1.9	2.7	3.6	6.0	3.8	13.8	2.1	6.3	4.8	2.1	1.6	3.0	3.1	1.8	1.7	3.5	1.3	1.7	1.4	3.8	3.4	4.3	1.5	4.2	9.3	2.9	3.7	2.5	1.6	0.8	4.0	5.9	3.1	1.9	4.6	14.1	1.7	1.4	0.5	5.1	3.7	2.4	2.8	12.1	1.8	16.9	3.2	10.9	1.7	0.5	9.4	2.4	2.3	3.5	32.0	9.4	59.1	17.3	1.4	7.6	18.8	12.0	9.1	22.6	24.3	19.6	10.8	22.5	16.1	7.7	19.8	13.7	39.8	13.5	29.4	36.8	34.3	33.7	27.9	9.5	2.1	37.0	11.9	4.2	4.0	21.0	11.9	4.1	8.9	30.9	44.8	31.4	15.2	11.8	31.5	33.5	48.9	17.2	21.6	38.9	49.5	14.5	10.2	24.0	44.7	18.6	37.5	10.2	21.6	14.3	9.8	18.2	7.3	25.8	22.7	20.6	17.9	11.6	15.6	57.9	9.4	36.0	9.4	0.0	1.0	0.0	3.8	0.7	3.2	0.9	2.8	3.5	2.3	0.9	1.5	3.0	0.1	1.6	0.2	1.4	4.6	1.4	3.6	3.8	6.3	4.8	3.8	3.4	2.9	3.7	3.1	2.8	3.2	3.5	1.9	0.0	1.1	3.3	3.2	5.9	1.2	2.7	3.4	8.2	14.4	1.4	2.1	0.0	1.3	1.8	0.0	8.2	4.1	0.6	3.9	1.5	37.8	1.1	4.9	4.1	0.0	23.1	18.3	2.6	6.3	3.1	2.6	1.9	4.5	15.4	4.2	0.2	2.7	3.3	19.6	1.8	6.1	2.2	2.9	18.7	0.9	1.6	3.6	5.6	2.1	1.6	6.2	16.6	3.1	1.2	1.7	0.7	7.1	0.9	0.5	0.4	2.0	5.1	6.6	1.5	4.1	30.5	21.4	4.3	3.7	2.2	5.3	7.6	3.6	1.0
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692481-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.0	1.1	0.7	7.9	1.0	33.5	2.0	0.2	0.9	1.7	0.0	9.4	8.3	1.3	1.8	9.2	1.0	1.1	0.6	0.5	0.4	0.8	1.3	1.5	19.5	0.6	0.4	0.6	0.8	0.5	0.6	4.4	0.5	0.7	11.3	1.9	1.8	0.5	0.3	6.3	7.3	2.8	0.3	4.9	4.9	22.5	0.6	38.8	0.6	0.5	22.7	2.0	2.9	0.7	108.5	45.5	84.4	62.1	3.6	7.0	57.2	79.6	39.5	137.2	96.6	71.9	78.8	130.2	31.5	50.5	54.5	59.4	97.8	52.4	141.9	86.8	44.9	116.8	49.2	57.3	0.8	113.8	58.4	2.8	3.8	77.1	67.3	15.3	60.9	91.1	100.7	135.6	99.1	47.7	106.1	68.9	98.8	61.7	62.8	102.2	115.6	74.4	31.0	43.8	75.4	33.3	87.5	40.6	52.4	71.7	60.1	42.4	37.3	67.8	70.6	39.2	126.0	91.4	128.1	176.3	31.6	104.7	79.6	0.0	0.7	1.3	1.5	1.6	2.8	1.7	3.6	2.2	0.7	1.4	1.1	2.3	3.0	4.1	3.9	1.2	5.9	1.7	0.7	1.0	0.2	0.9	0.5	0.4	0.6	0.4	0.5	0.3	0.6	0.7	0.8	0.0	0.5	1.3	4.8	3.3	0.8	2.4	1.8	1.3	1.9	1.5	0.7	2.8	0.4	0.0	0.0	17.1	1.9	12.4	0.0	1.2	1.0	1.7	1.6	1.9	3.6	34.1	1.2	0.6	26.0	2.9	6.6	2.5	0.0	12.0	3.6	1.0	11.6	1.7	0.9	8.2	2.0	3.5	1.9	2.8	1.5	3.7	1.8	0.0	1.6	0.1	2.1	0.5	0.9	2.4	4.0	1.2	15.8	1.3	1.9	0.6	4.7	1.0	19.7	0.2	6.3	76.8	42.0	17.1	2.7	2.9	5.5	1.2	13.2	1.2
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696354	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772"	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (3.63e-4)"	30.1	38.5	20.2	10.4	20.4	19.5	26.7	20.3	32.8	49.3	22.0	38.2	22.7	25.9	8.7	35.3	36.3	8.6	27.3	21.0	19.5	52.9	77.0	31.0	14.7	18.6	18.7	43.2	49.2	13.5	55.5	12.5	19.6	39.1	11.3	7.6	24.8	7.5	33.8	32.1	36.1	8.2	17.0	37.5	38.5	17.0	18.4	10.8	54.5	4.1	7.0	32.3	36.5	19.1	27.5	17.8	13.9	5.8	5.7	11.0	14.2	22.3	12.6	15.2	4.9	13.1	21.2	23.9	9.8	19.3	9.1	15.5	5.8	30.8	9.3	5.3	14.1	9.7	21.0	1.7	23.4	15.8	17.1	13.3	10.7	9.3	15.3	10.3	27.0	16.1	25.5	3.2	17.7	36.6	19.5	45.0	28.5	29.7	13.1	26.5	19.0	34.1	27.9	21.2	10.1	29.6	28.0	13.0	6.8	15.2	30.3	25.0	24.1	9.1	26.6	10.1	15.4	11.7	6.4	7.5	16.4	25.0	15.5	5.1	14.0	4.2	14.8	19.7	12.8	7.8	13.2	10.7	18.1	9.0	15.1	12.6	1.5	20.4	15.4	12.4	11.6	11.4	20.2	20.4	20.3	32.8	21.0	19.5	18.6	18.7	19.6	17.0	18.4	19.1	28.2	12.8	26.6	35.3	21.2	15.4	24.2	26.9	23.3	17.2	24.5	25.1	6.5	38.6	20.0	27.6	25.0	28.6	26.7	44.8	43.0	28.6	6.1	20.7	21.9	23.0	67.7	15.4	44.5	12.5	19.8	19.6	85.1	16.9	9.5	40.3	21.8	41.1	18.8	18.5	33.3	49.4	26.4	17.4	16.0	8.8	23.9	17.0	19.6	17.8	15.5	8.5	26.8	24.6	20.0	13.6	41.5	12.4	20.8	30.7	58.3	53.7	28.1	32.3	6.6	11.4	16.3	27.3	28.7	22.4	15.5	27.9	22.0	54.8	58.2	22.9
CEACAM18		ENSG00000213822	"CEA cell adhesion molecule 18"	A8MTB9	19	51478622-51490952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	26	"intestine: 10.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.8;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"CACO-2: 4.3;OE19: 3.5;RT4: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059487	Uncertain		Approved	Midbody		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Midbody		"HPA059487: AB_2684036"			"unprognostic (1.12e-1)"								"unprognostic (1.87e-2)"			"unprognostic (1.00e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELF2	"BRUNOL3, CUGBP2, Etr-3, NAPOR-2"	ENSG00000048740	"CUGBP Elav-like family member 2"	O95319	10	10798397-11336675	"Predicted intracellular proteins"	"mRNA processing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 558.0;Excitatory neurons: 1676.4;Inhibitory neurons: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 200.2;HMC-1: 186.2;REH: 86.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016395, HPA035813"	Enhanced		Supported	"Nucleoplasm,Vesicles,Midbody ring"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Vesicles, Midbody ring"	"CAB016395: AB_2086271, HPA035813: AB_2674797"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.45e-1)"	39.6	5.7	33.7	30.7	42.7	78.9	17.7	0.2	42.0	14.2	0.0	16.5	9.2	15.0	5.0	21.4	13.3	17.2	37.5	42.5	7.2	3.0	4.3	28.2	42.4	0.9	13.9	46.8	4.4	3.5	6.5	8.6	0.4	14.1	17.9	35.4	9.6	12.2	17.6	8.6	23.4	23.2	8.6	31.1	10.3	7.6	23.7	60.7	8.5	15.0	29.4	16.2	8.0	21.0	0.1	0.0	47.6	0.0	7.4	2.7	5.3	7.0	0.2	1.1	0.2	0.1	0.0	0.1	5.3	6.1	0.0	0.1	6.8	0.2	0.4	40.4	11.9	200.2	0.7	0.0	1.7	58.0	186.2	3.0	0.3	0.4	0.0	0.7	6.7	70.6	9.3	80.7	59.6	0.0	71.9	42.0	19.3	0.0	0.0	86.7	50.8	18.0	3.4	0.0	7.1	0.5	0.1	0.2	51.1	15.2	0.0	39.0	0.1	8.9	2.5	29.9	0.1	30.7	30.1	9.3	2.9	68.8	21.6	68.0	43.2	90.8	54.8	57.5	69.2	48.1	54.1	60.5	53.4	51.0	56.1	52.7	115.1	73.5	67.8	37.9	60.9	63.5	33.7	42.7	0.2	42.0	42.5	7.2	0.9	13.9	0.4	8.6	23.7	21.0	20.4	160.3	147.3	558.0	165.6	19.9	3.4	5.8	12.5	68.2	18.8	13.7	122.7	5.7	22.4	12.9	102.2	1.1	233.5	11.8	15.6	1.6	135.9	5.3	11.3	34.7	59.3	45.2	1676.4	2.1	0.9	106.0	11.2	17.0	128.5	0.7	13.2	5.1	90.0	134.6	576.9	37.5	24.4	261.4	134.3	110.3	111.6	192.9	115.6	376.6	263.6	90.5	256.4	324.7	21.6	1.5	16.9	89.5	124.3	10.1	2.4	1.0	5.8	99.2	52.6	117.6	33.7	4.1	11.5	5.7	14.5	1.9	232.5	8.5	23.8	2.4
CENPC	"CENP-C, CENPC1, hcp-4, MIF2"	ENSG00000145241	"Centromere protein C"	Q03188	4	67468762-67545503	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049740, HPA058252"			Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"HPA049740: , HPA058252: AB_2683654"	"unprognostic (4.35e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.31e-3)"	"unprognostic (7.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (6.40e-2)"	"prognostic favorable (9.67e-4)"	"unprognostic (3.22e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.32e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-3)"	1.5	1.6	2.5	1.0	3.2	3.6	3.3	5.6	2.6	2.8	0.2	2.0	1.1	3.1	2.3	1.5	2.9	1.1	1.5	2.2	2.0	2.0	1.4	1.5	1.8	1.3	1.8	5.6	3.8	1.5	2.5	1.3	1.7	2.9	1.2	2.7	2.0	1.6	1.1	2.3	1.8	1.5	1.3	2.0	2.1	1.7	1.7	2.0	3.1	1.1	1.5	2.0	2.3	2.8	0.4	0.5	1.6	0.9	1.9	1.1	0.9	0.6	0.5	0.7	0.5	0.7	1.3	2.7	0.8	0.8	0.2	0.8	2.2	0.9	1.2	0.8	0.4	2.1	0.9	0.9	0.6	3.9	0.8	1.4	0.3	0.5	1.3	1.2	0.4	1.8	3.0	1.6	1.1	0.7	5.3	3.5	1.8	0.8	0.3	2.4	4.0	0.9	1.0	0.8	2.8	1.3	1.2	2.5	0.7	1.6	0.7	1.3	0.4	1.0	0.5	0.7	0.5	1.3	0.5	2.7	1.1	2.2	0.6	0.5	0.2	0.5	0.7	0.4	0.3	0.8	0.8	0.9	0.2	1.1	1.2	0.9	0.2	0.5	0.2	0.4	0.4	0.2	2.5	3.2	5.6	2.6	2.2	2.0	1.3	1.8	1.7	1.3	1.7	2.8	53.1	32.1	35.5	38.8	68.4	15.2	25.3	17.7	35.9	53.7	26.0	32.3	24.3	18.6	31.6	16.5	14.6	20.2	75.0	17.7	11.7	13.5	4.1	21.0	39.0	33.7	13.1	31.7	58.5	16.7	12.9	41.3	35.7	25.1	26.6	39.8	23.2	14.1	12.8	52.2	57.0	18.4	18.3	16.7	7.9	5.5	34.8	26.7	16.0	31.9	27.4	31.6	60.8	46.3	74.6	14.6	13.0	25.6	89.1	15.3	24.2	20.4	27.2	29.0	19.7	54.1	34.2	47.2	44.4	34.7	9.2	18.3	69.8	43.3	16.4	23.9
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105349-103198445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 10.0;lymphoid tissue: 9.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011110, HPA042294"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA011110: , HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	0.4	0.2	0.4	2.7	0.4	10.0	0.6	0.3	0.5	0.4	0.4	1.8	1.5	0.6	0.0	2.0	0.2	0.8	0.2	0.3	0.6	0.2	0.5	0.8	5.6	0.5	0.5	0.1	0.1	0.3	0.0	1.4	0.9	0.3	2.0	0.4	0.3	0.2	0.0	2.0	1.7	1.1	0.3	1.2	1.1	4.1	0.5	9.2	0.2	0.6	4.9	0.8	0.6	0.5	42.6	11.8	42.2	20.5	2.7	6.2	8.4	36.7	18.2	26.9	17.9	19.6	22.2	28.6	9.2	13.7	19.2	18.2	30.3	15.1	42.2	35.9	11.3	33.5	26.8	13.6	0.4	39.9	18.6	1.8	1.1	21.7	18.0	6.0	22.9	25.2	34.4	32.5	34.8	15.6	31.5	18.9	13.8	17.0	17.9	20.9	38.5	9.3	8.0	8.4	19.3	11.5	32.9	22.9	9.0	16.0	12.9	13.9	26.1	25.8	27.2	27.2	38.6	15.9	28.6	28.8	14.2	21.7	27.8	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.5	0.2	0.6	0.0	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.9	0.3	0.5	0.5	1.4	3.2	2.2	1.0	6.6	3.6	1.5	2.9	0.0	7.6	1.8	2.7	1.9	0.0	1.3	0.0	8.4	12.7	3.9	4.7	0.0	0.5	7.7	3.5	5.7	4.2	1.2	75.1	2.0	0.0	28.4	6.5	4.6	6.9	7.0	32.0	4.2	0.9	14.1	0.0	1.9	4.3	4.1	10.4	5.7	3.5	0.9	9.6	0.0	0.0	6.0	1.3	2.1	0.5	3.1	1.8	1.4	2.6	16.0	1.4	0.8	0.3	0.3	2.6	0.0	5.7	7.4	75.3	51.0	8.3	2.8	3.6	6.6	7.0	11.6	1.9
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189574-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.8;testis: 29.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 74.5;Spermatocytes: 222.7;Spermatogonia: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.2	2.0	1.4	7.5	1.7	33.8	7.7	1.7	2.0	3.9	1.0	7.4	6.5	4.5	2.1	7.5	4.0	1.8	4.0	1.5	1.6	1.6	3.6	2.8	17.7	1.6	1.5	3.9	1.5	2.0	1.4	5.2	1.6	3.3	8.1	2.5	2.9	2.3	4.0	9.2	5.9	3.7	1.4	5.2	3.7	29.7	1.6	18.5	2.5	4.0	18.8	3.8	4.4	2.2	64.6	19.4	88.6	70.2	5.8	18.3	48.0	31.2	32.6	66.9	71.8	26.5	79.6	138.9	36.6	18.1	39.1	47.0	59.0	70.4	85.1	42.7	41.4	32.7	32.5	26.4	2.0	47.1	32.1	7.1	14.6	43.6	47.7	18.9	23.2	73.7	58.7	53.3	52.2	35.6	152.4	67.3	78.1	20.7	17.0	93.2	118.2	108.2	21.1	22.9	61.6	81.9	34.6	22.8	27.5	47.7	31.9	31.4	11.4	33.4	56.1	44.5	78.7	65.5	106.3	111.8	51.1	94.2	64.7	1.0	2.0	3.0	4.7	3.5	7.7	13.3	7.9	6.0	3.1	14.1	9.9	8.6	0.4	8.6	4.2	6.7	9.7	4.8	1.4	1.7	1.7	2.0	1.5	1.6	1.6	1.5	1.6	1.4	1.6	2.2	4.8	0.0	2.6	1.0	18.3	36.7	17.7	17.4	9.6	3.4	10.8	11.7	3.3	4.3	7.1	0.0	0.0	37.4	9.2	5.1	0.0	12.3	26.5	5.5	5.1	6.9	1.2	74.5	1.3	9.1	49.0	7.4	2.6	4.8	5.1	22.4	4.6	1.1	17.0	0.0	1.1	9.5	12.2	7.5	18.2	22.5	3.7	6.3	8.8	1.0	4.3	7.3	6.2	1.0	0.9	7.0	2.5	4.9	14.4	6.9	1.4	3.4	10.8	3.5	19.7	6.4	9.3	222.7	222.8	12.1	19.2	10.0	12.0	6.9	15.9	15.2
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 100.4;Spermatogonia: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 106.4;JURKAT: 105.1;NTERA-2: 103.4"	"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.0	4.7	11.7	0.6	11.3	5.1	4.6	9.3	11.7	4.4	7.1	9.1	9.8	5.9	3.5	0.5	6.6	1.3	5.6	11.9	13.2	3.4	10.7	2.6	1.2	11.6	11.0	6.2	4.0	3.9	7.0	1.2	10.0	3.1	8.0	4.0	1.5	4.0	21.1	0.8	10.6	4.0	11.6	1.1	13.2	10.3	11.4	17.1	2.4	9.5	1.2	4.2	1.7	11.9	10.7	20.4	106.4	53.4	3.0	2.7	18.2	8.7	8.6	26.5	20.0	20.5	4.7	42.5	17.0	6.5	4.9	3.2	69.3	0.6	16.8	0.0	85.9	10.1	5.0	41.1	29.2	10.1	0.0	7.6	2.8	31.6	18.7	3.0	15.2	105.1	17.4	0.0	8.0	1.8	80.2	34.2	103.4	69.1	0.0	57.1	4.1	4.9	6.1	15.4	56.8	43.9	22.2	0.3	5.2	48.6	0.3	24.8	1.0	0.0	8.6	1.2	0.0	0.0	0.0	24.9	0.0	14.0	0.6	0.0	0.0	1.3	0.1	0.0	0.0	1.4	0.0	0.0	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	11.7	11.3	9.3	11.7	11.9	13.2	11.6	11.0	10.0	11.6	11.4	11.9	13.3	0.0	2.7	3.9	13.7	1.0	29.7	0.5	4.6	40.0	22.5	31.6	4.2	30.0	4.4	1.8	4.2	19.6	19.6	43.0	31.3	7.5	16.3	2.6	32.4	5.0	39.4	12.6	18.9	23.3	22.1	9.2	59.1	2.7	5.7	39.7	1.8	50.1	6.0	11.8	21.8	63.0	0.0	1.4	0.7	9.0	8.7	4.6	8.8	3.7	2.0	45.9	13.4	19.6	11.7	17.8	83.9	11.7	10.7	38.0	100.4	43.5	2.5	15.0	26.3	4.2	17.9	81.6	124.2	2.5	2.6	6.4	10.7	8.7	78.9	45.0
CEP112	"CCDC46, MGC33887"	ENSG00000154240	"Centrosomal protein 112"	Q8N8E3	17	65635537-66192133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.0"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1061.4;Late spermatids: 1606.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 32.0;RH-30: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069724			Approved	"Nucleoplasm,Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Centrosome"	"Midbody ring, Cytosol"	"HPA069724: "	"unprognostic (9.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	11.3	3.9	5.0	2.7	5.4	1.7	9.5	7.1	5.8	8.3	11.9	7.8	2.0	8.5	8.2	4.3	8.3	7.0	8.0	7.4	5.1	5.6	3.2	7.4	2.5	5.8	5.7	8.2	4.6	8.7	8.3	7.2	4.2	7.2	3.1	25.4	3.0	7.9	8.8	3.3	2.9	8.0	3.4	8.8	4.2	49.0	5.5	2.8	7.1	14.0	1.7	5.4	5.9	3.4	5.0	10.5	13.3	3.8	6.9	14.0	0.4	4.5	7.7	5.5	5.0	1.5	2.0	1.6	4.3	9.8	15.5	0.6	2.9	2.9	7.8	2.6	4.8	0.3	4.7	1.9	2.9	0.6	0.2	8.4	4.8	5.2	1.6	11.0	16.8	2.7	0.3	5.0	32.0	0.7	5.3	0.4	1.3	1.1	4.4	1.5	75.9	0.4	6.0	0.3	3.5	7.4	4.7	0.5	3.6	11.4	3.8	0.4	7.9	14.3	8.2	3.9	6.7	2.3	2.1	0.2	4.4	0.2	5.3	1.3	0.4	0.4	0.3	0.2	0.6	0.3	0.8	0.3	0.2	0.8	0.5	0.3	1.3	0.8	0.2	1.4	0.5	0.1	5.0	5.4	7.1	5.8	7.4	5.1	5.8	5.7	4.2	3.4	5.5	3.4	39.7	9.6	35.8	83.6	1.1	2.5	2.9	2.2	2.2	36.7	2.7	5.5	28.3	4.3	15.3	1.8	20.9	0.7	0.8	1.5	1.9	7.4	1061.4	15.3	15.8	25.4	1.8	0.4	117.4	4.7	1.5	12.4	1.5	3.3	2.5	11.2	19.2	0.2	1.8	1.7	103.8	0.3	0.0	0.8	11.3	1606.0	24.8	2.3	14.2	99.3	0.0	14.7	1.0	29.7	6.6	4.4	0.5	19.9	0.4	1.5	0.0	4.3	23.7	154.3	13.1	43.7	12.5	40.6	16.5	2.4	1.6	0.1	2.5	3.1	1.5	1.3
CEP131	"AZ1, AZI1, KIAA1118"	ENSG00000141577	"Centrosomal protein 131"	Q9UPN4	17	81189593-81222999	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024019	Approved		Supported	"Microtubules,Cytokinetic bridge,Centriolar satellite"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Microtubules	"Cytokinetic bridge, Centriolar satellite"	"HPA024019: AB_1845227"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (9.68e-5)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.32e-3)"	9.1	8.6	6.7	5.2	6.4	10.2	10.3	7.8	10.0	14.7	7.5	9.8	4.6	11.4	0.9	9.1	11.5	2.0	16.8	6.5	5.8	11.7	6.8	10.7	7.9	6.8	6.2	12.8	10.1	2.2	15.4	4.1	6.2	12.0	0.8	1.8	9.3	2.1	11.1	10.5	10.3	1.6	5.7	19.0	9.9	28.2	6.7	3.5	10.3	2.0	2.2	10.4	10.7	6.8	21.1	20.0	10.6	19.4	1.7	2.7	33.6	14.4	2.5	10.3	7.9	23.8	10.5	14.8	8.0	3.5	6.3	14.9	3.1	7.0	2.5	6.2	26.8	14.3	32.7	41.3	2.9	12.5	30.6	2.3	4.6	7.5	2.1	3.3	7.3	15.6	10.6	8.5	2.7	23.5	29.0	24.3	9.5	6.1	17.7	29.0	12.1	6.1	3.9	18.4	24.2	27.2	18.5	11.4	18.0	3.9	17.2	12.3	10.0	18.6	32.1	16.7	19.2	22.0	4.0	11.3	9.6	10.7	13.5	2.1	0.8	0.5	1.2	2.3	0.3	2.9	0.7	1.1	1.8	1.7	1.1	0.8	1.3	1.0	4.6	2.0	0.1	0.8	6.7	6.4	7.8	10.0	6.5	5.8	6.8	6.2	6.2	5.7	6.7	6.8	6.5	0.0	4.4	5.5	6.6	0.0	3.4	0.0	3.4	5.8	3.3	4.4	13.4	2.8	1.3	3.7	6.2	8.7	4.8	5.6	0.0	4.5	14.0	8.4	3.5	6.0	6.7	5.7	2.1	3.7	7.2	6.9	6.6	2.8	15.9	9.3	2.5	1.7	5.2	5.0	2.9	5.1	0.0	1.9	0.0	17.9	9.6	3.6	0.0	1.0	1.3	6.0	7.2	2.5	2.8	5.2	0.8	3.0	4.4	1.2	1.8	1.4	3.6	6.9	0.0	4.3	5.7	14.7	20.5	3.7	0.0	6.0	3.5	8.4	7.9	2.7
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496612-93529092	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4;testis: 21.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA023430	Approved		Approved	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	1.3	0.6	0.0	7.6	0.0	5.0	1.4	0.0	0.2	1.7	0.0	7.0	6.7	1.4	0.1	7.3	0.4	1.4	0.3	0.0	0.1	0.3	0.6	1.3	14.7	0.1	0.3	0.2	0.2	0.2	0.3	3.5	0.2	0.3	8.8	0.0	1.2	0.3	0.1	4.5	6.3	5.2	0.0	2.4	4.6	21.7	0.4	27.4	0.5	0.2	15.5	3.1	2.3	0.1	208.5	81.5	53.0	67.7	5.8	12.0	29.6	112.4	78.2	103.5	106.4	87.2	108.6	55.4	48.2	72.8	69.6	115.4	64.8	54.8	123.4	167.2	33.7	21.0	49.2	29.9	0.6	36.3	46.3	2.8	3.8	110.6	133.5	30.7	97.1	89.9	19.3	101.8	118.5	48.3	96.3	54.8	20.9	64.2	58.8	41.3	86.9	30.3	47.1	25.5	21.7	30.7	86.3	26.3	64.9	40.1	68.9	36.4	61.4	65.3	90.6	90.5	186.7	45.1	66.1	66.8	51.0	134.8	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.1	0.2	0.0	1.3	0.0	2.7	3.6	0.9	1.9	0.0	0.0	1.8	2.0	0.4	2.8	0.2	0.0	0.0	7.7	0.9	3.3	0.0	0.6	29.4	1.7	2.0	1.5	0.0	2.5	0.5	0.2	17.1	2.3	8.2	3.6	0.0	19.8	2.2	0.3	12.9	0.0	0.3	4.5	4.1	7.0	5.1	8.2	0.3	5.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.4	14.8	1.1	0.4	0.0	0.2	0.0	0.0	0.5	4.5	77.3	17.3	16.1	1.3	1.5	4.3	1.6	7.9	1.7
CFAP53	"CCDC11, FLJ32743"	ENSG00000172361	"Cilia and flagella associated protein 53"	Q96M91	18	50227193-50266495	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Ciliopathy, Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 28.5;testis: 79.6"	"Group enriched"	"Detected in many"	14	"Early spermatids: 809.6;Endometrial ciliated cells: 331.5;Late spermatids: 528.4;Respiratory ciliated cells: 216.5;Spermatocytes: 481.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.7"									"HPA041069, HPA066142"	Enhanced		Approved	Midbody		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"	Midbody		"HPA041069: AB_10805835, HPA066142: AB_2732739"	"unprognostic (1.73e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.85e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.61e-3)"	0.3	1.2	3.0	0.4	3.4	0.7	1.1	5.0	3.2	2.0	8.5	0.5	0.2	1.1	5.7	0.4	28.5	0.7	0.5	3.1	3.7	2.7	0.4	3.3	0.3	6.8	7.8	1.0	1.1	2.5	3.3	0.3	6.0	0.9	0.2	3.5	0.6	1.2	2.3	1.0	0.4	0.3	5.3	0.4	0.5	79.6	3.4	0.5	3.9	0.4	0.2	0.6	0.6	5.0	1.2	0.8	0.5	1.0	0.7	1.3	0.9	0.2	0.1	0.1	0.2	0.1	1.0	0.7	0.7	0.3	0.3	0.5	0.3	0.5	0.2	0.5	0.7	0.3	0.3	0.1	0.3	0.5	0.4	0.4	2.0	0.5	4.7	1.1	0.3	1.9	1.4	0.4	0.3	1.2	1.2	0.2	0.2	0.2	0.5	0.1	0.2	1.0	1.4	0.0	0.8	0.6	0.1	0.0	0.4	1.3	0.6	0.1	0.0	0.7	0.5	0.4	0.4	2.1	0.8	0.1	0.7	0.5	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.2	0.0	0.2	0.2	0.0	3.0	3.4	5.0	3.2	3.1	3.7	6.8	7.8	6.0	5.3	3.4	5.0	0.6	6.4	4.2	2.6	0.6	0.0	2.0	0.0	1.8	4.3	4.7	3.8	0.4	0.0	21.1	9.2	8.4	1.7	0.2	0.3	9.8	3.4	809.6	331.5	3.8	1.4	0.0	0.4	3.8	0.6	0.5	2.2	2.6	7.9	1.3	1.4	1.8	1.0	0.4	1.7	4.4	0.2	0.0	0.0	0.0	528.4	8.4	1.3	0.0	2.8	1.0	2.7	1.0	3.0	6.5	0.8	0.1	5.7	0.9	1.3	0.8	20.5	216.5	10.5	6.6	2.1	0.7	481.5	32.5	1.3	0.0	0.7	1.0	1.7	0.4	1.1
CFAP99		ENSG00000206113	"Cilia and flagella associated protein 99"		4	2418974-2462942	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"brain: 4.8;choroid plexus: 5.8;fallopian tube: 3.9;retina: 1.5;testis: 5.3"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Early spermatids: 11.6;Endometrial ciliated cells: 13.6;Late spermatids: 11.2;Rod photoreceptor cells: 5.5;Spermatocytes: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA071642			Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA071642: "	"unprognostic (7.54e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.93e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.49e-1)"	0.0	0.8	0.5	0.0	0.5	0.0	0.0	0.8	0.3	0.2	5.8	0.0	0.0	0.2	0.1	0.0	3.9	0.0	0.0	0.9	0.8	0.2	0.1	0.6	0.0	3.2	4.8	0.0	0.3	0.0	0.8	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	5.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.8	0.3	0.9	0.8	3.2	4.8	1.8	2.0	1.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	0.0	1.8	3.7	4.2	0.0	0.0	0.0	0.0	0.2	11.6	13.6	0.2	0.1	0.0	0.0	1.2	0.6	0.1	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	1.5	2.9	5.5	0.0	0.0	0.0	14.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314482-114337626	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	9.9	7.1	3.4	9.8	3.3	14.2	9.5	6.6	5.2	8.1	3.8	8.7	10.0	8.5	8.0	6.4	9.8	7.6	6.2	3.0	4.3	8.9	15.2	8.9	15.7	2.7	3.4	12.1	15.4	9.3	3.6	9.9	3.4	10.0	9.9	9.1	8.4	9.3	7.9	9.2	8.0	10.1	2.3	9.6	7.7	6.9	2.7	16.5	10.7	9.7	17.3	7.5	4.4	3.1	36.9	15.8	56.6	24.2	20.1	30.9	24.3	38.2	32.0	35.6	39.4	23.5	22.0	75.2	15.1	30.0	22.3	23.0	41.8	30.6	52.7	29.8	50.0	49.7	21.8	20.7	22.5	73.3	28.3	30.4	18.8	27.8	27.3	12.6	17.4	25.8	32.1	20.3	46.1	14.6	48.6	21.4	43.1	45.2	20.2	48.1	26.9	26.0	27.0	22.2	27.5	32.8	22.2	49.2	36.7	39.1	28.2	61.3	19.3	19.5	30.8	20.7	23.6	25.7	27.9	80.4	38.6	42.7	38.1	7.5	3.3	4.4	3.7	4.0	4.6	5.4	3.3	3.7	3.9	5.8	2.6	3.0	0.8	3.5	6.6	12.5	2.4	2.1	3.4	3.3	6.6	5.2	3.0	4.3	2.7	3.4	3.4	2.3	2.7	3.1	11.2	9.6	9.6	3.6	13.9	3.3	6.6	7.6	10.8	12.5	11.3	10.8	5.7	11.5	4.1	12.9	4.2	14.2	18.1	9.3	13.7	11.7	1.0	8.5	14.8	10.9	10.8	24.4	6.1	11.4	18.1	11.5	10.2	8.3	10.1	13.1	13.9	21.6	21.7	15.2	7.8	12.5	6.1	20.7	7.8	1.6	11.8	13.0	12.4	7.5	18.4	8.8	17.5	4.0	8.0	10.9	7.8	11.3	17.6	13.2	12.5	17.0	7.6	10.9	6.6	11.7	10.5	10.6	20.7	13.1	3.8	7.9	11.4	12.4	11.4	3.5
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851413-11854444	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 361.4"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Midbody	Nucleoplasm	"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favorable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	43.3	35.7	24.5	36.2	25.9	61.2	29.0	19.6	25.4	25.6	30.0	39.1	38.7	28.3	26.2	39.1	24.8	39.3	40.7	25.9	25.6	33.1	31.1	29.7	29.9	21.9	23.2	29.6	24.8	39.9	29.3	27.8	22.6	27.8	37.5	17.6	29.5	35.0	361.4	40.4	48.8	23.6	20.3	30.2	30.5	14.0	24.0	46.0	52.2	53.2	24.8	49.5	23.8	23.6	30.0	28.8	36.5	31.1	46.9	32.7	52.9	31.4	52.6	21.0	27.9	37.5	29.4	18.5	45.9	34.2	35.0	25.0	16.8	43.7	18.5	17.2	20.8	13.5	43.6	31.1	34.6	51.7	22.3	47.7	92.5	23.5	53.9	46.8	30.7	41.6	23.1	23.4	33.3	37.3	36.1	39.6	15.3	94.9	14.3	18.4	18.8	32.1	56.5	40.5	35.5	35.5	53.1	24.7	50.5	33.9	20.2	47.2	45.2	46.7	24.5	37.3	34.0	27.8	34.3	23.5	43.3	23.8	22.7	32.5	38.8	66.7	15.4	35.7	14.3	14.7	14.3	18.5	30.2	14.7	17.6	16.4	77.9	18.3	36.6	26.7	21.5	29.2	24.5	25.9	19.6	25.4	25.9	25.6	21.9	23.2	22.6	20.3	24.0	23.6	71.2	67.3	47.0	0.0	152.9	419.6	141.8	291.8	216.9	30.5	71.3	59.4	21.7	52.9	157.7	132.4	8.4	135.9	171.0	281.4	60.7	123.0	80.4	146.6	110.2	69.9	143.8	40.4	0.0	80.3	144.4	99.3	70.8	298.3	149.9	38.4	52.8	44.1	118.0	28.6	0.0	104.6	111.9	139.9	440.8	42.6	37.9	354.5	158.3	0.0	102.1	32.2	78.2	0.0	0.0	134.0	393.7	37.2	21.8	93.9	179.2	139.1	84.8	16.8	78.9	61.2	94.5	16.0	21.1	177.1	514.7	253.2	135.5	43.9	96.8	252.2
CHMP4C	"MGC22825, Shax3, VPS32C"	ENSG00000164695	"Charged multivesicular body protein 4C"	Q96CF2	8	81732448-81759515	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023763, HPA023799"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Microtubules, Cytokinetic bridge"		"HPA023763: , HPA023799: AB_1846670"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (7.54e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.99e-2)"	"prognostic favorable (1.96e-6)"	"unprognostic (3.29e-3)"	"unprognostic (4.95e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (6.45e-4)"	1.7	5.8	1.2	2.1	1.3	1.2	16.6	1.6	1.3	7.5	2.8	16.2	41.8	2.3	5.8	22.6	8.7	8.0	3.6	1.1	1.0	13.9	7.7	7.2	0.5	1.5	1.4	0.5	20.1	15.8	10.1	5.8	1.5	10.0	14.8	0.2	28.1	7.6	0.2	29.1	31.7	0.8	1.1	8.5	23.7	1.1	1.4	1.9	17.5	0.5	5.2	9.7	14.2	2.0	37.2	7.6	0.0	0.2	0.0	0.0	16.6	1.9	2.2	0.1	0.0	14.3	41.5	0.1	28.8	0.0	6.4	22.1	0.2	15.7	0.0	0.0	17.9	0.7	9.9	13.6	0.8	0.1	0.1	0.0	51.4	0.0	41.6	15.3	0.0	0.0	10.0	12.4	0.0	18.4	0.1	0.3	0.1	73.1	14.9	0.1	0.0	8.3	36.3	22.0	7.9	0.1	9.9	16.3	0.1	8.5	23.9	0.2	0.0	0.1	8.9	0.1	0.2	6.5	4.3	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	0.1	0.0	0.1	1.2	1.3	1.6	1.3	1.1	1.0	1.5	1.4	1.5	1.1	1.4	2.0	5.3	25.6	21.5	0.0	3.2	4.6	35.4	17.1	18.2	0.0	27.2	29.3	4.1	21.5	22.4	5.5	0.0	40.2	0.6	42.0	25.4	47.4	0.4	18.6	2.9	4.0	9.1	1.7	0.1	71.6	38.9	1.0	25.5	31.0	1.3	6.5	4.2	7.6	4.4	0.0	0.1	36.4	12.2	0.3	0.7	1.3	0.0	0.9	8.8	1.0	0.0	0.0	1.0	0.0	0.1	78.7	52.8	0.0	5.7	28.9	80.4	22.6	19.1	0.0	0.0	0.2	7.0	0.3	0.7	25.0	17.5	44.5	1.3	0.1	34.4	33.6
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282070	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol		Yes	No		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	54.6	54.6	48.3	36.7	49.2	30.5	49.6	50.4	63.8	56.4	50.0	55.7	55.2	41.3	48.1	64.6	43.8	42.1	50.8	49.0	50.3	77.8	56.3	53.5	41.6	50.4	49.7	42.9	32.7	63.9	49.7	63.8	50.7	54.8	55.9	53.8	43.7	39.4	48.2	47.0	59.2	33.9	52.7	43.5	54.6	36.2	49.4	44.9	55.8	44.3	38.1	49.7	56.5	56.9	92.2	66.5	67.0	43.5	99.0	89.0	61.9	90.1	99.7	138.3	152.6	50.9	56.9	49.0	96.3	84.3	95.9	39.2	70.5	72.8	111.1	102.5	49.3	41.5	129.7	55.8	85.9	53.4	78.8	95.6	131.3	93.6	86.4	114.5	73.3	68.3	44.9	63.6	110.5	41.3	56.1	164.1	61.8	70.1	80.6	34.0	59.2	32.9	115.2	48.7	32.7	83.6	91.0	53.4	87.2	77.8	54.2	82.7	74.4	69.5	73.0	60.2	80.8	42.3	87.6	57.0	100.5	36.0	45.6	98.6	50.3	106.3	25.3	56.5	27.6	31.0	33.7	33.8	46.5	26.4	30.6	29.4	129.4	47.4	67.3	71.2	43.4	51.3	48.3	49.2	50.4	63.8	49.0	50.3	50.4	49.7	50.7	52.7	49.4	56.9	182.7	89.8	59.0	14.0	52.9	188.1	156.2	372.5	71.7	63.7	85.2	75.1	64.7	94.4	228.6	110.3	27.1	172.0	77.4	241.0	285.7	141.7	245.2	228.0	90.6	133.8	80.2	90.1	19.6	86.1	186.1	104.4	56.1	167.0	58.4	66.5	97.5	70.5	154.9	26.9	19.0	137.9	246.2	100.9	103.2	35.9	93.2	95.3	117.4	15.0	166.3	156.2	38.1	14.6	26.8	151.9	247.9	104.6	45.2	182.4	226.3	355.2	328.9	68.2	85.5	97.0	130.0	99.5	68.7	70.1	236.3	259.0	68.5	71.4	78.5	246.0
CHRNA2		ENSG00000120903	"Cholinergic receptor nicotinic alpha 2 subunit"	Q15822	8	27459756-27479883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 72.1;prostate: 29.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.5;Inhibitory neurons: 14.8;Prostatic glandular cells: 2.4;Theca cells: 3.4"	"Cancer enriched"	"Detected in single"	421	"prostate cancer: 30.2"	"Region enhanced"	"Detected in many"		"thalamus: 72.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA048348			Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge"	"HPA048348: "	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"			"unprognostic (2.23e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (6.29e-3)"			"unprognostic (1.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.47e-1)"		0.0	0.5	15.8	0.2	5.5	0.9	1.4	38.1	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	8.0	0.0	0.0	0.2	0.1	15.7	21.5	0.0	0.2	0.0	0.3	0.0	3.5	29.0	0.0	3.7	0.0	0.0	0.1	0.2	0.2	0.0	2.3	0.1	0.0	0.0	72.1	2.9	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	15.8	5.5	38.1	2.9	0.7	8.0	15.7	21.5	3.5	2.3	72.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0
CISH	"CIS, CIS-1, G18, SOCS"	ENSG00000114737	"Cytokine inducible SH2 containing protein"	Q9NSE2	3	50606489-50611774	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 38.5;Distal tubular cells: 58.7;Proximal tubular cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 316.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034039, HPA040812"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Cytokinetic bridge"	"CAB034039: AB_2080282, HPA040812: AB_2677148"	"unprognostic (2.36e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (8.54e-2)"	"unprognostic (9.38e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (6.97e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (2.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	19.0	4.8	1.0	8.7	1.0	7.6	24.5	1.1	1.3	10.0	1.9	9.9	10.2	9.4	3.1	9.6	9.8	4.5	26.5	0.9	1.4	47.6	60.7	28.0	8.5	2.8	1.9	14.5	20.2	22.1	14.3	23.2	2.2	7.5	8.9	0.3	13.1	8.9	40.0	13.3	8.8	4.9	1.7	9.9	10.4	2.3	1.6	9.7	36.4	5.2	6.7	5.9	10.0	1.5	2.4	0.8	2.8	5.9	0.7	3.4	2.5	0.6	0.6	0.3	0.4	2.3	0.6	0.0	2.0	0.9	1.3	2.8	4.7	3.8	0.3	316.3	0.8	18.7	1.8	2.5	2.1	2.5	22.0	14.2	1.6	0.7	1.3	0.2	0.6	2.0	75.6	0.6	0.6	14.8	4.1	17.4	2.7	8.7	2.9	1.8	1.2	19.4	6.3	2.7	1.4	4.7	1.0	37.7	0.7	0.8	20.9	15.4	0.5	0.8	2.2	2.8	1.4	0.3	0.4	0.0	0.5	22.7	0.4	21.3	10.2	13.7	33.8	6.2	51.1	0.9	54.0	41.6	7.0	0.4	40.5	40.6	8.6	2.0	3.9	4.6	35.3	19.6	1.0	1.0	1.1	1.3	0.9	1.4	2.8	1.9	2.2	1.7	1.6	1.5	7.1	3.2	38.5	0.0	1.8	8.0	7.4	1.9	10.2	0.7	18.3	12.1	14.3	0.0	6.7	18.4	0.0	9.1	14.1	8.9	58.7	11.7	2.6	6.6	4.3	3.5	2.4	11.6	0.1	16.4	4.0	11.6	3.6	8.5	1.3	16.9	2.2	7.0	12.7	0.0	0.0	9.6	2.0	8.4	10.0	0.6	8.4	12.8	1.8	1.0	17.3	0.1	14.4	0.0	0.0	7.2	6.7	3.8	4.0	3.0	6.5	58.2	0.8	0.2	13.1	7.6	8.8	1.0	1.3	7.3	8.9	15.9	31.0	3.4	12.1	3.6
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 67.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 122.9;Granulosa cells: 88.6;Spermatocytes: 151.7;Spermatogonia: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA008410, HPA027821"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centrosome"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Centrosome	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	6.0	6.4	3.7	10.0	3.8	67.8	5.7	10.8	5.3	3.2	1.3	8.9	12.1	5.1	4.4	10.4	3.5	4.1	6.0	3.2	4.1	5.1	4.0	5.3	19.4	4.8	3.8	3.2	1.5	4.3	4.5	10.6	5.2	5.6	9.5	7.7	4.6	4.2	2.9	13.9	9.5	8.5	3.3	9.4	5.4	32.5	3.7	33.7	6.3	3.4	20.2	7.2	5.0	3.1	77.6	40.0	155.7	76.4	19.7	19.5	39.6	124.7	70.7	137.4	87.2	59.7	92.3	142.5	19.3	89.2	65.7	86.2	107.6	61.7	188.8	103.0	90.4	129.8	42.6	41.4	8.6	129.7	50.4	14.5	24.6	64.5	83.3	41.2	84.0	62.0	55.3	58.1	152.8	36.0	91.2	64.8	92.2	116.6	42.4	86.2	88.6	62.6	42.1	40.9	47.6	62.4	68.9	49.0	37.1	78.7	54.4	61.7	56.7	38.7	60.9	62.0	124.1	33.4	56.3	173.9	27.3	67.3	105.7	86.0	14.1	22.0	10.3	21.0	9.3	25.3	15.7	12.8	15.8	33.0	12.0	10.4	4.3	5.8	28.7	32.8	33.6	10.0	3.7	3.8	10.8	5.3	3.2	4.1	4.8	3.8	5.2	3.3	3.7	3.1	6.7	6.4	2.8	5.2	41.2	15.0	4.5	32.8	22.2	13.1	11.2	13.2	10.8	2.8	11.4	1.8	6.2	44.3	30.9	7.5	9.8	4.9	41.3	19.4	16.1	12.7	7.2	122.9	10.3	6.0	38.1	12.1	10.7	10.1	16.5	88.6	17.5	5.5	31.8	1.7	12.4	13.6	20.3	24.5	13.7	51.7	7.5	18.5	0.0	6.5	22.9	12.9	5.2	3.5	2.0	2.6	4.6	17.0	30.8	3.7	6.3	9.4	3.7	6.6	6.6	7.6	12.1	151.7	87.5	41.3	15.3	10.0	27.1	29.6	17.9	3.9
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736349-112764664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	0.4	0.1	0.2	2.6	0.2	13.1	0.4	0.4	0.3	0.4	0.0	1.6	1.5	0.3	0.1	2.3	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.2	0.2	0.3	0.0	0.0	1.5	1.1	1.1	0.0	0.9	1.0	4.5	0.2	12.1	0.2	0.0	5.2	0.8	0.6	0.2	47.9	9.6	35.4	16.2	2.0	3.3	7.2	38.5	32.2	37.9	36.1	8.7	13.3	32.0	15.5	15.1	48.3	18.0	20.4	19.6	64.1	44.8	8.9	53.6	12.7	7.7	0.1	25.2	30.9	0.9	1.9	47.4	27.2	10.1	17.5	22.8	14.3	44.9	31.2	6.9	31.0	10.6	15.4	20.0	29.5	22.3	37.0	8.4	6.9	18.7	19.7	12.7	15.2	12.8	13.3	13.2	12.4	11.8	12.9	42.7	33.7	34.5	28.5	9.9	20.1	26.6	18.5	18.1	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.2	0.6	0.0	1.2	3.3	2.1	2.7	0.6	0.0	0.5	0.8	0.5	1.5	0.4	0.0	0.0	11.1	1.3	1.3	0.0	0.4	2.4	1.1	1.6	1.1	0.0	25.2	0.3	0.4	10.6	2.0	1.5	2.1	0.0	12.5	2.9	0.1	6.6	0.0	0.2	3.1	2.0	1.9	1.4	2.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	5.6	1.1	0.1	0.1	0.4	0.0	0.0	0.4	2.8	33.0	35.7	9.5	1.7	1.0	2.5	0.7	3.8	1.1
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 18.2;brain: 26.7;ovary: 64.7"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 552.2"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		130000		"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	18.2	4.8	17.3	0.3	15.3	0.0	8.8	0.0	26.7	4.2	0.0	1.4	0.5	5.1	0.7	1.0	4.7	2.1	6.1	23.4	0.0	4.3	0.8	1.1	2.7	13.3	3.1	64.7	1.6	0.8	0.9	0.9	9.1	5.3	0.8	2.7	1.3	1.1	1.6	2.0	1.3	6.8	0.0	0.1	1.0	0.6	0.0	0.7	2.8	2.2	0.2	1.6	3.2	15.6	0.0	0.0	5.1	0.0	2.2	0.6	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	2.1	0.0	0.0	0.0	42.7	2.2	9.4	0.0	1.0	0.5	1.4	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	15.3	0.0	26.7	23.4	0.0	13.3	3.1	9.1	0.0	0.0	15.6	2.1	0.0	0.0	18.3	0.0	0.5	0.3	0.0	8.6	1.8	10.9	2.2	8.0	0.0	0.6	3.7	0.0	0.2	0.1	0.0	1.9	0.2	39.8	0.5	8.9	0.8	0.0	0.0	552.2	0.2	0.0	9.1	0.0	0.2	0.0	25.0	2.2	0.0	0.1	0.0	111.5	0.0	0.0	0.3	1.5	31.1	28.0	0.8	0.0	5.6	0.0	0.8	0.0	108.6	29.4	0.0	0.0	0.7	0.0	5.0	0.0	32.3	3.0	3.8	0.0	28.3	13.7	0.8	0.8	0.4	0.0	0.0	0.7	0.5	0.0	0.3
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390297	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 952.0;esophagus: 3093.3;vagina: 1442.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 57.9;Breast myoepithelial cells: 51.6;Squamous epithelial cells: 71.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"memory B-cell: 61.2;naive B-cell: 70.2"	"Lineage enriched"	"Detected in many"	12	"B-cells: 70.2"	"Cell line enhanced"	"Detected in many"		"A549: 18.1;HEK 293: 25.7;MCF7: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge"	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favorable (4.02e-5)"	"unprognostic (2.45e-1)"	4.3	5.3	1.8	0.4	4.2	0.6	12.9	1.9	2.2	952.0	1.3	3.2	0.4	1.5	7.3	3093.3	1.6	0.1	1.9	1.9	2.8	2.3	1.4	0.9	0.7	2.1	1.9	1.0	3.3	1.6	2.2	0.1	1.7	8.6	1.3	0.1	661.6	1.1	1.7	555.6	3.5	0.5	1.7	3.3	3.3	2.4	2.9	2.8	1.8	0.0	276.8	2.4	1442.7	1.6	6.0	18.1	0.4	1.6	0.8	0.9	0.2	1.0	0.3	0.4	0.4	1.0	1.6	5.1	8.0	0.2	1.2	2.4	1.5	2.3	0.1	0.0	25.7	0.4	6.9	1.9	0.0	0.0	0.1	1.8	4.0	1.0	0.0	0.1	0.0	4.7	1.1	0.2	0.0	12.6	0.1	0.1	6.6	8.1	5.4	2.2	0.3	2.9	1.6	2.3	2.7	7.7	3.4	5.1	2.5	2.7	6.2	2.6	0.0	0.0	5.3	0.2	0.1	5.8	7.6	3.6	0.1	2.2	0.3	0.1	4.6	0.1	1.7	3.9	0.4	61.2	1.3	1.2	5.9	70.2	0.6	0.9	1.3	0.0	0.9	1.3	0.1	2.2	1.8	4.2	1.9	2.2	1.9	2.8	2.1	1.9	1.7	1.7	2.9	1.6	32.7	3.2	2.2	0.0	24.6	4.6	16.8	28.5	14.8	0.1	57.9	51.6	0.8	2.8	20.2	33.1	0.0	0.2	2.1	24.5	7.9	13.1	1.5	20.6	3.9	9.3	32.5	3.6	0.1	2.5	0.3	2.3	4.6	23.9	4.5	7.2	3.9	0.7	5.7	0.0	0.2	33.4	14.2	3.8	7.7	3.9	5.3	6.3	3.6	0.0	6.4	0.3	7.2	0.0	0.1	2.4	39.4	4.5	0.5	11.5	43.8	12.3	10.5	0.1	0.0	0.9	8.0	0.4	17.4	71.8	12.9	0.3	1.3	1.1	41.8	27.0
COPS2	"ALIEN, CSN2, TRIP15"	ENSG00000166200	"COP9 signalosome subunit 2"	P61201	15	49106068-49155661	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016867, HPA018271, HPA061071"	Approved		Supported	"Vesicles,Cytokinetic bridge"		Yes	No		190000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Vesicles	"Cytokinetic bridge"	"HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424"	"unprognostic (3.47e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.10e-3)"	61.7	43.4	24.8	34.4	28.5	124.5	67.0	35.0	36.8	61.9	25.3	43.2	43.3	58.4	44.0	63.2	43.2	53.7	61.5	26.1	30.4	60.8	57.6	35.0	45.5	30.9	27.7	76.7	54.0	65.7	26.4	45.0	32.8	45.2	41.6	32.2	40.0	47.0	92.6	35.5	37.2	56.5	35.2	32.0	36.4	51.0	27.5	49.6	61.8	112.1	48.8	59.0	35.3	41.7	92.0	53.1	111.6	94.4	134.2	189.9	76.7	157.3	149.8	135.4	123.5	113.0	49.1	151.1	105.2	152.2	108.7	131.9	160.3	130.9	148.0	103.3	64.5	141.0	105.4	91.7	102.6	134.7	70.7	161.2	104.3	110.4	193.3	149.3	144.0	82.5	184.4	78.8	149.3	49.5	72.3	67.3	72.6	128.4	68.9	78.2	105.2	227.7	143.5	136.5	108.4	78.6	90.7	96.4	127.8	129.4	95.6	133.3	93.4	132.1	71.0	249.6	167.9	71.0	196.3	191.0	123.4	215.1	109.4	11.7	17.9	12.2	13.1	23.5	24.4	14.6	19.7	19.2	21.0	13.9	24.8	16.2	7.4	16.6	22.9	13.3	28.4	16.0	24.8	28.5	35.0	36.8	26.1	30.4	30.9	27.7	32.8	35.2	27.5	41.7	72.8	76.9	56.1	14.4	50.0	87.1	57.1	90.8	80.8	23.2	47.6	59.3	104.3	27.1	69.8	23.9	10.4	56.1	48.2	18.5	54.8	40.3	28.2	56.7	91.6	53.6	20.8	50.1	35.2	29.9	71.0	79.6	36.2	94.0	52.6	39.3	46.1	32.5	43.9	33.7	36.1	25.1	32.6	47.5	44.9	21.6	55.3	46.1	35.6	19.7	49.3	24.8	27.8	21.6	48.7	35.9	21.6	53.4	63.5	53.0	41.0	84.8	47.4	19.7	19.7	74.6	109.0	93.1	43.3	63.2	98.9	131.9	54.0	58.6	34.6	64.4
CPEB3	KIAA0940	ENSG00000107864	"Cytoplasmic polyadenylation element binding protein 3"	Q8NE35	10	92046692-92291078	"Predicted intracellular proteins"	"Translation regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 32.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 176.0;Early spermatids: 226.2;Excitatory neurons: 233.7;Inhibitory neurons: 286.9;Late spermatids: 408.9;Oligodendrocyte precursor cells: 148.8;Oligodendrocytes: 128.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.1;U-266/70: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070942			Approved	"Nucleoplasm,Plasma membrane,Midbody,Cytosol"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane, Midbody"	"HPA070942: "	"unprognostic (4.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.95e-5)"	"prognostic favorable (5.06e-5)"	"unprognostic (4.09e-4)"	"unprognostic (2.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.84e-9)"	"unprognostic (3.33e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.40e-1)"	1.9	3.9	6.1	1.8	7.2	1.7	3.2	6.2	17.3	2.5	2.1	2.3	3.1	1.9	4.5	4.6	1.8	2.0	5.1	6.4	4.3	4.6	32.2	2.2	1.9	10.4	5.6	3.5	3.5	3.2	4.0	1.6	11.0	4.2	2.6	7.1	7.5	2.4	19.7	4.0	3.0	2.0	1.4	2.6	2.8	12.9	4.4	1.5	6.5	9.5	2.1	1.9	3.1	7.0	0.9	0.2	0.3	1.9	0.5	0.5	0.7	0.8	0.6	1.2	0.9	0.6	1.9	1.1	1.0	0.3	0.5	2.5	0.9	0.6	0.7	1.1	0.9	1.4	1.3	0.8	1.4	0.6	1.4	0.4	1.5	0.6	2.4	1.0	1.1	1.3	0.9	12.1	0.5	0.7	0.9	0.8	0.2	1.3	0.9	1.1	1.6	2.1	1.2	0.4	1.4	0.5	0.8	2.2	1.6	1.0	2.7	1.6	0.8	0.6	0.6	0.4	0.7	6.3	1.7	1.1	0.3	2.2	0.1	2.6	0.4	0.8	0.2	0.5	0.2	0.7	0.1	0.3	0.3	0.1	0.1	0.1	0.5	0.2	0.6	0.2	0.1	0.2	6.1	7.2	6.2	17.3	6.4	4.3	10.4	5.6	11.0	1.4	4.4	7.0	6.1	6.4	7.0	176.0	6.2	8.8	4.0	4.0	7.4	26.0	20.5	10.7	25.3	5.7	4.4	12.9	50.1	2.1	3.0	11.3	5.9	3.2	226.2	9.0	3.0	7.1	19.8	3.6	233.7	2.6	1.6	5.5	4.1	10.8	3.8	4.1	12.5	75.2	4.8	30.3	286.9	9.9	8.2	23.9	3.4	408.9	5.9	10.3	5.4	87.1	8.9	3.2	4.1	148.8	128.6	3.2	4.0	7.9	4.2	10.7	10.1	5.0	8.7	24.7	0.0	4.4	4.1	13.2	7.2	22.0	13.9	1.2	3.3	3.4	5.9	6.5
CRACDL	"C2orf55, KIAA1211L, MGC42367"	ENSG00000196872	"CRACD like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 31.6"	"Cell type enriched"	"Detected in some"	9	"Adipocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 12.8;basal ganglia: 20.0;cerebral cortex: 30.8;hippocampal formation: 29.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.0;HDLM-2: 61.7;Karpas-707: 17.4;MCF7: 16.3;SiHa: 17.3;SK-BR-3: 22.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"amygdala: 19.1;basal ganglia: 45.5;cerebral cortex: 36.9;hippocampal formation: 54.9;olfactory bulb: 15.9"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"		Yes	No				"Cluster 68: Epididymis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: AB_2681337, HPA061678: AB_2684584"	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (2.22e-2)"	5.0	0.9	12.8	1.5	20.0	0.5	5.1	0.0	30.8	5.1	0.0	5.9	8.0	2.1	31.6	11.2	22.6	2.9	3.4	29.7	0.0	4.1	0.3	6.0	0.8	0.0	0.0	0.6	4.7	7.7	6.6	4.5	0.0	2.3	4.6	0.1	11.0	4.6	1.7	6.4	7.5	2.3	0.0	1.3	8.3	6.2	0.0	1.0	5.0	1.5	1.8	2.2	5.5	3.6	8.4	0.4	0.2	3.2	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.4	4.9	0.0	10.4	0.0	0.2	7.4	0.3	0.4	0.0	61.7	1.2	0.0	0.5	0.5	0.0	0.0	0.1	0.3	2.3	0.1	1.2	0.1	2.5	0.0	0.0	17.4	0.0	16.3	0.2	1.3	0.1	8.3	0.9	0.0	0.0	0.8	3.2	6.5	5.8	0.9	17.3	22.5	0.1	0.0	8.7	1.4	10.7	0.0	1.3	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	20.0	0.0	30.8	29.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
CRYBB3	CRYB3	ENSG00000100053	"Crystallin beta B3"	P26998	22	25199858-25207359	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 2.6;Distal tubular cells: 1.9;granulocytes: 4.5;Muller glia cells: 4.3;Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;HEK 293: 1.4;HeLa: 1.8;hTERT-HME1: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA055840	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA055840: AB_2682939"	"unprognostic (1.36e-2)"	"unprognostic (6.27e-4)"	"unprognostic (6.30e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-3)"	0.2	0.5	0.9	0.1	0.6	0.0	0.7	0.0	1.0	0.5	0.0	0.6	0.3	0.3	0.2	0.6	0.4	0.4	0.5	0.9	0.0	2.0	2.0	0.3	0.1	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.8	0.4	0.7	1.0	0.4	0.7	0.9	0.7	0.1	0.0	0.1	0.5	0.2	0.5	0.2	1.3	0.1	0.3	0.1	0.4	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	1.4	0.8	0.6	0.0	0.0	1.4	0.0	1.8	1.0	0.0	0.0	0.0	0.0	0.7	0.4	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.5	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	1.0	0.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.6	0.3	0.4	1.5	0.1	0.0	0.0	0.0	0.0	2.6	1.9	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.3	10.5	0.4	0.3	0.0	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.1	0.0	0.3	0.1
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 128.8;granulocytes: 139.9;Inhibitory neurons: 194.9;Oligodendrocyte precursor cells: 428.8;Oligodendrocytes: 444.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"non-classical monocyte: 7.7"	"Lineage enriched"	"Detected in single"	26	"monocytes: 7.7"	"Group enriched"	"Detected in some"	6	"HEL: 57.6;HMC-1: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	6.9	1.8	11.4	0.7	16.7	0.0	3.8	13.0	14.7	5.7	6.8	2.4	1.6	10.6	4.8	12.1	6.0	3.5	1.8	12.7	14.8	6.4	1.8	1.8	0.2	15.7	14.7	3.1	7.8	9.3	2.9	1.7	16.3	3.4	2.4	7.9	3.4	1.8	0.5	1.8	2.4	5.2	11.9	2.2	1.3	1.0	15.1	0.7	5.5	0.9	0.9	4.2	4.2	26.1	0.0	0.9	1.6	0.0	0.0	0.0	1.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.1	8.3	0.0	0.0	0.0	2.5	57.6	0.5	0.0	0.2	0.0	74.1	0.3	0.4	0.0	0.0	1.0	1.6	0.0	0.0	0.1	1.1	0.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	0.2	10.6	0.0	6.1	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	2.6	1.0	0.1	0.0	0.7	0.0	0.2	5.0	0.0	1.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	11.4	16.7	13.0	14.7	12.7	14.8	15.7	14.7	16.3	11.9	15.1	26.1	15.6	3.2	4.8	10.1	0.0	1.9	3.4	3.7	15.9	33.6	1.9	6.7	3.6	10.0	5.6	7.3	56.3	2.8	0.3	1.8	1.9	6.3	1.8	5.1	32.5	10.2	1.8	0.0	128.8	4.2	2.1	9.1	1.1	7.4	139.9	3.8	20.0	1.1	9.2	74.0	194.9	1.1	24.4	10.1	12.3	3.3	0.9	8.0	7.2	75.9	1.3	97.2	0.0	428.8	444.2	0.6	2.1	1.2	0.3	2.1	0.3	24.3	1.4	6.6	0.0	3.3	9.6	0.6	2.1	38.8	0.3	1.1	2.7	0.2	6.8	1.4
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.2;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3273.9"	"Lineage enriched"	"Detected in many"	111	"granulocytes: 3273.9"	"Group enriched"	"Detected in some"	11	"BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1"					"Low region specificity"	"Detected in all"			"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	13.8	1.5	0.3	40.0	0.6	7.3	0.8	0.2	2.6	4.5	0.1	0.9	0.2	0.4	1.3	27.2	2.9	7.8	1.0	0.3	0.1	0.4	2.4	6.5	0.7	0.6	0.5	0.4	2.9	0.4	0.2	4.6	1.4	0.6	0.7	0.0	3.0	3.8	0.5	4.8	1.2	2.4	0.3	27.3	0.7	0.2	0.5	2.8	0.6	11.6	3.0	7.8	7.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.3	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	15.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	63.5	29.5	50.3	28.8	7.4	0.4	0.2	1.3	7.3	13.5	0.2	1.1	9.9	3273.9	6.8	3.6	25.0	0.5	17.4	0.3	0.6	0.2	2.6	0.3	0.1	0.6	0.5	1.4	0.3	0.5	0.4	0.0	0.0	10.5	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.7	12.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	6.3	3.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	1.6	0.0	0.0	2.8	0.0	1.0	3.7	0.0	40.2	0.0	0.1	0.0	2.2	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.0	11.6	0.1	0.3	4.1	0.1	0.1	1.9
CYSRT1	"C9orf169, MGC59937"	ENSG00000197191	"Cysteine rich tail 1"	A8MQ03	9	137224635-137226315	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 239.5"	"Group enriched"	"Detected in some"	10	"Pancreatic endocrine cells: 58.0;Squamous epithelial cells: 66.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 23.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 25.1;CAPAN-2: 28.9;HaCaT: 33.3;HeLa: 30.6;MCF7: 49.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021883, HPA021886"	Approved		Approved	"Nuclear speckles,Vesicles,Midbody"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear speckles"	"Vesicles, Midbody"	"HPA021883: AB_1853190, HPA021886: AB_1853192"	"unprognostic (1.35e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.31e-3)"	"unprognostic (6.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	0.6	1.1	0.6	0.2	0.4	0.4	1.5	0.3	1.6	43.1	0.0	0.6	0.4	0.5	0.4	239.5	1.8	0.7	0.9	0.8	0.8	3.7	1.7	1.1	0.7	1.4	1.3	0.3	1.5	0.6	7.3	0.3	0.6	2.6	0.1	0.6	29.9	0.5	0.4	34.4	0.8	0.0	1.0	0.7	2.0	4.1	0.9	0.3	2.4	0.0	14.3	1.2	57.7	0.5	25.1	2.4	1.8	3.9	0.0	0.1	5.3	0.4	0.4	0.5	0.2	1.3	28.9	1.3	1.2	0.3	0.7	33.3	0.5	7.0	0.0	2.7	1.8	0.3	30.6	16.8	0.9	0.2	1.4	0.4	3.5	0.9	0.2	1.3	0.3	1.4	0.6	3.1	1.6	49.5	0.7	1.0	0.7	4.8	3.0	2.4	2.8	3.5	0.6	1.6	0.4	1.8	4.5	3.5	0.9	1.5	7.7	0.4	1.0	1.1	0.9	3.2	0.6	1.9	1.7	1.2	1.4	1.3	1.4	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.6	0.4	0.3	1.6	0.8	0.8	1.4	1.3	0.6	1.0	0.9	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.5	0.4	1.5	2.5	5.5	0.0	0.6	0.1	0.4	0.0	4.6	0.5	2.1	0.2	0.3	0.0	0.0	0.3	5.8	0.2	0.1	3.1	1.7	0.0	0.6	0.7	0.8	0.2	0.0	0.3	0.6	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	58.0	1.1	0.4	0.1	0.2	1.6	0.9	0.0	0.6	0.0	0.3	0.3	3.0	1.1	66.0	0.0	0.0	0.1	0.9	0.5	1.7
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315341	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.3;lymphoid tissue: 67.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 117.5;granulocytes: 57.0;Hofbauer cells: 76.8;Kupffer cells: 71.5;Langerhans cells: 87.5;Macrophages: 55.0;NK-cells: 120.5;T-cells: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 34.1;HMC-1: 141.1;THP-1: 95.2;U-266/70: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	21.5	8.8	4.9	67.3	4.5	58.3	5.1	4.4	8.5	5.3	6.0	10.7	8.5	4.4	1.6	6.1	4.8	16.4	5.6	4.7	5.6	4.1	5.7	18.9	57.0	8.8	7.4	3.4	2.5	2.1	2.9	28.0	7.8	3.6	10.0	0.3	7.3	4.3	2.2	2.2	15.2	12.9	6.7	59.2	11.5	2.7	9.7	25.6	3.0	5.1	40.3	23.2	2.5	9.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	9.3	0.3	0.0	2.5	0.1	0.0	0.6	0.0	5.3	0.0	9.8	0.0	0.0	0.0	34.1	141.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	23.2	0.0	0.0	0.5	13.5	0.0	0.1	1.0	1.3	0.2	19.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	95.2	0.3	0.0	0.1	0.1	0.0	28.4	4.0	4.5	18.5	11.5	0.2	15.8	62.6	87.5	55.4	102.5	39.0	30.3	30.5	44.8	47.5	31.8	30.0	38.3	199.1	45.0	129.4	113.8	30.7	76.2	4.9	4.5	4.4	8.5	4.7	5.6	8.8	7.4	7.8	6.7	9.7	9.1	1.1	3.2	8.4	0.0	37.0	2.4	0.8	0.0	0.6	0.1	0.7	1.5	2.0	0.0	1.8	0.0	0.0	0.5	117.5	0.1	0.0	0.0	0.4	0.1	0.2	2.5	0.0	2.5	0.2	0.2	0.6	1.9	2.0	0.1	57.0	0.0	2.2	1.1	76.8	0.0	0.2	0.2	0.0	71.5	87.5	0.9	0.6	55.0	7.2	24.4	42.7	0.0	120.5	0.5	0.0	0.8	0.0	0.0	25.1	0.3	0.0	0.8	0.0	0.1	0.0	0.9	1.0	0.0	0.2	0.3	2.3	1.0	43.9	0.0	0.2	0.5
CZIB	"C1orf123, FLJ20580"	ENSG00000162384	"CXXC motif containing zinc binding protein"	Q9NWV4	1	53214099-53220634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 29.2;Cardiomyocytes: 45.8;Cytotrophoblasts: 60.7;Extravillous trophoblasts: 76.7;Fibroblasts: 22.2;Hofbauer cells: 66.5;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043835	Uncertain		Approved	"Vesicles,Mitotic spindle,Cytosol"		Yes	No		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Vesicles, Mitotic spindle"	"HPA043835: AB_10796797"	"unprognostic (1.09e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.27e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (6.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-1)"	55.8	35.5	56.1	22.3	58.0	21.9	49.4	57.2	74.6	53.6	56.9	66.5	22.5	57.1	39.8	32.3	52.3	30.2	52.5	57.7	56.6	39.4	43.5	33.1	30.0	57.9	56.6	47.2	25.1	34.6	28.5	30.6	57.0	41.0	34.8	21.6	24.8	45.4	76.5	26.2	31.6	59.2	57.1	32.5	40.3	31.0	57.4	36.3	35.1	65.3	29.7	57.7	37.6	59.0	32.6	34.7	44.7	41.0	101.6	129.1	39.4	47.8	50.4	47.3	50.8	29.6	27.5	50.1	39.0	58.1	45.8	12.6	27.9	46.9	57.0	65.0	47.5	51.0	24.9	45.0	100.0	59.5	32.1	84.6	50.3	50.6	53.3	71.5	78.5	61.0	53.7	13.7	60.1	54.6	73.5	55.6	74.8	39.7	54.3	52.8	56.8	39.7	55.8	32.6	37.6	36.1	45.1	40.9	47.7	72.2	29.2	59.8	49.3	54.5	31.9	38.2	47.2	19.5	30.7	57.3	43.9	58.5	42.8	60.7	56.6	58.6	50.9	72.3	46.9	46.9	49.8	53.6	68.8	45.1	55.0	54.9	22.8	59.0	60.3	46.3	68.2	51.1	56.1	58.0	57.2	74.6	57.7	56.6	57.9	56.6	57.0	57.1	57.4	59.0	29.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	60.7	8.2	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	76.7	22.2	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	46.7	1.3	0.0	0.0	0.0
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: AB_2674256, HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	43.3	40.0	90.5	27.0	94.7	23.7	37.4	76.4	113.2	44.3	20.8	51.3	22.2	51.4	17.0	42.6	38.7	28.2	82.6	99.9	80.1	27.6	18.2	36.0	22.8	110.9	85.1	39.2	28.6	118.0	61.2	32.6	112.6	30.0	25.5	43.5	56.3	38.0	87.6	44.2	32.2	49.9	76.0	26.5	39.5	51.3	101.9	34.7	31.3	63.4	24.6	47.6	39.0	116.2	65.0	74.7	68.4	71.9	122.5	90.7	55.2	102.0	105.2	127.0	89.9	99.9	48.6	88.8	40.8	213.0	70.1	63.5	84.3	129.5	96.1	111.2	85.0	92.5	55.6	84.7	94.4	50.7	109.3	109.6	62.0	138.3	82.3	86.9	110.3	79.4	40.3	61.4	97.3	55.6	92.8	52.5	74.0	78.6	78.3	82.3	120.1	63.8	70.2	39.6	83.3	74.1	57.1	67.7	60.6	59.0	43.5	36.5	84.3	115.0	82.7	50.0	77.2	37.8	32.7	78.9	107.6	81.4	82.5	8.3	11.3	12.7	14.4	13.0	11.7	10.1	8.2	10.8	11.2	6.8	5.6	6.3	9.2	9.2	15.6	8.8	7.7	16.5	90.5	94.7	76.4	113.2	99.9	80.1	110.9	85.1	112.6	76.0	101.9	116.2	28.6	32.1	25.4	9.8	23.2	10.1	10.3	19.1	25.6	27.2	19.6	17.8	56.4	18.6	20.0	29.5	25.0	29.8	19.4	41.0	19.6	22.5	7.3	21.5	32.8	26.6	16.7	27.3	28.4	19.9	27.1	25.1	49.5	27.8	29.2	30.8	29.6	19.9	28.8	90.9	26.7	31.8	24.4	21.0	11.3	9.3	44.7	21.2	16.0	8.4	27.3	14.9	23.7	12.1	29.7	26.6	33.6	51.9	24.7	9.6	34.2	19.6	19.4	45.5	19.7	28.3	30.0	40.6	38.5	29.0	11.8	25.2	20.0	33.9	24.9	10.7
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814691-117832377	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 376.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	25.3	21.4	14.9	30.2	15.9	21.8	32.7	16.1	18.0	23.4	15.1	28.3	22.4	30.0	22.9	24.8	23.6	22.2	21.2	14.1	15.9	27.0	35.2	24.8	41.1	15.7	15.2	25.5	21.1	21.4	10.8	26.2	16.1	23.2	31.0	19.4	19.3	23.0	18.6	22.9	23.4	26.3	16.6	32.3	22.8	20.6	15.1	34.5	30.2	18.3	41.7	33.2	17.3	19.0	94.0	41.9	61.3	55.5	35.5	31.9	101.0	54.7	43.0	73.7	64.6	104.2	60.6	137.8	85.9	45.6	68.0	71.1	120.3	70.7	108.0	70.6	83.9	132.0	36.9	105.1	49.5	178.4	66.0	33.4	63.9	93.7	94.3	37.6	44.9	70.3	146.5	58.4	57.1	58.6	98.2	92.6	154.4	79.1	62.3	84.4	95.8	121.3	48.8	55.2	58.8	99.3	62.7	69.2	73.4	62.1	43.9	96.7	34.9	65.6	96.5	46.8	99.5	66.3	87.9	376.0	48.2	82.9	30.1	11.7	23.0	16.3	24.9	28.9	32.0	37.4	29.8	28.9	20.7	30.3	35.6	31.7	5.8	29.7	33.1	33.7	25.7	32.1	14.9	15.9	16.1	18.0	14.1	15.9	15.7	15.2	16.1	16.6	15.1	19.0	144.4	96.1	62.5	24.8	153.9	192.7	114.4	149.4	100.2	150.5	82.8	94.5	50.4	101.5	103.8	121.4	83.4	110.3	140.6	69.0	117.4	125.4	17.1	92.2	125.1	109.1	56.9	76.4	24.3	115.2	120.9	98.2	63.2	102.8	110.3	71.8	107.1	195.6	87.9	82.4	28.0	108.0	109.9	104.8	100.8	17.7	106.6	100.6	92.5	20.6	117.1	70.3	135.9	26.7	39.1	130.0	68.8	103.8	103.3	118.1	53.3	186.5	90.6	132.9	65.7	158.7	110.1	138.6	129.9	81.4	160.5	88.8	143.2	67.4	114.6	65.3
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565804-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	21.3	21.8	24.8	21.5	25.6	16.6	17.1	25.5	29.0	19.2	25.3	18.6	20.8	15.4	17.3	25.9	27.2	15.8	20.3	25.1	25.3	16.2	30.1	15.7	29.4	25.6	25.2	22.1	28.2	27.1	7.9	20.1	25.7	18.2	15.7	7.3	24.6	20.2	27.4	32.2	16.4	21.2	25.2	19.5	20.8	10.4	25.2	24.5	23.5	21.5	27.1	28.4	7.3	26.0	69.5	118.8	32.0	70.0	36.6	40.3	62.3	60.9	43.7	107.6	83.9	139.2	90.7	109.8	65.0	59.4	143.5	111.4	70.9	97.5	38.5	45.9	99.2	64.3	90.9	86.1	59.9	77.0	66.4	57.9	78.8	105.8	82.2	35.5	62.0	55.8	150.2	42.8	78.3	103.7	67.3	104.4	108.8	127.8	103.6	70.7	54.3	76.7	69.8	65.4	68.8	90.6	64.2	199.4	58.9	21.3	120.6	105.5	52.4	71.0	86.0	52.6	155.1	88.7	135.0	167.1	75.2	115.1	146.1	36.3	50.8	21.1	37.6	66.3	47.7	48.3	40.9	41.6	63.8	55.0	49.2	38.7	3.6	63.2	67.7	34.8	44.9	59.7	24.8	25.6	25.5	29.0	25.1	25.3	25.6	25.2	25.7	25.2	25.2	26.0	21.5	16.0	29.0	13.1	22.8	17.1	23.9	45.1	21.1	26.6	18.4	14.7	12.3	11.5	40.3	22.0	14.6	57.0	19.1	29.0	27.4	39.4	41.4	21.0	21.1	26.4	18.5	35.8	6.1	32.3	48.5	24.6	30.5	20.6	28.5	35.3	16.8	30.1	35.4	6.7	8.0	24.9	38.7	13.2	17.5	37.5	21.1	17.9	14.2	3.7	28.8	22.4	23.7	6.6	6.2	37.5	18.8	19.9	18.2	24.8	37.2	63.0	31.8	26.9	13.1	22.4	25.1	36.2	25.6	30.1	19.9	47.2	23.6	40.3	36.8	21.3
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056739	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	768	"intestine: 9759.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 1740.2;Undifferentiated cells: 1753.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 28.3;NB-4: 24.2;RPMI-8226: 26.6;SH-SY5Y: 19.6;U-2197: 8.5"									"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"	Yes	NA		110000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favorable (9.44e-5)"											"unprognostic (3.91e-2)"				0.3	0.4	0.1	12.7	0.1	0.2	0.5	0.1	0.5	0.0	0.1	56.6	5185.1	3.9	0.1	0.8	0.0	0.0	0.4	0.1	0.2	0.2	1.1	0.4	6.0	0.1	0.2	0.4	0.8	0.0	1.1	0.0	0.2	0.7	0.2	0.1	0.7	0.0	0.3	0.3	9759.8	0.1	0.1	0.4	0.9	0.8	0.2	0.4	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	2.5	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	325.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	399.9	0.0	0.0	0.0	1740.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	1753.0	0.0
DENND4A	"IRLB, MYCPBP"	ENSG00000174485	"DENN domain containing 4A"	Q7Z401	15	65658046-65792293	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 59.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 195.4;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 180.2;Rod photoreceptor cells: 155.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065343	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA065343: AB_2685476"	"unprognostic (1.10e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.83e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.48e-1)"	6.2	9.8	4.0	11.4	6.5	33.8	6.8	29.9	7.5	7.4	11.2	6.6	5.8	8.8	5.1	6.6	7.2	11.2	5.1	5.6	5.1	7.9	16.8	9.5	19.7	3.5	4.7	12.8	15.5	10.1	8.4	8.5	4.7	6.0	6.8	59.3	6.1	5.6	9.2	6.5	6.3	7.4	4.2	12.4	8.9	7.9	3.3	12.7	9.3	7.8	18.2	10.2	4.5	7.6	9.9	9.6	4.9	5.1	14.3	15.9	5.9	10.1	13.9	6.8	9.9	5.5	7.8	52.0	6.8	15.1	8.4	18.1	9.7	9.2	12.0	56.7	11.2	49.4	11.7	10.4	8.3	16.8	16.7	10.6	10.3	9.5	20.0	12.0	18.5	11.4	15.2	31.5	7.9	5.2	8.1	9.1	1.5	30.5	6.9	3.9	17.2	45.1	8.0	19.0	7.7	7.0	9.8	6.9	8.9	5.8	6.7	43.1	19.6	9.3	10.3	16.7	14.2	16.8	20.1	19.3	13.1	36.2	7.8	3.2	2.6	5.2	3.6	1.0	5.5	5.4	3.1	4.6	2.3	6.1	3.2	3.1	1.4	3.5	0.9	0.9	3.3	1.5	4.0	6.5	29.9	7.5	5.6	5.1	3.5	4.7	4.7	4.2	3.3	7.6	22.7	16.0	23.1	126.7	81.5	27.9	29.8	7.9	36.5	73.8	23.9	12.2	12.3	20.0	15.2	9.2	60.5	5.6	47.8	5.8	0.0	10.1	2.4	29.3	22.2	23.7	17.4	83.1	195.4	13.0	6.8	22.4	25.0	46.1	48.8	10.5	21.0	25.9	20.4	111.0	140.3	9.7	0.0	19.0	47.5	3.0	13.1	42.2	24.9	145.2	24.5	26.9	20.6	176.5	180.2	12.0	10.1	12.4	55.1	20.2	6.4	9.8	18.1	155.9	6.6	37.9	15.7	11.3	10.9	18.7	17.0	12.6	56.5	13.2	10.0	17.3
DESI1	"D15Wsu75e, DESI-1, FAM152B, POST, PPPDE2"	ENSG00000100418	"Desumoylating isopeptidase 1"	Q6ICB0	22	41598028-41621043	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 761.4;Late spermatids: 415.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053415	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Cytokinetic bridge"	"HPA053415: AB_2682141"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.16e-3)"	"unprognostic (8.75e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	11.9	18.5	34.3	10.4	36.0	7.5	10.9	37.1	36.6	10.7	23.6	13.3	11.6	11.2	11.3	26.4	10.2	8.9	38.1	34.4	37.5	22.3	47.3	14.7	11.6	36.1	37.9	12.4	12.5	13.1	12.2	9.3	35.5	13.0	10.6	12.9	12.0	10.6	16.1	15.5	12.6	11.3	34.9	13.5	16.4	18.7	38.6	8.8	9.2	17.6	13.6	12.7	11.9	35.3	16.7	17.4	17.0	23.4	23.5	28.0	9.6	33.0	21.0	30.0	21.9	23.2	10.4	63.2	22.2	38.2	15.7	23.8	45.7	36.8	31.1	28.6	34.7	14.2	32.5	19.7	28.8	56.4	18.4	24.1	42.2	36.8	34.1	24.3	45.8	21.7	42.0	69.5	24.0	21.2	12.9	17.2	16.8	62.2	26.0	17.3	7.2	65.2	38.0	10.5	12.1	6.3	31.8	34.5	23.0	19.3	11.4	18.3	46.8	22.0	16.0	23.4	16.3	25.4	21.1	29.7	54.4	24.4	29.7	9.1	6.6	7.8	3.3	9.0	4.3	4.1	4.0	3.9	5.2	3.7	3.5	4.3	3.8	2.1	6.2	3.0	5.3	4.2	34.3	36.0	37.1	36.6	34.4	37.5	36.1	37.9	35.5	34.9	38.6	35.3	21.2	9.6	18.9	10.7	27.1	8.7	36.6	42.1	13.1	19.8	29.7	29.8	55.2	18.6	21.7	9.2	6.2	31.1	15.0	29.0	39.2	50.8	761.4	29.5	24.7	24.1	19.7	11.8	13.9	30.2	39.5	17.6	19.4	55.0	10.8	27.6	19.6	72.9	50.4	21.9	18.1	19.9	22.4	28.1	18.6	415.8	19.0	33.8	14.2	6.5	49.4	18.6	30.9	11.6	13.3	50.0	29.5	10.5	46.5	111.0	80.1	53.7	10.8	11.4	26.3	14.3	24.3	149.4	30.7	43.6	13.2	83.6	22.4	28.9	26.3	72.3
DET1	FLJ10103	ENSG00000140543	"DET1 partner of COP1 E3 ubiquitin ligase"	Q7L5Y6	15	88494440-88546681	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA048873: AB_2680541"	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.67e-2)"	3.7	5.2	2.5	2.0	2.8	1.2	3.6	2.7	2.7	6.0	3.2	4.2	3.5	6.7	5.4	2.2	5.6	3.0	5.6	2.5	2.6	3.2	2.7	2.1	2.9	2.7	2.5	10.3	3.6	3.7	3.7	3.5	2.8	4.1	3.2	5.0	4.1	3.8	9.7	2.6	3.2	5.5	2.4	2.5	3.4	1.5	2.6	5.6	4.1	11.7	3.0	4.5	3.3	3.2	1.7	6.2	8.6	6.0	3.4	6.0	1.1	5.4	6.1	4.5	5.1	1.0	4.8	3.3	4.1	7.3	4.5	2.4	8.7	1.3	3.9	0.2	5.9	6.9	3.1	1.5	6.7	2.5	1.1	5.0	5.9	1.9	6.9	4.4	3.8	2.9	8.5	3.8	6.7	2.6	3.2	2.8	3.6	2.6	1.8	4.2	6.9	3.8	2.4	5.3	3.0	4.9	6.5	2.0	14.9	5.6	2.9	5.2	3.0	5.1	3.7	4.8	5.4	2.3	1.4	2.1	5.4	4.3	4.5	0.0	2.3	1.6	2.2	3.4	1.4	1.8	1.7	1.9	3.7	2.2	2.6	1.9	0.3	1.4	2.3	1.9	2.4	1.3	2.5	2.8	2.7	2.7	2.5	2.6	2.7	2.5	2.8	2.4	2.6	3.2	3.5	3.2	2.7	6.8	3.5	0.6	2.0	3.7	4.6	11.5	4.3	3.8	2.3	1.5	2.1	3.7	10.4	7.2	1.7	2.1	1.9	3.4	1.2	3.4	6.1	2.3	3.0	5.5	5.7	3.9	6.3	4.9	2.0	2.4	0.0	10.6	2.2	2.8	4.4	6.7	6.8	2.7	2.0	1.6	2.2	0.6	4.4	2.5	3.6	3.7	4.7	7.1	2.1	6.0	9.5	3.1	1.0	3.8	1.6	1.5	3.1	2.6	3.1	7.9	0.0	5.6	4.5	8.1	9.9	1.5	1.3	4.1	2.7	8.4	3.3	1.4
DHRSX	"DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6"	ENSG00000169084	"Dehydrogenase/reductase X-linked"	Q8N5I4	X	2219506-2502805	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003035, HPA075955"	Approved		Uncertain	"Mitotic spindle,Cytosol"	"Secreted to blood"	Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol	"Mitotic spindle"	"HPA003035: AB_1080631, HPA075955: "	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.69e-2)"	13.1	16.2	7.0	4.8	8.2	5.2	12.2	6.7	7.7	13.3	11.9	12.7	6.5	13.0	8.0	6.0	11.0	8.8	19.9	6.1	6.8	14.7	30.6	10.3	5.6	11.5	10.1	12.6	21.9	11.5	10.6	8.2	8.4	13.2	8.3	2.2	14.7	7.0	12.4	9.0	10.8	6.9	8.5	10.1	16.5	6.4	10.9	6.1	13.3	7.0	3.9	11.2	9.3	8.2	8.1	35.7	23.9	11.0	28.8	18.0	18.5	17.8	29.9	13.3	17.9	26.9	16.8	12.6	22.6	21.5	31.4	3.9	16.4	14.3	9.4	24.1	26.1	12.2	17.9	21.2	33.8	6.6	9.5	22.3	17.7	11.6	11.4	22.7	10.9	13.9	14.0	6.1	21.7	9.2	28.5	9.7	6.9	10.6	9.9	10.4	12.4	3.5	14.5	19.3	24.3	22.9	17.0	20.3	14.2	14.8	8.7	10.8	15.6	14.5	3.6	8.4	10.6	7.1	0.1	33.2	9.7	8.7	6.7	14.9	38.3	34.6	15.1	30.6	16.0	25.0	13.5	12.7	35.1	20.1	12.3	10.6	56.4	17.7	19.5	28.3	18.2	21.0	7.0	8.2	6.7	7.7	6.1	6.8	11.5	10.1	8.4	8.5	10.9	8.2	8.7	19.2	9.3	64.3	19.2	10.6	22.9	58.0	20.5	9.5	19.3	16.9	23.4	25.8	24.4	25.8	10.4	42.9	17.0	32.9	13.7	52.3	0.6	16.1	15.9	14.8	19.2	13.7	41.2	81.2	43.5	26.9	21.4	14.4	17.8	27.1	15.0	50.6	38.4	3.3	42.7	21.4	32.6	20.8	30.7	3.0	24.2	26.3	12.4	61.8	35.9	9.4	14.4	46.3	31.9	71.0	28.8	25.2	29.1	65.3	49.2	43.7	14.8	6.2	19.7	12.0	18.3	12.0	21.2	11.3	6.5	107.3	14.0	14.6	24.1	29.2
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 51.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.9;Excitatory neurons: 39.1;Horizontal cells: 21.9;Inhibitory neurons: 27.9;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;NTERA-2: 4.2;SCLC-21H: 12.5;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	0.3	0.4	46.9	0.5	41.2	1.1	0.2	0.0	48.2	0.2	0.0	0.3	0.2	0.3	0.0	0.1	0.3	0.1	0.1	36.0	19.1	1.3	0.1	0.2	0.3	0.0	17.8	0.1	1.1	0.2	4.8	0.0	0.0	0.2	0.0	1.8	0.2	0.2	0.1	0.2	0.5	0.0	0.0	1.9	0.3	7.5	51.6	0.3	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	8.0	0.1	0.0	1.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.3	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	12.5	2.4	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	46.9	41.2	0.0	48.2	36.0	19.1	0.0	17.8	0.0	0.0	51.6	0.0	0.2	0.0	0.0	1.0	1.8	0.3	0.9	0.8	1.8	4.1	0.7	0.8	1.0	0.0	0.1	1.8	4.2	0.1	0.9	0.8	3.9	0.4	18.9	0.2	0.1	0.4	1.2	0.0	39.1	0.6	0.2	0.4	0.0	0.1	0.0	0.3	0.4	0.1	10.1	21.9	27.9	0.4	0.0	7.1	0.6	19.3	0.9	4.1	0.0	1.9	0.7	1.5	1.0	8.0	0.7	0.2	0.0	0.0	0.8	0.2	1.3	0.8	0.0	2.2	0.0	0.7	0.4	3.4	4.9	1.1	0.3	0.0	1.3	0.1	0.9	0.6
DNHD1	"C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184"	ENSG00000179532	"Dynein heavy chain domain 1"	Q96M86	11	6497260-6593758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.5;Erythroid cells: 35.6;Excitatory neurons: 41.4;Inhibitory neurons: 32.8;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039698, HPA040267, HPA057639"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytokinetic bridge"		"HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.45e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-4)"	"unprognostic (8.15e-2)"	2.2	1.7	2.6	1.5	3.3	4.5	2.2	2.1	4.3	2.9	2.3	3.3	1.6	2.5	2.1	1.6	2.6	1.4	2.0	2.1	3.2	2.5	2.8	3.3	2.5	4.7	2.8	3.3	1.7	0.4	2.2	0.8	5.0	2.4	1.4	4.0	1.8	1.3	2.0	2.3	3.3	1.4	2.4	2.8	2.0	10.3	3.5	2.1	2.4	0.8	2.0	2.4	2.5	6.2	2.1	2.0	2.4	1.9	2.0	2.9	2.6	1.0	1.2	0.7	0.9	1.3	2.3	2.4	0.4	1.0	1.8	3.7	1.1	1.1	0.9	1.5	2.3	1.8	3.7	1.5	1.3	2.1	0.8	2.0	1.8	2.2	3.6	1.2	0.6	3.1	2.0	2.3	1.0	0.6	0.9	3.0	2.6	0.7	2.0	1.4	0.9	1.5	1.3	1.6	1.1	2.2	0.8	2.2	1.9	1.8	1.3	2.5	1.2	1.3	1.4	1.8	1.4	6.6	5.0	3.0	1.3	2.6	1.7	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.3	0.3	0.4	0.1	0.0	0.0	0.2	0.2	0.1	2.6	3.3	2.1	4.3	2.1	3.2	4.7	2.8	5.0	2.4	3.5	6.2	2.3	0.0	3.4	69.5	3.8	0.9	1.2	1.9	0.6	9.9	2.7	3.0	3.8	0.0	4.3	0.0	4.2	0.3	4.0	2.2	0.0	0.3	12.7	4.0	1.5	2.8	0.0	35.6	41.4	0.4	0.2	2.2	2.6	3.6	1.3	4.7	3.3	4.8	0.8	10.1	32.8	1.7	0.0	2.5	1.5	13.9	0.9	4.0	0.0	19.7	2.2	3.4	3.1	36.2	67.4	0.4	1.6	1.2	1.7	1.8	2.2	0.6	7.3	9.5	0.0	2.1	1.7	19.5	2.0	1.5	3.8	0.7	2.4	1.8	2.1	1.8
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791954-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 124.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 43.3;granulocytes: 124.8;monocytes: 50.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	19.9	19.4	22.8	24.7	23.2	44.1	20.0	23.3	26.1	21.0	23.9	33.2	17.5	27.2	25.0	19.5	24.7	21.7	27.3	23.1	24.2	19.2	19.3	22.3	23.7	23.2	24.3	20.6	15.8	26.1	20.8	23.1	23.4	22.0	38.7	21.7	19.4	22.8	62.0	28.2	21.0	24.4	23.4	25.3	24.6	30.4	23.8	30.1	19.6	31.0	28.0	34.0	19.3	24.4	79.8	41.6	42.1	40.2	31.7	34.1	43.7	29.2	47.1	92.7	83.4	134.8	126.1	32.8	93.2	42.9	147.1	58.4	37.3	62.8	61.1	18.0	47.2	36.0	45.2	87.2	64.4	70.0	56.7	34.4	58.0	60.8	58.2	42.4	55.1	46.9	33.9	32.6	56.0	107.5	57.9	108.2	28.7	44.8	280.7	46.0	52.3	34.4	47.4	37.9	39.5	35.6	59.7	48.2	65.2	32.7	47.6	111.4	32.6	55.4	41.1	54.0	71.0	35.5	24.8	41.0	120.5	44.8	48.1	16.7	50.9	71.0	4.1	22.0	4.2	12.0	5.5	7.0	43.3	11.1	10.1	4.7	124.8	3.3	13.6	16.6	9.3	13.5	22.8	23.2	23.3	26.1	23.1	24.2	23.2	24.3	23.4	23.4	23.8	24.4	21.2	16.0	22.9	10.1	22.0	25.5	44.8	43.1	22.2	19.8	20.3	23.0	19.9	21.5	37.1	25.8	4.2	60.7	14.3	37.2	50.9	57.6	37.9	35.1	19.4	22.6	22.2	9.7	11.2	75.4	43.0	25.7	26.5	20.6	6.3	26.4	25.0	16.6	70.8	20.2	9.5	92.7	59.0	26.3	34.7	15.7	28.3	32.4	16.0	11.2	68.3	53.1	15.5	7.5	10.6	105.0	50.5	27.1	21.9	38.2	33.3	44.2	48.0	29.7	0.0	20.8	26.5	92.9	35.4	19.4	27.6	57.7	16.3	32.9	34.8	60.7
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866284-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044502: AB_10960277, HPA053707: AB_2682236"	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	5.0	3.7	4.9	3.5	5.2	15.3	5.0	10.3	6.7	3.5	5.6	3.4	2.7	4.0	6.3	4.4	3.5	4.5	4.5	5.5	5.4	4.2	5.0	3.7	5.5	4.8	4.9	4.3	3.4	3.8	2.1	4.6	5.1	3.7	3.6	4.2	2.9	3.0	8.9	5.5	2.7	3.7	3.8	4.5	3.6	4.5	5.3	4.3	4.7	5.0	5.2	6.5	2.8	6.8	14.3	6.6	7.2	7.8	6.9	6.2	11.1	9.4	6.6	11.0	9.4	7.3	6.1	18.8	12.2	9.9	13.8	7.7	11.9	11.2	15.6	11.4	6.6	15.4	11.3	11.0	7.2	17.4	5.3	6.8	11.9	11.9	9.8	5.5	7.9	6.0	18.6	6.0	15.1	6.3	12.2	11.3	14.2	6.3	10.6	7.0	15.6	7.2	11.3	10.8	8.7	7.7	9.8	14.4	10.5	9.2	6.2	12.6	7.7	8.8	9.2	10.2	15.9	6.4	9.3	15.3	5.1	13.6	5.9	9.7	5.7	11.6	6.4	8.3	7.7	8.2	5.8	5.8	5.1	8.4	5.3	6.9	8.0	9.6	8.5	3.5	6.4	6.8	4.9	5.2	10.3	6.7	5.5	5.4	4.8	4.9	5.1	3.8	5.3	6.8	98.9	57.7	78.2	3.6	66.7	54.4	163.0	57.9	43.3	33.9	27.5	38.9	73.0	11.5	91.2	12.9	58.4	52.0	110.2	17.3	21.5	74.3	53.8	85.1	72.0	74.2	8.4	20.6	6.8	60.3	44.4	54.3	38.2	122.4	119.4	36.6	25.7	19.4	38.1	20.2	7.7	14.5	46.8	29.5	72.1	11.0	25.7	75.8	23.2	8.4	52.1	29.2	48.4	3.5	7.2	88.6	20.1	25.9	50.1	96.7	17.2	19.6	85.1	34.4	19.7	90.7	79.0	62.8	65.9	40.0	50.6	55.8	87.7	44.4	23.1	112.0
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.2;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.3"	"Group enriched"	"Detected in some"	4	"HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	12.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	89.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	327.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.5	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	22.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.4	0.1	0.0	17.2	0.5	0.0	0.0	1.3	0.0	0.4	1.6	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.7	0.0	0.0	0.9	0.3	0.3	11.7	0.0	0.0	6.2	0.5	0.2	0.0	0.3
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 component of MIS12 kinetochore complex"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	5.9	9.9	4.2	7.5	4.2	14.3	8.6	3.9	4.5	5.0	5.2	9.2	6.8	4.4	9.3	7.9	4.1	4.4	5.1	4.3	4.4	4.8	9.1	6.3	12.8	4.0	3.9	4.3	4.3	5.5	3.5	8.8	4.1	6.5	10.8	10.7	5.9	6.3	4.0	8.0	7.8	6.3	3.9	9.6	7.3	23.3	4.1	16.4	5.1	4.8	14.3	4.4	4.7	4.7	36.7	29.1	35.7	29.5	14.0	18.0	24.7	42.9	35.1	63.9	70.2	52.5	44.4	39.3	27.4	23.0	69.1	45.8	33.3	32.7	60.3	18.2	22.7	78.3	26.2	36.1	3.0	46.2	34.0	7.0	9.4	43.7	13.8	10.4	31.5	42.4	30.9	33.7	41.7	25.3	59.2	34.5	16.8	63.3	55.1	46.1	109.4	28.4	16.2	20.5	37.8	16.9	52.9	53.7	25.8	26.3	55.9	30.5	16.4	60.1	35.0	56.9	46.1	27.3	39.1	46.4	49.8	40.8	42.6	53.4	6.4	14.5	7.4	11.0	8.4	14.6	8.1	10.3	7.1	18.4	10.1	9.0	11.9	11.1	10.1	46.9	12.2	6.7	4.2	4.2	3.9	4.5	4.3	4.4	4.0	3.9	4.1	3.9	4.1	4.7	6.5	6.4	4.4	1.6	10.3	5.0	11.4	7.6	3.4	8.0	8.7	7.6	5.4	2.8	8.6	5.5	29.2	49.8	9.8	9.2	7.9	6.8	10.6	5.5	5.9	8.1	2.4	22.1	6.3	6.4	30.4	8.4	20.9	9.4	3.8	21.8	7.9	6.2	14.7	6.7	4.4	13.6	4.1	6.3	4.6	8.0	8.7	6.7	1.8	5.6	7.4	6.0	7.2	3.0	3.6	5.1	5.4	7.5	22.9	7.1	7.7	3.6	8.2	17.5	0.0	5.3	8.2	115.5	75.1	12.3	7.2	47.5	7.7	6.9	13.6	11.0
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522807-15663058	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 127.0"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	16.2	9.3	40.8	17.6	60.1	16.7	14.8	35.1	46.6	13.2	32.5	26.0	11.8	13.5	18.3	11.3	11.6	12.6	21.5	42.8	45.7	18.0	8.6	14.7	29.3	40.2	41.9	11.0	11.9	21.0	11.5	14.9	40.8	13.8	16.4	127.0	13.7	14.8	26.8	13.6	17.4	17.8	38.0	22.1	17.1	12.0	44.3	21.4	13.2	16.0	30.9	19.8	12.5	37.8	30.6	12.9	10.9	23.7	15.5	17.8	16.6	15.3	20.0	36.0	32.4	17.6	13.7	42.9	40.5	21.8	29.6	10.4	21.8	16.3	32.6	27.3	28.9	30.2	15.4	25.7	27.3	30.6	24.8	16.9	24.7	18.5	26.8	16.6	32.2	29.0	29.3	10.2	22.1	35.9	31.9	48.7	7.7	25.4	18.6	37.7	21.2	33.4	33.7	31.7	22.1	9.5	12.1	28.4	36.4	25.1	20.6	19.4	15.2	20.5	13.4	21.2	28.6	27.7	57.3	30.9	9.5	27.1	39.5	11.1	10.1	14.4	19.5	12.4	13.1	24.8	16.5	17.2	11.0	31.3	15.5	12.6	11.6	49.3	9.0	30.8	12.1	11.5	40.8	60.1	35.1	46.6	42.8	45.7	40.2	41.9	40.8	38.0	44.3	37.8	23.2	12.8	11.3	35.3	42.6	29.1	16.5	12.5	11.4	47.2	14.3	13.1	29.3	15.7	11.4	14.7	58.4	41.4	29.6	18.6	37.2	37.5	50.5	16.3	9.8	31.7	13.8	5.5	36.3	35.8	17.9	16.9	14.3	14.5	54.6	54.1	20.0	6.0	54.8	25.2	38.6	17.5	8.2	18.5	32.4	26.6	10.2	22.1	37.4	39.4	29.8	55.2	64.9	26.7	36.3	26.5	12.1	15.4	20.2	12.9	27.2	81.6	13.0	173.4	6.6	12.3	20.8	22.3	18.3	8.6	22.0	16.7	29.1	11.0	19.2	12.0
DTWD1	"MDS009, MGC111207"	ENSG00000104047	"DTW domain containing 1"	Q8N5C7	15	49621037-49656232	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042214	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"HPA042214: AB_2677903"	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.70e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.35e-1)"	19.6	11.8	7.7	13.0	10.1	5.4	18.2	8.2	9.1	27.4	6.5	21.1	7.4	22.6	16.8	13.3	21.1	23.0	11.0	9.0	8.9	11.0	11.5	10.9	12.9	5.7	6.9	22.7	33.3	11.5	9.2	12.8	6.0	15.7	11.9	8.8	21.5	14.7	10.3	12.2	9.1	20.5	6.4	9.0	14.9	9.5	9.9	11.7	17.6	21.1	10.0	20.4	15.9	9.8	10.0	11.9	21.2	11.5	41.3	84.1	16.6	29.3	28.6	36.8	27.5	4.2	8.3	16.7	20.3	38.7	16.8	17.8	15.6	15.8	37.7	10.8	11.2	13.8	23.5	14.5	29.1	18.0	11.1	38.8	20.4	24.3	29.7	32.9	15.5	19.3	26.3	17.3	41.7	23.3	12.3	15.1	12.4	22.6	15.7	17.4	44.7	64.9	12.3	7.1	18.6	14.4	34.7	11.5	27.3	22.1	12.1	25.4	10.7	43.6	17.3	25.6	32.3	13.2	22.2	10.0	37.5	53.9	28.3	8.7	9.7	5.2	6.8	11.7	9.8	9.7	10.3	11.6	12.8	10.1	12.0	11.5	2.6	13.9	15.3	25.3	8.9	6.0	7.7	10.1	8.2	9.1	9.0	8.9	5.7	6.9	6.0	6.4	9.9	9.8	39.9	19.2	15.0	36.6	16.6	19.2	15.4	31.9	18.2	41.8	23.0	34.0	18.8	12.8	22.1	35.0	31.3	23.4	27.1	4.7	31.3	20.1	21.0	27.8	88.1	23.6	15.5	20.8	57.2	21.0	27.7	49.9	20.4	14.1	7.0	29.3	25.4	14.9	19.5	18.5	55.2	19.2	40.7	16.4	14.9	11.2	37.9	16.7	16.0	18.7	10.4	20.3	18.6	33.7	66.1	20.8	10.3	28.2	27.0	21.5	9.5	22.0	37.9	40.0	6.6	35.5	46.7	51.2	44.3	19.6	19.0	9.7	16.2	35.4	17.1	12.7
DUSP11	PIR1	ENSG00000144048	"Dual specificity phosphatase 11"	O75319	2	73762184-73780157	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021052			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge"		Yes	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli fibrillar center"	"Cytokinetic bridge"	"HPA021052: AB_2670577"	"unprognostic (2.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.87e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.28e-3)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (7.20e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.84e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.46e-1)"	16.0	13.3	7.9	17.1	7.7	35.2	20.4	13.4	11.2	22.4	7.6	16.0	17.3	21.2	19.3	30.5	39.0	15.9	14.2	8.1	6.9	20.2	17.9	14.3	25.3	6.1	5.7	23.5	11.0	14.7	14.0	20.5	6.1	16.5	17.4	8.3	16.0	14.4	14.3	27.6	15.3	19.6	4.8	19.0	16.3	16.8	6.5	24.8	16.5	17.8	26.1	25.2	22.4	8.3	39.4	16.7	17.6	18.6	31.2	38.7	31.2	28.2	36.7	35.8	36.4	24.2	29.1	50.6	17.7	30.6	32.1	26.7	22.0	56.8	34.3	35.2	22.9	31.2	12.0	37.3	32.7	35.5	28.0	31.6	67.3	32.1	44.1	31.1	40.4	24.2	33.6	28.6	40.2	21.3	34.3	37.6	28.4	36.7	22.7	13.6	47.3	46.0	29.3	32.1	25.9	14.1	26.1	30.6	35.7	21.0	16.4	18.6	23.1	25.4	31.4	29.5	33.7	30.7	26.2	68.1	23.5	35.5	25.3	72.5	42.2	99.5	56.3	39.3	73.5	68.3	65.8	67.4	47.3	65.9	69.4	65.5	65.2	69.8	40.6	35.7	88.6	71.7	7.9	7.7	13.4	11.2	8.1	6.9	6.1	5.7	6.1	4.8	6.5	8.3	26.5	9.6	12.0	7.5	39.5	83.2	55.1	93.0	39.3	11.0	12.9	15.1	8.6	27.1	45.7	12.9	4.2	32.8	34.8	15.5	50.9	29.6	9.1	18.0	15.7	34.6	12.0	21.0	14.9	27.3	42.0	26.5	16.3	13.6	40.7	20.5	52.1	15.3	30.7	5.0	12.7	18.0	36.7	20.2	27.1	7.0	28.9	17.0	23.2	10.3	34.8	9.8	41.2	13.0	13.8	28.2	17.8	25.6	31.8	30.0	22.8	50.4	38.2	16.6	6.6	18.2	23.1	23.8	34.6	42.8	83.0	38.6	39.8	20.7	18.8	60.9
DVL3	KIAA0208	ENSG00000161202	"Dishevelled segment polarity protein 3"	Q92997	3	184155377-184173614	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046486, HPA058265"	Approved		Approved	"Intermediate filaments,Midbody ring,Centrosome"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Midbody ring, Centrosome"	"Intermediate filaments"	"CAB046486: AB_10610845, HPA058265: AB_2683658"	"unprognostic (2.20e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (8.61e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.77e-5)"	"prognostic unfavorable (1.53e-8)"	"unprognostic (1.87e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.95e-1)"	35.2	28.1	16.4	18.7	17.4	18.6	29.8	17.4	18.9	39.0	15.9	46.0	17.2	44.7	16.1	30.3	34.5	22.6	35.0	16.4	17.1	25.7	20.0	31.7	13.9	18.1	17.3	42.0	25.6	17.9	24.4	38.3	17.6	29.1	16.1	22.8	25.6	25.8	34.9	33.8	27.1	31.7	16.6	25.6	27.9	15.1	17.0	12.4	30.0	22.3	15.9	36.6	31.6	18.3	47.9	13.6	36.4	41.4	37.5	37.8	95.0	28.4	28.9	32.7	27.6	43.6	18.3	33.6	73.3	37.0	32.4	40.8	29.6	22.2	23.4	54.0	32.2	38.1	21.3	28.2	56.6	21.2	27.8	38.4	39.9	23.4	27.3	55.9	24.6	21.6	38.9	44.2	35.5	46.5	28.3	25.2	32.8	34.6	22.1	49.9	42.7	30.0	31.7	36.2	36.3	51.0	34.9	39.8	67.4	35.8	98.7	26.8	25.0	29.5	28.5	31.0	43.8	48.3	38.8	37.0	30.0	22.4	23.6	0.1	0.6	1.3	0.6	1.0	0.8	0.7	0.4	0.7	0.6	0.5	0.5	0.3	0.9	0.4	0.3	0.8	0.2	0.4	16.4	17.4	17.4	18.9	16.4	17.1	18.1	17.3	17.6	16.6	17.0	18.3	15.9	25.6	14.1	16.6	10.8	18.7	15.7	12.9	15.9	20.1	23.5	16.5	26.9	12.8	17.2	22.0	27.1	34.4	14.6	40.8	23.5	13.3	12.8	23.2	30.9	15.9	34.3	6.9	11.4	16.6	21.6	22.6	32.6	27.7	17.1	29.7	19.2	20.5	20.3	62.2	11.8	22.3	12.2	16.2	14.4	47.5	33.5	17.4	12.4	14.0	10.8	19.7	14.4	9.0	11.5	20.7	18.9	37.2	13.9	20.8	25.2	18.3	13.4	18.5	19.7	23.6	27.1	10.6	12.4	20.4	21.7	52.1	10.3	21.9	21.5	25.7
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.3;testis: 83.8"	"Group enriched"	"Detected in many"	12	"Early spermatids: 179.4;Late spermatids: 580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	"Nucleoplasm,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Mitotic chromosome"	"HPA028522: AB_2672656, HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	9.5	19.6	4.8	2.7	4.8	4.7	10.9	4.1	6.2	12.5	4.8	12.4	5.3	11.9	7.8	11.7	13.8	3.3	20.0	4.7	3.6	16.2	7.5	8.8	4.6	3.5	3.4	11.6	10.3	6.5	31.5	2.7	3.6	13.0	2.1	4.1	14.3	3.3	131.3	14.8	10.2	2.6	1.2	14.0	12.1	83.8	3.6	5.2	16.5	49.9	2.5	11.4	10.5	3.0	0.4	9.3	8.8	6.2	4.9	4.6	0.7	2.9	1.8	2.6	2.3	0.9	3.6	1.4	11.0	3.4	0.1	3.2	1.3	2.0	2.3	5.4	7.8	0.6	5.9	0.9	4.1	0.3	1.9	6.2	1.2	0.8	2.9	8.6	0.6	3.5	1.5	2.0	0.4	4.7	2.1	0.8	2.2	2.7	2.1	1.0	0.2	0.6	5.7	2.2	12.7	14.5	4.5	4.4	0.2	4.6	4.4	0.5	4.5	1.1	2.0	1.0	0.9	3.2	1.1	1.0	7.4	0.9	0.4	0.7	1.6	1.8	3.0	1.7	3.6	2.4	2.0	3.1	1.9	1.6	1.0	1.7	2.5	3.3	1.6	4.5	2.2	1.7	4.8	4.8	4.1	6.2	4.7	3.6	3.5	3.4	3.6	1.2	3.6	3.0	6.0	0.0	0.6	6.2	10.9	3.4	3.8	8.4	10.2	15.2	9.0	6.1	6.1	7.2	3.4	16.5	20.9	2.1	21.7	10.3	9.8	13.1	179.4	15.4	6.7	7.3	20.4	19.8	4.6	4.3	1.7	5.1	7.7	10.1	1.3	11.9	12.1	3.9	5.9	10.1	6.3	9.8	10.2	8.2	3.0	580.2	7.2	4.7	5.4	7.5	5.7	8.3	10.3	5.0	3.2	9.7	9.7	5.3	5.0	4.8	11.5	17.4	10.7	13.0	0.0	11.1	4.8	30.1	13.4	6.1	2.8	1.4	10.8	20.2	7.4	3.6
DZIP1L	"DZIP2, FLJ32844"	ENSG00000158163	"DAZ interacting zinc finger protein 1 like"	Q8IYY4	3	138061990-138115818	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030404	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA030404: AB_10601548"	"unprognostic (3.65e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.47e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.72e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.77e-2)"	4.9	1.4	1.7	2.2	2.2	8.8	4.7	5.9	2.1	8.6	15.3	5.0	2.2	8.1	1.9	2.5	12.8	5.7	3.3	2.2	2.3	5.6	1.0	5.7	0.9	5.7	7.4	7.0	6.3	2.7	2.1	2.0	4.2	4.1	1.5	4.6	2.1	3.3	1.0	7.8	2.1	4.6	4.3	2.6	7.2	4.1	2.6	0.4	3.6	0.9	0.7	6.1	5.3	2.2	5.4	3.1	6.1	5.1	3.8	5.1	1.4	8.6	5.1	5.0	6.3	2.0	0.4	0.0	4.3	8.0	7.0	1.7	4.5	2.0	2.4	1.2	4.4	2.4	7.5	0.3	3.1	1.8	4.0	5.4	2.0	5.5	2.6	5.1	2.8	1.4	1.8	0.0	6.9	0.3	0.0	0.8	7.4	0.0	1.1	0.0	7.1	0.0	2.3	8.5	2.1	4.8	8.9	0.0	4.3	3.4	2.3	3.7	2.2	12.3	5.6	6.0	4.5	0.0	0.0	0.1	4.9	2.6	4.8	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	2.2	5.9	2.1	2.2	2.3	5.7	7.4	4.2	4.3	2.6	2.2	1.4	3.2	2.0	4.2	0.0	3.6	0.6	1.9	7.4	8.6	0.2	2.5	2.9	7.2	7.7	1.8	8.4	0.1	0.0	0.0	5.9	3.8	17.4	58.8	8.5	2.6	0.0	1.3	4.0	1.2	0.1	6.5	7.1	1.1	0.0	7.4	0.0	0.0	1.4	3.3	2.9	0.0	2.0	3.2	2.6	1.8	6.2	3.5	0.0	3.7	0.6	2.7	0.0	2.5	0.2	5.9	0.0	4.1	0.0	0.4	0.0	0.8	74.0	19.4	0.0	7.2	9.8	0.6	2.3	1.7	4.3	0.0	0.5	1.7	0.0	0.1
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	35.1	38.8	30.3	35.2	31.1	34.3	39.5	28.8	33.5	30.0	32.5	35.4	23.6	35.5	55.7	46.5	43.5	21.7	37.1	31.1	31.0	55.7	126.6	27.7	35.9	29.3	28.5	27.3	36.1	45.6	48.9	33.1	30.0	29.0	36.5	19.6	34.5	31.0	51.9	36.8	24.5	35.0	29.6	24.8	33.4	44.4	31.8	30.5	41.4	28.6	39.8	52.5	34.5	31.1	325.0	180.2	66.0	192.7	52.1	58.3	142.6	219.4	107.8	338.7	210.5	215.2	192.5	211.0	167.9	157.0	157.2	218.2	144.5	200.9	360.5	101.2	146.5	144.8	160.9	188.5	95.7	248.7	106.8	47.6	197.4	248.6	197.3	64.2	185.5	145.2	220.3	67.8	165.1	172.8	190.0	152.0	290.8	209.5	165.0	139.2	150.4	235.5	123.7	135.0	132.0	139.9	127.3	228.6	219.0	105.6	94.5	136.1	147.6	128.7	248.9	211.4	360.7	102.9	219.7	262.7	107.6	258.7	265.2	19.7	45.4	24.9	52.3	54.1	55.2	61.5	52.8	54.5	68.7	68.5	48.3	48.3	3.9	59.6	53.3	65.6	60.5	43.6	30.3	31.1	28.8	33.5	31.1	31.0	29.3	28.5	30.0	29.6	31.8	31.1	38.0	35.3	39.5	5.9	36.9	123.0	91.6	78.0	40.5	26.3	50.6	62.1	32.0	52.9	52.5	31.3	6.2	102.2	23.3	34.0	90.1	144.5	163.5	56.8	47.3	51.0	24.1	45.0	5.6	124.4	135.1	51.5	33.1	31.6	50.7	35.1	27.8	148.3	63.3	15.2	3.8	49.7	48.8	22.5	24.7	94.9	33.2	28.9	55.2	3.7	41.4	55.7	35.0	6.0	4.9	135.3	25.8	38.4	53.1	179.3	29.4	135.9	81.3	29.5	39.5	55.0	68.1	92.6	97.8	54.2	99.4	84.3	26.8	57.8	66.2	95.3
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035347, HPA035348"	Approved		Approved	"Mitotic spindle,Centrosome,Cytosol"	"Secreted to extracellular matrix"	Yes	NA		10000000		"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Centrosome, Cytosol"	"Mitotic spindle"	"HPA035347: AB_10669856, HPA035348: "	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	122.1	14.3	5.0	2.1	5.0	0.6	34.8	6.0	4.9	43.5	8.1	6.8	9.0	40.8	23.2	9.0	30.0	31.7	31.5	4.5	11.6	28.4	81.5	22.5	8.3	5.2	10.3	91.6	6.3	9.1	6.1	3.5	5.8	21.2	7.4	0.3	7.2	22.2	7.4	9.7	14.8	27.8	4.4	0.9	4.3	16.8	8.0	5.0	11.4	24.6	7.8	13.3	11.1	12.0	0.7	0.1	0.4	0.0	19.1	34.5	1.3	0.8	1.1	0.1	0.5	0.6	0.0	0.0	0.1	1.9	0.3	0.5	0.9	0.8	0.1	4.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	36.8	42.8	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.1	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.0	6.0	4.9	4.5	11.6	5.2	10.3	5.8	4.4	8.0	12.0	12.9	0.0	2.3	5.5	0.3	11.5	0.1	0.6	0.6	3.0	0.3	1.3	5.5	1.5	2.0	0.0	2.1	0.1	0.3	0.2	0.0	0.1	5.1	0.6	18.6	5.2	0.0	0.8	3.4	0.0	16.2	73.3	0.5	0.5	0.0	18.2	2.2	49.3	0.4	0.0	2.8	0.4	0.0	1.3	15.4	8.9	122.1	1.1	5.4	17.8	0.1	0.1	0.0	0.5	2.9	0.0	0.2	69.6	1.4	0.1	11.1	9.2	3.3	2.5	26.3	43.6	50.2	0.9	0.6	0.9	9.1	0.8	0.9	13.5	0.6	0.2
EEF1AKMT3	"DKFZP586D0919, FAM119B, METTL21B"	ENSG00000123427	"EEF1A lysine methyltransferase 3"	Q96AZ1	12	57771492-57782541	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	7	"RH-30: 152.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043020, HPA045492"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome,Centrosome"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nucleoplasm, Mitotic chromosome"	"HPA043020: AB_2678274, HPA045492: "	"unprognostic (2.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.34e-3)"	"unprognostic (7.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.23e-1)"	7.5	6.2	2.5	3.6	2.3	2.6	9.2	4.1	2.7	10.5	2.6	5.6	3.9	9.3	9.6	5.6	8.4	5.4	3.7	2.4	1.8	11.6	6.5	5.3	3.6	2.6	2.4	11.4	21.7	6.4	3.7	4.6	2.7	8.2	4.6	3.7	19.4	8.7	2.9	7.3	3.8	7.6	2.1	4.0	7.2	4.2	2.4	1.9	10.1	3.1	3.1	6.3	7.3	3.1	5.4	11.0	4.6	5.9	12.8	12.0	4.0	5.8	10.9	8.9	9.0	5.6	9.5	3.1	7.4	7.6	7.2	5.2	3.7	3.3	9.3	4.0	5.6	14.9	6.6	9.2	11.3	3.7	6.6	12.6	8.7	9.3	9.8	15.2	9.7	13.2	8.9	22.6	5.4	3.8	4.7	11.0	3.4	4.3	8.0	8.5	152.1	10.0	6.0	5.3	4.4	6.0	10.0	7.5	6.2	4.1	11.9	10.0	9.5	13.7	7.7	5.8	6.4	5.7	2.3	3.8	11.3	15.4	10.0	0.4	3.0	0.1	1.8	1.1	7.8	0.5	3.5	2.2	3.1	0.4	1.7	1.4	0.7	1.5	4.6	1.5	2.2	2.3	2.5	2.3	4.1	2.7	2.4	1.8	2.6	2.4	2.7	2.1	2.4	3.1	3.9	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	7.6	0.0	0.0	1.8	1.8	0.0	3.4	1.3	0.0	5.9	5.5	0.0	2.0	6.0	1.9	0.0	0.0	0.0	12.7	4.9	3.4	0.0	2.5	2.5	5.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	16.4	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.6	0.5	4.7	0.0	0.0
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.6;fallopian tube: 19.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.3	0.4	0.8	0.1	1.0	0.8	0.3	1.7	1.1	1.1	12.6	0.1	0.0	0.3	0.8	0.0	19.7	0.2	0.3	1.4	1.5	0.8	1.2	1.7	0.1	4.9	7.0	1.0	0.6	1.7	3.6	0.1	3.2	3.0	0.0	1.6	0.2	0.2	0.0	0.1	0.3	0.0	3.6	0.4	0.7	6.9	2.4	0.2	1.2	0.0	0.2	0.0	0.1	1.0	0.1	0.7	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.7	1.1	1.4	1.5	4.9	7.0	3.2	3.6	2.4	1.0	0.2	3.2	1.7	0.3	0.5	0.5	0.1	0.8	0.0	0.4	0.7	0.4	1.3	1.5	1.8	0.0	2.1	0.0	0.3	0.1	0.0	0.2	29.6	31.9	0.7	0.5	0.0	0.0	2.7	0.2	0.1	0.5	3.1	1.9	0.0	0.1	0.0	1.1	0.1	5.0	0.8	0.3	2.0	0.0	0.0	20.1	0.3	0.3	0.0	0.0	0.1	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.9	46.0	5.6	0.0	0.5	0.6	6.8	2.7	0.7	0.3	0.0	0.3	0.3	0.0	0.2
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772605-43777315	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.7;skin 1: 25.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 10.5;naive B-cell: 15.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9"	"Region enriched"	"Detected in single"	11	"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA028938, HPA073494"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA028938: AB_10795352, HPA073494: "	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.5	0.9	1.0	9.7	1.0	0.2	5.2	1.0	1.1	1.6	4.7	8.0	14.1	0.6	1.1	4.5	3.9	0.7	0.5	1.0	1.1	1.4	0.7	1.5	49.7	1.0	1.1	1.7	0.4	1.6	0.5	3.7	1.1	2.0	12.3	0.1	2.2	1.0	0.4	25.0	12.9	1.0	1.0	1.0	1.8	16.2	1.4	1.5	0.7	1.9	57.7	0.7	0.8	1.1	2.1	0.2	0.6	1.1	4.9	1.2	0.4	0.2	1.3	2.8	3.1	0.0	1.3	73.8	0.1	1.2	0.1	13.7	1.3	0.7	1.4	1.6	7.3	0.4	2.6	4.6	1.0	0.1	0.0	1.4	12.3	0.7	0.2	0.2	1.1	0.4	0.2	0.0	0.7	4.0	1.5	1.4	0.1	28.5	2.4	0.8	0.0	0.0	1.8	0.0	9.5	0.0	1.7	21.5	0.0	0.3	39.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	149.9	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	10.5	0.6	0.1	0.0	15.9	1.1	0.2	0.0	0.1	0.0	2.2	0.6	0.6	1.0	1.0	1.0	1.1	1.0	1.1	1.0	1.1	1.1	1.0	1.4	1.1	0.1	0.0	0.0	0.0	2.2	0.4	0.1	0.2	5.2	0.0	0.7	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.3	1.2	0.0	0.1	1.8	0.4	0.1	0.2	0.0	0.4	0.1	0.7	0.0	0.5	4.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.5	0.0	0.0	0.5	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	6.5	0.1	3.1	0.0	0.0	0.2	0.4	0.2	0.2	21.0	1.0	0.3	0.1	0.1	2.3	0.2
EMG1	"C2F, Grcc2f, NEP1"	ENSG00000126749	"EMG1 N1-specific pseudouridine methyltransferase"	Q92979	12	6970913-6997428	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039304, HPA039666"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA039304: AB_2676432, HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	16.8	18.0	13.0	15.2	14.2	12.6	17.3	14.4	20.2	14.9	15.9	14.0	11.1	14.5	13.6	20.2	16.1	4.6	22.6	13.2	14.1	23.2	22.8	15.9	13.4	14.4	14.2	13.9	13.6	9.4	12.8	8.6	14.5	15.7	9.7	9.3	13.6	6.1	21.2	17.4	14.0	7.4	14.3	18.1	14.6	9.9	14.0	12.3	15.6	12.8	12.8	16.1	14.1	15.3	55.5	53.7	20.5	25.2	15.8	11.5	84.7	40.1	17.9	31.2	21.2	106.4	57.6	55.4	14.7	25.1	56.8	39.8	18.9	46.1	35.2	40.1	30.6	76.8	51.7	99.6	20.3	79.0	47.8	18.5	27.2	45.5	51.8	16.2	13.9	38.6	38.6	12.1	29.8	65.3	41.4	48.3	169.6	45.4	28.0	56.3	41.2	44.0	20.0	68.8	11.9	35.7	42.2	43.9	41.4	57.5	12.0	57.8	29.2	32.4	42.6	26.8	92.9	14.6	17.9	97.7	34.8	33.7	52.8	15.5	44.1	22.3	60.7	66.4	63.3	85.3	63.6	67.6	51.2	88.0	74.4	69.1	6.2	60.9	86.4	55.8	68.1	81.3	13.0	14.2	14.4	20.2	13.2	14.1	14.4	14.2	14.5	14.3	14.0	15.3	30.1	16.0	41.3	1.3	34.0	36.6	92.2	79.1	25.0	14.7	29.0	36.8	0.0	24.3	60.9	42.3	8.4	107.3	22.8	18.1	49.0	75.3	9.6	23.1	24.8	32.3	9.6	16.0	1.3	66.8	121.0	31.8	11.7	22.7	60.9	27.7	23.2	35.9	65.4	16.8	1.4	25.7	71.2	25.0	29.3	15.5	37.9	27.7	28.4	1.9	45.1	24.5	43.3	2.0	2.7	75.7	19.8	25.9	17.3	69.0	25.1	81.1	54.0	16.0	39.5	29.2	86.5	28.9	59.7	28.4	39.9	74.3	30.6	46.4	35.7	75.8
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359962-41366818	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 53.6"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 17.7;Granulosa cells: 7.6;Microglial cells: 4.7;Oligodendrocyte precursor cells: 3.5;Peritubular cells: 4.9;Skeletal myocytes: 3.2"	"Group enriched"	"Detected in many"	5	"glioma: 10.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;HAP1: 11.1;NTERA-2: 7.0;SCLC-21H: 13.0"	"Region enriched"	"Detected in single"	30	"cerebellum: 3.3"	"Region enriched"	"Detected in single"	4	"spinal cord: 4.1"	"HPA044034, HPA059912, HPA078559"	Enhanced		Approved	"Golgi apparatus,Microtubules,Cytokinetic bridge"	"Secreted to extracellular matrix"	Yes	NA		1200000		"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	"Microtubules, Cytokinetic bridge"	"HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.6	1.4	2.5	0.1	2.4	0.0	3.5	2.3	3.8	8.6	1.8	4.9	0.6	2.3	53.6	0.8	4.2	0.3	7.8	2.1	2.2	1.0	0.6	0.3	0.1	3.7	2.7	8.9	0.2	0.1	1.8	0.0	3.0	6.7	0.3	0.0	1.0	9.9	0.9	3.9	1.7	0.9	2.5	0.1	2.0	1.7	2.6	0.5	0.3	2.6	0.2	2.3	4.7	3.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	11.1	0.0	0.2	0.0	1.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.0	1.3	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.4	2.3	3.8	2.1	2.2	3.7	2.7	3.0	2.5	2.6	3.0	0.6	0.0	0.0	0.7	0.0	0.9	0.2	0.0	0.0	0.3	1.2	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	17.7	0.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.7	0.0	7.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	1.8	0.1	0.0	4.7	0.0	0.1	0.0	3.5	0.1	0.0	1.2	4.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	3.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;kidney: 36.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 55.2;Excitatory neurons: 13.0;Proximal tubular cells: 35.7"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 3.7"	"Region enriched"	"Detected in some"	10	"cerebral cortex: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 3.7;HEK 293: 8.3;HMC-1: 1.6;RPTEC TERT1: 1.4;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"amygdala: 2.7;cerebral cortex: 10.5;hippocampal formation: 7.8"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.1	0.1	0.0	1.3	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.8	0.0	0.7	0.1	0.0	0.0	0.0	1.3	0.0	36.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	13.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	55.2	0.0	0.1	0.0	1.2	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	35.7	0.0	0.0	0.0	0.0	0.0	1.5	5.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305497-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053785, HPA077297"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: AB_2682260, HPA077297: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	27.3	35.5	25.5	15.8	29.8	16.3	23.6	36.4	31.4	17.5	33.6	67.6	81.8	15.5	4.7	62.7	14.6	10.2	154.9	23.5	31.6	70.3	91.5	30.9	11.0	30.9	31.7	8.1	56.3	23.9	15.9	15.4	29.8	26.4	22.9	5.1	48.5	12.6	195.3	35.9	65.4	7.1	26.6	32.0	52.4	8.4	37.5	8.4	28.3	88.8	12.4	31.0	28.8	23.7	25.9	40.2	9.8	23.6	13.0	12.7	54.2	25.0	11.9	9.2	9.0	37.4	30.3	34.9	45.1	12.8	23.7	66.0	16.9	33.0	3.5	23.0	21.0	22.9	51.7	30.1	18.0	39.3	55.3	17.4	49.8	20.7	27.0	12.8	12.8	18.1	37.9	18.7	15.3	57.9	19.4	55.9	27.9	30.4	74.4	20.4	19.7	79.6	31.1	52.4	20.6	26.2	12.8	81.2	83.8	5.5	25.8	38.2	28.9	16.6	20.4	47.4	25.6	28.6	25.5	23.6	26.9	38.2	13.4	0.2	2.9	4.8	2.7	5.4	2.6	1.7	2.3	1.9	2.7	2.3	2.3	3.3	5.3	1.8	5.1	2.1	3.6	1.7	25.5	29.8	36.4	31.4	23.5	31.6	30.9	31.7	29.8	26.6	37.5	23.7	20.8	9.6	22.7	21.2	14.7	18.6	41.0	29.7	18.8	28.8	30.9	24.3	9.2	100.1	21.3	20.2	33.3	103.8	20.9	159.2	54.8	51.3	3.4	18.7	17.4	15.3	37.8	19.4	13.6	80.2	61.3	12.4	39.8	20.3	7.6	9.3	35.0	266.3	33.6	33.7	16.6	82.5	28.5	82.7	11.7	1.1	6.5	22.2	17.8	11.2	28.8	20.1	27.8	9.0	6.4	81.1	103.1	12.0	8.2	42.8	199.7	82.2	19.8	20.4	13.1	18.7	21.7	3.5	7.1	26.3	18.5	134.2	14.5	22.2	113.7	65.0
ETV4	"E1A-F, E1AF, PEA3"	ENSG00000175832	"ETS variant transcription factor 4"	P43268	17	43527844-43579620	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 23.3;Cholangiocytes: 17.2;Distal tubular cells: 17.6;Enteroendocrine cells: 14.9;Extravillous trophoblasts: 19.8;Syncytiotrophoblasts: 14.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 80.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 177.7;Hep G2: 173.0;SK-MEL-30: 197.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005768	Approved		Supported	"Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli rim"	"Mitotic chromosome"	"HPA005768: AB_1848294"	"unprognostic (2.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.58e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.08e-2)"	"prognostic favorable (7.60e-4)"	"unprognostic (1.69e-1)"	0.5	2.4	1.2	1.0	1.6	0.0	7.0	0.8	2.2	3.6	0.0	2.0	6.1	2.4	1.0	9.2	2.5	6.4	3.1	1.3	0.8	5.4	1.2	2.2	0.6	1.0	0.9	0.4	7.8	7.9	14.7	5.2	1.4	4.5	1.7	3.0	4.6	3.6	1.3	6.4	4.2	1.4	0.3	0.4	3.8	1.2	0.7	0.3	6.9	2.5	4.8	2.1	5.3	0.9	24.5	67.0	80.4	177.7	3.1	20.1	17.9	7.9	21.1	14.9	15.2	38.1	33.9	0.1	4.3	4.1	36.6	43.6	2.7	40.2	13.2	0.8	0.5	2.3	10.7	173.0	4.3	47.0	20.9	3.6	1.4	56.8	35.0	16.8	32.1	0.3	48.9	0.1	31.0	9.8	0.2	82.9	116.9	123.1	110.9	99.8	9.8	58.9	33.0	17.3	0.1	71.4	2.1	4.5	197.0	43.8	0.8	13.9	15.1	10.6	52.0	15.7	22.1	7.3	47.8	0.1	18.9	8.9	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.8	2.2	1.3	0.8	1.0	0.9	1.4	0.3	0.7	0.9	0.2	0.0	0.0	1.3	0.0	1.9	2.5	3.6	23.3	3.2	10.4	12.3	1.1	17.2	2.4	0.0	0.0	2.3	0.1	1.1	17.6	6.5	3.1	0.7	0.3	1.5	14.9	0.0	1.6	1.0	19.8	1.9	3.1	1.6	0.0	0.2	0.7	0.0	0.8	0.0	1.0	4.0	2.0	0.3	0.3	6.0	0.3	0.2	3.6	1.0	0.0	10.9	0.0	1.0	0.0	3.7	3.3	0.4	0.0	0.9	1.9	0.1	1.0	0.3	0.0	2.1	1.7	0.0	1.3	3.6	1.1	14.9	0.3	0.1	7.7	4.3
EVC2	LBN	ENSG00000173040	"EvC ciliary complex subunit 2"	Q86UK5	4	5542772-5709548	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease variant, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.6;Basal squamous epithelial cells: 12.0;Fibroblasts: 8.9;Leydig cells: 11.5;Skeletal myocytes: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.7;HHSteC: 13.0;hTERT-HME1: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040910, HPA048122"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Microtubules, Cytokinetic bridge"	"Nucleoplasm, Cytosol"	"HPA040910: AB_2677195, HPA048122: AB_2680272"	"unprognostic (6.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.57e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (1.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.61e-2)"	"unprognostic (6.29e-5)"	4.8	0.7	1.3	1.5	1.4	0.1	3.6	1.2	1.1	6.0	2.3	3.7	0.6	4.7	1.7	2.2	4.7	2.7	3.1	1.3	1.4	2.6	0.7	2.1	1.9	1.6	1.5	7.8	1.7	3.1	1.1	1.3	1.2	3.2	0.6	0.3	2.8	2.0	1.1	3.8	2.0	2.3	1.4	1.0	2.1	1.6	1.5	1.0	3.8	1.9	1.7	4.1	4.4	1.3	0.0	2.7	0.0	6.6	8.4	9.3	0.0	4.1	9.7	3.6	6.0	0.0	0.0	5.2	0.0	3.3	2.0	2.8	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	5.9	4.6	4.6	10.6	0.0	3.9	0.0	0.0	0.2	5.3	0.0	0.0	0.0	3.9	0.0	0.0	8.6	8.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	1.6	0.0	0.5	6.7	0.0	0.0	2.4	0.0	4.1	4.7	1.2	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	1.4	1.2	1.1	1.3	1.4	1.6	1.5	1.2	1.4	1.5	1.3	0.6	0.0	0.5	17.6	0.8	2.2	4.9	2.3	12.0	0.0	0.9	2.2	1.0	1.5	1.3	0.0	0.0	8.3	1.7	0.0	0.0	1.9	2.2	0.7	5.6	1.2	0.0	0.4	0.3	0.5	0.3	8.9	0.5	1.7	2.5	4.7	1.4	0.1	0.5	0.0	0.3	0.0	0.0	0.3	1.2	0.9	11.5	0.8	0.0	6.5	0.0	1.9	1.0	1.0	0.3	0.6	0.0	7.9	1.7	2.8	0.0	0.9	1.0	0.1	0.0	14.7	3.2	1.8	2.1	4.4	0.9	1.4	2.8	3.4	0.0	1.4
EXOSC8	"bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p"	ENSG00000120699	"Exosome component 8"	Q96B26	13	36998816-37009614	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034240, HPA039702, HPA043942, HPA075230"	Uncertain		Supported	"Nucleoli fibrillar center,Mitotic chromosome,Vesicles"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitotic chromosome, Vesicles"		"CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: "	"unprognostic (8.67e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (8.39e-7)"	"unprognostic (9.58e-3)"	"unprognostic (7.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.51e-1)"	15.0	14.2	16.6	19.1	17.6	27.5	18.8	17.9	24.3	16.8	16.6	17.0	12.6	14.2	14.4	18.2	16.8	8.4	19.4	16.9	17.8	17.9	19.8	13.5	21.2	17.5	17.1	16.4	13.9	11.6	10.8	15.6	18.1	14.2	19.0	15.3	11.3	13.2	24.2	16.6	14.0	16.6	17.3	17.5	15.3	27.8	17.0	31.5	12.3	24.8	25.1	16.2	14.7	19.7	47.5	33.5	97.7	66.4	28.4	30.1	73.8	68.9	48.8	93.2	74.2	72.7	93.6	65.1	29.8	38.2	91.4	64.7	92.7	67.1	111.5	96.3	73.9	174.8	34.2	87.4	37.0	148.3	58.9	17.4	51.3	62.6	100.2	24.1	72.8	93.6	86.6	41.3	66.4	59.1	78.6	116.6	101.4	113.2	44.0	48.5	98.6	53.5	51.1	30.8	23.8	46.1	38.1	44.5	65.3	51.1	35.4	117.6	37.2	35.5	49.1	42.9	95.5	23.3	29.4	135.7	56.0	104.1	66.8	28.9	29.8	23.5	42.8	39.6	44.8	66.0	54.1	50.5	33.9	57.2	67.1	62.7	6.0	46.2	41.7	54.8	54.6	52.4	16.6	17.6	17.9	24.3	16.9	17.8	17.5	17.1	18.1	17.3	17.0	19.7	43.5	32.1	38.9	15.7	40.1	36.1	51.6	109.6	25.0	20.8	25.0	50.0	50.2	18.6	69.5	11.0	8.4	86.8	46.8	13.1	56.7	58.1	115.7	21.5	31.4	39.4	13.2	57.9	7.0	52.1	92.3	41.8	19.4	20.6	103.6	46.2	18.5	17.4	46.8	28.6	8.6	19.1	79.3	13.6	34.2	54.6	40.7	26.0	26.6	10.3	32.6	27.1	35.0	17.1	22.0	36.1	16.4	36.5	38.8	29.0	18.0	26.6	53.4	32.0	26.3	38.8	52.1	163.3	85.9	29.0	36.2	67.0	38.7	42.7	30.2	37.7
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042800	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli rim"	"Mitotic chromosome"	"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	15.6	22.7	42.8	5.4	51.1	3.2	13.5	25.0	57.6	17.3	20.5	26.4	7.5	19.1	5.0	13.2	20.6	10.2	29.6	68.2	39.2	13.3	5.5	16.9	4.4	29.5	27.5	24.1	13.7	14.5	54.8	5.8	29.9	17.0	3.7	4.8	10.8	12.3	17.3	30.1	13.8	10.0	22.5	10.7	16.6	16.4	38.8	3.1	12.8	18.0	2.9	17.1	15.2	40.1	14.5	6.1	9.5	16.3	12.1	10.2	8.8	6.5	13.7	9.6	7.5	4.7	5.1	2.1	25.9	6.0	20.7	13.5	0.0	11.8	5.8	15.7	16.0	0.1	9.4	10.2	12.4	0.3	10.8	7.3	1.9	8.4	19.2	9.2	19.4	9.7	3.2	2.1	3.3	11.3	5.6	0.3	16.1	8.7	11.8	10.4	4.0	14.0	9.8	0.5	28.2	29.3	4.1	10.5	14.7	5.9	31.9	3.3	20.2	12.1	9.3	9.9	20.0	22.9	15.4	1.5	38.5	2.1	8.3	1.5	3.8	4.8	1.1	4.9	1.2	1.4	0.8	1.1	4.2	1.4	0.9	1.1	8.3	1.2	2.7	1.7	1.7	2.2	42.8	51.1	25.0	57.6	68.2	39.2	29.5	27.5	29.9	22.5	38.8	40.1	15.5	6.4	5.0	13.7	5.5	11.1	20.0	6.1	5.7	24.0	8.0	11.0	7.6	14.3	4.1	14.7	14.6	9.0	4.6	11.6	1.9	6.0	4.4	6.5	10.5	11.5	9.6	6.1	30.8	3.5	3.5	9.7	5.1	11.0	7.0	55.9	13.6	1.4	7.9	23.5	16.6	7.5	6.1	5.7	14.2	2.5	18.6	7.7	1.8	11.2	9.6	13.1	6.2	6.6	11.9	10.7	9.6	20.7	2.5	15.2	15.7	3.4	15.8	15.9	6.6	13.0	14.4	12.9	7.1	3.5	14.6	33.2	5.0	20.0	8.7	15.9
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109713825-109770495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 116.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA075616"	Uncertain		Approved	"Golgi apparatus,Cell Junctions,Midbody ring"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Cell Junctions, Midbody ring"	"HPA040181: AB_10796448, HPA075616: "	"unprognostic (8.59e-3)"	"prognostic favorable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	0.7	19.0	23.7	0.7	45.2	0.6	1.2	36.7	34.2	0.6	5.6	1.9	4.8	0.3	0.8	2.3	0.4	0.8	8.9	20.0	27.6	10.6	4.0	2.1	0.4	41.2	43.1	13.4	3.9	0.7	22.4	0.1	37.7	1.8	1.0	22.1	3.4	0.5	4.3	3.2	2.2	0.4	29.0	6.2	7.2	23.4	48.4	0.4	0.7	0.6	0.6	0.9	1.8	65.6	2.0	3.1	1.6	3.7	1.0	0.0	1.1	0.6	0.3	1.6	0.2	28.1	0.5	0.3	2.2	0.8	1.7	1.2	1.9	0.1	0.6	16.8	4.0	3.5	0.9	6.5	0.2	2.8	3.6	0.2	0.2	0.3	0.0	0.4	0.1	2.0	1.2	0.6	0.3	11.5	0.7	3.6	3.0	3.3	5.3	2.3	8.0	1.2	3.5	1.5	19.2	116.4	2.5	3.7	8.2	0.5	4.5	3.0	0.2	0.5	3.2	1.3	2.4	2.9	4.0	2.4	0.3	2.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	45.2	36.7	34.2	20.0	27.6	41.2	43.1	37.7	29.0	48.4	65.6	2.1	0.0	0.0	2.3	3.6	2.2	0.9	0.1	3.4	23.4	7.4	6.1	8.1	1.5	0.8	1.8	33.3	0.3	10.4	1.2	7.9	1.7	29.1	1.2	0.5	1.3	7.7	0.0	1.3	0.8	0.2	1.5	1.5	1.8	0.0	0.7	0.7	1.3	0.3	77.4	6.7	5.8	0.0	0.0	2.1	13.4	1.2	1.9	7.2	0.0	0.1	11.2	0.0	9.5	78.5	1.1	0.2	0.4	1.3	1.7	0.9	0.7	0.6	50.3	0.0	2.6	1.5	1.1	5.7	3.3	1.8	0.8	3.7	6.0	1.6	0.4
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"FAM3 metabolism regulating signaling molecule A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"	"Secreted to blood"	Yes	No		15000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"CAB025016: , HPA035268: , HPA056991: AB_2683303"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	28.4	37.3	43.5	11.3	49.1	11.3	27.6	50.8	51.3	44.6	38.8	35.3	28.0	36.0	7.7	41.3	38.9	8.4	58.7	40.6	45.8	38.6	63.1	26.8	9.4	52.2	47.6	51.5	52.0	14.8	40.9	10.1	47.8	39.1	6.8	6.1	28.5	12.7	36.8	31.1	33.8	7.4	46.9	28.2	36.1	10.0	46.4	12.1	39.9	13.7	5.5	35.8	35.3	58.1	44.4	41.1	10.3	34.5	30.3	15.4	28.8	22.3	15.1	14.8	17.6	19.1	26.2	28.5	109.2	36.8	29.0	31.6	16.2	19.3	3.6	23.4	21.7	11.2	36.9	13.8	47.2	7.6	17.6	19.0	17.5	30.7	21.4	17.7	10.5	18.1	21.6	20.5	17.3	46.3	14.2	32.7	4.6	47.8	52.4	17.3	10.4	79.6	16.6	18.0	20.4	15.6	10.3	24.4	37.3	7.4	18.7	11.8	12.0	19.9	12.0	54.7	30.6	77.6	46.5	36.0	36.4	19.6	20.8	23.4	10.8	15.2	13.4	12.7	13.2	6.1	8.6	9.6	11.0	8.7	10.0	12.0	5.8	10.6	11.3	14.6	9.1	10.1	43.5	49.1	50.8	51.3	40.6	45.8	52.2	47.6	47.8	46.9	46.4	58.1	23.5	12.8	16.7	13.1	16.9	16.3	23.4	29.2	22.8	25.4	21.9	24.9	21.9	22.8	16.3	22.0	14.6	47.0	19.3	60.2	27.4	27.6	1.0	13.4	18.3	18.3	17.5	29.9	7.1	42.5	50.0	28.4	50.0	15.0	5.7	34.8	23.6	30.3	29.8	21.9	9.4	58.9	18.3	16.4	15.3	2.8	33.5	18.0	33.8	6.5	17.6	28.9	24.7	11.1	14.3	28.2	57.5	29.3	32.5	28.7	116.2	33.1	12.7	20.4	6.6	26.7	24.5	5.2	10.1	32.1	21.2	71.3	19.3	23.7	39.7	22.9
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849373-3851320	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.3;MCF7: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	6.9	9.1	11.7	3.7	14.3	1.8	7.0	12.3	15.1	8.3	8.5	10.2	6.6	9.7	3.9	6.6	8.8	3.7	18.0	12.5	13.6	9.8	12.9	5.3	5.1	11.7	11.1	9.3	9.2	4.2	10.4	1.7	11.5	6.4	1.4	5.5	10.2	5.8	32.1	7.1	6.5	2.8	11.2	7.1	8.1	14.0	13.0	3.9	9.8	8.8	3.5	9.7	6.3	12.6	6.6	8.7	0.1	0.0	4.9	4.7	0.4	7.6	3.7	5.1	6.5	0.0	11.7	7.0	8.0	5.5	2.0	4.9	0.0	3.0	3.8	88.3	4.6	0.0	21.1	0.0	5.2	0.0	0.1	5.2	6.0	4.0	1.1	1.6	5.1	0.0	0.0	0.0	4.6	27.5	0.0	9.8	1.9	4.0	4.1	0.0	0.0	0.0	2.5	0.0	11.8	10.3	12.4	7.7	0.4	0.0	8.4	7.8	7.2	0.0	0.9	10.1	0.0	0.0	19.7	0.0	2.7	0.6	14.1	5.7	7.9	4.4	11.3	10.8	26.7	25.0	21.8	14.6	10.5	20.8	17.7	11.2	3.3	33.8	17.7	17.3	36.0	9.0	11.7	14.3	12.3	15.1	12.5	13.6	11.7	11.1	11.5	11.2	13.0	12.6	11.4	16.0	7.0	2.6	8.3	6.4	5.7	10.2	15.4	18.1	8.7	13.5	19.8	17.2	8.3	12.9	4.2	4.2	9.3	2.3	33.2	13.5	31.5	6.8	5.0	6.7	1.2	6.7	2.5	11.1	6.9	8.0	7.1	3.3	3.8	7.5	11.0	21.6	10.1	15.2	2.6	3.5	8.2	6.8	4.7	28.8	8.4	5.6	12.4	1.0	8.7	20.9	4.1	1.0	4.6	8.5	5.1	10.9	6.9	3.3	7.4	36.9	6.8	16.0	0.0	13.0	8.4	38.3	43.9	12.5	6.7	1.0	6.1	7.8	3.8	2.1
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 84.7;intestine: 83.1;smooth muscle: 95.3"	"Group enriched"	"Detected in many"	4	"Basal squamous epithelial cells: 44.9;Erythroid cells: 72.6;Extravillous trophoblasts: 67.5;Squamous epithelial cells: 71.7;Syncytiotrophoblasts: 152.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.1;NK-cells: 1.1;T-cells: 2.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.44e-6)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	1.6	1.8	0.8	7.2	1.6	23.3	1.1	0.9	1.4	4.1	0.2	83.1	8.4	1.0	1.6	84.7	1.0	13.6	1.0	0.9	0.5	5.7	3.7	5.2	4.5	0.5	0.4	0.5	0.4	0.2	0.4	3.4	0.5	16.2	8.6	0.2	7.8	1.7	0.2	10.2	34.7	95.3	0.5	1.9	44.9	5.0	0.5	6.6	1.0	0.2	12.2	27.0	17.1	0.9	112.2	67.3	52.0	44.0	5.8	6.5	93.6	49.3	30.2	94.7	57.4	103.4	49.7	28.3	47.6	32.1	73.4	93.1	71.8	83.9	87.9	9.4	28.6	32.6	50.7	75.2	4.7	14.6	16.5	3.3	4.2	54.6	31.4	11.4	52.7	12.3	29.6	39.5	54.4	59.7	22.7	21.3	43.2	64.4	85.1	21.8	96.0	15.6	27.6	28.0	24.3	40.2	143.0	117.4	20.6	48.1	73.6	14.9	25.4	62.4	76.4	71.6	110.1	12.0	19.6	29.0	28.1	21.2	46.7	0.0	0.0	0.0	0.2	0.1	0.9	0.6	1.0	1.1	0.0	1.1	1.1	1.4	0.0	1.1	0.1	0.0	2.0	0.5	0.8	1.6	0.9	1.4	0.9	0.5	0.5	0.4	0.5	0.5	0.5	0.9	3.9	0.0	1.3	0.3	2.3	2.3	5.8	7.0	44.9	0.0	2.8	9.0	0.8	1.5	18.0	0.0	0.0	17.3	6.3	6.5	0.0	0.1	0.5	1.1	1.6	2.2	1.8	72.6	3.7	0.0	67.5	2.7	18.3	2.1	0.0	8.2	1.8	5.7	4.8	0.0	1.2	6.0	4.1	1.6	0.5	0.6	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	6.0	0.0	12.5	1.6	1.7	8.3	4.5	0.0	19.7	0.3	4.0	15.7	18.3	71.7	1.8	152.6	5.2	0.3	10.2	4.1
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30890559-30943108	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	6.2	8.5	9.3	0.9	9.5	0.5	6.7	9.4	9.7	10.1	9.3	10.7	0.9	9.2	6.6	6.5	9.0	1.2	8.8	8.9	9.5	9.5	9.6	5.5	0.8	9.7	9.8	11.8	12.7	5.9	11.4	3.0	10.0	11.5	2.0	2.7	9.8	1.4	18.7	10.8	7.3	2.4	9.5	6.8	8.6	8.9	9.9	4.4	10.0	7.3	0.7	9.3	9.7	10.0	5.2	9.9	3.6	1.9	12.4	9.3	0.8	4.4	2.1	4.7	5.0	4.5	1.7	0.6	7.6	3.6	7.4	9.2	4.7	9.4	5.0	4.2	1.4	1.3	5.5	1.9	4.8	1.2	1.9	2.8	7.3	3.0	7.3	7.2	3.4	5.7	4.7	6.1	4.7	0.6	8.6	3.1	2.2	11.5	2.8	7.0	12.0	2.3	6.7	2.3	4.5	4.6	9.2	5.6	3.0	8.8	4.4	3.3	3.3	9.4	3.0	5.0	3.4	7.4	8.7	1.1	4.1	1.9	1.1	0.0	0.1	0.0	1.4	0.3	2.0	1.2	1.2	0.7	0.9	1.5	1.8	1.1	0.0	1.8	4.3	1.1	1.4	0.7	9.3	9.5	9.4	9.7	8.9	9.5	9.7	9.8	10.0	9.5	9.9	10.0	9.1	16.0	8.4	21.2	5.4	4.1	5.8	4.9	9.6	17.0	11.2	9.8	17.0	0.0	10.7	9.2	20.9	6.5	3.5	7.6	9.8	4.5	11.9	10.2	12.9	8.8	7.8	6.9	23.7	2.9	2.2	8.4	8.6	9.0	8.8	15.5	6.8	13.4	3.7	26.9	25.5	11.0	8.2	5.4	2.5	7.1	10.5	3.9	5.4	15.0	3.4	14.9	7.2	13.6	44.2	3.6	6.4	6.8	7.0	6.0	4.2	8.0	13.6	23.5	6.6	9.4	7.6	20.9	16.4	7.2	2.4	4.1	5.3	9.2	10.3	3.7
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	12.8	11.5	7.3	12.9	8.4	9.8	13.9	8.1	9.9	14.1	8.2	12.5	9.6	12.5	11.1	10.5	10.0	11.5	17.4	7.0	7.7	12.9	18.0	14.5	14.6	8.0	7.6	12.3	9.5	18.5	10.2	13.8	8.0	14.6	13.0	11.0	11.5	12.0	18.7	12.2	11.6	12.3	7.5	14.4	12.5	12.4	7.8	20.2	12.2	16.8	15.6	13.8	11.2	9.9	12.6	13.2	20.1	14.7	22.1	24.6	10.4	16.1	30.7	22.4	30.5	19.6	15.1	18.2	15.5	26.2	23.6	17.2	21.2	20.3	26.8	20.1	13.6	10.8	19.0	13.3	21.9	29.6	17.0	24.0	17.1	21.6	21.1	24.0	30.7	16.6	12.2	19.1	22.3	5.1	18.8	13.8	9.4	13.9	19.8	16.6	29.3	18.4	21.7	14.5	17.9	17.3	21.4	14.2	21.2	17.1	15.0	21.2	20.2	20.4	7.3	10.8	18.2	23.3	25.1	15.3	20.3	16.6	15.8	15.1	6.1	9.1	5.0	8.0	5.5	4.9	4.7	5.0	7.5	3.8	4.8	6.2	11.2	7.7	15.2	3.7	7.4	4.9	7.3	8.4	8.1	9.9	7.0	7.7	8.0	7.6	8.0	7.5	7.8	9.9	10.6	16.0	45.7	25.1	13.8	3.3	5.5	7.4	7.4	10.3	8.5	6.7	18.7	11.5	10.6	11.0	10.4	7.5	13.4	11.3	5.9	8.8	11.2	8.9	9.9	10.8	9.6	7.2	40.2	6.7	6.8	11.8	14.8	10.4	15.8	9.6	11.4	16.9	12.6	13.5	37.4	10.1	6.1	24.9	6.4	2.9	9.0	17.8	3.6	38.4	12.3	5.9	12.3	33.2	44.4	9.9	8.9	18.4	11.0	8.6	9.3	9.3	16.4	9.0	0.0	6.9	7.8	20.6	8.6	9.2	3.8	12.3	12.1	11.2	9.0	8.7
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 206.9;salivary gland: 85.4;stomach 1: 85.5;thyroid gland: 99.9"	"Cell type enriched"	"Detected in many"	9	"Intestinal goblet cells: 6081.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 63.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;Daudi: 1.8;JURKAT: 1.7;MOLT-4: 1.8;RH-30: 7.1"									"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Golgi apparatus, Cytokinetic bridge"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.28e-5)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.08e-1)"	5.9	10.0	5.1	14.0	7.2	0.4	3.2	4.0	8.4	56.4	15.0	206.9	68.7	1.2	0.6	4.6	9.8	49.2	2.9	5.6	6.8	11.3	1.0	1.9	0.9	20.1	10.6	3.7	4.9	0.5	3.4	2.9	11.1	3.8	67.7	0.6	85.4	1.4	0.4	14.8	148.7	2.6	5.9	1.5	85.5	2.9	14.0	1.5	99.9	0.0	0.7	3.4	1.6	12.0	0.0	4.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.1	1.8	0.6	0.1	1.5	0.3	0.1	7.1	1.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.0	0.1	5.1	7.2	4.0	8.4	5.6	6.8	20.1	10.6	11.1	5.9	14.0	12.0	0.6	3.2	5.1	2.6	4.6	3.7	1.9	15.8	1.2	1.1	1.3	3.4	2.8	70.1	60.0	25.8	0.0	0.7	1.8	622.2	0.0	5.2	7.2	4.2	0.3	26.7	81.1	0.0	0.6	0.9	0.4	1.9	552.0	4.0	15.9	0.4	0.7	1.3	44.0	0.0	0.4	6081.9	2.0	30.2	12.6	9.2	0.9	21.6	8.8	15.9	0.9	0.4	1.0	0.5	0.2	3.9	253.6	0.0	2.1	13.8	413.5	1.2	11.0	2.0	59.2	0.5	1.1	0.5	2.4	0.4	6.8	0.4	5.6	0.9	191.4	164.1
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FKBP prolyl isomerase like"	Q9UIM3	6	32128707-32130288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.3	4.2	2.9	2.0	2.5	2.8	4.0	2.2	3.2	3.8	2.2	4.1	1.6	3.1	6.1	10.7	4.3	1.6	2.9	2.6	2.4	4.0	5.2	3.2	3.1	2.9	2.4	3.2	5.5	4.0	2.9	1.7	2.6	3.2	3.4	1.8	6.4	1.1	4.5	9.8	3.6	3.6	2.1	4.7	6.1	6.2	2.5	5.5	5.6	4.4	1.1	2.9	5.1	3.6	0.0	0.9	8.1	13.8	11.6	8.2	3.4	5.4	6.1	10.0	9.7	17.5	7.3	0.0	1.8	9.3	13.1	4.2	11.3	10.5	6.9	0.0	13.7	0.0	11.9	10.2	6.5	0.0	6.6	8.0	5.6	19.3	6.1	7.3	10.6	15.8	11.9	15.0	10.2	6.0	6.9	5.9	6.0	16.1	3.0	0.0	5.0	13.6	10.4	1.5	15.3	1.0	5.5	9.6	10.2	2.4	16.8	11.8	4.7	14.3	4.1	7.5	13.3	7.7	1.5	5.7	5.6	7.1	9.1	6.6	1.8	0.5	0.7	2.5	0.7	2.1	1.1	1.3	1.9	0.5	1.0	1.0	2.6	3.4	0.8	1.6	0.3	1.5	2.9	2.5	2.2	3.2	2.6	2.4	2.9	2.4	2.6	2.1	2.5	3.6	8.8	6.4	5.9	0.3	7.8	11.2	4.7	6.7	51.2	2.9	11.5	8.5	2.0	7.2	6.2	1.8	0.0	9.9	6.1	9.3	5.9	8.1	4.2	11.6	6.1	9.6	6.0	19.8	0.7	6.7	13.3	5.6	6.1	8.1	2.5	12.4	5.0	3.3	5.0	10.1	0.6	7.0	8.2	2.8	8.8	5.5	2.8	4.2	7.2	1.0	3.7	7.3	3.1	0.0	0.5	6.0	6.2	3.4	7.7	5.2	10.3	9.9	3.2	4.9	0.0	5.4	17.4	11.1	8.8	34.1	10.2	14.1	6.8	14.9	6.5	4.1
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497357-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.5"	"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 1148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	8.8	5.4	12.2	13.2	43.5	15.0	7.9	26.6	22.6	8.4	0.8	37.9	10.4	8.4	3.7	6.6	6.1	8.3	8.6	12.1	19.9	8.4	5.7	9.7	13.4	34.8	23.4	7.9	5.6	20.3	2.7	10.5	31.2	6.5	36.7	29.2	6.8	6.6	4.5	10.2	12.8	9.2	22.2	10.8	10.7	6.3	25.7	16.7	7.9	12.0	13.1	10.2	3.4	81.5	19.7	11.6	26.8	16.4	11.3	16.1	14.5	18.1	17.4	17.6	21.2	9.4	14.7	25.0	14.3	19.3	32.9	11.8	17.8	28.1	37.9	14.3	6.1	45.6	11.3	4.3	7.0	31.6	16.8	11.6	10.5	24.0	24.9	16.4	26.4	21.3	14.8	9.2	22.9	9.6	34.5	10.9	4.6	8.9	9.8	25.4	35.0	4.7	15.7	20.8	23.1	9.9	17.7	5.2	9.9	12.8	6.8	19.6	40.3	19.8	25.5	10.1	35.3	12.4	17.5	22.1	16.6	20.6	19.8	13.5	0.9	1.8	2.0	1.4	1.6	1.5	1.8	1.7	1.0	1.2	2.0	1.9	2.8	2.7	1.0	1.7	1.3	0.7	12.2	43.5	26.6	22.6	12.1	19.9	34.8	23.4	31.2	22.2	25.7	81.5	87.1	38.5	33.1	92.1	50.1	47.3	24.3	32.0	38.7	45.3	23.7	17.0	33.5	18.6	28.9	16.5	135.5	23.6	59.9	122.8	3.9	13.8	11.6	48.2	29.0	74.8	79.5	80.6	110.1	11.6	21.5	23.7	128.4	56.8	46.9	25.6	48.9	15.2	19.4	47.1	172.5	195.1	38.7	30.1	34.0	3.9	17.1	40.1	26.6	214.5	35.1	32.8	63.8	146.8	1148.7	28.8	87.3	18.4	38.6	43.4	50.4	8.4	21.0	105.6	19.7	31.2	37.3	12.8	10.9	37.3	49.3	10.8	54.4	15.6	93.9	53.3
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA 2'-O-methyltransferase 3"	Q8IY81	17	63819433-63830012	"Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.7	20.7	11.8	18.2	12.4	15.8	18.0	12.3	12.7	20.4	12.0	20.5	14.2	20.2	17.2	19.0	18.8	15.1	20.8	11.3	12.0	23.3	18.8	14.8	20.9	12.6	12.1	22.3	15.7	20.6	12.4	13.1	12.5	18.7	18.0	8.8	17.7	18.1	28.8	23.9	18.4	22.6	12.3	21.0	17.8	15.2	12.3	21.0	17.2	14.6	23.8	20.1	18.7	12.7	63.0	97.0	36.8	52.5	57.9	49.5	57.0	61.4	44.7	68.8	54.2	81.4	40.9	83.4	24.7	36.2	36.0	42.6	69.3	58.4	87.8	14.4	69.2	75.0	68.6	76.6	42.2	95.9	52.5	35.1	45.3	106.9	51.2	34.9	58.2	50.2	75.9	33.1	46.5	105.5	84.9	31.1	99.4	70.2	97.7	74.6	100.9	58.6	44.8	56.3	33.9	132.5	72.3	60.9	43.1	72.7	58.0	31.8	52.7	50.9	71.6	57.4	115.1	79.5	120.9	81.4	45.6	62.6	50.3	4.5	11.4	7.0	11.0	13.0	14.5	9.6	11.6	14.5	13.6	8.6	9.2	11.5	2.5	13.9	10.1	10.3	15.1	10.0	11.8	12.4	12.3	12.7	11.3	12.0	12.6	12.1	12.5	12.3	12.3	12.7	16.2	32.1	30.2	4.2	17.3	13.8	13.6	16.1	26.7	6.6	10.6	12.6	27.7	18.6	25.7	14.7	10.4	16.0	19.4	15.7	13.7	28.0	8.8	23.5	27.5	25.1	12.7	20.8	2.0	33.8	17.0	18.4	11.2	24.1	24.1	17.5	14.3	19.9	14.2	3.3	2.0	12.0	16.2	13.8	9.3	17.8	24.2	16.3	8.8	1.9	19.3	16.0	15.5	1.5	3.8	30.6	14.0	19.2	18.6	10.6	15.5	29.8	24.3	9.3	46.0	21.0	20.5	11.7	15.7	20.8	12.8	16.3	18.6	15.7	21.1	9.5
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015974-96215612	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 18.9;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	0.0	0.4	10.5	0.0	12.6	0.0	0.6	14.5	11.7	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	11.8	13.6	0.2	0.0	0.0	0.0	3.4	18.9	0.0	4.8	0.0	0.4	0.4	3.2	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	5.5	0.0	23.2	0.0	15.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	6.5	6.3	0.1	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	12.6	14.5	11.7	11.8	13.6	3.4	18.9	3.2	5.5	15.3	6.4	0.0	0.0	0.0	776.4	0.2	0.0	0.6	0.0	0.0	4.2	1.4	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.1	1.3	0.0	0.0	333.5	2.0	0.0	0.1	56.1	1.4	0.0	0.4	0.0	0.0	0.1	0.0	238.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.2	0.0	168.9	224.7	0.5	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113537	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 447.4"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 32.1;MCF7: 50.6;OE19: 53.3;SK-BR-3: 165.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	7.1	2.4	6.1	6.0	6.1	1.8	5.4	6.8	11.4	18.7	5.9	25.9	8.4	5.3	9.3	45.6	5.7	2.5	5.2	6.0	6.1	17.9	2.1	6.4	4.2	7.5	6.1	6.8	2.2	0.4	4.8	11.4	8.0	5.7	17.2	6.5	9.0	2.2	2.1	11.0	10.2	5.2	6.3	9.0	18.8	1.8	6.1	4.1	4.7	0.9	20.9	5.4	19.1	6.8	21.8	0.3	5.2	1.5	1.6	5.5	5.5	0.6	1.3	1.8	1.7	1.0	15.2	0.6	2.9	1.5	0.6	1.8	1.6	0.5	1.8	2.5	4.0	0.2	1.0	32.1	1.0	0.7	1.3	0.2	1.6	4.5	0.3	4.1	5.1	4.2	1.0	2.3	2.2	50.6	1.5	2.0	2.6	53.3	0.6	6.3	1.4	7.1	2.6	7.4	1.1	2.2	0.2	165.0	0.5	1.6	3.0	2.7	2.7	0.9	1.1	1.9	1.8	2.7	0.9	1.5	4.2	2.7	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.1	0.0	6.1	6.1	6.8	11.4	6.0	6.1	7.5	6.1	8.0	6.3	6.1	6.8	5.9	6.4	1.1	1.6	1.0	1.3	0.9	4.4	1.2	1.6	4.1	3.0	1.5	0.0	22.2	5.5	0.0	24.2	1.2	98.2	5.9	0.9	67.8	2.6	3.8	4.3	3.5	0.0	0.6	1.3	71.9	2.1	30.1	4.1	0.0	2.0	3.9	0.3	3.1	1.7	0.8	34.2	6.1	1.9	1.0	447.4	3.4	1.4	1.8	1.9	1.2	0.6	0.0	1.5	1.2	19.2	36.7	3.0	0.1	1.1	46.0	100.6	9.0	1.7	6.6	0.6	2.7	1.4	1.3	5.1	2.0	9.3	1.9	1.3	13.9	4.8
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GFM2	"EF-G2mt, EFG2, FLJ21661"	ENSG00000164347	"GTP dependent ribosome recycling factor mitochondrial 2"	Q969S9	5	74721206-74767147	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036863, HPA069871"	Uncertain		Approved	"Nucleoplasm,Midbody ring,Mitochondria"		Yes	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	"Nucleoplasm, Midbody ring"	"HPA036863: AB_2675354, HPA069871: "	"unprognostic (2.58e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (9.55e-2)"	"unprognostic (4.15e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.82e-2)"	9.6	18.1	9.7	10.2	10.5	15.0	14.1	10.2	14.5	10.7	16.1	13.9	9.3	11.1	17.4	11.9	23.4	9.0	33.3	10.8	10.7	23.3	34.0	9.0	12.2	9.5	9.1	11.4	10.0	30.4	10.7	13.5	10.0	13.0	15.8	16.8	13.4	11.2	30.6	11.3	10.8	10.8	9.4	8.5	17.9	15.8	10.2	17.2	13.1	38.5	15.5	12.9	7.0	11.1	39.5	34.3	27.2	52.2	20.3	27.1	28.2	41.5	24.7	41.5	44.1	36.4	24.9	39.7	44.9	21.9	65.7	32.1	55.0	59.6	54.8	34.8	35.5	22.9	31.7	27.0	27.1	23.6	26.0	32.1	26.3	33.6	40.5	29.8	30.3	39.4	40.7	32.9	48.5	23.3	32.1	15.1	11.4	14.8	29.7	41.1	43.5	49.3	32.0	24.7	46.6	24.8	46.3	38.1	44.3	30.1	33.0	44.0	24.0	16.2	27.8	20.5	27.2	19.0	38.3	40.1	24.1	34.2	24.6	22.8	6.9	9.2	6.7	7.2	6.6	8.3	5.5	7.5	6.7	7.2	7.5	7.3	3.5	16.0	11.8	4.4	7.0	5.2	9.7	10.5	10.2	14.5	10.8	10.7	9.5	9.1	10.0	9.4	10.2	11.1	6.4	12.8	12.9	19.9	8.5	6.0	7.1	13.0	8.6	9.1	7.7	6.9	11.0	7.2	12.5	7.3	6.2	20.1	7.5	8.9	21.5	9.5	11.5	42.4	9.2	6.4	5.4	17.9	35.7	5.3	15.9	6.3	15.3	13.7	2.5	10.4	5.3	22.4	9.9	16.8	34.1	9.7	30.5	8.5	2.4	2.6	7.2	6.8	8.8	13.1	17.9	13.0	7.2	34.2	29.1	9.8	9.9	7.5	11.4	4.6	8.5	11.2	61.5	9.6	0.0	5.6	7.8	15.2	11.7	10.0	7.0	16.0	7.3	11.1	10.0	7.5
GLI4	"HKR4, ZNF928"	ENSG00000250571	"GLI family zinc finger 4"	P10075	8	143267433-143276931	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA023131	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytokinetic bridge"		"HPA023131: AB_2671080"	"unprognostic (4.98e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.45e-3)"	"unprognostic (5.03e-1)"	"unprognostic (6.88e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.71e-3)"	11.6	6.6	8.8	4.7	8.2	5.8	10.7	8.3	15.4	12.3	3.3	10.8	6.4	10.3	2.1	12.8	10.2	2.7	13.0	9.6	7.1	13.7	12.0	6.9	5.6	7.4	6.8	13.4	12.6	4.6	9.3	2.0	7.5	13.4	3.7	2.5	9.2	3.9	9.2	12.9	10.4	1.8	5.1	11.6	11.5	10.4	7.5	5.5	10.1	2.0	4.8	11.3	11.1	7.2	6.7	13.5	6.2	9.9	9.9	4.1	7.0	3.9	2.3	2.9	3.5	3.9	19.1	8.7	7.2	6.5	4.2	8.7	3.4	4.3	1.9	15.3	10.3	13.4	7.1	4.6	7.1	4.2	4.3	12.9	2.3	4.0	8.5	6.7	6.4	13.2	7.2	14.1	8.0	18.5	19.7	3.5	5.8	12.8	19.0	11.9	2.9	8.8	7.0	15.0	6.0	7.0	11.7	5.0	8.2	5.7	22.1	1.9	3.6	4.3	12.1	6.2	4.1	18.6	9.7	7.0	7.0	8.0	7.3	0.0	0.3	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.3	0.6	0.2	0.3	1.1	0.0	1.1	0.6	0.2	8.8	8.2	8.3	15.4	9.6	7.1	7.4	6.8	7.5	5.1	7.5	7.2	9.5	0.0	0.0	13.1	11.2	7.4	12.7	1.3	13.6	14.6	10.9	12.2	2.0	12.8	1.1	12.9	20.9	5.0	20.6	15.4	25.4	2.6	6.3	8.2	10.6	6.8	11.5	5.9	7.2	4.0	4.5	9.5	11.7	7.3	4.5	15.8	8.9	7.7	7.2	6.7	8.4	7.6	2.0	10.1	5.7	4.3	16.1	9.9	8.8	12.2	6.9	11.9	13.4	4.5	15.5	3.6	17.9	16.6	8.8	9.4	16.4	20.1	2.3	11.9	6.6	11.2	10.6	13.4	14.7	15.8	10.7	2.9	11.9	14.6	13.7	9.9
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	47.2	47.1	17.1	42.1	17.0	27.4	68.8	18.4	24.4	38.8	18.7	40.0	38.8	33.8	25.6	65.0	28.2	28.0	29.6	17.9	19.4	33.4	50.3	29.7	51.5	17.9	17.7	35.8	60.7	27.1	35.9	36.4	17.8	46.7	46.0	16.0	46.4	26.3	78.2	39.1	29.6	32.2	16.9	34.0	41.0	26.8	17.9	35.9	28.6	42.9	64.9	92.3	41.3	19.1	110.4	79.1	114.4	125.3	105.6	105.1	178.1	133.0	101.5	135.4	100.6	121.3	80.8	255.4	42.2	100.1	104.6	78.2	189.1	125.1	180.5	156.3	134.6	196.8	139.0	189.3	218.1	283.7	138.0	96.1	216.5	147.8	224.1	90.3	107.8	99.7	214.8	136.2	93.8	77.7	170.6	162.1	195.6	153.4	151.2	99.3	93.0	315.0	108.9	153.9	81.4	105.6	82.1	190.5	193.6	101.7	74.7	155.8	86.6	92.8	100.0	139.2	281.7	147.6	252.0	387.0	96.9	203.5	148.4	1.2	15.2	3.3	19.9	16.7	34.1	28.7	26.8	24.1	26.1	23.9	30.4	29.4	1.8	26.1	12.9	40.7	18.8	20.2	17.1	17.0	18.4	24.4	17.9	19.4	17.9	17.7	17.8	16.9	17.9	19.1	34.6	22.4	48.2	5.2	84.3	163.7	146.0	111.9	77.4	19.0	72.6	46.4	51.3	25.8	144.9	12.9	10.4	73.2	78.5	42.8	41.1	105.1	54.4	44.7	76.5	53.4	47.8	51.5	11.6	104.6	117.5	92.9	47.9	53.0	63.1	47.5	23.2	41.9	40.9	21.9	11.1	71.7	67.1	24.2	77.6	28.2	51.9	43.0	78.2	5.6	59.5	17.7	38.1	7.1	9.4	99.9	34.4	34.3	122.3	126.1	19.1	47.2	56.5	14.8	6.6	106.2	79.1	37.9	74.4	59.4	153.7	90.3	63.0	74.5	85.8	135.7
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.5;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0"	"Low region specificity"	"Detected in many"							"HPA038129, HPA070760"	Approved		Approved	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA038129: AB_2675846, HPA070760: "	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.1	0.0	1.7	0.6	1.6	0.0	0.9	5.9	2.1	0.9	0.4	6.2	3.6	0.0	0.0	4.4	0.3	0.2	0.0	0.6	6.7	5.7	0.3	10.5	0.0	5.5	4.9	0.1	5.7	2.1	4.2	0.0	5.7	1.9	3.4	0.1	2.8	1.1	0.1	17.4	8.0	0.1	1.8	0.0	5.1	3.0	9.7	0.0	3.4	0.0	0.5	0.6	2.0	1.0	10.2	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.0	1.7	0.3	0.3	0.1	3.7	12.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.9	2.1	0.6	6.7	5.5	4.9	5.7	1.8	9.7	1.0	0.0	19.2	3.7	0.0	0.0	1.7	2.8	1.9	2.8	0.3	1.4	1.0	0.2	7.2	2.1	3.7	0.0	0.0	0.0	30.4	0.0	11.3	9.3	0.0	0.0	0.1	6.6	0.0	0.7	20.2	0.0	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	30.8	0.0	0.0	0.3	20.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	13.1	0.4	0.0	2.1	21.7	4.0	1.8	0.1	0.0	0.0	0.2	2.9	0.8	2.4	6.1	0.0	0.1	0.0	7.3	1.3
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 479.1;liver: 609.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.8;Cardiomyocytes: 6.0;Club cells: 6.7;Hepatocytes: 5.5;Kupffer cells: 7.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Region enriched"	"Detected in all"	18	"cerebral cortex: 479.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 87.0;HeLa: 96.1;HHSteC: 78.6;hTEC/SVTERT24-B: 73.0;HUVEC TERT2: 62.4;MOLT-4: 115.4;U-266/84: 64.4"	"Low region specificity"	"Detected in all"							"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	55.5	155.7	26.1	17.4	26.4	9.7	56.9	24.9	479.1	61.5	26.9	39.1	27.9	38.1	69.6	152.3	45.8	29.4	30.5	25.9	25.8	37.3	609.6	28.2	1.8	25.5	26.3	178.4	66.8	48.7	33.5	8.7	26.1	47.0	22.4	10.2	43.8	128.6	69.3	73.5	47.3	64.3	25.0	63.6	59.5	57.0	26.6	33.5	27.7	0.0	17.9	127.0	135.2	25.3	0.3	0.6	0.3	1.3	0.0	0.0	0.5	0.0	0.3	0.2	0.4	1.0	7.0	26.9	0.1	41.6	0.0	1.3	0.1	0.6	0.7	0.1	0.4	87.0	96.1	1.7	78.6	0.0	0.7	0.1	0.1	73.0	0.3	48.1	62.4	50.1	0.0	56.8	2.5	0.0	115.4	0.7	54.6	0.1	0.0	0.4	0.6	11.1	9.0	0.1	5.3	0.7	0.0	0.3	0.5	2.6	1.1	44.5	0.2	35.5	2.0	0.9	0.1	45.1	64.4	3.7	30.7	1.1	2.0	2.2	26.1	32.2	28.8	39.1	31.0	30.8	31.4	28.5	77.8	32.5	33.1	32.6	2.0	30.1	17.4	41.1	38.9	28.5	26.1	26.4	24.9	479.1	25.9	25.8	25.5	26.3	26.1	25.0	26.6	25.3	0.3	9.6	6.8	0.0	0.2	1.8	0.6	2.0	0.0	0.1	2.7	1.9	6.0	2.8	6.7	0.0	0.0	0.0	0.8	0.4	0.0	1.2	0.0	0.9	1.9	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	2.5	0.0	5.0	5.5	0.1	0.0	0.0	0.3	0.0	7.1	2.2	0.4	3.7	0.5	0.0	0.0	0.7	2.4	0.0	0.0	0.0	0.6	0.1	2.2	0.0	0.1	1.9	0.0	5.1	0.0	0.0	0.3	1.4	0.5	0.4	0.0	1.6	0.0	0.8	0.0	0.2	1.8
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656099-109674836	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 149.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 382.8;Proximal tubular cells: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"eosinophil: 351.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 351.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favorable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	22.3	31.1	19.7	15.3	23.7	5.9	22.5	19.1	23.8	24.5	40.0	45.4	149.5	22.6	24.3	31.3	22.2	17.8	33.5	19.2	19.9	45.9	41.2	14.6	11.8	20.7	20.9	42.9	21.2	57.8	18.6	7.6	20.2	25.8	38.5	12.5	21.2	41.0	92.4	20.6	99.4	25.7	21.1	30.2	28.8	15.1	20.1	9.9	27.7	45.5	15.6	36.8	28.8	20.2	13.5	6.0	10.5	78.9	23.0	35.1	13.4	4.3	34.1	9.8	12.8	43.3	1.5	12.5	16.1	19.1	19.3	13.6	27.1	14.4	6.2	18.9	0.0	27.4	23.5	38.8	37.1	9.5	31.8	22.3	14.0	12.6	0.0	27.5	8.1	31.7	12.8	18.4	6.9	12.7	8.1	41.9	8.2	56.3	31.9	16.9	5.8	18.5	38.8	9.6	7.4	17.6	0.2	68.2	54.9	7.8	18.6	20.1	3.6	11.4	44.0	12.5	6.3	27.0	51.4	1.1	37.1	13.9	32.5	11.9	14.5	351.7	12.2	14.5	7.4	17.0	9.3	14.1	37.8	14.9	8.9	10.7	1.8	12.8	3.6	12.6	14.1	12.6	19.7	23.7	19.1	23.8	19.2	19.9	20.7	20.9	20.2	21.1	20.1	20.2	6.9	9.6	2.7	11.4	9.9	18.1	27.3	17.9	18.8	6.2	14.7	19.0	30.2	21.5	9.5	31.3	0.0	21.0	13.9	53.0	101.8	45.9	3.0	4.5	10.8	8.6	7.2	4.2	3.3	57.7	18.6	22.9	13.3	5.4	21.0	13.3	14.3	35.7	35.6	5.0	3.3	45.9	6.1	17.2	26.0	6.4	30.1	14.9	40.9	2.8	14.8	23.9	17.5	5.0	3.4	35.4	38.6	24.8	13.3	6.7	382.8	109.8	7.5	5.4	32.9	15.3	23.2	7.0	7.3	23.0	15.3	8.8	11.2	12.6	96.7	26.9
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109711780-109775428	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 929.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 59.0;Leydig cells: 143.5;Muller glia cells: 213.3;Peritubular cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.9"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 21.6;HHSteC: 10.3;HSkMC: 10.9"									"HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 5: Breast - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	21.7	6.4	60.3	4.6	65.3	0.5	929.9	60.4	71.1	72.5	62.9	13.9	2.3	35.1	32.9	11.6	62.0	25.8	17.0	61.4	54.5	5.5	3.9	18.0	5.0	57.2	55.4	213.9	4.7	0.2	9.4	0.8	56.7	27.9	7.8	12.4	7.9	32.6	3.9	12.2	10.3	26.5	60.1	7.7	13.2	11.4	53.5	6.4	9.1	14.0	6.5	27.9	47.6	58.6	0.0	0.0	0.0	0.0	1.7	1.6	0.4	1.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	21.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	10.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.6	0.0	3.9	0.9	0.7	60.3	65.3	60.4	71.1	61.4	54.5	57.2	55.4	56.7	60.1	53.5	58.6	2.5	0.0	0.5	32.3	0.0	6.6	0.9	0.2	0.0	2.0	0.5	0.8	0.9	1.5	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	9.0	0.3	12.3	2.2	0.0	2.1	0.1	0.0	0.1	59.0	1.1	0.3	0.0	0.6	5.7	0.0	0.3	0.0	0.5	0.1	0.0	0.6	9.3	15.1	143.5	0.6	10.6	1.9	0.0	213.3	0.0	2.0	0.3	0.0	0.0	127.2	0.1	0.1	0.1	0.0	0.0	6.8	26.3	2.3	9.4	2.0	1.8	1.0	6.5	0.0	2.8	2.4	0.1	0.6
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888046-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	6.0	3.8	2.6	5.2	5.3	1.8	4.0	4.3	3.2	5.7	2.6	3.7	0.6	5.6	2.5	3.2	5.1	10.1	13.6	2.0	2.4	0.9	0.3	3.8	1.5	6.2	5.8	16.5	4.2	2.4	1.9	4.0	4.1	3.3	2.0	0.4	5.3	4.0	0.8	1.7	1.2	5.5	5.3	0.7	1.3	5.8	4.6	6.7	8.8	1.5	1.0	5.7	3.6	6.9	0.2	1.8	0.1	11.2	9.9	19.3	1.7	1.8	4.2	4.0	9.8	0.5	1.2	0.0	3.1	4.9	22.3	0.1	1.0	2.2	3.8	0.0	1.3	0.0	7.2	12.4	12.6	4.9	0.0	18.8	1.1	9.7	1.6	6.0	0.0	22.1	5.8	0.1	2.4	2.7	36.5	0.1	6.6	0.1	2.2	0.2	9.5	0.0	1.3	1.7	1.1	5.0	9.8	0.5	1.3	2.0	3.7	1.5	0.1	4.3	13.5	13.3	6.5	1.0	0.1	0.2	11.1	2.3	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.3	0.0	2.6	5.3	4.3	3.2	2.0	2.4	6.2	5.8	4.1	5.3	4.6	6.9	1.6	3.2	2.6	7.2	0.1	1.9	1.9	5.3	0.0	0.6	1.5	7.6	14.6	2.8	2.3	0.0	0.0	0.2	1.5	1.4	0.0	0.1	47.9	5.7	45.4	0.6	3.5	0.0	8.3	1.1	0.3	23.0	0.0	7.5	0.0	8.0	0.7	0.0	0.4	0.0	9.0	2.9	0.0	0.0	4.0	27.1	8.1	0.5	0.0	12.2	0.0	2.5	0.0	3.0	61.3	0.8	0.4	7.2	0.0	2.0	0.6	0.5	2.1	0.4	0.0	40.0	3.9	2.5	4.2	0.2	0.4	0.8	0.4	22.9	1.6	0.4
HAUS3	"C4orf15, dgt3, IT1, MGC4701"	ENSG00000214367	"HAUS augmin like complex subunit 3"	Q68CZ6	4	2078998-2242276	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040649, HPA048190"	Approved		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA040649: AB_2677060, HPA048190: AB_2680308"	"unprognostic (4.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.78e-5)"	9.6	8.6	3.5	7.5	3.5	27.5	8.9	9.0	4.6	8.1	1.9	8.3	6.5	7.3	4.9	8.0	7.2	4.2	5.8	3.4	3.2	6.2	7.4	9.0	10.2	3.4	3.4	7.3	10.5	4.0	5.6	6.5	3.3	8.5	5.3	5.8	8.5	4.5	7.4	8.9	9.2	4.7	2.3	12.0	9.0	10.7	3.4	8.6	7.4	4.6	8.3	7.1	7.7	4.3	9.8	4.7	14.2	13.0	5.5	8.5	12.8	14.3	6.0	12.7	10.6	9.5	12.5	18.9	6.5	5.7	14.3	9.3	11.9	7.2	15.9	6.8	6.9	12.5	13.1	7.0	4.5	11.6	11.2	4.3	10.2	11.0	5.8	6.6	10.3	8.8	22.0	21.2	12.5	5.4	19.6	19.5	11.2	8.5	12.3	13.9	12.4	10.4	6.3	6.7	18.4	10.0	10.1	7.6	8.4	10.5	15.7	7.8	8.5	18.1	7.8	11.1	17.0	11.2	10.6	16.9	8.8	16.8	12.0	9.6	4.2	12.2	7.9	5.8	10.1	5.5	8.2	8.9	3.8	9.1	9.5	8.9	4.7	10.7	6.9	6.8	12.0	6.6	3.5	3.5	9.0	4.6	3.4	3.2	3.4	3.4	3.3	2.3	3.4	4.3	15.5	3.2	4.8	0.0	15.8	12.6	5.0	6.4	15.4	11.9	9.3	8.8	5.8	7.2	10.3	3.7	12.5	7.3	24.0	3.9	1.9	7.4	11.8	8.9	11.8	9.4	7.2	23.1	0.0	5.7	11.7	9.6	4.6	8.3	13.3	12.1	6.8	3.7	7.2	25.2	0.0	6.4	12.2	5.4	9.3	6.4	9.9	10.4	12.4	0.0	7.9	6.5	16.5	0.0	0.0	5.3	1.8	8.6	22.5	5.1	5.8	2.6	5.4	12.5	0.0	12.3	17.7	34.4	25.3	10.5	7.7	5.1	26.5	10.1	5.8	3.0
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188534-93226469	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 96.2"	"Group enriched"	"Detected in some"	11	"Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SCLC-21H: 172.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		210000		"Cluster 9: Intestine - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.1	0.0	2.3	0.0	2.5	8.9	0.0	0.1	0.0	0.0	64.3	30.1	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	15.2	0.0	0.1	0.0	0.1	0.1	0.0	4.3	0.4	7.3	0.2	0.0	0.8	96.2	0.0	2.6	1.4	0.0	0.0	48.0	1.5	0.1	0.1	10.1	3.2	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	172.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.4	0.3	1.1	0.7	0.0	0.0	15.1	6.6	0.2	0.0	0.9	5.5	0.0	0.0	0.0	17.2	9.8	0.1	2.5	0.0	0.0	0.1	218.2	18.7	0.5	0.0	0.0	0.1	27.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.6	387.5	349.9	0.0	0.0	2.4	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	2.2	0.0	318.1	0.0	0.1	0.9	11.5	0.0	0.3	0.0	0.0	0.0	0.1	5.6	1.2	0.0	0.1	0.1	0.1	0.0	19.7	0.3
HIGD1B	"CLST11240, CLST11240-15"	ENSG00000131097	"HIG1 hypoxia inducible domain family member 1B"	Q9P298	17	44846353-44850476	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.6;choroid plexus: 65.0;placenta: 105.2"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 762.6;Smooth muscle cells: 209.3"	"Cancer enhanced"	"Detected in all"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA079501			Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA079501: "	"unprognostic (6.85e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.52e-2)"	11.7	0.5	71.0	0.7	71.0	0.5	8.8	70.3	114.6	8.3	65.0	3.7	2.1	9.9	11.6	5.0	5.3	11.3	46.4	68.8	71.4	11.5	0.6	38.6	2.6	71.4	70.9	2.9	3.1	8.0	1.4	105.2	72.4	9.5	1.1	2.3	1.4	6.4	14.5	2.0	4.3	11.3	68.9	0.1	3.7	1.5	73.0	1.8	5.0	30.8	1.4	4.3	4.4	69.1	0.2	0.6	0.0	0.7	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.3	0.2	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.7	0.1	0.8	0.5	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.7	0.5	0.0	0.3	0.7	0.7	0.4	0.3	0.3	0.8	0.4	1.0	0.0	0.5	0.7	0.3	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.6	0.2	0.4	0.5	0.4	1.2	0.6	0.5	1.1	0.7	1.7	0.6	0.2	1.2	1.0	0.4	0.2	0.7	0.9	1.2	0.3	0.9	0.7	0.0	0.7	0.1	0.3	0.8	0.5	71.0	71.0	70.3	114.6	68.8	71.4	71.4	70.9	72.4	68.9	73.0	69.1	88.9	0.0	0.5	0.0	0.3	3.4	0.6	0.3	0.0	0.5	1.2	2.8	11.0	0.0	1.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.7	70.2	0.0	0.0	0.7	0.0	0.2	4.4	0.0	0.3	0.0	0.0	0.7	0.1	0.8	1.7	0.6	0.0	0.0	0.0	3.9	0.6	0.3	1.6	0.0	2.8	0.0	1.0	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.9	762.6	9.5	209.3	0.0	0.3	0.7	2.4	0.3	0.8	32.3	0.0	0.7
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 114.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.2	2.5	0.5	0.0	1.0	0.2	0.3	2.3	0.1	20.6	100.5	0.4	1.2	0.3	1.0	12.1	0.0	0.3	0.3	17.4	12.9	0.2	0.1	0.4	0.5	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.6	0.0	0.4	0.4	0.0	0.0	114.6	0.9	0.4	0.1	8.1	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.3	0.3	0.4	0.5	0.3	0.4	0.3	0.3	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 23.1;placenta: 17.1;prostate: 22.3;seminal vesicle: 23.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 41.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		Yes	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.0	9.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	22.3	11.9	0.0	0.0	23.3	2.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	14.1	0.0	2.2	1.6	0.0	2.5	0.2	0.0	0.1	13.2	14.4	5.1	3.3	2.8	0.2	0.0	1.6	6.2	0.7	0.0	26.9	0.0	4.3	0.0	37.3	1.9	6.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	8.7	0.0	11.8	18.4	2.7	0.6	0.0	0.1	42.1	0.7	0.0	3.3	0.0	0.3	2.0	0.0	18.2	0.0	0.5	4.5	0.3	0.1	0.0	0.0	0.0	0.0	20.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.6	0.1	4.0	1.1	8.4	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.5	0.0	0.0	0.1	0.1	0.1	0.0	10.3	3.1
HPF1	"C4orf27, FLJ20534"	ENSG00000056050	"Histone PARylation factor 1"	Q9NWY4	4	169729470-169757944	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 71.0;Distal tubular cells: 92.0;Extravillous trophoblasts: 61.2;Granulosa cells: 56.4;Hofbauer cells: 56.3;Proximal tubular cells: 63.9;Theca cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043467	Uncertain	Approved	Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA043467: AB_10793949"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.68e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (5.63e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (6.34e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.09e-1)"	19.3	18.6	18.6	16.4	19.9	16.8	21.2	19.6	26.0	19.6	22.0	22.0	12.2	23.3	24.8	15.7	17.1	13.1	22.5	19.2	19.7	18.1	22.1	14.3	21.1	20.2	19.3	22.7	14.4	16.0	19.5	16.8	20.9	17.3	17.7	21.3	13.2	15.7	21.3	19.6	12.8	24.8	19.6	17.5	15.8	14.1	19.6	26.9	18.8	20.9	21.1	16.8	16.8	22.2	33.7	21.0	71.2	37.7	42.6	52.4	30.3	59.9	58.8	72.8	76.7	14.3	35.5	17.5	15.7	39.2	53.3	14.7	49.5	43.6	76.7	55.1	33.7	57.0	30.0	20.5	29.9	48.7	20.1	34.1	43.2	47.1	14.5	44.1	64.1	59.1	43.7	66.2	64.4	27.3	102.7	42.4	29.2	32.2	27.0	44.7	33.8	21.2	41.9	21.9	17.2	63.1	39.7	17.2	56.3	49.1	34.0	43.1	31.3	24.8	39.2	58.4	54.3	31.3	49.8	52.4	68.3	47.0	40.3	19.3	20.0	22.4	28.7	24.0	34.6	22.0	33.0	35.1	26.1	18.1	32.1	33.3	5.3	25.4	23.7	17.9	38.1	21.9	18.6	19.9	19.6	26.0	19.2	19.7	20.2	19.3	20.9	19.6	19.6	22.2	41.6	44.8	26.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	19.9	29.6	0.0	0.0	17.3	27.6	0.0	71.0	14.3	0.0	92.0	45.7	0.0	31.9	36.9	20.1	0.0	0.0	0.0	46.3	61.2	26.1	0.0	21.9	17.7	56.4	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	31.1	0.0	0.0	1.6	0.0	0.0	63.9	15.3	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	16.3	10.5	56.0	0.0	0.0
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 77.7"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 140.8;Syncytiotrophoblasts: 502.0"	"Cancer enriched"	"Detected in single"	4	"urothelial cancer: 1.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.0;cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 64.1;SuSa: 26.5"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		Yes	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	1.2	0.2	0.0	1.0	0.0	1.5	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	77.7	0.0	0.1	0.5	0.0	0.1	0.0	0.1	4.5	8.7	0.5	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.0	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	7.0	0.7	0.8	26.5	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	140.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	502.0	0.0	0.1	1.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"adrenal gland: 2174.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 40.6;Proximal enterocytes: 38.8;Theca cells: 68.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.4"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		Yes	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.2	2174.8	0.3	2.1	0.8	0.0	0.1	0.0	0.7	0.2	0.0	7.7	0.0	0.2	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.9	1.0	0.5	0.0	0.0	0.0	0.9	0.5	0.0	0.1	3.6	0.1	0.4	1.0	0.0	1.0	0.0	0.1	0.2	38.7	0.1	0.0	0.2	0.3	2.9	0.2	0.5	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	3.5	0.0	0.0	0.0	40.6	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	38.8	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	68.9	1.7	0.0
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin like and fibronectin type III domain containing 1"	Q86VF2	1	201190824-201228952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 186.3"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 103.8"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"HeLa: 76.6"	"Group enriched"	"Detected in many"	7	"amygdala: 3.3;basal ganglia: 1.2;cerebral cortex: 2.9;hippocampal formation: 1.9"	"Low region specificity"	"Detected in some"			HPA050415	Enhanced		Approved	"Midbody ring"		Yes	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"	"Midbody ring"		"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.3	0.9	0.6	0.1	0.0	10.4	15.1	0.0	0.9	0.2	0.3	1.2	0.6	0.1	0.1	0.5	0.1	0.1	0.2	0.2	7.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.3	186.3	0.3	0.0	0.8	0.0	0.0	0.1	2.5	0.4	0.0	14.6	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	76.6	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	4.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.2	0.6	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.1	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	22.1	0.4	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	103.8	0.7	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123998-62153169	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.9"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;NK-cells: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279"	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	3.1	2.5	2.7	7.5	1.1	20.9	2.8	6.2	3.0	4.6	0.0	4.8	6.8	3.0	8.1	14.0	3.5	2.2	2.8	2.9	0.5	2.4	1.9	3.0	11.6	1.6	0.8	3.8	3.1	3.1	1.5	4.1	1.3	2.5	3.6	3.4	6.1	2.9	4.2	7.9	5.7	3.4	0.1	5.5	4.5	6.4	0.5	17.8	5.1	3.4	8.2	2.8	5.5	1.2	74.3	69.4	51.6	45.5	6.8	8.4	28.1	47.6	21.2	44.4	28.3	37.0	50.7	70.0	36.2	16.0	46.2	72.6	52.2	28.4	31.8	60.5	36.6	45.7	68.0	29.6	2.7	53.5	62.1	4.3	6.5	41.3	23.6	6.8	25.8	50.2	48.8	57.6	25.3	59.7	85.0	43.3	56.2	28.0	34.4	79.3	66.4	53.4	12.0	35.8	40.1	42.2	46.8	30.8	27.9	19.8	48.2	19.4	28.5	41.8	51.9	59.8	50.0	29.7	48.3	75.8	23.5	34.7	50.6	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.7	1.1	6.2	3.0	2.9	0.5	1.6	0.8	1.3	0.1	0.5	1.2	1.2	3.2	2.3	1.3	3.4	5.6	0.8	1.0	2.8	2.4	1.1	0.6	1.3	0.0	3.7	0.0	0.0	4.2	4.2	5.4	0.0	1.9	1.0	2.0	2.1	1.5	0.0	10.9	3.3	2.5	7.1	1.9	9.2	2.7	3.8	5.7	0.0	0.7	4.2	0.0	2.5	3.4	0.0	0.9	1.6	0.5	2.8	3.3	3.6	1.0	5.0	1.5	3.1	2.0	1.5	2.2	1.6	1.5	10.9	1.2	1.3	0.3	2.6	2.3	0.0	1.9	4.3	6.5	7.8	15.1	3.3	2.2	3.7	1.9	4.8	1.1
IQCB1	"KIAA0036, NPHP5, SLSN5"	ENSG00000173226	"IQ motif containing B1"	Q15051	3	121769761-121835079	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding	"Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 155.3;Spermatogonia: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 131.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042028	Approved	Approved	Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA042028: AB_2677806"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (3.08e-5)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-3)"	11.6	11.2	9.6	14.7	10.0	20.4	23.1	11.0	10.5	15.7	10.8	13.0	12.0	15.5	19.7	12.5	16.6	12.1	9.7	10.1	10.1	12.2	8.9	12.3	24.3	9.7	9.5	17.9	18.3	13.9	15.3	11.5	9.5	15.9	16.2	18.9	15.6	15.5	11.4	15.5	14.1	11.8	9.7	18.3	12.3	28.9	10.4	22.1	10.5	5.7	25.7	14.2	13.7	11.0	38.3	10.1	48.9	55.5	7.5	11.6	57.2	17.4	10.8	19.7	23.8	33.6	18.1	76.8	23.9	10.1	30.2	28.7	30.5	14.5	29.3	15.1	23.8	51.2	22.2	28.7	20.0	64.1	14.8	7.4	27.2	13.7	30.3	10.2	15.2	32.4	31.0	27.9	22.3	19.3	41.7	44.5	40.1	22.6	18.1	40.4	23.4	24.9	11.4	16.9	26.0	20.9	17.3	12.2	31.3	16.0	10.8	49.4	12.9	18.5	22.4	9.1	23.4	66.4	44.9	131.2	17.9	29.0	17.1	3.2	6.6	11.7	7.2	12.3	10.5	22.8	9.8	9.0	9.6	21.6	11.5	7.2	2.8	12.2	14.1	8.7	11.7	6.4	9.6	10.0	11.0	10.5	10.1	10.1	9.7	9.5	9.5	9.7	10.4	11.0	15.8	6.4	15.0	48.3	28.4	18.9	19.2	20.0	19.9	15.2	19.6	17.3	8.4	11.5	26.5	11.0	27.1	26.6	21.9	7.7	3.9	11.1	3.7	31.1	12.7	11.2	7.2	21.5	60.1	12.9	8.2	15.4	11.7	12.6	8.8	21.9	6.8	6.2	10.5	13.5	66.8	8.6	20.3	9.8	14.1	7.4	15.5	11.3	14.2	51.5	15.8	12.8	17.5	49.3	59.5	13.9	8.2	13.5	45.2	15.7	7.9	7.5	69.2	27.7	13.1	17.8	15.9	155.3	96.5	16.2	20.6	14.1	19.9	8.4	11.9	16.3
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	0.7	0.7	0.2	2.2	0.4	15.5	0.6	0.0	0.6	1.1	0.2	4.1	6.6	0.5	1.1	5.2	0.2	0.7	0.4	0.5	0.1	0.6	0.6	1.6	1.6	0.9	0.4	0.1	0.2	0.1	0.1	2.8	0.9	0.4	5.0	0.0	1.0	0.1	0.3	3.7	5.7	2.9	0.0	0.8	4.6	3.8	0.6	3.4	0.2	0.0	2.2	0.9	2.1	0.4	59.2	28.4	25.6	18.1	1.6	4.0	12.4	43.1	28.3	41.0	36.6	32.4	52.5	5.2	15.6	25.2	21.6	54.6	17.5	22.1	36.3	0.1	15.7	7.8	62.6	16.1	0.2	9.7	0.1	1.2	2.5	34.3	50.0	10.0	24.1	12.5	16.1	8.1	30.2	31.2	5.7	13.7	18.6	57.7	28.0	18.9	28.8	6.1	10.4	20.3	16.3	25.2	38.7	44.9	14.9	29.8	35.8	25.6	16.8	36.8	43.7	30.4	51.4	4.0	2.1	2.4	12.4	15.1	42.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.4	0.0	0.6	0.5	0.1	0.9	0.4	0.9	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.4	0.6	0.0	1.4	1.3	1.0	2.8	0.1	0.0	0.0	2.2	0.1	3.9	0.0	0.3	6.5	0.5	0.7	0.6	1.2	6.5	0.7	0.0	3.6	0.9	11.2	1.4	0.0	4.4	2.5	0.4	3.9	0.0	0.2	3.7	0.0	1.3	6.1	26.6	0.3	1.9	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	0.4	0.8	0.4	0.0	0.0	0.0	0.0	1.4	6.4	2.6	3.6	1.0	0.8	0.2	0.3	7.4	0.4
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.1;Late spermatids: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: AB_2732646"	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	7.4	6.2	4.2	7.6	4.4	1.7	8.8	4.5	4.9	9.8	4.3	7.1	7.2	8.4	7.4	5.9	10.1	6.6	6.1	4.0	5.3	6.7	4.2	6.2	9.3	4.7	4.7	13.2	5.1	6.9	4.1	8.4	4.8	8.4	9.0	11.1	8.8	6.9	4.1	7.8	8.4	6.9	4.4	7.5	8.6	11.7	4.7	9.6	9.6	4.4	9.2	6.8	6.0	5.3	9.4	5.8	11.8	8.9	23.1	25.7	8.6	15.6	10.5	10.9	14.2	9.8	22.2	12.8	22.3	14.4	13.9	14.5	5.9	10.6	12.6	13.9	5.5	11.9	17.0	7.5	18.7	6.8	7.4	12.2	16.3	15.8	19.6	20.3	10.0	14.5	6.4	5.5	17.9	1.9	8.8	19.8	1.8	16.7	7.9	8.9	11.5	10.5	13.5	9.7	4.7	8.6	9.1	6.2	7.1	11.0	7.6	9.1	12.4	21.1	9.4	18.6	6.4	4.7	10.9	7.5	9.8	10.9	9.2	3.3	2.6	2.6	1.6	2.1	2.3	2.2	2.6	2.0	2.6	1.6	3.2	2.9	0.9	1.8	2.5	4.1	1.3	1.6	4.2	4.4	4.5	4.9	4.0	5.3	4.7	4.7	4.8	4.4	4.7	5.3	6.2	9.6	5.8	4.2	5.0	4.7	10.3	6.6	2.8	7.4	7.6	8.9	6.8	15.7	12.0	0.0	4.2	6.0	11.7	9.0	1.9	11.5	171.1	9.9	13.6	5.8	6.0	4.8	3.4	5.1	5.0	9.9	7.1	6.8	3.8	5.0	6.4	2.2	5.0	8.4	3.0	10.5	4.1	7.2	5.2	49.3	8.4	6.0	1.8	1.0	6.9	5.2	6.2	3.5	8.2	8.2	4.5	9.4	2.4	8.4	7.6	6.1	25.3	12.3	0.0	6.0	9.6	9.9	4.9	5.3	6.0	4.0	4.8	7.5	9.7	8.4
KATNBL1	"C15orf29, FLJ22557"	ENSG00000134152	"Katanin regulatory subunit B1 like 1"	Q9H079	15	34140674-34210096	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 128.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 128.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062573	Approved		Supported	"Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Midbody, Mitotic spindle"	"Nucleoplasm, Cleavage furrow"	"HPA062573: AB_2684796"	"unprognostic (5.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.94e-3)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (2.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	22.0	12.1	16.3	22.9	16.6	16.3	20.8	25.0	20.8	22.5	22.4	19.9	15.9	20.7	19.0	39.9	16.8	15.9	13.4	15.8	14.9	17.0	17.6	18.4	17.6	15.0	13.8	14.4	14.0	14.5	12.1	32.4	16.0	16.9	21.2	31.2	14.6	13.6	13.2	31.4	15.7	25.4	12.9	18.6	17.7	18.0	18.2	15.2	12.5	13.0	20.3	17.8	27.7	25.3	37.1	31.5	49.7	33.4	39.5	39.0	37.0	49.6	30.0	38.7	38.4	17.8	19.9	17.6	31.2	32.2	54.5	47.5	24.9	28.5	45.8	36.9	12.6	31.8	34.6	21.6	27.0	33.9	33.1	23.6	40.8	26.1	51.3	39.7	70.6	45.4	34.3	36.7	53.1	17.6	21.4	27.4	35.8	47.4	25.0	32.3	30.3	16.1	35.9	49.5	28.1	24.8	30.1	21.9	14.7	49.2	27.0	38.8	40.4	51.9	26.7	46.8	39.7	21.5	32.5	37.1	46.5	35.7	38.9	62.8	18.2	29.7	18.4	17.3	23.3	23.9	19.6	18.8	20.7	25.6	21.5	19.2	128.5	13.2	11.5	28.4	17.9	12.0	16.3	16.6	25.0	20.8	15.8	14.9	15.0	13.8	16.0	12.9	18.2	25.3	59.7	38.5	25.2	83.9	41.7	41.3	65.2	60.5	34.7	57.0	42.1	43.1	12.8	24.3	51.6	25.8	52.1	58.6	42.3	30.6	33.2	59.1	75.4	40.5	53.3	47.0	23.9	39.8	104.3	54.5	86.2	38.8	39.3	50.8	44.9	68.7	37.9	20.8	39.1	67.3	96.7	35.6	52.9	27.6	48.8	59.2	31.7	36.2	32.0	64.6	49.9	53.1	27.8	86.0	114.4	105.3	37.4	33.1	41.1	116.8	21.4	41.6	49.6	44.7	59.2	52.2	45.3	47.8	44.3	45.0	54.3	179.5	39.7	31.6	39.1	132.6
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537225-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;lymphoid tissue: 2.3;retina: 4.6"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 264.8;Excitatory neurons: 279.1;Inhibitory neurons: 241.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;HDLM-2: 1.4;HEK 293: 3.4;SCLC-21H: 2.7"					"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.1	0.4	1.7	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	2.4	2.2	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.5	0.0	1.1	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.3	0.0	1.3	2.3	0.4	0.3	1.5	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.0	1.4	2.4	2.2	1.0	2.6	0.4	1.3	1.5	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	17.4	0.0	0.0	0.3	0.0	0.0	1.8	264.8	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	17.9	0.0	279.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	241.2	0.6	0.0	0.0	0.0	6.8	1.2	0.0	0.0	3.7	0.0	0.7	0.0	11.6	4.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.1	0.1	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0
KCNV1	Kv8.1	ENSG00000164794	"Potassium voltage-gated channel modifier subfamily V member 1"	Q6PIU1	8	109963636-109975771	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 4.9"	"Group enriched"	"Detected in some"	6	"Enteroendocrine cells: 7.1;Excitatory neurons: 28.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 36.6"	HPA067233			Supported	"Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytokinetic bridge"		"HPA067233: "			"unprognostic (1.41e-1)"		"unprognostic (1.81e-2)"			"unprognostic (5.01e-4)"		"unprognostic (2.30e-1)"	"unprognostic (3.76e-2)"		"unprognostic (1.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.17e-2)"		0.1	0.1	1.9	0.1	4.9	0.5	0.1	0.0	4.6	0.0	0.0	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	3.3	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.4	0.1	0.3	0.2	0.0	0.2	0.4	0.7	0.2	0.1	0.1	0.4	0.3	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.1	0.5	0.6	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.5	0.1	0.0	0.1	0.2	0.1	0.3	0.6	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.6	0.0	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.2	0.5	0.4	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.9	4.9	0.0	4.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	7.1	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0
KCTD1	C18orf5	ENSG00000134504	"Potassium channel tetramerization domain containing 1"	Q719H9	18	26454910-26657401	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 106.4;Distal tubular cells: 117.4;Excitatory neurons: 283.7;Squamous epithelial cells: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 106.6;HaCaT: 113.5;hTCEpi: 100.6;RPTEC TERT1: 97.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057808, HPA062486"			Approved	"Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite"		Yes	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytokinetic bridge, Centriolar satellite"	"HPA057808: , HPA062486: "	"unprognostic (1.15e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.35e-4)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (3.65e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.60e-8)"	"unprognostic (3.87e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.02e-2)"	7.8	16.5	21.7	2.7	41.5	0.6	32.4	14.0	44.3	19.2	9.5	9.7	4.1	14.2	22.6	50.6	50.2	8.4	23.8	31.2	10.3	28.8	3.5	5.5	2.7	9.8	13.6	15.1	7.4	12.0	10.8	11.4	9.2	21.6	10.6	18.4	19.9	22.6	5.1	61.1	3.7	12.5	10.2	3.9	10.3	5.9	13.7	17.6	19.9	6.9	14.3	13.0	36.9	29.6	17.5	55.1	106.6	11.6	61.8	9.7	13.4	14.3	21.5	22.0	21.9	5.1	19.1	2.9	52.2	30.5	18.0	113.5	20.5	30.6	20.6	2.2	8.7	3.1	10.2	8.2	11.1	1.7	4.7	16.7	100.6	6.2	41.4	28.0	21.0	24.1	1.3	1.2	16.0	24.5	16.3	5.2	10.5	57.1	27.1	8.5	5.7	2.3	97.8	25.2	10.3	40.5	20.7	27.5	8.7	61.3	24.1	4.0	11.7	24.4	6.8	4.8	15.0	4.8	4.1	0.4	8.7	11.0	36.8	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	41.5	14.0	44.3	31.2	10.3	9.8	13.6	9.2	10.2	13.7	29.6	3.0	3.2	4.1	80.0	0.7	31.7	55.9	17.2	106.4	5.0	27.3	29.7	13.9	8.6	15.0	25.8	8.4	45.5	0.8	6.2	117.4	8.3	28.0	47.0	7.8	2.9	1.2	0.8	283.7	3.6	7.6	5.5	7.1	42.4	0.0	66.3	2.5	1.7	4.4	21.9	66.1	4.3	20.3	0.8	1.7	12.0	5.3	1.2	23.2	16.9	0.4	21.4	1.0	81.4	42.1	11.8	2.4	3.0	6.6	36.4	0.4	10.7	29.3	5.9	0.0	2.7	6.2	1.8	5.1	109.0	44.5	33.2	1.0	6.3	4.0	51.2
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	9.2	7.4	3.6	4.9	4.5	4.4	8.2	3.9	4.7	7.7	2.1	8.9	4.5	10.4	3.5	6.5	7.8	5.4	9.8	3.4	4.0	7.0	4.9	5.7	6.4	4.4	4.3	11.0	7.5	8.1	4.7	6.4	4.4	9.0	5.1	5.8	7.0	6.2	17.4	7.0	6.5	7.4	3.7	6.4	7.0	3.1	4.1	9.2	8.4	9.0	7.2	8.1	6.5	6.0	8.3	5.3	14.7	10.2	9.8	15.1	7.3	9.3	13.1	11.7	11.9	5.3	7.2	20.2	6.9	9.8	5.6	5.6	17.5	9.9	15.4	11.2	5.9	14.7	9.6	6.5	6.7	18.6	9.9	10.9	11.7	12.0	11.3	13.0	9.9	12.3	21.2	10.8	11.6	4.7	20.9	13.1	13.9	8.7	6.8	8.5	14.0	11.5	7.5	7.0	7.3	12.5	10.9	8.3	7.5	9.8	13.9	15.8	11.5	6.5	5.8	17.2	10.7	6.9	21.1	12.1	12.0	17.8	9.7	2.6	2.3	4.0	2.8	2.5	2.4	2.5	2.4	2.2	2.2	2.3	2.5	2.4	2.3	3.1	3.8	1.5	2.1	1.9	3.6	4.5	3.9	4.7	3.4	4.0	4.4	4.3	4.4	3.7	4.1	6.0	35.8	38.5	39.4	5.9	32.9	34.5	31.6	44.1	25.0	20.0	24.5	24.0	28.4	32.9	43.6	23.9	8.4	40.6	32.5	18.8	68.4	45.5	245.7	29.0	32.4	34.6	15.6	27.3	5.4	62.6	55.8	28.9	18.3	29.3	38.6	17.6	37.1	26.4	35.0	15.2	6.0	24.6	26.4	42.9	27.3	84.4	37.6	30.3	14.2	5.6	37.7	44.8	41.2	5.5	10.1	48.9	24.0	49.2	19.1	51.0	23.5	45.2	30.5	14.0	0.0	43.3	28.3	53.8	40.5	22.3	27.8	57.2	35.3	25.7	25.7	46.7
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92574105-92655395	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.4;lymphoid tissue: 37.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	1.1	0.7	0.5	8.5	0.7	19.4	2.5	0.4	0.6	1.4	0.5	6.3	5.5	1.8	1.0	6.7	1.0	1.2	0.6	0.5	0.5	1.0	1.1	1.3	17.5	0.6	0.6	0.6	0.5	0.7	0.3	3.9	0.6	1.0	7.4	0.8	1.3	0.7	0.2	6.0	5.3	2.5	0.5	2.9	3.9	11.6	0.4	37.9	1.6	0.3	18.5	2.3	2.3	0.6	103.1	45.2	100.6	94.5	7.3	10.5	24.2	72.6	62.8	78.8	78.1	39.6	67.2	111.1	36.5	34.4	32.9	72.0	72.1	36.5	92.4	68.3	41.3	70.5	41.4	42.4	1.4	116.0	63.0	3.6	3.3	61.4	55.9	18.3	50.0	46.1	51.2	126.4	61.1	41.4	99.3	65.8	40.3	42.5	30.7	106.6	98.8	40.2	21.0	30.1	30.0	42.9	56.4	25.9	29.2	34.1	67.9	37.6	28.6	35.7	51.3	37.1	96.9	35.4	58.3	113.4	29.5	82.3	50.3	0.8	0.0	0.1	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.1	0.2	0.2	1.0	0.1	0.1	1.1	0.2	0.5	0.7	0.4	0.6	0.5	0.5	0.6	0.6	0.6	0.5	0.4	0.6	0.4	0.0	2.0	1.3	3.5	2.9	1.1	1.6	3.4	1.0	1.8	1.8	1.7	1.5	2.5	1.8	0.0	6.7	2.3	2.9	1.9	0.5	16.3	3.4	4.3	2.0	0.0	39.1	2.1	0.6	11.4	4.7	9.2	4.9	0.0	20.7	2.2	0.4	8.2	0.0	1.8	4.3	4.1	4.6	3.4	4.4	0.9	4.0	0.0	0.0	1.0	0.7	2.1	2.5	1.1	0.2	0.4	0.7	15.2	0.8	0.5	0.6	3.7	0.4	0.0	1.7	3.7	38.0	23.4	12.6	3.3	1.5	4.5	2.5	8.0	1.7
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"		Yes	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.2	0.2	0.1	2.0	0.0	6.5	0.3	0.2	0.3	0.2	0.1	0.9	1.2	0.3	0.0	1.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.2	3.2	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.2	0.1	0.1	0.0	0.0	1.0	1.1	0.6	0.0	0.6	0.6	2.5	0.1	10.9	0.1	0.0	3.2	0.4	0.3	0.1	29.7	17.3	26.8	15.0	0.8	3.0	14.8	20.0	11.7	18.7	16.8	10.5	15.1	18.0	7.0	9.6	11.6	23.0	21.6	13.3	26.7	22.1	11.3	28.8	24.8	10.3	0.1	45.5	15.7	0.6	0.6	20.9	17.8	4.0	13.5	26.3	44.0	22.6	23.5	12.1	26.9	14.2	22.6	8.7	15.0	24.3	35.4	22.8	6.3	8.3	12.7	14.0	28.3	9.5	11.0	19.8	12.9	11.6	11.1	14.7	17.3	16.2	35.3	8.2	8.9	25.8	8.6	24.0	30.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	1.9	2.4	1.0	1.1	0.6	2.3	1.5	1.9	0.8	0.0	0.9	0.0	2.1	4.2	0.6	2.5	0.0	0.2	4.1	3.7	2.2	1.6	0.0	27.1	1.1	0.0	7.7	3.3	10.2	5.0	2.5	13.2	2.5	0.9	5.4	0.0	0.9	5.2	0.0	2.9	1.9	2.5	0.6	2.3	0.0	0.0	0.4	0.5	0.0	0.5	0.8	0.3	0.0	0.7	11.3	1.2	0.2	0.1	1.4	0.8	6.6	1.4	2.1	22.8	16.3	8.3	0.9	1.4	2.3	0.7	4.3	1.9
KIF18A	"DKFZP434G2226, PPP1R99"	ENSG00000121621	"Kinesin family member 18A"	Q8NI77	11	28020619-28108156	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 8.2;lymphoid tissue: 9.6;testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.1;Spermatocytes: 78.7;Spermatogonia: 28.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.1;memory B-cell: 1.0;NK-cell: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039312, HPA039484"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Cytokinetic bridge"		"HPA039312: AB_10794087, HPA039484: AB_10795252"	"unprognostic (3.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.09e-3)"	"unprognostic (3.80e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.72e-4)"	"unprognostic (4.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.88e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-1)"	0.2	0.1	0.0	1.9	0.1	8.2	0.7	0.0	0.1	0.7	0.1	1.6	1.5	0.5	0.3	1.4	0.3	0.5	0.0	0.1	0.1	0.3	0.3	1.0	4.7	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.1	0.3	2.0	0.6	0.3	0.4	0.2	1.2	1.4	0.8	0.1	0.7	0.6	13.7	0.2	9.6	1.1	0.1	4.6	0.7	0.5	0.1	27.9	27.4	27.2	19.0	0.9	3.7	9.1	28.3	13.2	44.2	46.0	9.2	11.0	23.3	10.0	14.7	24.1	27.2	23.4	11.1	61.4	23.4	14.2	15.2	17.8	11.8	2.1	22.6	13.4	6.8	1.4	15.5	18.1	7.8	17.2	19.0	24.6	20.0	25.2	14.8	23.1	16.7	13.4	18.0	11.1	17.8	65.0	11.6	12.5	8.0	16.3	12.6	23.7	11.1	7.8	16.5	23.8	6.9	10.1	35.0	27.2	33.2	37.4	7.9	19.8	23.4	21.0	16.5	25.2	4.1	0.0	0.3	0.1	0.2	0.3	1.0	0.4	0.2	0.3	0.4	0.3	0.1	0.0	1.4	0.0	0.3	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	3.2	0.0	0.0	4.7	2.3	1.3	1.4	1.2	0.3	1.3	2.9	0.5	0.0	2.2	0.0	6.2	4.6	2.8	1.9	0.0	0.6	43.1	3.4	2.5	1.1	1.8	15.4	0.2	0.9	7.1	5.4	1.5	3.4	4.5	9.7	1.4	0.0	2.2	0.0	0.1	1.9	0.0	1.6	1.4	8.7	0.6	1.4	0.0	1.0	1.1	0.7	1.0	0.5	0.9	0.5	0.1	0.4	5.1	0.2	0.2	0.6	1.7	1.9	0.0	2.5	1.9	78.7	28.3	4.3	1.0	1.6	3.9	2.7	3.6	0.5
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187723	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 24.6;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.0;Erythroid cells: 24.6;Extravillous trophoblasts: 13.1;Granulosa cells: 11.1;Spermatocytes: 21.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 6.6;T-reg: 2.5"	"Group enriched"	"Detected in many"	46	"NK-cells: 6.6;T-cells: 2.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036909, HPA036910"	Approved		Uncertain	"Nucleoplasm,Cytokinetic bridge"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"		"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (2.14e-12)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	0.7	0.8	0.0	4.5	0.1	14.1	1.3	0.1	0.1	1.0	0.1	3.3	3.5	1.4	0.0	6.6	0.4	0.8	0.5	0.0	0.1	0.4	0.9	0.9	8.6	0.1	0.2	0.2	0.2	0.1	0.0	5.4	0.1	0.2	5.1	0.0	1.0	0.1	0.1	4.4	2.8	5.8	0.0	1.9	2.1	11.7	0.5	24.6	0.5	0.1	13.1	1.6	2.0	0.1	87.8	59.5	127.8	84.4	6.7	12.3	53.9	75.0	68.9	162.3	121.4	111.9	80.5	38.8	39.2	96.5	60.6	85.9	121.7	142.5	160.9	56.4	57.4	57.2	101.1	70.7	0.3	28.2	25.1	4.8	2.3	86.2	49.5	27.1	106.7	53.9	24.4	70.4	113.9	81.5	47.6	26.7	80.6	51.8	63.7	51.2	128.5	39.5	43.9	42.3	37.8	37.5	144.1	47.9	30.9	161.6	60.8	28.5	51.1	41.6	60.5	38.0	126.4	36.0	37.5	42.0	26.7	81.1	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.3	0.0	1.7	0.0	0.8	0.4	0.4	2.9	0.0	0.0	1.1	1.3	0.3	0.0	0.7	0.0	0.0	11.0	0.1	2.8	0.0	0.1	1.0	1.0	1.9	1.7	0.0	24.6	0.0	0.0	13.1	3.1	2.6	1.3	4.5	11.1	3.3	0.4	6.1	0.0	0.0	1.6	6.1	2.2	0.4	2.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.4	3.0	0.3	1.2	0.0	0.9	0.0	0.0	0.5	4.4	21.7	7.5	5.3	0.4	1.0	0.7	0.8	3.4	0.6
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701590-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.2;lymphoid tissue: 9.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 89.2;Spermatocytes: 165.4;Spermatogonia: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050214	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	1.3	0.7	0.3	4.5	1.0	10.2	2.5	2.4	0.4	1.5	0.1	3.2	3.6	2.3	0.4	3.3	1.2	1.3	0.9	0.3	0.3	1.3	1.3	1.5	8.0	0.5	0.3	2.7	0.7	1.1	0.2	2.4	0.6	1.3	4.0	1.1	1.0	0.9	0.4	2.5	3.4	2.2	0.4	3.3	2.5	6.9	0.6	9.8	1.8	0.7	7.5	1.6	0.7	0.6	84.8	17.0	24.3	21.7	4.7	8.0	20.2	33.8	30.9	34.8	36.3	22.6	38.1	32.5	10.4	17.3	13.0	41.8	27.3	18.9	46.4	39.5	18.6	33.1	30.5	19.5	1.4	57.1	26.3	3.4	2.8	33.7	33.9	12.2	22.8	17.0	32.2	36.5	31.3	14.6	33.6	10.8	25.0	13.8	16.1	23.1	47.8	14.3	10.7	11.2	7.7	13.9	24.4	11.0	12.2	17.3	28.5	16.3	17.9	22.2	22.1	29.1	55.3	10.1	29.5	43.2	21.1	49.4	16.8	13.1	2.4	4.2	5.5	4.1	6.8	13.0	7.4	6.1	1.3	16.0	8.6	8.0	0.2	3.0	4.5	5.2	9.5	2.2	0.3	1.0	2.4	0.4	0.3	0.3	0.5	0.3	0.6	0.4	0.6	0.6	11.5	3.2	13.5	2.3	36.4	17.7	6.2	20.8	6.8	14.3	8.3	8.5	8.7	1.5	10.7	0.0	10.4	21.4	32.3	8.8	3.9	6.9	13.1	10.6	13.2	11.0	1.2	89.2	8.1	4.7	38.1	13.2	14.8	12.9	44.4	37.2	9.3	4.4	20.7	13.5	9.5	8.6	16.2	21.0	17.9	10.5	8.1	17.1	5.4	23.4	11.3	7.5	24.7	9.0	9.1	4.1	5.7	8.6	51.4	3.7	8.9	3.2	6.6	9.8	6.6	16.9	17.1	165.4	96.7	26.1	14.1	5.2	34.2	12.9	25.5	5.2
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822927-53825193	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	508	"testis: 75.3"	"Group enriched"	"Detected in some"	68	"Early spermatids: 744.0;Late spermatids: 623.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	744.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	623.2	6.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	10.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290104-70420886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 18.6;Erythroid cells: 29.5;Extravillous trophoblasts: 11.5;Granulosa cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.3	0.3	0.3	3.2	0.2	11.2	0.7	0.1	0.3	0.6	0.3	3.7	3.1	0.8	0.0	3.6	1.5	0.5	0.2	0.2	0.5	0.2	0.5	0.5	5.5	0.9	0.7	0.1	0.1	0.1	0.5	2.3	0.6	0.1	4.5	0.6	0.5	0.1	0.1	2.2	3.3	1.3	0.7	2.4	1.7	1.5	0.6	12.6	0.2	0.0	6.6	0.9	1.1	0.2	60.2	41.1	61.0	30.1	2.9	5.1	24.0	44.7	23.8	59.7	51.6	46.7	34.3	36.7	27.4	22.1	46.2	35.1	66.6	24.2	66.8	42.5	33.4	41.7	50.1	33.4	0.7	46.7	27.8	1.7	1.5	49.6	28.2	7.3	37.0	27.7	53.8	79.1	57.0	38.7	43.0	23.1	61.7	63.8	43.2	47.1	82.2	34.6	14.5	23.4	40.1	33.5	72.9	30.5	18.6	30.6	24.5	18.1	26.0	39.3	50.6	42.6	54.1	22.6	41.7	52.0	20.8	50.4	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.1	0.3	0.2	0.5	0.9	0.7	0.6	0.7	0.6	0.2	0.1	0.0	0.5	1.3	1.3	1.8	0.3	1.4	0.6	0.2	1.1	0.8	0.4	1.5	0.2	0.0	0.0	7.0	0.9	2.2	0.0	0.0	0.4	18.6	1.5	1.3	1.2	29.5	1.9	0.0	11.5	2.1	3.1	1.6	0.0	12.2	1.1	0.1	5.3	0.0	1.9	4.6	2.0	1.3	0.7	0.8	0.0	1.4	0.0	0.0	0.2	3.1	0.0	2.0	0.7	0.1	0.1	0.0	8.2	0.4	0.3	0.1	0.4	0.0	0.0	0.2	2.9	8.7	5.4	7.2	0.3	1.8	1.8	1.3	6.6	0.5
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018141	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 3.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Early spermatids: 5.4;Late spermatids: 4.3;Spermatocytes: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57546026-57586633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease variant, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"brain: 1628.2;choroid plexus: 951.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.7;Early spermatids: 12.2;Endometrial stromal cells: 12.9;Excitatory neurons: 28.4;Horizontal cells: 26.9;Inhibitory neurons: 21.7;Late spermatids: 15.2;Rod photoreceptor cells: 11.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.2;K-562: 15.3;NTERA-2: 17.7;SCLC-21H: 34.4;U-87 MG: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	0.4	10.6	1198.6	4.6	1243.7	4.2	0.5	1056.4	1628.2	2.5	951.3	4.5	3.6	3.8	1.4	1.4	0.6	0.7	0.6	1242.7	1056.4	0.8	0.2	0.8	0.7	1103.5	1046.7	0.6	2.6	9.0	21.3	0.1	1113.3	0.9	1.9	48.0	1.1	0.6	0.3	1.1	2.5	2.0	1002.7	0.8	1.3	4.8	1052.3	0.1	2.3	0.1	0.4	0.5	1.5	1313.2	0.5	0.1	7.2	5.7	0.0	0.0	0.6	1.4	1.3	2.2	3.5	1.2	0.2	3.2	0.4	1.9	1.3	0.8	3.8	0.1	2.5	33.2	4.1	0.5	1.8	7.0	1.9	1.5	1.3	1.0	0.4	1.6	0.1	0.5	0.5	2.8	15.3	9.4	0.0	0.6	0.8	0.0	17.7	0.0	0.0	0.5	0.2	0.3	1.1	0.5	34.4	9.1	0.0	1.6	0.0	2.0	0.9	0.2	0.9	0.6	5.3	1.1	2.1	5.3	7.7	1.9	14.5	0.1	0.6	0.2	0.4	0.1	1.0	0.5	1.6	0.7	0.7	1.2	0.3	0.5	0.9	2.2	1.1	0.3	1.1	0.3	1.0	0.4	1198.6	1243.7	1056.4	1628.2	1242.7	1056.4	1103.5	1046.7	1113.3	1002.7	1052.3	1313.2	0.1	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	40.7	0.1	0.9	2.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	12.2	0.5	12.9	0.7	0.0	0.4	28.4	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	26.9	21.7	0.2	0.0	0.0	0.2	15.2	0.0	0.1	0.0	0.0	0.0	6.4	0.0	8.5	3.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.7	3.3	7.9	0.0	0.1	0.0	0.3	0.0	0.1	0.1
KLHDC4	DKFZp434G0522	ENSG00000104731	"Kelch domain containing 4"	Q8TBB5	16	87696485-87765992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 61.6;Late spermatids: 79.9;NK-cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 112.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041665	Approved		Approved	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Mitotic chromosome"	"HPA041665: AB_10796352"	"unprognostic (2.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.61e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.88e-1)"	"prognostic favorable (1.69e-4)"	10.6	10.8	7.6	11.6	7.2	13.3	10.7	11.7	9.0	11.8	5.2	14.0	8.9	11.6	4.4	11.9	12.0	6.7	8.9	7.8	7.7	14.0	14.6	11.4	16.1	7.6	7.0	12.2	18.4	10.3	13.1	5.4	7.4	13.2	10.9	6.2	11.8	7.8	12.5	11.9	13.7	7.1	6.3	19.8	14.0	12.5	7.3	15.6	13.1	6.4	13.4	11.5	12.9	7.1	16.6	29.7	14.8	22.8	6.0	7.9	23.3	15.1	14.5	24.8	11.6	43.9	23.3	25.6	19.6	12.1	8.8	26.6	23.1	20.0	18.0	4.2	24.9	15.0	20.6	29.4	14.9	14.3	14.8	3.6	10.7	21.9	25.0	12.4	20.8	42.5	48.3	13.4	17.1	72.0	32.7	40.3	25.5	18.9	21.8	31.3	17.3	15.3	15.0	19.2	22.5	21.4	31.9	16.4	7.8	12.6	25.8	22.0	13.4	13.1	23.3	7.1	29.5	63.2	23.4	112.0	13.2	35.2	9.7	0.0	7.8	5.9	18.3	10.8	16.2	7.8	7.2	14.1	6.0	7.7	7.3	11.3	0.6	25.7	16.0	8.0	6.8	8.7	7.6	7.2	11.7	9.0	7.8	7.7	7.6	7.0	7.4	6.3	7.3	7.1	8.4	0.0	16.8	11.1	14.7	4.6	10.9	6.8	12.5	17.8	12.7	9.9	9.9	14.3	14.2	9.2	27.1	14.4	36.1	16.5	11.7	12.3	61.6	8.9	6.0	8.8	24.0	16.0	9.1	16.7	9.4	9.0	19.4	11.4	3.8	17.7	12.1	13.3	13.3	11.8	10.1	15.9	8.2	13.3	6.1	79.9	6.5	9.9	8.8	7.5	10.2	6.5	77.2	7.1	9.2	13.1	9.3	7.5	35.9	15.1	13.8	25.1	9.0	18.0	0.0	16.7	8.5	22.8	11.8	8.6	6.7	11.9	25.5	11.6	21.8	16.5
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 29.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 424.7;Late spermatids: 448.2;Spermatocytes: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HDLM-2: 1.5;HEK 293: 1.8;MCF7: 1.4;T-47d: 1.4;U-266/70: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043197			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favorable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	0.4	3.0	1.3	0.1	1.8	0.0	0.7	1.0	2.9	1.1	2.1	1.4	0.2	1.4	0.5	0.5	2.2	0.0	0.9	1.7	2.2	4.7	1.9	0.8	0.0	1.7	1.8	1.0	2.4	1.1	4.6	0.0	1.6	1.7	0.2	0.4	1.0	0.4	0.7	0.3	0.8	0.0	1.2	0.3	1.3	29.0	2.4	0.0	2.4	0.1	0.1	1.0	0.5	0.9	0.1	1.1	0.4	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	1.5	1.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.2	0.9	1.0	0.0	0.7	0.2	0.0	1.0	0.4	0.0	0.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	1.0	2.9	1.7	2.2	1.7	1.8	1.6	1.2	2.4	0.9	2.4	0.0	6.7	8.8	1.5	0.9	11.7	11.5	0.6	13.7	15.3	16.3	9.3	14.3	11.7	29.5	2.1	2.3	0.4	7.6	56.7	10.2	424.7	57.5	2.8	3.4	5.4	0.0	8.9	5.5	3.6	3.2	3.1	10.3	1.3	1.6	3.9	9.5	0.6	3.3	6.8	10.6	16.2	0.6	0.7	448.2	8.1	0.9	7.2	2.8	0.6	35.1	1.0	6.0	1.7	3.9	8.2	8.2	2.1	6.4	2.5	47.8	77.8	20.0	13.1	2.8	4.4	198.1	15.6	2.6	0.9	0.8	1.2	1.7	8.7	8.2
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495844	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 41.1;Excitatory neurons: 42.9;Inhibitory neurons: 51.1;Oligodendrocyte precursor cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA040766			Supported	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA040766: AB_2732488"	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favorable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favorable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	13.7	14.2	24.1	10.2	23.0	11.3	11.9	25.9	25.1	20.5	18.2	16.6	7.7	20.4	17.2	8.0	17.9	13.6	14.2	22.9	21.4	15.6	10.8	11.8	17.6	18.0	18.1	22.3	16.5	22.9	19.6	11.6	18.7	18.7	10.6	15.3	14.0	18.0	22.1	11.7	10.4	21.7	14.8	15.6	12.2	10.2	23.1	8.0	20.8	18.0	20.7	13.4	10.9	21.2	17.1	16.5	37.5	29.9	30.6	35.5	9.0	21.4	37.6	21.0	23.6	8.2	6.4	11.9	7.0	37.3	16.9	21.3	25.6	9.2	18.1	25.9	15.1	12.6	17.4	8.3	30.6	2.6	11.7	26.9	14.2	19.3	12.4	26.8	31.3	9.1	32.7	11.4	20.7	25.9	2.5	15.6	6.3	14.1	11.4	23.5	13.8	0.5	12.3	19.9	19.9	20.3	23.0	16.9	15.8	12.3	15.7	9.3	14.2	25.1	12.2	17.5	8.9	6.4	7.4	7.9	13.5	11.1	16.6	8.9	4.6	19.3	8.1	6.3	6.4	8.3	10.2	7.5	15.5	6.2	7.7	8.3	10.6	16.6	8.3	5.6	19.2	6.5	24.1	23.0	25.9	25.1	22.9	21.4	18.0	18.1	18.7	14.8	23.1	21.2	4.6	0.0	3.7	41.1	8.2	1.7	2.8	8.4	4.0	11.7	4.3	5.2	4.8	10.0	5.3	9.2	4.2	17.9	5.2	2.9	3.9	8.4	0.8	3.2	7.1	4.8	3.0	1.3	42.9	2.6	6.6	9.2	5.1	3.9	5.1	14.2	4.2	6.3	7.9	13.5	51.1	5.2	12.2	5.7	4.9	1.8	12.2	4.8	1.8	16.9	4.2	13.9	7.2	41.2	26.8	5.6	3.5	19.9	5.4	3.9	3.0	10.9	4.3	6.7	6.6	4.7	5.3	17.3	15.4	2.8	1.4	13.4	7.8	17.7	3.8	1.8
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487551-183555706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 31.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 35.7;Endometrial ciliated cells: 28.3;granulocytes: 51.1;Hofbauer cells: 24.1;Macrophages: 33.3;Plasma cells: 63.6;Respiratory ciliated cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.3;HEL: 26.6;HMC-1: 26.7;U-266/70: 82.1;U-266/84: 45.5;U-698: 121.3"	"Low region specificity"	"Detected in all"							HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	1.5	0.7	0.7	11.8	0.8	3.5	0.9	1.0	1.0	0.8	0.7	2.5	2.5	0.6	0.2	0.6	4.8	2.1	0.7	0.6	1.4	0.4	1.0	4.2	29.3	2.6	1.4	0.3	0.6	0.2	0.2	1.9	2.0	0.5	2.3	0.1	1.3	0.1	0.2	0.1	4.8	0.7	1.5	6.3	4.1	0.2	3.1	10.0	0.6	0.3	31.0	1.8	0.3	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	26.6	0.0	0.0	0.0	7.3	26.7	0.0	0.0	0.0	0.0	0.0	4.6	0.5	0.4	18.4	0.0	0.0	8.8	4.1	0.0	0.0	0.0	14.8	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.5	0.0	0.1	0.0	0.1	82.1	45.5	121.3	0.0	8.0	0.0	7.8	2.8	11.8	0.6	2.2	0.7	3.6	2.4	1.0	2.0	2.4	2.9	1.8	2.4	2.2	2.7	4.6	4.2	2.6	0.7	0.8	1.0	1.0	0.6	1.4	2.6	1.4	2.0	1.5	3.1	3.7	4.0	6.4	6.5	0.7	35.7	1.1	1.7	0.6	0.6	0.6	0.3	0.4	4.8	0.0	5.4	0.0	2.1	0.2	16.6	0.2	0.0	0.1	2.0	28.3	0.5	4.6	0.0	7.6	0.3	0.0	0.3	1.7	2.0	0.8	51.1	8.1	1.1	0.2	24.1	0.0	0.3	0.0	0.0	20.7	22.4	0.8	0.3	33.3	8.8	14.0	10.1	0.3	5.2	1.0	0.3	0.0	0.1	0.0	63.6	1.2	0.0	0.4	24.4	0.7	0.0	1.8	1.5	0.3	0.4	0.1	0.6	0.5	16.8	0.0	0.2	1.2
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 253.0;esophagus: 94.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 23.9;Breast myoepithelial cells: 16.1;Collecting duct cells: 11.0;Oligodendrocytes: 87.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 575.5;CAPAN-2: 1346.5"	"Region enhanced"	"Detected in all"		"pons and medulla: 167.8"	"Region enhanced"	"Detected in many"		"spinal cord: 371.7"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		10000000		"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.2	0.0	71.8	0.0	135.8	0.0	7.2	170.8	119.8	53.1	45.6	0.1	0.2	1.5	0.4	94.2	28.9	3.5	0.0	72.9	94.3	20.4	0.0	0.0	0.0	213.8	130.8	0.8	0.0	0.0	0.7	0.0	182.1	0.1	0.0	0.0	15.8	2.2	0.0	9.9	0.0	0.0	123.6	5.8	0.1	0.9	118.1	1.5	0.0	0.0	36.4	0.0	27.4	253.0	575.5	0.0	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.7	1346.5	0.0	8.1	0.0	0.6	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	131.0	2.2	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	5.6	18.2	1.0	1.9	0.0	1.1	46.3	0.0	1.3	0.0	0.4	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.8	135.8	170.8	119.8	72.9	94.3	213.8	130.8	182.1	123.6	118.1	253.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	0.0	23.9	16.1	0.3	0.0	1.7	11.0	0.0	0.1	0.4	0.0	0.0	0.1	2.3	0.6	7.5	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	87.9	7.8	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	1.6	0.0	0.3	0.1	0.0	0.0	2.4
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin (SPAG5) binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.6;thyroid gland: 53.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 328.2;Late spermatids: 600.1;Spermatocytes: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	8.0	6.2	6.3	8.1	7.1	14.1	14.3	7.7	8.6	5.1	4.5	7.9	9.2	6.4	12.3	9.1	5.7	4.4	7.4	7.2	6.2	7.2	12.0	5.8	14.5	6.2	6.2	5.1	5.0	8.4	5.6	10.7	6.5	6.8	10.4	9.0	10.3	7.2	12.2	6.7	6.2	10.2	5.9	7.1	10.2	63.6	6.1	25.6	53.1	12.4	16.1	5.6	5.6	7.7	103.4	47.5	92.7	61.0	20.1	30.9	48.1	69.9	54.0	141.0	123.3	102.6	44.2	39.7	34.8	47.3	112.1	115.7	100.0	64.8	126.5	70.8	48.8	117.7	107.4	65.2	18.9	63.8	58.6	16.1	36.5	71.3	70.6	34.5	80.3	97.6	86.3	66.8	120.0	52.2	55.6	51.2	58.6	87.7	71.2	56.4	69.7	45.7	49.7	42.3	89.9	62.5	58.3	63.3	15.1	55.8	66.5	45.3	41.6	67.5	68.8	69.7	98.3	56.5	98.6	70.5	41.8	84.0	56.5	13.2	17.6	17.4	7.9	24.3	6.8	9.5	5.7	7.0	18.4	11.2	5.4	5.5	9.7	9.8	47.8	12.7	9.4	7.1	6.3	7.1	7.7	8.6	7.2	6.2	6.2	6.2	6.5	5.9	6.1	7.7	2.4	9.6	1.1	2.6	4.1	2.2	2.9	7.6	3.4	8.2	4.2	3.4	7.3	1.5	5.4	0.0	8.4	25.2	2.5	1.9	3.9	8.5	328.2	5.9	4.9	3.7	2.4	34.3	5.1	9.3	40.8	5.2	5.6	4.4	1.3	16.9	3.6	8.0	21.6	5.0	4.9	5.3	14.2	9.8	2.0	600.1	9.0	8.2	3.6	4.7	8.0	8.5	6.2	2.0	4.3	12.3	0.5	7.2	12.6	4.9	2.8	5.8	7.2	8.5	0.0	3.7	6.5	145.7	19.2	7.0	1.4	21.1	5.1	8.5	6.4	3.0
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1 small subunit processome component homolog"	Q13601	12	75490863-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	15.2	14.2	6.5	15.6	7.0	43.9	16.7	9.3	10.4	11.6	7.6	12.5	12.1	15.0	9.0	16.0	9.8	10.0	11.8	6.9	8.2	16.2	20.4	11.5	19.0	6.6	7.3	15.0	10.7	20.3	8.0	14.5	7.0	13.2	10.9	16.0	19.3	9.8	23.5	12.7	10.3	10.9	7.4	12.6	12.7	12.0	7.5	17.9	14.9	22.7	18.0	15.9	9.8	8.2	59.4	48.1	29.2	27.1	21.8	20.1	54.1	51.0	31.7	38.5	24.8	35.7	30.7	62.2	40.3	23.9	39.0	30.5	39.1	43.0	42.4	52.0	39.9	60.9	25.0	41.8	26.4	107.0	37.1	21.3	35.8	44.8	41.7	39.1	26.6	57.4	67.7	19.8	38.2	39.2	63.1	30.8	43.6	32.4	42.4	49.9	56.1	37.4	42.6	73.6	35.4	29.6	48.0	33.7	59.5	27.9	56.2	42.9	34.4	36.2	24.1	37.7	53.2	38.8	52.3	39.0	19.6	37.0	66.2	13.3	3.2	13.2	13.1	6.5	16.4	23.0	18.3	15.0	5.5	20.6	18.6	17.9	1.5	12.9	5.5	15.3	18.2	7.6	6.5	7.0	9.3	10.4	6.9	8.2	6.6	7.3	7.0	7.4	7.5	8.2	62.9	70.5	49.2	13.4	64.0	49.1	104.3	70.3	48.9	56.4	41.1	50.5	25.6	24.3	55.7	40.5	33.3	68.5	86.4	18.7	58.7	50.9	5.4	52.5	63.8	46.7	18.0	55.8	25.3	49.0	55.7	48.2	21.4	62.6	38.0	41.3	31.1	40.9	29.5	74.0	24.3	25.7	46.8	24.2	21.3	7.6	52.5	30.0	12.4	6.5	42.4	66.4	66.9	19.1	16.3	42.8	28.1	53.4	37.9	45.6	19.2	47.0	42.3	55.5	13.1	79.2	50.2	72.6	61.1	46.8	44.3	70.5	65.4	59.6	29.3	63.2
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.7;Exocrine glandular cells: 38.2;Extravillous trophoblasts: 39.9;Proximal tubular cells: 35.6;Syncytiotrophoblasts: 83.5;Theca cells: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	19.3	22.5	8.3	16.0	9.3	13.4	29.8	10.0	12.2	18.0	12.3	19.9	22.6	21.3	21.7	26.5	18.3	20.0	11.3	9.4	9.5	30.5	27.4	15.4	22.1	8.5	9.5	25.7	30.0	33.4	15.2	22.7	9.2	21.1	21.7	11.0	20.5	22.1	10.6	18.8	17.4	15.7	8.7	17.6	22.7	9.9	8.7	21.6	26.2	10.0	23.7	24.6	14.9	8.9	55.1	11.1	52.2	18.0	19.1	51.2	46.4	31.7	57.2	39.8	49.4	15.6	18.9	35.6	23.8	23.8	27.3	15.7	15.6	25.6	57.7	22.7	21.3	32.4	9.8	26.8	61.8	45.6	8.5	44.9	25.2	29.0	50.1	26.8	37.0	41.0	41.5	19.0	37.9	17.8	48.0	21.6	31.0	42.5	10.3	49.3	36.2	19.2	87.0	49.2	38.9	45.6	44.4	60.0	29.1	31.8	33.3	13.9	27.7	17.5	11.4	55.5	23.1	23.7	13.6	23.6	8.4	19.5	14.7	8.3	12.1	7.5	8.0	7.7	11.1	8.6	10.6	9.5	16.3	8.9	10.6	9.3	8.8	11.3	10.2	5.9	16.3	8.3	8.3	9.3	10.0	12.2	9.4	9.5	8.5	9.5	9.2	8.7	8.7	8.9	10.6	12.8	11.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	16.0	13.7	0.0	0.0	8.1	12.9	0.0	70.7	13.1	0.0	25.4	34.4	0.0	12.7	14.1	4.6	0.0	0.0	0.0	38.2	39.9	10.1	0.0	14.3	5.1	17.5	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	1.8	0.0	0.0	35.6	3.6	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	83.5	7.6	43.3	0.0	0.0
L3MBTL1	"dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3"	ENSG00000185513	"L3MBTL histone methyl-lysine binding protein 1"	Q9Y468	20	43489442-43550954	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 31.2;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SuSa: 5.1"									HPA059648			Supported	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA059648: "	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.65e-4)"	"unprognostic (6.02e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-4)"	2.7	4.8	8.6	0.8	8.5	0.8	3.9	6.4	10.2	6.4	6.1	6.1	1.1	5.0	2.0	4.2	6.9	0.6	3.9	8.0	9.4	5.9	2.0	3.0	0.8	8.0	8.8	7.5	3.3	1.1	16.7	0.6	8.7	6.4	0.7	3.4	4.6	1.7	5.1	3.9	4.8	0.8	6.1	5.5	3.9	10.1	10.8	0.8	6.9	1.1	0.5	4.8	6.4	7.6	0.1	0.1	1.6	0.9	0.1	0.0	2.6	0.2	0.3	0.5	0.4	0.2	1.7	0.9	0.4	0.9	0.5	1.1	0.0	0.4	0.3	0.0	1.1	0.3	1.4	2.1	0.3	0.0	0.3	0.3	0.6	0.1	0.0	2.9	0.3	0.9	0.6	0.2	0.1	0.3	0.4	1.2	1.0	0.7	1.4	0.6	0.2	0.5	1.2	0.4	0.4	1.3	0.5	0.5	0.1	5.1	0.6	1.7	0.6	0.2	1.1	0.0	0.4	1.0	0.4	0.3	1.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.2	8.6	8.5	6.4	10.2	8.0	9.4	8.0	8.8	8.7	6.1	10.8	7.6	1.2	3.2	3.2	16.0	3.3	0.9	2.0	1.9	8.0	17.2	2.7	2.8	1.9	1.5	4.2	5.5	14.6	2.1	5.2	0.9	1.9	1.3	2.0	2.4	2.6	2.2	1.2	1.7	12.4	0.2	3.3	1.9	2.0	1.8	5.1	8.3	1.8	0.6	1.4	6.7	24.4	2.1	4.1	1.6	1.8	2.8	5.0	2.0	3.6	4.7	1.0	4.7	4.1	31.2	25.4	0.8	1.9	6.0	1.7	2.5	3.1	0.7	6.6	10.8	0.0	4.2	2.8	13.9	12.3	1.5	1.1	1.9	2.3	4.6	1.8	1.4
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.6;retina: 29.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 78.4;Granulosa cells: 22.2;Horizontal cells: 60.6;Inhibitory neurons: 38.9;Theca cells: 23.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"plasmacytoid DC: 141.3"	"Lineage enriched"	"Detected in many"	31	"dendritic cells: 141.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 469.4;SH-SY5Y: 86.4;THP-1: 169.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: AB_2686309"	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"	0.5	4.3	41.7	1.5	96.6	2.3	0.9	11.0	51.8	8.8	3.7	2.2	1.2	4.8	6.3	0.4	10.6	3.1	0.4	39.1	14.3	0.8	0.2	0.9	5.7	47.7	10.1	21.9	1.2	0.7	6.3	0.1	43.7	2.3	1.2	29.6	1.1	3.8	0.1	0.7	1.3	3.9	29.1	1.8	1.4	0.9	35.3	1.4	0.9	0.2	5.2	0.7	1.2	13.6	0.1	0.2	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	469.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	86.4	0.0	0.0	0.1	0.4	0.0	169.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	21.1	0.3	4.2	1.7	0.0	0.0	0.3	0.2	4.5	0.0	0.1	9.5	0.5	0.0	0.0	0.4	0.0	0.0	141.3	0.0	2.4	41.7	96.6	11.0	51.8	39.1	14.3	47.7	10.1	43.7	29.1	35.3	13.6	0.5	0.0	1.1	6.2	3.4	0.1	0.0	0.0	0.0	12.3	0.3	4.3	0.3	0.0	0.0	0.0	8.4	0.0	78.4	0.0	0.0	0.8	5.4	0.2	0.7	0.8	0.0	0.0	10.0	0.0	0.0	8.4	0.0	0.7	0.0	22.2	0.0	0.0	1.3	60.6	38.9	0.0	0.0	0.6	0.8	7.5	0.6	3.5	3.6	4.7	5.4	3.9	0.0	13.0	1.5	0.4	0.0	0.0	5.5	0.5	0.0	0.0	0.0	5.7	0.0	0.3	13.9	0.6	1.1	0.0	0.0	0.0	0.9	23.2	0.1	0.0
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577198-17607972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		3500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	92.8	52.6	33.0	131.4	34.8	59.2	60.3	39.0	42.9	30.7	31.4	60.3	78.3	34.4	25.4	44.6	45.4	67.3	65.0	31.8	36.3	106.3	190.4	100.6	150.4	46.3	37.7	24.0	30.9	61.0	22.1	70.9	42.2	36.7	62.0	20.0	67.7	31.0	68.1	40.3	61.3	76.2	45.6	94.1	55.3	43.8	41.9	56.8	46.4	63.8	94.3	82.8	25.3	42.9	51.7	44.4	41.6	39.4	80.5	97.9	0.4	79.6	89.1	282.3	340.3	81.4	96.1	202.0	51.7	61.6	167.9	31.3	157.7	56.3	106.7	77.7	45.2	112.1	47.3	107.6	94.1	102.3	69.2	100.0	35.3	92.7	48.6	32.3	99.7	52.2	110.6	139.9	67.6	55.6	91.9	139.5	87.1	96.3	83.9	139.8	39.8	102.7	73.5	59.6	61.4	50.2	72.9	44.4	161.1	57.3	37.9	39.1	65.2	71.3	48.5	76.1	140.6	127.7	208.8	172.7	96.3	167.2	70.8	43.1	200.6	44.7	33.7	210.0	31.0	32.7	31.2	36.3	204.6	23.5	26.7	28.3	28.1	54.0	158.1	116.6	60.2	135.8	33.0	34.8	39.0	42.9	31.8	36.3	46.3	37.7	42.2	45.6	41.9	42.9	230.6	28.9	49.6	10.7	34.4	22.0	26.1	60.1	21.6	8.1	53.5	41.7	48.9	18.6	44.1	27.6	2.1	35.9	68.3	44.2	117.4	68.6	100.5	67.3	45.7	129.7	16.3	31.7	6.4	109.2	54.7	42.0	29.6	40.7	64.1	29.4	71.0	95.5	262.1	6.7	9.6	35.6	42.7	92.1	50.5	31.7	23.0	141.9	42.7	18.7	195.0	103.8	28.8	9.5	21.2	53.3	31.8	35.0	71.2	26.9	52.4	274.0	92.5	15.4	32.9	31.3	57.8	95.7	13.7	32.5	22.9	55.7	42.4	80.7	45.6	27.1
LARP6	"acheron, FLJ11196"	ENSG00000166173	"La ribonucleoprotein 6, translational regulator"	Q9BRS8	15	70829130-70854157	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 429.0;Late spermatids: 259.8;Spermatocytes: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 232.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020338, HPA049029"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Microtubules	"Cytokinetic bridge"	"HPA020338: AB_1844500, HPA049029: AB_2680604"	"unprognostic (1.35e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.96e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.90e-5)"	"unprognostic (4.51e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.43e-1)"	51.4	9.8	42.8	6.5	69.8	0.1	44.0	56.9	65.5	27.5	22.8	18.5	2.1	22.8	28.4	7.9	29.0	10.9	43.4	44.5	52.0	27.9	10.6	17.9	2.3	57.8	56.6	30.4	10.9	19.6	23.6	7.7	56.4	26.1	4.0	11.8	19.5	14.1	17.6	14.0	10.3	12.1	46.8	2.6	26.9	9.6	55.9	5.1	40.8	26.1	1.5	21.1	31.0	90.4	42.3	44.2	14.1	28.3	70.2	77.9	0.1	127.7	99.0	67.4	71.2	12.9	12.0	0.0	50.9	69.9	65.4	22.7	32.0	11.2	66.4	0.4	78.3	0.2	37.6	12.0	127.1	0.2	0.2	49.0	45.6	67.9	107.5	70.6	22.2	15.4	0.1	0.6	30.4	7.3	0.3	0.3	14.9	0.0	113.9	0.2	50.6	0.3	22.0	35.9	8.4	18.5	42.5	0.5	93.1	21.7	2.3	2.4	29.6	27.4	109.6	232.0	107.5	0.2	0.3	0.4	116.9	0.0	14.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	42.8	69.8	56.9	65.5	44.5	52.0	57.8	56.6	56.4	46.8	55.9	90.4	32.3	0.0	1.1	2.9	0.1	18.1	47.7	20.4	9.6	41.4	15.4	18.3	22.2	24.3	11.8	12.9	2.1	0.5	1.0	0.3	54.8	59.4	429.0	24.6	31.8	24.5	12.0	0.0	10.8	25.1	0.8	87.5	4.1	8.4	0.0	7.5	11.4	15.3	1.2	25.2	11.8	1.5	10.2	0.6	13.3	259.8	73.3	3.2	19.6	7.5	0.1	28.5	0.0	5.5	105.9	62.9	0.0	45.9	0.5	61.9	0.0	100.9	16.8	4.8	19.7	28.3	34.8	166.8	11.0	1.4	8.9	0.4	1.9	5.3	0.6	37.7
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 5.3;liver: 8.7;stomach 1: 3.2"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 3.7;Proximal tubular cells: 7.5;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.5;Hep G2: 22.1;SK-MEL-30: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.9;olfactory bulb: 1.0"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Midbody	"HPA044257: AB_2678880"	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	1.3	0.3	0.3	0.4	0.3	0.4	0.6	0.9	0.4	0.4	0.0	1.1	5.3	0.3	0.2	0.2	0.2	0.4	0.3	0.1	0.2	1.3	8.7	0.5	0.4	0.5	0.2	0.1	0.7	0.1	0.0	0.5	0.5	0.3	0.1	0.1	0.5	0.3	0.4	0.9	4.8	0.2	0.1	1.1	3.2	0.1	0.4	0.0	0.3	0.0	0.1	0.3	0.2	1.3	4.4	1.6	0.0	0.1	2.0	1.5	7.1	0.3	0.2	0.4	0.4	10.5	6.2	0.2	1.7	0.8	0.6	1.7	0.0	0.3	0.0	9.0	1.8	4.7	0.7	22.1	1.4	0.3	3.0	1.9	1.6	1.6	0.3	0.2	1.8	0.1	3.1	2.2	0.3	2.3	0.1	0.7	0.4	1.7	0.2	0.4	0.4	0.2	0.2	1.4	0.2	1.1	2.6	0.4	10.1	0.1	0.2	0.3	4.1	1.5	6.6	8.1	0.2	2.9	2.3	0.2	1.5	0.8	4.8	0.5	1.5	0.1	0.3	0.8	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.2	0.6	1.1	2.2	0.2	0.0	0.7	0.3	0.3	0.9	0.4	0.1	0.2	0.5	0.2	0.5	0.1	0.4	1.3	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.7	0.5	0.7	1.5	0.5	1.8	0.0	0.3	0.5	0.9	0.0	0.6	0.0	0.4	0.5	1.0	2.4	0.4	0.0	0.6	0.5	1.3	1.1	0.2	0.0	0.0	1.4	3.7	1.1	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	2.4	7.5	0.7	0.0	6.6	0.0	0.9	0.4	0.1	0.3	0.1	0.5	0.5	0.2	1.0	0.1
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 32.4;retina: 42.6"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 289.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Group enriched"	"Detected in some"	13	"RPTEC TERT1: 53.5;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	0.0	0.3	24.0	0.2	22.3	0.3	0.0	24.7	16.2	0.0	7.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	26.6	30.7	3.1	0.0	0.0	0.5	31.1	32.4	0.0	0.0	0.0	1.5	0.4	24.7	1.5	0.3	42.6	0.0	5.8	0.0	0.1	0.2	0.2	32.2	0.1	0.4	0.1	26.1	0.0	4.6	0.0	0.0	0.0	0.0	29.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.0	22.3	24.7	16.2	26.6	30.7	31.1	32.4	24.7	32.2	26.1	29.1	0.0	0.0	0.0	21.2	1.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.7	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.3	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	289.4	0.0	0.5	1.4	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation factor"	Q9BRT6	12	66116555-66130750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048920, HPA058786"			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	"Mitotic chromosome"	"HPA048920: AB_2680556, HPA058786: AB_2683820"	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	21.6	34.4	12.3	24.4	13.5	50.3	18.6	12.7	16.0	13.2	11.2	20.1	19.2	15.2	18.6	19.5	13.2	14.7	23.2	12.8	13.7	20.9	21.2	15.5	26.3	13.5	14.3	17.6	17.2	17.0	10.7	17.5	13.7	15.3	20.3	7.4	14.5	14.1	29.7	13.8	18.2	19.4	13.0	18.2	19.1	22.1	13.5	22.1	17.3	25.3	25.6	27.3	14.0	14.2	77.0	61.1	36.4	44.2	42.6	40.8	44.5	87.0	56.4	63.9	53.6	52.8	31.0	87.0	70.6	58.6	50.7	63.6	57.2	52.9	85.7	78.4	48.8	94.5	41.7	47.3	49.8	162.5	61.8	41.9	53.6	53.7	58.3	50.1	56.6	44.1	81.5	60.9	76.1	81.3	74.1	110.4	77.9	61.6	63.0	61.9	67.2	62.7	63.3	90.8	36.3	45.1	57.0	58.3	97.4	38.0	77.4	89.5	60.5	48.3	71.3	60.9	80.4	45.7	77.6	130.2	65.4	76.0	76.8	34.3	32.0	35.5	27.8	38.0	32.0	29.2	32.3	30.6	31.3	27.5	27.4	29.2	43.8	27.4	48.4	27.0	38.9	28.8	12.3	13.5	12.7	16.0	12.8	13.7	13.5	14.3	13.7	13.0	13.5	14.2	34.2	12.8	33.9	2.9	47.6	27.1	53.9	86.3	30.1	15.9	24.5	28.4	25.1	41.5	64.3	31.3	4.2	66.3	49.4	34.1	66.5	68.3	63.3	40.5	45.4	32.5	13.8	33.4	5.0	71.3	70.4	34.8	35.7	46.6	89.4	61.2	35.7	60.2	64.2	21.9	4.4	31.1	85.5	50.4	26.5	17.0	43.8	45.6	35.6	3.7	84.1	30.8	59.8	3.0	5.8	96.3	43.3	30.1	27.3	46.3	44.0	86.5	35.8	15.2	26.3	29.7	36.8	126.6	48.6	30.6	30.5	72.7	43.8	126.4	36.1	60.6
LMO4		ENSG00000143013	"LIM domain only 4"	P61968	1	87328880-87348923	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial stromal cells: 508.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 586.8;T-47d: 373.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022345, HPA045877, HPA061638"	Approved		Supported	"Nucleoplasm,Midbody ring"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Midbody ring"	"CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572"	"unprognostic (5.39e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.97e-3)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.46e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (1.42e-4)"	"unprognostic (1.70e-1)"	49.0	16.3	102.1	28.6	116.5	21.9	34.7	79.8	173.7	51.7	70.8	44.7	26.7	43.2	39.4	50.9	32.4	45.5	42.2	117.4	82.9	42.7	33.3	38.2	29.5	82.1	78.9	39.6	25.5	22.9	31.6	63.9	80.1	56.4	31.6	34.5	87.4	81.0	47.6	39.7	43.1	30.3	79.4	38.7	90.7	28.0	83.2	23.5	33.8	25.5	87.8	38.8	54.0	100.6	55.1	42.3	32.3	586.8	96.6	113.9	81.8	48.4	38.3	44.9	49.8	104.3	34.0	127.5	60.3	57.2	72.4	44.7	13.1	33.8	44.5	68.6	32.4	116.5	87.2	32.3	92.9	63.6	151.2	60.2	76.4	70.0	39.8	80.9	30.8	48.7	26.8	109.8	24.5	22.3	1.8	41.3	118.1	58.6	39.3	72.8	45.0	28.5	56.1	206.7	26.5	1.7	195.3	28.7	149.6	61.1	373.3	171.8	20.1	208.9	39.0	50.6	161.7	99.7	70.6	28.8	26.1	13.8	30.7	30.5	9.1	19.5	7.8	11.6	9.0	10.1	6.9	8.0	6.9	6.9	1.8	4.4	15.0	22.4	11.5	10.3	2.1	5.1	102.1	116.5	79.8	173.7	117.4	82.9	82.1	78.9	80.1	79.4	83.2	100.6	103.5	44.8	24.1	50.9	88.6	98.4	49.3	105.6	245.3	226.2	170.0	191.5	72.4	153.0	78.1	36.8	73.0	322.8	116.5	50.0	62.6	74.2	2.1	106.5	508.1	65.6	31.1	48.1	204.4	127.6	363.3	149.0	159.6	131.5	307.4	19.5	78.1	85.7	74.0	111.0	37.5	80.6	14.2	138.4	73.2	7.5	95.1	76.1	65.8	22.5	74.6	82.7	83.4	52.8	25.8	107.2	29.9	235.5	174.6	49.3	90.3	56.8	31.0	35.9	32.9	80.6	175.5	4.4	97.9	200.3	92.9	256.0	77.9	61.7	64.9	37.5
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102913000-102945111	"Predicted secreted proteins"	Osteogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 76.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 31.3;Granulosa cells: 68.6;Leydig cells: 101.9;Peritubular cells: 31.6;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	94	"eosinophil: 9.9"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.9"	"Cell line enriched"	"Detected in many"	5	"LHCN-M2: 1237.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"	Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Cytokinetic bridge"	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.30e-4)"	8.1	2.4	1.6	1.1	1.7	0.2	12.9	1.6	2.4	22.5	1.7	2.7	1.6	15.7	12.1	6.0	17.3	27.4	13.2	1.7	1.6	2.8	3.5	3.2	2.1	1.6	1.7	76.2	2.3	2.0	2.4	0.6	1.5	5.6	3.3	1.8	2.7	3.2	2.1	3.0	2.3	6.0	1.6	3.3	6.9	5.0	2.3	6.2	3.8	2.8	1.0	4.4	5.8	1.6	0.0	0.0	58.8	0.5	6.0	29.4	0.1	1.6	18.2	0.6	2.8	0.0	0.2	0.0	3.4	1.5	7.3	0.1	0.0	0.0	4.3	0.0	1.4	0.1	0.0	0.1	8.3	0.5	0.2	28.1	0.7	21.5	0.0	141.1	140.9	0.6	0.0	0.1	1237.5	0.0	0.1	0.4	3.1	0.1	0.1	0.1	244.0	0.2	0.2	0.1	1.3	1.3	0.1	0.0	0.1	0.1	0.0	1.7	11.8	0.2	1.5	15.2	2.3	1.1	0.4	0.0	0.3	0.0	0.3	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.7	1.6	2.4	1.7	1.6	1.6	1.7	1.5	1.6	2.3	1.6	3.6	0.0	1.1	4.6	0.2	0.9	0.2	0.9	0.0	3.7	0.7	0.8	1.1	0.0	0.5	1.8	2.1	0.3	0.3	0.0	0.0	1.7	3.5	2.7	15.3	4.4	0.0	0.0	6.9	0.4	0.2	31.3	1.1	4.6	1.3	68.6	6.1	0.5	0.4	0.0	8.7	0.1	2.0	0.0	2.7	2.9	101.9	0.5	5.4	10.3	0.6	0.6	0.0	2.5	5.3	0.2	0.3	31.6	0.0	0.3	0.1	0.3	0.1	2.2	65.7	16.1	17.8	0.6	0.5	0.4	0.6	0.0	0.9	6.6	0.2	0.2
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793003-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 137.9;Respiratory ciliated cells: 129.6;Spermatocytes: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 8.1;HL-60: 8.9;JURKAT: 7.1;NTERA-2: 7.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	1.5	0.4	1.6	0.6	2.1	1.4	1.1	1.6	2.7	0.9	2.8	0.5	0.2	0.7	0.3	0.2	5.5	0.3	1.1	1.2	2.1	0.7	0.2	1.0	0.8	2.1	2.5	0.8	0.2	0.3	2.8	0.2	2.2	0.6	0.1	5.6	0.3	0.7	0.4	0.5	0.4	0.2	2.1	0.7	0.4	12.8	1.9	0.6	0.9	0.4	0.3	0.4	0.4	1.8	2.3	0.4	0.5	0.0	0.9	3.0	0.0	0.9	1.9	2.4	2.1	0.1	0.0	1.5	0.1	0.6	3.1	0.0	1.8	0.0	0.8	0.4	5.6	8.1	0.2	0.0	0.6	8.9	1.8	0.9	0.4	0.8	0.0	0.1	1.6	7.1	0.2	0.0	0.9	0.0	0.8	1.1	7.7	0.0	2.6	4.0	0.0	0.4	2.1	0.2	4.0	3.1	0.5	0.3	0.0	0.2	0.0	4.2	0.5	0.4	0.0	0.3	0.1	0.1	0.1	1.9	3.5	0.1	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	1.6	2.1	1.6	2.7	1.2	2.1	2.1	2.5	2.2	2.1	1.9	1.8	3.9	3.2	2.6	8.5	1.5	0.4	0.9	5.3	0.0	6.9	0.4	0.9	3.2	0.0	12.9	5.5	37.5	0.2	1.6	0.1	1.9	0.5	137.9	33.8	5.8	3.0	4.2	4.2	15.1	0.2	0.3	5.0	0.5	1.0	1.3	1.0	10.4	0.3	2.4	11.8	12.5	0.4	6.1	0.8	1.2	36.3	10.5	1.2	0.0	3.7	3.8	7.4	0.0	9.5	3.6	0.3	0.0	10.5	0.7	0.4	0.0	3.6	129.6	18.8	0.0	3.6	3.7	104.4	9.2	0.1	0.3	0.5	0.9	1.9	0.2	0.4
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040546-6054060	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.3;lung: 9.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 3.9;Collecting duct cells: 1.8;Ductal cells: 3.8;Proximal tubular cells: 2.4"	"Group enriched"	"Detected in many"	7	"lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"RPTEC TERT1: 79.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA075974			Uncertain	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		73000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA075974: AB_2686770"	"unprognostic (6.16e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.40e-3)"	"unprognostic (9.04e-3)"	"unprognostic (5.95e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.84e-3)"	8.3	0.0	0.3	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.2	0.6	2.2	0.1	9.7	0.0	0.2	0.2	0.4	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	1.4	0.0	3.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	79.6	0.0	0.3	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	1.0	0.2	0.6	0.2	0.2	0.0	0.1	0.7	0.0	0.0	9.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 188.1;Late spermatids: 464.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 154.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 154.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Midbody	"HPA059840: AB_2684137"	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favorable (9.50e-4)"	37.8	31.1	26.7	16.4	27.2	24.2	30.0	28.7	31.4	30.4	31.6	32.0	13.8	27.6	35.2	18.7	34.4	16.2	50.8	27.1	28.3	51.8	95.8	18.8	24.2	28.1	27.7	34.0	27.3	33.5	21.2	13.6	28.7	29.1	20.4	26.5	16.2	26.8	42.3	19.2	18.0	22.6	27.3	16.9	27.9	37.6	27.7	25.1	22.8	34.1	21.9	34.8	23.0	28.5	33.2	29.7	30.3	25.9	74.1	64.0	9.6	27.9	39.3	14.8	21.7	42.8	39.2	22.6	92.2	31.5	21.6	21.6	14.1	25.5	25.6	41.6	19.8	10.1	8.3	112.1	56.6	35.9	20.4	45.0	24.5	40.0	98.6	41.4	58.5	37.3	23.2	39.6	59.0	43.5	39.1	26.3	34.3	46.5	17.2	47.8	18.4	30.8	56.3	15.1	29.8	27.7	16.6	26.3	45.1	18.5	27.5	19.5	16.0	21.4	15.8	35.1	19.6	35.1	51.2	38.5	59.7	35.6	20.1	154.9	16.7	59.3	19.7	21.8	28.2	29.5	29.8	24.2	14.3	24.8	24.3	24.1	63.8	22.1	25.9	17.9	33.0	24.5	26.7	27.2	28.7	31.4	27.1	28.3	28.1	27.7	28.7	27.3	27.7	28.5	32.5	19.2	18.9	9.1	29.9	21.0	57.6	26.8	25.6	28.9	41.2	39.4	55.1	27.1	17.2	23.9	14.6	29.1	24.6	9.6	76.3	41.3	188.1	24.2	12.9	35.8	30.0	8.4	10.6	44.2	10.6	30.8	21.9	15.9	15.8	20.5	15.0	53.9	16.5	15.2	14.1	15.0	28.5	16.4	14.5	464.6	28.9	16.2	17.8	4.7	45.7	48.0	22.6	9.5	11.2	30.2	14.6	38.0	15.8	41.6	19.2	125.4	25.4	34.0	13.1	25.8	26.3	112.5	27.5	18.2	20.9	14.9	22.9	16.3	24.5	56.7
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427710-76431342	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.2;Excitatory neurons: 12.2;Horizontal cells: 28.6;Inhibitory neurons: 12.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.8"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favorable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	1.6	3.2	10.0	1.6	10.2	0.3	1.6	3.0	20.6	2.8	0.0	2.2	0.5	3.3	1.7	1.0	2.5	1.1	2.2	12.1	17.0	2.1	0.3	1.3	2.5	7.7	5.1	4.7	2.6	6.1	6.0	0.0	7.9	3.2	0.9	6.4	1.7	4.0	1.1	1.8	1.8	2.6	1.0	2.7	1.6	0.4	9.8	2.9	2.1	0.9	1.9	2.1	1.7	6.7	0.2	3.8	3.9	7.5	2.7	1.5	3.4	2.9	2.9	2.4	1.3	0.8	0.6	0.8	1.4	2.5	7.8	2.9	5.8	5.4	1.9	1.9	0.1	0.0	0.0	2.5	0.5	1.5	0.5	1.1	2.4	0.6	0.6	0.1	0.9	4.2	0.3	0.0	3.6	0.5	4.3	0.2	4.7	0.0	5.8	3.4	2.9	0.0	3.1	0.0	0.0	2.0	0.0	0.4	0.6	3.9	1.7	0.1	0.5	3.6	4.5	3.8	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.2	0.5	0.0	0.2	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.1	10.0	10.2	3.0	20.6	12.1	17.0	7.7	5.1	7.9	1.0	9.8	6.7	0.8	3.2	2.6	3.3	1.7	0.5	0.7	1.2	1.2	11.2	0.9	1.9	1.9	1.5	1.1	1.8	4.2	0.2	1.4	0.3	1.9	1.4	0.0	0.4	1.3	2.4	0.0	0.4	12.2	1.5	0.4	1.3	1.1	0.4	1.3	1.5	1.8	0.2	0.1	28.6	12.2	0.4	0.0	0.3	0.0	0.1	1.5	0.1	0.0	3.7	0.1	5.5	2.1	5.5	5.0	0.7	0.0	4.5	0.3	0.3	0.0	1.3	0.3	5.0	19.7	2.7	3.6	0.3	0.2	0.6	0.1	0.1	2.5	0.8	0.1	0.2
MAGIX	"FLJ21687, JM10, PDZX"	ENSG00000269313	"MAGI family member, X-linked"	Q9H6Y5	X	49162564-49168483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 46.9;Hepatocytes: 35.0;Proximal tubular cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 5.5;RT4: 12.8;SK-BR-3: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007390, HPA035302"	Uncertain		Approved	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Mitotic chromosome"	"HPA007390: , HPA035302: AB_10603015"	"unprognostic (1.11e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.64e-6)"	"unprognostic (6.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-2)"	"prognostic favorable (6.91e-9)"	"unprognostic (4.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (2.10e-4)"	1.3	2.1	3.9	0.7	3.6	1.4	1.8	9.5	4.3	2.4	7.9	3.4	1.7	1.8	1.2	4.3	4.0	1.3	9.9	3.9	3.9	9.7	19.1	2.8	0.4	4.2	4.2	1.0	13.9	3.7	5.9	0.5	4.2	5.1	1.0	1.1	10.0	2.8	2.1	2.7	1.5	0.3	3.5	1.2	12.4	0.7	4.0	0.6	7.0	0.5	0.3	2.8	2.1	3.7	0.3	1.9	0.4	0.5	0.5	0.1	1.4	0.3	0.3	0.3	0.3	1.1	5.5	0.5	0.5	0.6	0.7	1.2	0.3	1.3	0.0	1.6	1.8	2.4	3.4	0.6	0.2	0.6	4.7	0.5	0.2	0.4	0.1	0.6	0.4	0.8	0.3	2.0	0.4	0.7	0.5	1.7	0.5	1.5	1.0	0.3	0.1	1.0	1.0	12.8	2.4	0.5	1.1	5.7	0.6	0.3	4.5	0.5	0.2	0.6	1.4	0.5	0.4	1.3	0.7	0.4	2.3	0.8	1.8	3.1	1.1	2.0	0.1	1.0	0.4	0.6	0.5	0.0	0.7	0.5	0.3	0.5	4.2	0.7	1.1	1.4	0.1	0.6	3.9	3.6	9.5	4.3	3.9	3.9	4.2	4.2	4.2	3.5	4.0	3.7	1.6	3.2	5.4	1.0	2.8	3.2	10.3	5.6	4.6	8.0	18.7	10.4	8.5	11.5	7.0	12.9	2.1	2.1	3.9	33.7	46.9	13.1	0.2	24.7	2.5	2.0	17.5	0.4	1.2	20.8	4.1	2.4	28.5	16.0	0.0	0.8	4.2	35.0	5.1	8.4	1.1	23.4	2.0	3.2	5.7	0.0	0.6	5.7	1.8	0.0	4.8	8.3	0.0	1.0	1.3	8.9	30.7	0.4	5.2	5.8	15.2	44.3	20.4	9.7	0.0	6.9	3.8	3.0	2.7	8.0	4.4	3.8	3.9	1.7	15.3	9.9
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560087-50731826	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;parathyroid gland: 51.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 202.7;Excitatory neurons: 105.2;Inhibitory neurons: 58.5;Late spermatids: 66.4;Muller glia cells: 62.6"	"Cancer enriched"	"Detected in many"	4	"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;HeLa: 3.3;NTERA-2: 2.2;SCLC-21H: 11.6;SH-SY5Y: 2.8;SK-MEL-30: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	0.9	26.8	56.5	0.2	79.9	0.0	0.8	56.4	46.0	1.5	28.0	6.8	0.6	0.8	3.1	2.3	1.5	1.8	22.1	41.6	57.5	3.3	4.5	2.3	0.0	65.4	70.0	2.9	1.4	51.0	17.8	2.6	56.7	5.0	0.8	22.6	0.9	9.8	1.5	1.3	1.6	1.8	48.8	0.1	2.1	2.4	81.9	7.3	6.2	1.5	0.0	4.6	1.3	38.7	0.0	0.0	1.0	0.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.1	1.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.6	2.8	0.0	0.8	1.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.5	79.9	56.4	46.0	41.6	57.5	65.4	70.0	56.7	48.8	81.9	38.7	0.4	9.6	0.0	202.7	0.0	0.0	0.4	0.0	0.0	11.4	0.9	1.1	22.9	1.5	0.0	0.0	0.0	4.6	0.0	0.0	5.9	0.9	30.1	0.0	0.0	0.3	0.0	0.0	105.2	0.0	0.3	1.0	0.0	0.0	0.0	0.7	0.0	1.0	0.4	5.0	58.5	0.0	0.0	0.0	0.0	66.4	0.9	0.1	0.0	7.5	0.0	62.6	0.0	18.6	1.9	0.4	0.0	1.5	0.0	0.7	0.0	0.2	0.0	1.0	0.0	1.0	0.7	0.8	0.6	0.0	0.0	1.8	0.0	0.4	0.0	0.1
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.5;brain: 41.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 177.0;Hofbauer cells: 57.4;NK-cells: 422.2;T-cells: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 76.8"	"Group enriched"	"Detected in many"	57	"NK-cells: 76.8;T-cells: 46.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 108.3;HMC-1: 30.9;K-562: 48.9;MCF7: 34.4;NB-4: 74.8;SCLC-21H: 30.9;THP-1: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	4.7	1.3	18.3	6.6	21.3	20.5	2.5	2.9	41.9	1.1	1.6	2.1	6.6	0.9	0.1	2.1	4.0	4.4	1.4	25.9	8.7	2.4	3.2	9.9	9.4	10.4	11.0	0.7	1.2	0.7	2.7	1.0	8.8	1.3	1.1	2.2	3.2	0.7	0.8	1.9	6.2	0.8	4.7	16.5	4.0	3.1	14.1	3.8	1.6	0.2	4.0	1.6	1.1	23.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.2	1.7	0.0	1.0	10.6	13.8	0.4	0.0	0.0	18.1	12.0	1.5	2.9	0.0	108.3	30.9	0.1	0.0	0.2	0.1	0.0	0.0	1.2	48.9	0.1	0.0	34.4	0.3	74.8	8.4	9.0	0.3	0.0	0.1	0.0	0.0	0.0	30.9	0.1	0.1	0.1	0.1	0.9	0.0	27.4	3.3	0.0	0.6	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	46.2	0.0	31.3	0.0	5.7	29.3	0.8	0.9	2.7	16.4	1.0	76.8	0.2	0.3	0.4	7.6	18.3	21.3	2.9	41.9	25.9	8.7	10.4	11.0	8.8	4.7	14.1	23.6	1.4	0.0	1.1	0.3	11.1	0.4	0.1	0.0	0.0	1.4	4.9	7.2	1.3	0.0	0.0	0.0	12.5	0.3	177.0	0.3	0.0	0.0	2.0	0.2	0.5	1.9	7.1	28.6	17.7	0.0	0.5	0.8	11.7	0.5	44.5	0.1	8.6	1.1	57.4	0.0	8.3	0.3	0.0	6.0	14.6	5.1	0.0	11.5	1.8	4.7	3.0	1.3	422.2	2.0	1.6	0.0	1.1	0.0	17.1	0.1	0.3	0.2	0.7	2.0	0.0	0.5	1.2	0.4	4.5	1.3	1.1	0.3	99.7	0.0	1.1	0.0
MBD5	"FLJ11113, KIAA1461"	ENSG00000204406	"Methyl-CpG binding domain protein 5"	Q9P267	2	148021011-148516971	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 317.4;Excitatory neurons: 510.1;Inhibitory neurons: 456.0;Microglial cells: 288.6;Oligodendrocyte precursor cells: 604.2;Oligodendrocytes: 438.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035964			Supported	Nucleoplasm,Midbody		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody"		"HPA035964: AB_2674891"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.82e-1)"	2.5	3.2	3.7	2.2	4.3	2.0	2.3	7.2	5.1	3.1	0.5	5.2	1.8	3.2	1.6	2.6	2.2	3.2	2.8	3.9	3.1	3.4	2.0	2.3	2.4	2.2	2.2	3.7	1.7	4.1	3.8	3.0	2.1	3.0	1.9	5.7	1.8	2.5	2.8	1.9	2.3	2.7	2.0	2.6	2.7	3.1	3.3	4.2	3.4	3.0	2.2	3.7	2.2	4.1	1.1	1.1	4.4	4.1	3.5	3.6	2.9	4.0	3.9	3.1	2.3	2.8	2.9	1.9	0.9	3.4	1.7	0.8	3.1	5.1	4.1	1.6	1.6	3.5	2.8	1.5	2.0	0.6	0.6	2.9	4.1	4.5	3.3	5.0	4.1	2.7	1.9	3.6	4.8	2.7	1.5	2.7	2.2	2.5	1.7	1.6	1.2	0.8	3.2	3.8	2.9	3.5	3.2	1.6	3.0	3.2	2.3	3.4	2.8	3.7	1.8	0.6	1.9	2.4	1.1	1.5	4.8	1.6	3.6	0.8	0.1	0.5	0.3	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.3	0.1	0.1	3.7	4.3	7.2	5.1	3.9	3.1	2.2	2.2	2.1	2.0	3.3	4.1	27.3	16.0	13.7	317.4	23.4	3.8	11.9	4.1	10.8	24.7	16.5	15.0	10.5	11.5	14.8	12.9	37.5	7.3	23.8	5.0	3.9	18.6	94.5	14.8	25.8	15.2	11.5	36.6	510.1	15.7	9.8	15.5	12.2	18.0	3.8	35.9	15.0	8.4	7.0	13.5	456.0	4.9	6.1	16.9	3.3	37.6	18.0	15.1	0.0	288.6	13.6	8.1	24.7	604.2	438.3	20.4	4.6	10.5	22.8	7.8	9.4	14.0	8.5	17.4	6.6	16.5	16.8	15.7	9.4	10.4	3.3	8.5	27.7	23.7	5.8	12.6
MED9	"FLJ10193, MED25"	ENSG00000141026	"Mediator complex subunit 9"	Q9NWA0	17	17476994-17493221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056415	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Midbody	"HPA056415: AB_2683120"	"unprognostic (1.81e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (3.96e-2)"	"prognostic favorable (2.83e-9)"	"unprognostic (2.26e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-1)"	9.3	14.9	21.6	4.9	23.0	10.6	10.3	20.6	28.0	12.4	19.2	11.3	8.2	12.1	11.9	10.2	8.6	4.6	32.7	22.5	21.0	20.4	23.6	7.3	6.8	21.8	22.1	9.4	10.0	18.3	12.8	5.7	20.6	11.8	7.4	9.9	12.9	8.5	27.3	14.2	9.4	5.8	20.9	10.4	12.4	10.9	22.3	11.6	13.8	41.5	6.7	8.8	9.4	21.8	12.0	15.0	12.7	13.7	10.0	9.0	11.0	9.6	11.9	14.5	13.0	22.0	5.9	14.7	10.8	9.9	8.8	15.3	16.3	13.2	13.5	9.6	26.3	9.0	10.0	15.9	10.8	7.2	7.5	14.6	12.3	12.2	12.5	10.8	10.0	21.3	10.7	6.7	9.7	10.1	32.7	14.9	11.7	24.8	15.4	24.8	28.7	9.8	13.0	8.4	8.2	13.0	12.6	9.8	21.7	47.6	11.6	9.3	6.8	10.6	12.3	18.6	15.3	12.4	9.9	8.2	13.3	12.5	11.5	2.6	7.0	11.8	9.3	9.5	12.3	9.9	9.7	9.7	7.7	9.1	10.2	11.4	2.3	10.7	12.4	12.5	10.2	7.8	21.6	23.0	20.6	28.0	22.5	21.0	21.8	22.1	20.6	20.9	22.3	21.8	6.0	3.2	4.4	10.1	5.8	4.6	8.9	5.5	5.2	25.9	8.2	6.7	19.6	10.0	5.0	9.2	14.6	8.6	8.1	9.1	11.7	6.6	8.7	6.0	6.3	6.0	15.7	4.2	14.4	4.5	5.8	5.6	11.7	8.8	0.0	14.5	7.5	5.5	6.1	16.8	12.9	9.6	8.2	4.4	2.8	8.9	5.6	4.0	1.8	1.9	4.7	24.1	10.3	14.1	6.5	3.3	5.7	9.4	7.2	8.4	9.5	6.1	4.0	25.0	0.0	6.0	6.9	10.9	29.9	5.6	4.8	9.6	6.6	13.4	8.1	9.0
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3487951-3611508	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 20.6;Basal keratinocytes: 18.4;Basal squamous epithelial cells: 23.3;Melanocytes: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 51.1;HeLa: 56.3;hTERT-RPE1: 69.7;U-2197: 55.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted to blood"	Yes	No		1700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	25.9	4.3	2.9	3.9	2.7	10.8	20.0	2.6	2.8	14.5	1.4	14.1	2.1	9.6	1.4	13.2	28.9	11.2	14.2	1.9	3.2	5.9	5.0	22.1	5.5	3.5	5.8	18.0	6.5	0.4	4.1	2.8	3.6	26.5	1.1	1.8	19.3	4.7	4.8	44.6	10.0	1.4	2.1	10.7	10.1	3.3	3.7	3.4	11.6	1.9	3.4	11.0	22.8	1.9	11.6	14.1	4.3	6.6	0.4	0.3	1.0	51.1	14.1	5.2	1.6	3.3	10.4	0.0	13.8	24.6	4.4	6.7	0.0	0.5	1.7	0.0	0.4	0.0	56.3	3.3	0.0	0.2	0.9	0.1	0.6	0.4	0.8	69.7	5.6	0.1	0.0	0.0	0.1	6.0	0.0	10.9	2.7	3.3	0.9	2.2	3.0	6.2	1.1	3.8	3.8	3.1	18.8	1.1	6.4	11.4	4.9	1.5	2.2	19.6	1.7	55.6	3.9	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.0	0.0	0.0	0.8	0.1	2.9	2.7	2.6	2.8	1.9	3.2	3.5	5.8	3.6	2.1	3.7	1.9	5.0	22.4	20.6	8.8	2.7	18.4	7.1	3.9	23.3	0.8	3.6	3.0	3.3	5.7	4.4	1.8	0.0	0.2	0.4	0.6	0.0	3.6	0.2	1.4	0.6	7.0	0.0	4.8	6.5	1.4	1.3	9.4	6.6	5.0	1.3	9.8	16.8	0.9	1.0	0.0	7.2	1.4	0.0	0.3	7.5	0.5	11.5	2.8	19.6	5.6	0.7	14.7	1.0	4.5	5.2	4.5	0.1	3.4	0.4	4.0	0.5	1.2	0.3	1.2	0.0	0.5	2.7	0.3	1.1	7.6	11.4	0.4	3.6	0.1	1.1	2.7
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.0;breast: 26.1;heart muscle: 24.9"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	36.0	0.5	0.0	4.7	0.0	0.0	26.1	0.0	0.1	8.0	0.0	4.7	1.6	5.5	1.1	3.7	9.0	5.7	24.9	0.0	0.0	0.2	0.1	1.4	6.6	0.0	0.0	1.0	1.5	1.2	0.5	0.1	0.0	2.6	2.4	0.0	4.9	1.9	8.3	6.6	5.1	10.6	0.0	10.8	3.0	1.1	0.0	3.0	1.9	17.1	5.3	7.7	7.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898607-112029561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.6;Kupffer cells: 119.8;Macrophages: 46.5;Microglial cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 8.6;non-classical monocyte: 5.5"	"Lineage enriched"	"Detected in single"	50	"monocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;Hep G2: 39.9;HUVEC TERT2: 38.4;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		Yes	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: AB_2686759"	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	59.8	22.8	13.5	28.0	1.5	15.3	18.0	29.3	12.6	44.7	10.9	12.3	11.5	26.3	8.4	15.5	12.0	7.0	22.0	22.5	11.4	21.0	13.6	13.1	23.5	22.3	12.6	9.9	21.2	15.5	20.1	22.4	14.1	7.9	16.6	6.4	16.3	3.2	6.4	14.3	14.4	18.4	30.6	13.9	17.2	30.1	6.8	10.1	4.6	8.9	13.6	9.4	22.0	1.0	1.7	7.6	17.3	0.4	0.2	12.3	0.0	0.2	1.0	1.7	35.1	2.2	0.1	8.1	0.1	7.9	0.2	10.2	0.0	1.4	1.5	5.5	7.0	0.0	39.9	0.3	0.2	1.5	0.5	0.0	8.9	0.6	4.0	38.4	1.5	2.2	3.5	2.9	1.8	0.0	9.1	4.8	1.1	6.0	2.9	2.1	3.0	19.4	23.4	0.3	7.2	0.2	0.5	3.2	2.7	0.0	0.4	5.8	1.0	3.4	0.1	0.0	3.1	4.8	0.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.0	0.2	22.8	28.0	18.0	29.3	22.0	22.5	23.5	22.3	22.4	18.4	30.1	22.0	8.8	3.2	27.7	162.6	1.7	1.7	2.9	0.3	1.8	0.6	2.1	4.3	2.7	2.8	6.4	0.0	2.1	3.3	0.4	1.2	1.9	1.1	2.3	8.0	4.7	10.2	0.0	0.4	5.0	1.0	1.1	3.2	0.5	12.1	0.0	3.8	28.5	9.2	25.5	0.0	7.0	2.0	0.0	119.8	1.8	2.7	5.0	46.5	0.0	124.6	1.5	7.7	0.0	10.6	0.6	1.2	1.9	6.8	10.8	2.9	4.4	1.9	1.5	11.3	6.6	1.5	9.2	0.6	1.5	0.6	1.3	18.9	1.3	3.5	1.9	1.6
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B"	Q3V5L5	17	76868404-76950393	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 12.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.0;Early spermatids: 7.3;Excitatory neurons: 26.2;Inhibitory neurons: 21.9;Late spermatids: 8.1"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 12.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 32.1;SCLC-21H: 15.9;U-138 MG: 19.2;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: AB_2668423"	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	0.2	0.2	2.4	0.2	2.1	0.1	0.1	0.0	12.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.0	5.2	0.0	0.2	0.0	0.3	0.1	0.3	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	1.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	3.7	32.1	6.4	3.4	0.0	0.0	3.7	0.4	1.3	11.7	6.9	0.1	0.7	0.0	2.5	1.5	13.7	0.2	1.6	0.2	3.0	0.1	0.5	0.0	1.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	1.8	5.2	2.0	0.7	0.2	0.0	0.0	1.5	0.1	0.0	1.8	0.8	3.5	4.8	5.6	7.1	8.9	0.1	15.9	6.1	5.5	2.4	5.0	0.4	0.2	0.2	5.8	19.2	20.9	0.3	6.3	0.0	0.0	0.7	0.6	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	12.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.0	0.1	0.1	0.1	0.0	0.0	5.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.1	0.1	0.8	0.0	0.0	26.2	0.0	3.2	0.2	0.0	0.2	0.0	0.6	0.7	0.0	0.1	0.0	21.9	0.0	0.0	0.0	0.0	8.1	0.6	0.0	0.0	2.8	0.0	0.2	0.0	5.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	1.1	2.4	0.0	0.0	0.1	0.1	0.2	0.0	0.0
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024561	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.5;Inhibitory neurons: 164.6;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 104.9"	"Immune cell enriched"	"Detected in some"	4	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in all"		"WM-115: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	15.9	12.0	18.3	14.9	20.3	17.3	11.2	104.9	34.5	16.5	3.6	28.1	11.0	31.0	17.0	19.6	38.6	13.4	35.6	14.3	13.7	10.9	18.8	8.3	23.0	13.2	6.4	26.5	14.0	38.5	7.2	16.7	15.6	16.4	20.6	14.1	10.9	19.8	48.2	18.9	14.5	37.3	1.9	17.8	10.7	24.4	12.7	6.0	14.7	20.8	20.3	15.9	12.0	45.9	34.0	39.6	20.2	33.7	15.6	19.2	25.6	32.6	33.1	43.6	34.5	36.1	4.8	35.1	15.5	39.3	51.2	38.7	30.1	31.9	43.0	35.6	25.2	35.9	44.6	11.9	9.6	17.1	20.2	14.4	25.9	46.9	43.7	25.2	24.9	9.7	47.6	22.8	16.9	26.6	16.9	10.7	13.0	27.3	26.4	23.2	30.3	1.9	32.1	24.8	53.5	21.1	40.6	26.0	65.2	31.5	10.8	7.0	43.9	46.0	28.4	29.7	63.6	16.4	30.2	50.8	40.0	7.7	131.6	11.1	0.0	0.1	0.3	0.0	0.6	2.5	0.3	0.3	0.0	2.6	0.2	0.1	0.1	0.9	0.0	0.2	0.7	0.2	18.3	20.3	104.9	34.5	14.3	13.7	13.2	6.4	15.6	1.9	12.7	45.9	19.6	3.2	10.2	57.1	32.1	11.2	15.2	17.9	13.1	20.9	13.7	15.5	16.5	12.8	13.2	12.9	52.1	14.1	6.2	43.5	0.0	23.9	10.5	36.4	10.2	16.4	10.2	19.3	176.5	9.8	40.3	10.5	13.3	38.8	19.0	9.7	8.9	37.3	3.1	1.7	164.6	20.8	8.2	3.2	9.6	13.9	4.1	4.2	8.8	23.4	6.0	38.2	5.2	71.9	216.0	24.6	23.6	6.4	12.5	14.4	19.8	5.5	27.8	12.2	0.0	11.0	12.1	19.8	13.8	11.2	11.8	11.2	9.1	24.2	21.5	10.1
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130632-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947"	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	22.6	18.4	15.2	20.4	16.4	26.5	25.0	17.7	21.4	19.9	15.4	17.6	17.7	22.1	27.5	28.6	16.6	18.4	23.2	15.3	17.7	17.8	30.8	16.9	25.2	17.1	17.0	25.9	19.7	22.9	15.8	20.3	17.0	24.6	19.1	15.1	21.0	16.7	33.1	26.7	15.5	16.8	15.6	19.6	17.8	15.4	16.3	22.5	21.7	24.0	27.5	23.8	18.1	17.6	45.8	33.7	42.7	51.3	39.1	36.7	58.3	49.8	39.6	40.6	29.7	60.7	32.9	64.3	30.5	35.3	31.0	41.1	54.8	35.3	54.1	44.7	43.2	77.3	26.3	139.1	34.1	101.0	58.2	32.0	44.4	33.4	44.4	27.4	34.8	39.1	113.5	49.1	41.0	49.1	81.6	101.5	71.0	63.5	38.1	66.6	66.7	75.4	33.1	49.0	51.8	40.0	33.6	75.0	49.9	36.1	38.2	44.5	36.0	47.2	51.1	45.3	64.0	41.0	50.6	104.1	40.5	82.8	49.1	17.6	12.4	9.8	15.2	17.8	20.2	18.0	19.6	18.8	15.3	15.0	21.4	19.2	1.9	17.1	26.1	16.3	18.3	11.3	15.2	16.4	17.7	21.4	15.3	17.7	17.1	17.0	17.0	15.6	16.3	17.6	38.6	35.3	55.5	8.1	36.8	33.4	42.7	37.8	30.7	37.2	26.0	36.8	44.5	30.0	53.0	18.4	4.2	50.5	47.7	17.9	25.4	47.8	6.0	40.4	52.4	40.4	18.0	26.9	9.8	41.8	48.1	43.2	19.9	65.4	48.1	31.2	21.8	33.2	27.2	18.5	11.4	21.6	26.4	17.7	20.8	6.3	48.7	19.0	12.4	15.0	39.2	25.5	47.4	12.1	15.9	33.1	15.0	43.6	25.6	40.6	14.2	22.7	29.2	53.2	39.5	62.2	49.1	70.2	84.5	35.6	33.5	32.4	39.9	42.8	28.2	31.9
MRRF	RRF	ENSG00000148187	"Mitochondrial ribosome recycling factor"	Q96E11	9	122264603-122331337	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 210.0;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047177, HPA049987"	Supported		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Microtubules, Cytokinetic bridge"		"HPA047177: AB_2679970, HPA049987: AB_2680984"	"unprognostic (8.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (2.14e-8)"	"unprognostic (3.89e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.02e-2)"	"unprognostic (8.88e-3)"	18.9	19.3	10.4	12.1	10.7	14.2	19.3	11.7	13.3	13.9	15.3	25.1	23.7	10.1	13.1	25.5	11.4	8.8	28.2	10.6	11.3	23.4	24.3	13.3	14.0	11.4	10.9	11.3	18.3	23.2	12.5	9.0	11.3	14.7	28.6	14.5	15.3	10.6	40.6	22.1	18.5	10.1	10.6	15.6	14.4	18.1	11.3	13.8	16.3	32.1	20.4	16.9	16.4	11.5	34.7	45.8	25.6	43.0	35.7	32.5	48.7	33.7	43.0	44.5	26.0	55.0	40.6	75.0	16.7	27.0	35.5	99.3	74.1	78.8	36.3	25.2	30.3	25.6	53.4	30.5	23.6	72.3	32.7	30.5	52.7	40.0	70.8	22.4	50.4	29.6	44.2	27.8	45.1	55.1	36.2	23.6	30.0	86.0	45.7	26.8	48.8	79.7	76.6	34.8	30.3	19.9	36.2	58.3	27.9	24.3	62.8	18.2	27.1	19.5	29.6	51.0	42.0	19.1	50.1	33.0	36.8	42.4	22.8	4.7	17.5	6.0	13.3	29.0	14.2	15.6	13.3	12.5	29.8	12.7	13.8	16.5	2.0	22.9	31.3	12.9	16.3	11.1	10.4	10.7	11.7	13.3	10.6	11.3	11.4	10.9	11.3	10.6	11.3	11.5	22.7	3.2	9.1	21.9	18.8	15.4	22.1	30.3	26.2	13.2	20.1	17.3	21.8	18.6	17.8	14.7	12.5	29.0	10.8	21.4	35.2	36.0	210.0	16.2	15.7	22.5	7.8	29.3	28.6	29.5	49.2	11.1	23.9	12.1	24.7	14.5	14.3	19.2	30.4	5.0	39.1	22.0	18.3	17.0	16.5	191.7	9.6	16.0	14.2	20.6	18.3	6.3	11.3	22.1	31.0	24.0	20.6	7.5	19.4	18.1	41.2	37.3	16.2	23.5	19.7	15.1	11.7	30.2	16.6	32.5	22.4	37.1	12.3	31.1	33.9	22.7
MTUS2	"CAZIP, ICIS, KIAA0774, TIP150"	ENSG00000132938	"Microtubule associated scaffold protein 2"	Q5JR59	13	28820339-29505947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 50.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 548.4;Inhibitory neurons: 671.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 13.2;HeLa: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031473, HPA031474, HPA031475"	Enhanced		Supported	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Microtubules, Cytokinetic bridge"		"HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442"	"unprognostic (1.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.62e-2)"	0.2	0.2	0.4	0.1	1.7	0.1	0.1	1.2	9.7	0.6	1.8	0.9	0.1	1.5	0.0	0.3	0.8	0.1	50.2	1.0	0.0	0.1	0.9	0.1	0.6	0.0	0.1	7.5	4.8	0.0	6.1	0.0	0.0	0.3	0.2	4.6	1.0	0.1	0.1	0.2	0.4	1.2	2.2	0.5	1.3	1.2	1.0	0.2	0.5	0.1	0.1	1.3	0.2	2.4	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	13.2	0.4	0.0	0.0	0.0	0.5	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.0	0.0	2.3	1.6	0.1	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.7	1.2	9.7	1.0	0.0	0.0	0.1	0.0	2.2	1.0	2.4	0.1	0.0	0.5	10.4	0.1	0.5	0.7	0.1	0.0	0.0	0.3	0.4	145.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.4	0.3	1.0	0.7	0.0	0.8	548.4	0.6	0.0	5.9	0.0	1.1	0.0	1.2	0.4	0.5	0.1	0.0	671.8	0.7	0.0	0.0	0.8	3.3	0.9	0.2	1.8	15.0	0.1	0.0	0.0	18.1	16.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	3.6	0.0	0.0	1.6	1.0	0.1	4.1	1.8	0.1	0.3	0.3	19.6	0.0	1.1
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 67.8;skin 1: 41.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.9;Hepatocytes: 24.3;Intestinal goblet cells: 25.0;monocytes: 27.4;Squamous epithelial cells: 34.2;Urothelial cells: 27.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 17.3;intermediate monocyte: 8.2;myeloid DC: 18.7;plasmacytoid DC: 22.8"	"Group enriched"	"Detected in many"	72	"dendritic cells: 22.8;monocytes: 17.3"	"Group enriched"	"Detected in many"	7	"U-266/70: 444.0;U-266/84: 364.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Mitotic chromosome"	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.8	0.3	1.8	4.7	2.0	0.6	3.3	1.2	2.0	5.2	1.8	6.1	4.8	0.9	7.2	22.1	3.1	1.5	0.5	2.2	1.7	1.5	11.4	3.3	6.4	1.5	1.5	0.3	67.8	0.3	2.9	6.7	1.6	4.2	6.7	0.2	6.4	7.5	0.5	41.5	5.7	1.1	1.9	7.6	6.2	1.3	2.0	6.5	5.3	0.5	9.5	15.9	12.8	1.6	1.2	0.4	14.4	3.5	0.2	0.1	31.8	0.5	0.2	1.0	0.7	0.4	0.8	2.2	1.4	0.1	0.4	3.3	10.4	2.7	0.8	2.0	4.9	0.5	0.3	0.5	0.4	0.3	7.5	1.0	12.1	0.4	1.3	0.2	1.2	5.4	3.2	0.4	0.6	1.2	0.2	0.3	13.4	2.2	0.4	1.3	15.5	2.9	1.1	58.0	2.5	3.1	1.4	2.1	0.8	5.5	3.7	18.7	0.0	0.0	4.6	6.2	0.5	444.0	364.6	1.0	0.1	2.3	0.3	0.0	17.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.2	0.0	3.4	22.8	0.0	6.7	1.8	2.0	1.2	2.0	2.2	1.7	1.5	1.5	1.6	1.9	2.0	1.6	0.4	0.0	1.1	0.0	0.8	6.6	10.0	2.1	13.1	0.4	3.8	6.0	3.7	0.0	5.5	9.2	0.0	34.9	20.1	13.4	0.0	1.5	0.1	5.1	0.6	0.5	17.3	0.0	0.2	5.8	15.4	0.9	5.1	6.3	0.0	0.0	1.4	24.3	5.1	0.0	0.3	25.0	8.2	8.3	13.1	0.4	0.0	10.6	1.8	0.0	27.4	0.8	0.0	1.0	0.0	2.9	6.5	0.0	3.6	5.3	6.4	0.1	4.9	0.1	0.0	1.4	0.7	0.0	1.2	34.2	11.8	17.5	0.3	0.0	10.8	27.1
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 222.5;skeletal muscle: 321.5;tongue: 255.9"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 198.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 4.6;Hep G2: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		Yes	No		830000		"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles	"Golgi apparatus, Cytokinetic bridge"	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	0.4	0.2	0.0	0.2	0.0	0.0	0.7	0.3	0.1	0.2	0.0	0.6	1.1	0.3	0.0	6.0	0.9	0.4	222.5	0.1	0.1	31.4	0.2	0.3	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.1	4.5	0.7	1.2	7.1	0.0	321.5	2.2	5.2	0.2	0.0	0.0	0.2	9.0	0.0	1.7	0.3	255.9	0.1	0.1	0.4	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.3	0.0	1.9	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	18.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.2	0.1	1.0	0.2	0.5	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.6	0.2	0.1	0.6	0.0	0.1	0.6	198.3	0.0	0.0	3.7	0.0	0.0	0.1	3.6	1.9	0.1	16.2	0.4	0.0	1.6	1.2	0.0	0.4	0.4	0.0	6.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.7	10.3	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.5	2.4	0.0	0.0	0.2	13.0	33.2	0.0	2.5	6.6	10.0	1.3	0.0	0.2	0.0	0.6	0.0	0.3	2.3	2.2	0.3
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105617-34147670	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	20.6	24.2	16.0	17.3	15.4	20.4	19.6	14.7	17.4	20.1	14.0	17.0	10.2	20.0	13.7	25.7	19.2	9.4	18.4	15.1	15.4	19.5	22.3	14.9	23.4	14.3	13.6	23.1	25.3	16.8	17.5	15.1	14.7	19.4	15.5	16.3	16.7	12.2	24.8	28.9	17.5	15.5	12.6	22.8	18.7	22.0	15.6	19.4	17.2	12.5	27.5	20.3	20.5	16.9	40.0	55.5	29.3	62.0	34.2	30.2	33.6	38.8	28.5	48.4	38.4	62.6	22.6	127.6	28.3	33.0	41.8	59.5	110.5	59.4	59.5	35.9	70.2	58.0	44.5	58.9	31.0	147.3	40.7	31.1	40.0	31.5	88.3	22.8	37.4	60.6	128.6	43.5	40.8	76.0	120.5	65.7	41.9	69.3	65.7	89.3	98.0	53.7	27.8	68.5	43.1	32.6	52.3	54.9	23.6	28.2	55.0	41.0	30.5	42.8	34.0	63.7	72.8	47.0	61.0	120.3	43.3	60.0	43.4	0.7	8.3	2.8	11.7	13.7	15.5	12.2	12.6	13.4	15.5	10.6	12.7	13.2	0.9	15.0	12.9	11.6	12.0	9.1	16.0	15.4	14.7	17.4	15.1	15.4	14.3	13.6	14.7	12.6	15.6	16.9	8.5	6.4	20.7	10.4	12.7	12.2	11.3	6.9	12.5	12.2	8.8	10.2	12.6	7.2	15.1	14.7	12.5	18.1	8.0	5.8	5.9	9.2	6.1	10.1	18.3	10.9	7.2	21.0	22.8	9.6	13.4	14.5	5.6	12.2	5.1	17.3	5.7	7.5	12.0	11.8	21.7	8.9	4.1	5.5	4.4	3.4	9.3	8.5	1.8	6.5	12.9	5.3	7.2	11.6	16.0	8.7	3.5	13.2	9.8	14.8	3.7	5.8	10.6	11.0	13.1	19.6	8.4	20.5	21.6	13.1	13.8	14.4	11.0	19.7	14.3	7.6
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508224-50524780	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	25.7	21.9	32.9	24.5	33.6	78.8	26.9	32.7	39.2	31.8	25.4	29.3	17.7	29.8	12.4	30.3	30.0	13.0	36.7	32.0	30.9	26.6	27.6	28.2	27.6	32.6	29.0	37.6	40.7	16.7	38.6	17.1	28.7	28.4	11.7	15.5	25.7	16.6	30.7	32.6	28.4	14.7	27.5	33.2	30.2	52.3	28.5	29.6	28.9	19.3	20.2	25.9	26.9	33.5	60.7	32.1	53.8	57.1	15.8	18.4	71.6	45.8	31.6	81.8	89.5	67.2	41.4	68.8	25.5	32.9	45.5	47.1	49.0	44.2	23.5	40.3	82.8	39.8	86.7	63.6	19.1	90.3	69.5	16.1	27.6	64.4	22.2	12.2	26.2	59.4	51.5	132.5	33.4	83.9	61.7	109.9	39.3	34.9	37.9	103.3	71.0	77.2	23.8	40.6	35.6	47.5	36.7	55.4	44.3	16.5	37.5	86.7	17.6	64.2	80.5	54.4	72.3	67.7	45.8	110.1	48.8	45.7	62.3	11.9	9.8	18.2	18.7	11.6	22.9	16.0	19.4	19.1	8.0	14.2	19.9	17.3	11.4	13.9	14.4	11.8	19.3	15.5	32.9	33.6	32.7	39.2	32.0	30.9	32.6	29.0	28.7	27.5	28.5	33.5	10.1	22.4	24.5	12.1	15.9	18.9	23.8	17.5	6.2	18.3	11.5	12.6	19.6	15.7	10.4	9.2	4.2	36.3	15.5	24.6	15.6	16.6	36.8	8.5	7.5	12.9	13.1	31.5	8.6	23.5	55.1	13.8	14.8	14.5	17.1	16.3	8.9	10.6	19.3	8.4	8.8	18.8	6.1	7.9	16.3	111.5	17.4	9.2	12.4	3.7	16.2	14.7	18.6	3.0	8.2	17.3	13.5	17.3	26.6	15.2	18.4	9.5	5.9	16.1	19.7	17.8	16.9	36.2	39.7	10.9	18.5	31.5	15.9	7.6	22.6	18.2
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	212.0	192.8	128.8	226.0	146.3	301.4	228.7	129.1	139.6	180.0	114.1	183.6	160.7	205.2	150.2	228.8	173.2	132.2	164.3	115.9	152.3	166.2	218.5	147.4	289.7	148.8	141.5	258.2	209.0	258.9	115.9	203.4	140.4	155.4	219.2	147.1	157.0	160.9	350.9	197.1	157.4	201.0	137.9	176.3	164.7	126.2	142.1	347.0	198.4	228.2	329.0	271.1	169.1	143.9	718.3	691.8	715.7	640.1	485.7	592.0	823.0	790.4	497.2	690.8	628.2	1227.4	521.4	1083.7	608.6	651.0	892.6	719.5	1614.4	1059.9	1284.7	554.6	644.0	1587.3	605.9	1749.5	544.0	1930.4	632.7	513.5	613.2	872.3	1019.6	394.9	834.2	770.5	1745.4	378.6	760.5	1176.4	1443.2	1086.7	1202.0	728.7	435.9	1290.8	1452.0	918.4	583.8	959.9	749.0	502.0	555.8	704.5	706.9	625.7	476.8	985.3	686.3	611.4	626.7	714.5	1063.7	624.3	554.5	1885.9	467.2	1173.1	685.2	27.3	95.6	62.5	136.5	100.3	152.8	113.5	118.4	121.9	130.6	111.9	130.3	114.2	16.8	177.8	121.7	102.0	102.3	151.0	128.8	146.3	129.1	139.6	115.9	152.3	148.8	141.5	140.4	137.9	142.1	143.9	286.2	291.7	411.7	8.1	468.9	459.9	633.8	241.0	644.9	145.0	315.2	303.8	320.9	147.3	401.6	195.0	47.9	386.9	596.2	215.0	230.9	294.4	20.6	348.7	669.8	291.1	200.0	419.2	9.3	254.4	444.6	370.9	292.0	421.8	451.7	262.7	130.6	242.0	239.5	80.8	10.4	319.6	156.6	133.7	231.1	32.2	217.2	281.8	165.4	10.3	268.9	199.6	346.1	14.1	14.9	268.0	153.9	159.9	543.5	651.1	120.1	277.6	250.3	141.0	151.2	548.9	442.0	433.3	532.4	707.9	441.4	379.0	454.0	442.6	380.6	449.1
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24956721	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 675.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 32.7;Distal tubular cells: 103.7;Enteroendocrine cells: 33.3;Excitatory neurons: 64.6;Horizontal cells: 30.3;Rod photoreceptor cells: 110.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2"	"Lineage enriched"	"Detected in single"	113	"T-cells: 11.2"	"Group enriched"	"Detected in some"	4	"HEK 293: 456.2;PC-3: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nucleoplasm,Intermediate filaments,Midbody"		Yes	NA		200000	"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Intermediate filaments"	Midbody	"HPA014850: AB_1854397, HPA015021: AB_2669135"	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.1	18.0	35.4	1.3	36.7	0.0	0.0	103.6	675.9	2.0	0.0	2.5	0.6	0.1	0.3	5.4	1.3	0.1	0.1	50.9	75.6	5.0	0.0	0.0	0.1	425.7	41.1	0.2	0.2	0.1	4.0	0.0	231.3	1.8	1.5	89.5	0.0	15.6	0.0	0.9	1.9	1.1	33.9	0.2	0.8	1.7	216.1	12.7	0.7	0.1	0.3	0.0	1.4	184.0	0.0	0.6	68.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.6	0.0	0.0	456.2	0.0	0.0	0.0	21.6	0.0	1.0	8.3	2.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	18.8	0.0	145.4	0.0	0.0	0.0	31.7	4.2	30.9	31.6	11.2	0.0	1.9	2.2	0.0	0.0	0.0	2.2	31.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	1.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.2	1.5	35.4	36.7	103.6	675.9	50.9	75.6	425.7	41.1	231.3	33.9	216.1	184.0	0.1	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.6	32.7	0.0	0.0	3.2	0.0	0.0	0.0	8.4	0.0	0.1	0.1	103.7	0.1	0.4	0.1	0.3	3.7	33.3	0.0	64.6	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	30.3	29.1	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	27.2	0.1	27.8	0.0	14.6	18.4	0.0	0.1	9.4	0.0	0.0	0.0	0.2	0.0	110.0	0.0	0.1	0.2	0.0	13.2	1.5	0.0	0.0	1.6	1.4	0.0	0.0
NEK8	NPHP9	ENSG00000160602	"NIMA related kinase 8"	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040661, HPA040679"	Approved		Approved	"Nuclear speckles,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Microtubules	"Nuclear speckles, Mitotic spindle"	"HPA040661: AB_10794065, HPA040679: AB_10796226"	"unprognostic (2.63e-1)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (6.25e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.67e-3)"	1.5	3.1	1.7	3.3	1.9	1.7	2.4	1.4	1.9	2.5	3.8	2.4	3.0	1.5	3.2	2.5	3.9	2.0	1.0	1.4	1.6	9.1	5.2	3.3	5.8	2.0	1.7	1.9	4.5	2.9	4.4	2.6	1.7	4.0	2.2	0.6	3.7	2.6	0.5	3.1	4.2	1.2	1.6	5.8	3.4	3.8	1.9	2.7	7.2	0.4	5.0	2.6	2.2	2.3	2.1	3.4	3.5	2.8	1.9	2.1	10.9	0.9	2.1	1.3	1.7	5.4	5.0	13.1	3.5	2.8	2.5	3.8	5.2	4.8	1.3	3.5	6.4	2.9	5.8	10.1	3.3	1.8	3.7	4.8	1.8	2.5	5.8	1.8	0.9	1.9	4.3	1.3	1.5	4.7	1.9	3.4	3.3	3.7	1.0	4.9	2.3	5.9	7.0	5.7	6.4	1.5	3.0	6.3	1.6	4.7	9.3	2.4	0.8	1.3	2.2	1.6	1.0	1.5	1.8	8.9	2.0	1.6	3.1	3.3	0.9	1.2	0.7	0.5	0.8	2.8	0.6	0.7	0.1	4.2	0.7	1.0	0.4	1.3	1.1	14.8	0.5	0.8	1.7	1.9	1.4	1.9	1.4	1.6	2.0	1.7	1.7	1.6	1.9	2.3	2.7	9.6	19.3	3.9	22.9	2.8	9.2	8.3	7.4	2.8	10.1	14.1	1.7	12.8	11.6	25.8	8.4	17.6	19.1	14.9	7.9	5.8	9.5	12.8	6.0	2.9	10.3	7.0	0.7	6.0	9.2	3.9	6.1	15.2	26.6	3.2	3.3	9.4	3.9	1.7	0.5	14.4	10.2	5.0	2.7	2.0	3.4	4.4	3.6	2.8	4.0	2.6	3.1	1.5	1.6	3.9	17.2	2.6	7.2	8.6	13.4	4.3	14.3	1.8	0.0	11.7	3.0	19.9	11.4	8.8	1.6	11.1	4.9	7.8	15.9	4.2
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925472	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 1.4;Club cells: 2.5;Hofbauer cells: 1.3;Respiratory ciliated cells: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HAP1: 3.7;Karpas-707: 5.9;SiHa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: AB_2665984"	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.1	0.9	3.0	0.1	3.1	0.0	0.3	1.0	2.5	0.4	0.0	0.8	0.1	0.5	0.2	0.3	0.3	0.1	0.0	2.6	6.7	0.7	0.0	0.1	0.1	0.3	0.7	0.4	1.5	1.8	1.7	0.1	0.5	0.9	0.3	1.0	0.4	0.6	0.0	0.3	0.4	0.7	0.2	0.1	0.6	0.2	4.8	0.0	0.4	0.1	0.1	0.2	0.2	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.9	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.1	1.0	2.5	2.6	6.7	0.3	0.7	0.5	0.2	4.8	0.7	0.3	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90275778	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 385.3;skeletal muscle: 376.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	61.0	91.8	322.8	32.9	334.0	31.7	61.4	312.4	385.3	68.8	312.1	47.0	39.7	63.4	98.3	51.7	65.3	47.1	133.0	332.8	329.8	71.7	59.1	50.3	31.8	316.3	322.1	67.8	46.4	87.6	3.0	46.4	318.1	80.1	51.1	157.0	46.3	88.9	376.8	32.6	35.6	74.6	324.8	37.0	41.5	54.2	334.5	39.6	74.0	291.8	37.4	69.2	2.7	320.9	62.1	127.8	151.7	99.7	138.4	63.9	70.4	100.7	88.4	110.5	94.0	133.2	90.5	38.4	113.8	108.9	110.2	118.2	120.3	64.7	121.5	42.6	104.6	61.0	88.4	110.6	117.7	44.5	36.1	83.4	183.3	60.8	132.9	83.7	79.5	45.7	105.0	64.7	112.8	106.5	35.9	53.5	152.7	198.8	55.0	65.6	72.8	63.1	109.8	168.3	145.8	117.0	107.1	90.1	239.1	149.1	141.9	82.6	64.6	138.3	92.3	85.7	161.7	96.9	268.2	66.4	76.8	90.1	106.4	66.4	62.1	99.0	87.2	65.2	109.9	107.7	106.1	101.9	59.2	105.7	122.6	106.8	23.4	86.7	76.0	62.8	133.5	108.0	322.8	334.0	312.4	385.3	332.8	329.8	316.3	322.1	318.1	324.8	334.5	320.9	10.8	19.2	27.4	21.5	26.2	7.1	10.6	3.7	75.1	10.4	9.1	5.8	10.1	1.5	21.6	5.5	10.4	5.9	5.0	12.1	5.9	33.6	1.9	16.2	14.6	15.8	26.5	12.0	58.3	23.4	4.5	23.0	30.1	9.4	20.3	5.5	7.5	3.8	4.2	16.8	54.0	14.4	4.1	3.8	3.6	4.0	9.0	8.4	8.8	16.9	11.6	15.1	0.0	12.5	22.2	29.9	20.0	8.6	25.0	9.2	12.6	7.8	59.8	11.2	13.1	10.5	19.6	5.2	4.3	55.2	5.1	6.7	19.9	5.7	15.4	8.7
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736911	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	29.3	24.8	18.1	31.9	18.6	31.5	37.3	18.7	21.8	25.4	17.9	24.8	25.1	28.5	21.9	34.6	27.5	25.1	22.9	19.3	18.7	25.7	34.1	17.9	47.2	18.5	17.8	36.5	32.6	17.9	16.7	25.6	18.4	24.6	25.6	23.0	17.9	17.8	38.3	34.5	20.1	24.8	19.1	22.3	22.5	21.8	18.3	32.9	25.2	18.3	42.4	43.3	24.5	20.1	118.4	37.6	68.8	68.3	57.9	80.6	90.2	90.6	75.2	105.0	113.2	105.9	55.0	152.4	111.4	66.9	93.1	72.9	149.4	116.4	153.4	101.3	85.7	155.0	44.5	92.9	82.6	141.1	81.7	80.6	126.7	137.4	184.4	48.7	75.9	60.3	174.5	73.9	90.5	58.2	109.5	140.9	175.3	132.4	122.5	102.5	80.7	191.2	92.1	72.4	88.1	91.8	56.6	105.1	200.7	62.2	52.0	123.1	45.7	72.8	123.5	85.6	129.3	87.5	150.6	182.1	55.7	143.9	101.5	41.8	54.2	28.8	59.2	65.3	83.4	73.6	72.3	68.6	72.1	74.8	84.5	79.4	4.0	81.5	62.5	64.0	68.9	75.1	18.1	18.6	18.7	21.8	19.3	18.7	18.5	17.8	18.4	19.1	18.3	20.1	51.1	44.8	25.9	8.1	56.3	98.4	128.9	87.0	81.4	25.8	51.2	88.8	21.5	24.3	62.2	14.7	12.5	74.9	62.7	18.9	46.9	64.2	23.7	43.8	126.9	47.7	28.1	41.8	8.2	45.2	90.6	68.7	32.6	39.9	54.5	47.9	26.0	33.2	54.4	13.5	7.2	41.3	42.7	34.5	32.8	8.0	57.5	39.0	23.2	10.3	59.1	48.0	54.6	13.0	8.0	51.5	28.4	45.1	33.3	107.0	18.4	58.4	41.9	45.8	39.5	72.7	54.3	81.1	83.9	79.3	101.4	48.8	52.5	97.7	60.5	125.2
NINL	"KIAA0980, NLP"	ENSG00000101004	"Ninein like"	Q9Y2I6	20	25452697-25585531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.4;Granulosa cells: 29.6;Inhibitory neurons: 32.6;Oligodendrocyte precursor cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 37.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000686	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytokinetic bridge, Cytosol"		"HPA000686: AB_1079193"	"unprognostic (7.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.39e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (3.95e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.26e-2)"	4.0	8.6	4.9	2.0	5.9	0.6	4.0	10.4	6.1	10.1	8.8	9.8	3.2	7.2	7.2	5.8	5.2	3.3	4.0	4.4	6.9	15.1	8.1	4.1	2.2	7.9	7.1	18.9	5.4	8.2	9.9	1.5	7.0	8.8	2.1	4.7	4.4	3.7	4.5	2.4	3.9	3.5	5.5	4.9	6.3	7.7	6.5	15.7	10.2	1.2	2.2	3.6	8.5	6.8	1.0	10.8	23.0	15.1	2.6	7.5	7.1	3.6	3.1	3.1	4.4	2.8	7.5	0.6	5.0	5.6	7.6	0.8	3.4	0.7	2.6	0.5	4.7	1.6	5.0	37.5	5.4	0.6	0.1	9.2	0.7	3.6	0.0	8.8	6.8	17.8	1.9	0.3	3.8	9.6	21.7	0.7	6.5	0.1	1.1	0.5	17.9	0.8	1.5	1.3	22.7	16.0	8.2	3.0	9.1	18.3	4.9	6.4	0.3	0.1	8.6	0.1	0.2	2.3	4.4	0.1	0.2	0.6	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.9	10.4	6.1	4.4	6.9	7.9	7.1	7.0	5.5	6.5	6.8	1.2	0.0	14.6	42.4	0.8	2.0	4.9	2.5	5.7	3.0	2.8	3.3	6.5	12.8	4.8	7.3	25.0	2.8	0.6	0.4	0.0	5.6	0.6	4.2	7.3	2.3	6.1	0.0	7.4	1.2	1.3	8.7	4.6	3.4	0.0	29.6	8.9	8.4	2.3	8.4	32.6	2.3	8.2	0.3	2.0	2.7	13.1	0.8	0.0	12.2	0.0	3.2	2.1	47.3	19.4	2.8	1.5	12.4	0.9	4.5	0.7	8.8	13.7	1.9	6.6	10.8	4.7	2.5	5.0	4.3	0.9	1.5	1.1	21.0	2.5	1.9
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493068	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Enteroendocrine cells: 169.3;Peritubular cells: 246.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (6.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.96e-2)"	"unprognostic (8.33e-3)"	"prognostic favorable (1.91e-4)"	"unprognostic (1.40e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.05e-3)"	55.2	69.8	46.5	28.7	55.5	38.7	60.5	78.2	56.6	105.8	22.2	68.5	24.3	76.2	34.0	51.3	72.0	29.9	48.5	56.3	38.7	54.6	45.6	56.2	32.5	20.9	32.6	93.0	54.1	32.5	181.8	39.1	32.9	107.5	20.6	19.0	53.6	51.6	36.3	80.7	55.3	33.0	9.1	54.1	52.7	84.5	35.2	30.1	60.8	16.3	23.3	78.1	71.6	35.2	15.6	16.0	48.8	40.1	35.7	39.2	40.0	32.8	21.5	25.7	26.0	24.2	22.8	21.7	9.0	45.6	21.0	20.4	26.1	35.7	15.1	22.3	28.2	39.2	65.2	23.9	32.4	23.2	33.6	61.9	28.2	27.7	23.5	54.0	42.0	42.4	21.1	23.4	24.3	22.2	41.8	51.2	30.1	19.8	27.1	24.5	13.4	25.4	29.2	30.6	20.6	35.9	35.6	9.3	23.1	42.3	28.9	38.5	46.3	36.0	34.1	36.9	24.1	38.7	23.8	27.3	24.7	37.3	22.4	5.2	4.5	3.5	3.0	4.0	3.1	2.5	2.6	4.0	2.3	2.8	3.1	3.3	1.5	3.2	0.6	3.4	3.0	3.6	46.5	55.5	78.2	56.6	56.3	38.7	20.9	32.6	32.9	9.1	35.2	35.2	26.1	25.6	32.3	34.0	14.9	27.5	14.6	23.3	40.5	40.9	29.2	37.1	20.4	8.6	19.1	14.7	8.4	32.4	24.2	20.5	9.8	12.1	10.3	14.5	26.7	22.1	169.3	4.6	64.9	9.4	14.0	23.4	23.4	18.9	25.3	40.2	46.1	15.3	30.5	28.6	44.0	19.1	22.4	50.5	14.5	25.9	88.3	24.3	19.6	15.0	13.0	12.1	17.5	21.1	26.1	10.0	14.2	246.0	12.4	12.6	16.5	15.6	15.2	22.4	26.3	17.2	24.8	31.2	18.0	16.7	22.3	24.2	18.4	47.6	15.7	11.7
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 918.0;Gastric mucus-secreting cells: 438.3;Plasma cells: 778.5;Squamous epithelial cells: 1490.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	503.5	428.3	308.0	259.5	319.0	329.4	489.1	328.0	379.9	439.2	431.1	409.2	335.1	383.4	236.1	610.6	350.6	187.0	403.9	313.7	338.6	478.1	428.4	339.6	288.9	326.6	320.7	500.1	632.0	201.8	234.9	204.8	321.3	367.7	330.4	63.3	432.4	247.5	545.7	540.3	307.6	286.2	326.8	336.0	403.5	77.8	333.3	190.0	305.3	353.7	289.1	463.5	464.2	333.4	1638.6	2233.9	466.1	913.7	969.3	1399.2	1449.2	1091.7	954.0	1404.8	1053.5	1789.7	792.3	1314.3	1662.9	913.0	706.6	956.2	947.3	1273.3	1035.7	1604.8	3283.2	1120.3	1345.8	2513.4	1116.1	1736.0	760.5	1324.1	1420.0	901.9	1466.4	914.6	860.9	856.5	1541.7	773.7	956.1	2741.9	931.3	2144.8	831.4	2974.6	3364.2	875.9	1731.8	2157.2	1417.9	1800.2	1160.6	641.9	674.1	1472.7	1583.0	806.1	1201.7	1268.5	1013.5	1462.8	1158.2	1135.2	1774.8	1520.9	2176.6	1558.1	815.1	919.1	819.2	66.8	243.4	14.0	166.7	325.5	235.6	338.9	211.9	183.3	439.5	259.2	153.5	170.0	13.8	251.6	282.5	478.1	211.2	298.2	308.0	319.0	328.0	379.9	313.7	338.6	326.6	320.7	321.3	326.8	333.3	333.4	9.7	28.9	67.2	0.0	146.8	14.5	8.3	10.8	918.0	0.9	41.6	35.9	0.0	22.8	85.7	5.5	0.0	10.0	10.1	7.1	37.2	47.4	0.6	16.4	34.3	60.9	14.6	298.2	0.0	34.5	27.8	99.0	438.3	21.3	42.9	6.8	22.9	37.6	16.4	0.0	0.0	19.3	8.2	34.8	17.4	2.1	25.7	136.7	10.6	0.0	55.5	0.4	2.1	0.0	0.0	40.7	15.6	12.8	778.5	7.6	11.7	33.8	63.6	0.8	6.6	10.2	43.3	0.6	5.6	1490.1	14.9	8.8	87.0	6.8	25.0	11.0
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944203-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	26.7	23.6	17.1	23.0	17.1	30.1	26.4	16.8	21.2	29.5	14.3	28.0	17.9	30.3	10.3	47.3	27.7	14.1	32.8	18.1	18.5	27.1	33.7	23.6	23.1	18.5	17.0	26.0	35.6	21.2	24.4	15.8	19.5	26.8	11.6	9.6	26.5	16.0	73.0	45.0	25.2	15.0	15.1	28.0	28.4	36.0	17.6	20.1	24.3	26.4	15.9	32.7	31.7	18.5	112.8	110.4	19.8	129.5	34.5	31.0	70.2	82.3	38.9	114.4	62.1	148.5	110.5	126.3	113.3	56.0	94.0	102.2	147.6	122.8	49.2	79.2	161.5	67.0	141.2	132.0	77.4	151.1	63.8	50.3	35.0	125.3	84.3	35.3	56.4	44.6	190.8	58.2	51.6	182.1	98.7	92.6	112.0	82.3	128.8	120.0	81.5	155.9	53.6	47.4	136.0	133.0	109.3	166.3	105.1	30.3	74.8	81.1	64.1	68.3	95.9	75.2	143.0	97.6	112.5	225.7	84.3	209.1	57.7	21.3	30.9	22.2	23.9	46.4	31.3	23.9	23.3	23.4	36.8	19.3	23.3	18.6	2.8	34.5	57.5	23.6	19.9	31.7	17.1	17.1	16.8	21.2	18.1	18.5	18.5	17.0	19.5	15.1	17.6	18.5	21.5	16.0	23.1	12.4	42.7	69.3	90.8	42.9	47.8	54.6	33.4	34.7	4.5	28.6	29.8	36.8	62.6	63.7	24.7	27.4	17.6	49.9	10.2	34.8	40.9	27.8	30.0	23.8	12.6	46.2	65.5	29.9	28.1	36.9	13.9	36.4	24.7	24.0	39.6	45.4	12.4	27.6	36.7	24.6	29.2	10.3	29.5	24.4	24.9	12.2	35.7	20.6	60.8	9.5	10.6	39.2	21.4	21.4	42.6	71.9	22.9	19.6	27.1	77.0	32.9	41.2	34.6	43.0	83.9	47.4	82.0	58.8	36.6	51.8	53.1	69.3
NOL12	"MGC3731, Nop25, RRP17"	ENSG00000273899	"Nucleolar protein 12"	Q9UGY1	22	37681673-37693476	"Predicted intracellular proteins"		"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003547	Uncertain		Approved	"Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Mitotic chromosome"	"Nucleoplasm, Vesicles"	"HPA003547: AB_10602012"	"unprognostic (3.37e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (2.65e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.23e-3)"	"prognostic favorable (9.41e-4)"	"unprognostic (9.96e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (2.56e-6)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (3.24e-4)"	17.1	29.2	11.3	15.1	12.7	28.7	17.5	12.1	18.0	20.5	9.6	21.3	14.9	15.5	7.9	35.1	16.2	9.0	18.6	11.8	12.3	22.0	16.2	14.3	20.9	12.3	11.8	18.5	17.5	11.5	16.5	8.1	12.1	19.8	9.5	4.9	20.5	4.4	12.6	22.7	19.5	6.6	11.2	26.5	18.8	10.4	11.8	16.1	23.1	8.2	12.6	17.1	23.3	12.9	38.3	33.5	24.4	29.5	8.1	7.8	32.2	17.1	7.7	7.4	8.4	20.0	15.7	30.2	9.8	6.2	8.1	41.4	11.6	50.0	2.2	34.4	51.9	26.3	28.9	43.6	21.3	59.3	38.2	9.6	12.4	31.2	11.7	10.0	15.3	16.7	19.8	26.9	6.8	32.3	36.4	48.0	29.5	16.6	46.7	48.5	16.7	24.7	18.2	10.1	19.2	40.3	22.1	19.5	30.8	2.7	26.9	31.0	22.9	34.2	32.5	24.8	34.5	24.0	29.9	41.0	33.3	46.2	40.0	57.3	24.4	26.9	15.1	28.4	11.7	14.1	14.8	13.6	17.6	15.8	14.8	12.6	53.1	16.7	33.8	13.6	22.3	11.9	11.3	12.7	12.1	18.0	11.8	12.3	12.3	11.8	12.1	11.2	11.8	12.9	10.9	3.2	15.3	4.9	15.3	39.0	13.7	33.0	25.0	11.0	10.2	7.7	3.5	7.2	20.3	14.7	6.2	19.4	11.0	35.6	3.9	25.7	105.7	5.4	5.0	12.9	12.6	8.8	11.4	29.1	16.2	10.2	15.8	4.7	15.2	9.7	10.8	6.2	13.9	28.6	10.9	24.8	20.3	10.7	21.8	48.3	9.9	12.7	21.4	2.8	17.7	13.8	18.6	5.5	8.2	22.4	39.9	11.3	14.0	8.6	27.4	7.8	15.9	8.3	13.1	10.0	10.6	14.5	25.9	45.4	39.8	19.8	14.3	9.7	24.1	14.5
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615335-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	44.3	43.9	29.5	21.7	30.8	29.5	42.0	32.2	34.0	37.5	28.2	44.8	26.8	37.7	23.4	38.2	35.5	16.6	48.2	28.7	31.1	58.5	37.9	32.2	25.8	30.9	31.4	40.7	48.9	40.2	35.9	21.1	31.0	35.1	19.8	16.6	38.0	19.2	44.5	36.9	36.4	16.0	30.8	37.8	37.9	41.7	30.7	15.2	37.1	17.1	20.3	41.4	34.9	33.8	71.7	37.2	31.7	42.7	26.9	26.1	74.4	71.8	29.3	48.4	44.4	60.0	24.9	97.8	137.4	34.4	57.7	46.5	46.9	42.4	47.8	57.5	105.0	91.2	36.3	104.0	45.4	112.0	61.4	25.5	41.5	42.5	24.2	29.8	33.6	45.5	135.7	22.2	44.7	38.1	70.6	147.6	42.1	37.0	74.1	74.4	46.8	140.5	57.9	21.7	92.5	60.3	40.9	88.0	94.9	36.2	53.6	42.8	65.7	48.0	51.9	57.8	108.3	66.2	123.2	100.2	30.7	70.7	75.6	34.5	59.6	82.1	59.2	76.4	68.2	104.0	84.7	71.4	73.2	87.8	90.7	69.0	27.4	61.9	82.9	91.4	96.0	67.9	29.5	30.8	32.2	34.0	28.7	31.1	30.9	31.4	31.0	30.8	30.7	33.8	103.1	93.0	73.5	10.4	112.5	90.8	117.3	151.0	50.1	62.1	78.9	97.0	214.9	68.6	112.0	57.0	22.9	137.4	71.5	72.7	123.3	188.7	202.3	105.8	95.0	109.2	37.1	89.4	14.0	261.2	153.8	90.9	58.1	91.6	90.6	67.0	61.1	61.8	115.1	48.8	17.1	97.8	130.2	52.6	81.8	38.9	82.6	78.5	101.4	8.4	119.7	124.2	78.2	13.6	19.0	175.0	94.3	79.4	138.8	121.7	81.2	163.6	135.6	61.7	65.7	92.5	119.4	186.3	112.9	70.8	90.5	155.3	99.5	99.2	91.0	117.2
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	8.6	5.8	4.2	8.0	5.8	6.8	10.0	5.0	5.3	8.2	5.2	8.6	6.0	9.8	7.4	8.7	7.4	6.5	6.8	4.1	5.3	7.2	5.5	6.9	12.0	5.6	5.4	11.2	7.1	12.6	3.2	7.6	5.6	7.4	8.3	5.8	7.8	8.5	6.3	7.2	5.9	9.9	4.6	9.8	6.2	6.1	6.0	12.6	10.5	6.2	12.6	8.6	5.1	7.1	18.9	27.1	13.4	24.2	28.5	24.3	19.8	19.7	14.9	20.9	18.7	11.2	18.5	54.2	16.3	20.1	33.8	39.9	43.5	25.8	22.3	36.3	21.4	37.1	25.9	22.4	20.3	63.2	30.5	24.0	23.5	22.0	31.6	16.7	23.7	16.3	60.7	17.1	22.5	29.7	42.7	24.8	21.4	28.4	26.8	29.8	37.9	23.0	10.6	13.4	23.0	12.3	25.3	25.1	18.0	17.3	9.5	21.2	24.9	18.3	14.0	26.7	25.0	17.7	37.5	26.7	18.5	37.4	26.6	18.9	8.3	11.3	11.4	10.8	15.8	13.0	11.3	11.8	12.1	12.9	13.3	11.7	3.1	13.2	15.7	10.2	13.8	7.1	4.2	5.8	5.0	5.3	4.1	5.3	5.6	5.4	5.6	4.6	6.0	7.1	25.4	19.2	33.4	15.7	33.8	13.0	18.4	15.3	21.1	17.9	14.7	20.6	28.4	14.3	19.8	11.0	10.4	19.5	37.7	10.1	15.6	23.5	13.9	17.9	46.2	23.9	9.0	37.6	12.1	12.9	20.1	25.8	23.9	20.8	52.4	30.6	16.1	11.5	26.5	28.6	12.5	16.9	6.1	17.7	12.1	9.4	32.0	23.9	10.6	18.7	34.5	12.4	43.3	15.6	25.9	16.1	11.2	23.7	36.5	23.3	10.3	15.8	21.2	17.7	6.6	29.3	21.5	73.3	50.2	25.4	15.9	14.6	30.1	33.4	20.3	12.2
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: AB_2675447, HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	13.9	11.8	11.1	13.2	13.2	11.7	11.2	13.2	14.0	8.1	10.2	11.2	14.5	10.2	6.4	12.8	9.7	5.7	8.3	11.0	11.4	11.7	15.3	8.7	15.1	12.8	12.6	8.9	15.4	6.8	9.3	10.3	13.7	8.9	6.1	7.3	14.0	3.6	20.9	10.7	13.3	6.3	12.8	12.8	11.8	10.4	12.5	8.1	9.4	5.0	9.8	9.2	10.3	17.7	62.3	32.3	23.5	37.1	14.1	10.4	31.3	24.6	7.0	8.7	13.9	28.6	46.3	35.5	57.5	4.0	39.8	30.6	12.6	13.9	10.7	70.6	36.6	32.4	42.0	26.4	15.3	37.3	35.3	3.8	7.7	8.4	12.1	12.3	9.8	39.1	35.1	42.6	8.9	25.2	55.1	80.9	25.8	18.4	35.2	45.7	39.2	63.0	8.0	14.3	59.6	33.6	38.7	24.7	66.3	13.8	47.2	37.8	21.9	29.4	43.8	32.6	56.7	35.0	63.8	61.5	34.2	63.2	31.4	49.9	48.3	32.5	60.2	59.8	76.5	91.7	84.0	71.8	68.0	68.0	88.7	79.0	6.2	83.8	51.5	81.1	83.5	69.1	11.1	13.2	13.2	14.0	11.0	11.4	12.8	12.6	13.7	12.8	12.5	17.7	58.0	28.9	23.8	9.1	47.5	59.4	54.9	92.6	42.7	30.7	70.4	88.6	43.1	35.8	53.1	38.6	22.9	118.7	43.8	25.4	148.7	63.6	95.1	57.6	44.1	47.4	43.8	78.4	18.8	64.0	55.8	48.6	32.1	38.3	31.6	35.7	36.0	55.1	69.8	10.1	14.0	45.3	87.5	41.8	42.7	24.5	51.6	35.7	49.8	11.2	46.4	51.4	52.5	11.1	36.0	59.9	33.6	51.1	55.5	95.2	31.5	112.5	65.1	38.2	39.5	51.3	46.5	87.6	44.2	56.0	67.6	56.8	48.3	64.8	68.6	59.3
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2 component of NDC80 kinetochore complex"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	0.8	0.6	0.5	6.9	0.8	28.4	1.2	0.5	0.8	1.0	0.4	4.2	4.3	1.1	0.3	5.8	0.4	1.0	0.3	0.6	0.6	0.3	0.7	0.9	18.2	0.9	0.8	0.4	0.2	0.6	0.2	4.7	0.9	0.4	5.3	1.5	0.9	0.3	0.1	4.1	4.3	2.3	0.7	3.6	2.6	53.5	0.8	26.0	0.5	0.2	16.7	1.8	1.8	1.0	90.8	30.8	80.5	33.9	2.5	8.1	43.6	55.9	39.3	88.9	77.3	23.7	77.7	77.4	45.5	22.6	37.0	51.6	49.6	21.0	111.5	81.4	35.6	30.3	34.8	34.4	0.3	53.0	60.2	1.0	2.0	45.0	31.6	16.8	41.1	74.5	58.1	103.9	85.0	17.6	97.3	70.6	43.9	66.1	47.0	65.0	70.3	68.4	25.3	12.4	59.9	68.9	29.9	32.2	30.6	49.7	49.3	109.5	29.4	65.9	73.8	50.1	115.1	73.9	111.5	148.9	22.0	42.9	74.7	1.4	0.1	1.3	1.2	0.0	0.5	0.6	1.8	1.2	0.2	0.7	1.2	1.0	0.4	1.8	0.1	0.3	4.3	0.4	0.5	0.8	0.5	0.8	0.6	0.6	0.9	0.8	0.9	0.7	0.8	1.0	0.5	0.0	0.5	1.3	5.3	5.9	1.9	4.2	1.2	1.2	1.3	2.7	0.9	0.0	3.3	0.0	0.0	21.7	3.6	2.6	0.0	0.8	17.7	2.5	2.5	1.8	0.0	60.8	1.1	0.2	29.7	3.4	5.6	3.0	4.5	18.3	3.3	0.4	14.0	0.0	1.4	3.3	0.0	5.2	3.6	21.4	2.5	3.1	0.0	1.0	0.9	2.0	6.2	0.5	3.6	0.2	0.1	2.2	17.8	0.8	0.9	0.2	0.7	2.3	6.6	0.9	4.2	208.2	40.3	10.6	2.4	4.0	5.0	1.7	9.0	3.8
NUPR1	"COM1, p8"	ENSG00000176046	"Nuclear protein 1, transcriptional regulator"	O60356	16	28532708-28539008	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 1157.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 14.3"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 280.6;hTCEpi: 446.5;SK-MEL-30: 344.9;T-47d: 199.1;U-87 MG: 173.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006349			Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Cytokinetic bridge"	"HPA006349: "	"unprognostic (2.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.72e-3)"	"unprognostic (5.77e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.80e-2)"	190.1	270.7	66.9	32.2	71.3	1.2	185.8	70.4	83.7	148.5	55.3	221.1	12.3	137.8	81.8	110.1	146.3	70.7	108.8	64.7	82.8	87.8	345.4	164.4	29.9	83.9	77.0	188.9	1157.3	26.4	39.5	54.5	81.0	204.1	59.9	9.0	255.3	124.3	87.9	205.1	71.3	63.4	76.6	35.8	130.6	67.9	72.9	23.3	354.6	17.3	13.9	178.0	152.4	75.8	1.4	10.5	0.0	73.3	108.0	94.7	58.6	66.5	57.3	2.3	54.6	0.2	0.2	0.2	37.2	101.2	8.8	1.9	0.4	2.1	2.3	0.4	3.7	0.1	6.2	52.1	280.6	0.3	0.5	90.2	446.5	31.2	148.5	76.8	0.4	0.1	0.1	3.5	34.0	13.7	0.3	1.4	0.4	0.2	38.7	0.2	0.2	3.1	0.0	6.9	0.6	0.5	19.6	78.5	344.9	1.5	199.1	12.0	0.2	21.3	51.7	55.2	10.5	0.5	0.6	0.6	173.1	0.3	2.6	14.3	0.4	3.6	0.3	0.3	0.3	0.3	0.3	0.2	0.1	0.5	0.3	0.3	2.4	0.8	0.4	0.6	0.2	0.1	66.9	71.3	70.4	83.7	64.7	82.8	83.9	77.0	81.0	76.6	72.9	75.8	179.9	288.4	336.2	11.1	9.7	316.9	318.4	1162.8	253.8	3.5	379.6	348.1	146.1	121.5	639.3	323.7	2.1	142.3	5.2	276.3	21.5	242.0	14.8	186.4	291.8	165.4	61.1	53.5	0.2	567.2	73.6	407.5	58.6	597.3	20.3	198.3	262.3	734.9	296.8	1.7	0.5	464.9	225.9	45.2	115.2	61.0	528.8	100.6	154.7	3.7	6.3	200.2	1.0	0.5	4.7	222.5	71.1	704.5	7.7	374.2	0.9	272.6	514.1	5.3	203.8	129.5	368.3	9.8	4.9	211.2	531.8	707.8	20.0	66.3	376.1	483.8
NXPH3	NPH3	ENSG00000182575	"Neurexophilin 3"	O95157	17	49575871-49583827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Bipolar cells: 23.3;Fibroblasts: 7.6;Muller glia cells: 8.5;Peritubular cells: 14.3;Smooth muscle cells: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 11.4;BJ: 3.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 41.1"	HPA073819			Approved	"Vesicles,Mitotic spindle"	"Secreted in brain"	Yes	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Mitotic spindle"	"HPA073819: "	"unprognostic (2.39e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.59e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-3)"	3.9	0.9	1.8	1.0	1.8	0.0	2.9	16.4	3.5	9.0	0.7	11.0	0.4	12.0	0.6	1.5	7.0	1.7	2.9	3.5	0.5	0.4	0.1	2.7	0.5	6.3	3.8	5.2	0.6	1.3	7.5	1.3	6.4	5.9	0.3	0.6	3.1	4.7	1.2	2.3	1.7	2.5	0.1	1.0	3.4	1.6	3.9	0.3	1.4	2.0	0.3	8.9	6.9	3.0	0.0	0.0	0.1	0.0	0.0	0.2	11.4	3.2	0.4	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	16.4	3.5	3.5	0.5	6.3	3.8	6.4	0.1	3.9	3.0	0.5	0.0	1.3	14.0	0.0	0.4	0.3	0.2	0.6	23.3	0.9	0.5	1.7	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.0	2.5	0.2	3.2	7.6	0.0	0.5	0.0	0.0	6.4	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.4	0.0	4.4	0.3	1.8	0.0	4.2	8.5	0.0	2.5	0.5	0.0	0.0	14.3	0.7	0.3	0.0	0.0	0.0	1.2	0.0	0.8	8.9	0.1	1.3	0.0	1.1	0.1	0.2	0.1	0.0	0.1
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028813-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1296.1;pancreas: 671.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 497.1;Exocrine glandular cells: 900.9;Intestinal goblet cells: 791.9;Pancreatic endocrine cells: 933.7;Paneth cells: 556.9;Undifferentiated cells: 2419.9;Urothelial cells: 1989.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;BJ hTERT+: 18.8;HaCaT: 26.4;OE19: 10.4;RPMI-8226: 6.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted to digestive system"	Yes	NA		9300		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	1.9	0.1	0.2	195.4	0.5	126.0	6.8	0.1	0.5	7.9	0.2	451.6	1211.9	5.5	3.5	0.8	8.3	10.4	0.8	0.2	0.4	26.9	0.9	3.8	1.4	0.1	0.2	0.2	671.4	0.0	0.5	0.6	0.2	92.4	568.7	0.4	16.2	0.9	0.6	0.4	1296.1	52.6	0.2	18.0	16.1	0.3	0.2	4.2	0.4	2.1	0.2	127.0	285.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.4	2.4	18.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	26.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	10.4	0.0	0.0	0.8	6.2	0.2	0.0	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.9	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.5	0.2	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.3	3.8	0.1	168.5	0.3	0.0	0.0	9.8	2.5	0.5	0.0	11.9	139.8	0.0	0.0	0.0	98.7	1.9	497.1	0.2	13.5	0.5	1.4	92.3	0.8	1.0	900.9	0.0	1.5	0.0	17.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	791.9	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	10.3	4.0	0.0	0.0	0.2	933.7	556.9	0.0	0.4	209.4	300.6	0.0	0.5	0.2	0.0	2.1	9.2	0.0	0.1	0.0	0.0	0.0	3.1	0.2	2419.9	1989.0
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772485-128775794	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"retina: 41.0"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"LHCN-M2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	41.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTUD7B	"CEZANNE, ZA20D1"	ENSG00000264522	"OTU deubiquitinase 7B"	Q6GQQ9	1	149937812-150010726	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Oligodendrocytes: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027045, HPA076357"	Supported		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA027045: AB_1854847, HPA076357: "	"unprognostic (2.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.46e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.58e-2)"	11.7	7.7	21.0	3.8	39.2	1.1	7.8	28.7	18.5	9.9	6.8	7.6	6.2	10.5	3.8	7.7	9.3	4.8	7.1	15.3	22.1	5.6	10.7	7.3	1.9	41.4	37.2	10.9	6.1	10.9	3.4	7.1	35.5	6.6	7.1	10.1	7.8	7.5	18.6	5.8	6.2	10.8	27.9	3.6	6.7	12.7	31.7	2.1	6.7	16.2	3.2	6.3	5.2	43.0	17.2	13.5	9.3	15.6	12.0	11.1	8.8	11.8	17.3	14.0	9.6	10.0	13.6	0.2	7.5	21.7	6.3	13.4	13.2	13.1	14.6	16.5	6.7	6.6	18.9	6.8	12.8	7.6	6.9	12.4	9.9	23.7	20.6	10.9	11.5	2.0	18.4	18.1	10.1	17.5	1.3	2.1	11.9	12.8	13.1	1.8	12.9	4.4	5.4	23.2	6.0	11.4	20.8	15.2	18.5	12.1	12.6	4.0	13.9	14.4	13.2	9.8	14.0	19.1	20.0	2.0	12.8	2.2	24.1	2.0	0.0	0.4	0.7	0.0	0.5	0.1	0.3	0.4	0.0	0.1	0.2	0.3	0.3	0.4	0.0	0.1	0.1	0.0	21.0	39.2	28.7	18.5	15.3	22.1	41.4	37.2	35.5	27.9	31.7	43.0	10.2	35.3	11.7	56.8	3.0	15.9	22.7	8.7	13.1	28.0	18.3	9.3	22.2	12.8	15.3	11.0	106.3	23.5	5.1	41.1	7.9	14.5	63.4	21.8	17.8	16.7	17.4	14.9	20.6	11.1	11.6	14.8	21.4	40.2	0.0	22.0	20.3	33.0	3.1	23.5	24.6	15.8	8.2	0.8	5.9	79.4	14.6	2.4	37.4	22.5	4.3	23.6	15.5	33.2	176.8	20.6	21.3	23.0	4.7	20.2	17.1	11.5	17.4	66.9	0.0	19.8	17.9	11.1	7.2	11.8	16.6	21.2	7.5	11.1	11.1	34.0
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720234	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 321.8;eosinophil: 359.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 359.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		13000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favorable (9.14e-4)"	"prognostic favorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	26.3	14.2	36.8	30.8	43.9	26.0	49.9	46.4	50.0	49.6	26.5	20.4	16.0	47.1	43.0	36.2	48.4	26.4	15.9	41.9	40.8	31.7	10.3	44.4	32.9	53.2	41.4	29.2	49.3	26.9	15.8	17.2	51.8	41.1	24.7	22.3	66.0	25.9	6.1	49.7	15.8	33.6	51.1	17.4	62.8	17.0	41.8	35.4	20.3	9.9	51.7	31.7	23.7	66.3	33.6	29.7	49.1	62.1	59.1	74.0	39.6	42.4	77.2	39.4	53.1	45.7	46.7	51.3	26.0	76.1	30.4	40.7	46.8	81.6	50.5	124.2	35.5	60.4	62.6	103.0	32.3	93.0	99.8	61.7	41.2	45.7	37.1	95.2	88.7	63.9	13.6	97.0	111.6	50.7	77.3	28.2	52.6	35.3	33.1	62.4	78.0	15.0	59.6	45.6	55.5	81.4	42.9	63.3	51.9	61.9	37.9	14.1	52.9	49.3	51.0	33.6	35.4	76.9	57.2	48.7	60.1	69.3	79.2	321.8	49.9	359.8	15.6	56.2	18.8	44.8	21.2	18.0	51.4	26.4	13.2	14.9	55.5	27.6	60.8	9.8	39.9	36.7	36.8	43.9	46.4	50.0	41.9	40.8	53.2	41.4	51.8	51.1	41.8	66.3	19.7	96.1	20.2	41.4	25.4	32.0	36.3	73.2	33.6	19.9	48.4	41.5	7.4	50.1	92.3	57.0	10.4	20.6	7.0	10.5	17.6	36.8	6.2	124.2	84.6	25.1	23.4	15.3	112.2	44.7	48.7	35.2	62.2	444.3	42.5	25.0	20.3	10.2	55.1	30.3	64.7	17.5	32.6	46.5	27.8	6.7	18.0	53.5	60.5	29.0	37.4	35.0	10.3	100.0	150.3	33.6	9.1	25.6	86.4	29.1	6.9	28.8	110.0	13.3	26.3	45.2	29.1	19.6	14.7	62.9	40.9	8.9	22.2	19.2	14.8	29.4
PARP8	"ARTD16, FLJ21308, pART16"	ENSG00000151883	"Poly(ADP-ribose) polymerase family member 8"	Q8N3A8	5	50665899-50846519	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 124.9;Excitatory neurons: 197.9;Inhibitory neurons: 139.3;Microglial cells: 112.4;Oligodendrocyte precursor cells: 158.3;T-cells: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049183	Approved		Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA049183: AB_2680667"	"unprognostic (1.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.86e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (1.12e-4)"	11.7	13.1	4.6	26.8	8.8	78.2	9.2	0.0	7.9	8.3	0.3	8.8	14.5	6.6	4.2	7.7	9.9	25.7	6.9	14.7	12.6	7.0	8.0	19.8	42.0	3.4	4.5	11.6	12.2	13.8	4.9	12.4	0.1	11.3	9.3	4.6	10.3	7.4	4.8	7.6	15.0	8.4	2.7	43.6	20.2	9.1	7.7	19.2	43.1	2.1	22.5	14.5	5.4	2.0	24.8	0.1	12.2	18.8	3.2	5.7	18.0	4.3	15.7	4.1	12.0	0.9	33.5	14.8	16.9	0.5	43.3	12.4	2.1	13.1	10.0	20.2	15.9	10.6	9.2	1.1	6.3	28.1	0.2	6.8	10.9	8.5	6.0	24.6	0.2	23.1	1.6	9.1	5.9	8.8	31.8	32.5	12.3	0.4	6.0	15.4	24.0	17.1	7.6	12.8	13.0	19.0	13.8	21.6	3.7	17.6	1.0	91.2	0.0	1.0	15.4	1.2	12.6	6.9	0.2	29.5	13.8	7.6	17.7	27.4	13.7	31.9	43.6	4.0	70.6	13.4	34.3	50.5	9.2	16.7	20.9	34.9	28.6	39.5	2.9	4.2	22.5	22.7	4.6	8.8	0.0	7.9	14.7	12.6	3.4	4.5	0.1	2.7	7.7	2.0	6.2	32.1	21.1	29.4	51.7	8.0	5.2	12.7	26.2	13.6	10.4	6.5	5.6	14.3	19.1	22.0	0.0	22.5	124.9	17.2	7.9	14.2	28.7	11.8	8.4	3.9	15.0	7.4	197.9	10.2	6.4	13.4	46.9	10.6	14.5	12.6	6.8	5.0	14.3	6.7	139.3	4.2	8.2	26.1	16.9	15.3	1.2	27.1	8.8	112.4	43.4	0.7	93.7	158.3	7.3	18.7	8.4	3.0	65.0	7.7	8.2	4.3	25.6	2.1	6.6	12.3	13.0	12.8	6.0	14.3	4.0	24.8	157.3	6.5	9.6	13.7
PCDH20	"FLJ22218, PCDH13"	ENSG00000280165	"Protocadherin 20"	Q8N6Y1	13	61409685-61415522	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;smooth muscle: 9.0"	"Cell type enhanced"	"Detected in some"		"Club cells: 6.2;Excitatory neurons: 8.2;Inhibitory neurons: 7.9;Intestinal goblet cells: 5.3;Ionocytes: 6.1;Oligodendrocyte precursor cells: 32.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"RPTEC TERT1: 51.3"									HPA062669			Approved	"Vesicles,Cytokinetic bridge"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles	"Cytokinetic bridge"	"HPA062669: AB_2732687"	"unprognostic (2.40e-1)"		"unprognostic (1.80e-1)"		"unprognostic (2.45e-1)"		"unprognostic (7.83e-2)"	"unprognostic (6.79e-4)"			"unprognostic (2.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.34e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.12e-1)"		0.5	1.1	3.0	0.3	4.4	0.0	0.9	1.0	11.2	2.3	0.0	3.1	0.9	3.1	2.6	0.7	0.5	0.6	3.5	18.0	3.7	0.8	1.3	3.3	0.0	1.5	4.6	0.3	0.1	0.0	0.5	0.4	1.3	1.0	1.7	0.0	0.7	1.0	0.4	1.0	1.0	9.0	2.3	1.2	1.0	0.1	2.8	0.8	0.2	0.7	0.0	0.6	0.5	2.3	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	51.3	0.0	0.7	1.9	0.0	3.6	0.5	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	4.4	1.0	11.2	18.0	3.7	1.5	4.6	1.3	2.3	2.8	2.3	0.0	3.2	0.5	2.3	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	8.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.9	5.3	6.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	32.6	1.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.2
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.7;Late spermatids: 7.6;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.9;ASC TERT1: 6.6;hTERT-RPE1: 7.1;T-47d: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"		Yes	No				"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	0.6	0.7	1.8	0.1	1.2	0.0	0.5	2.1	1.6	0.6	0.0	0.3	0.0	1.2	0.4	0.3	0.4	0.5	0.5	2.9	1.6	0.4	0.1	0.6	0.0	1.9	3.3	1.4	0.8	2.3	1.0	0.2	2.4	0.6	0.1	1.6	0.3	0.9	0.2	0.2	0.1	0.9	2.4	0.1	0.1	0.4	1.8	0.0	0.6	0.3	0.0	0.3	0.3	3.5	0.1	1.9	1.6	0.0	12.9	6.6	0.1	1.2	3.2	0.5	0.7	0.2	0.5	0.5	4.2	0.5	3.1	0.6	0.3	0.2	0.4	0.0	0.8	0.0	0.2	1.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	7.1	0.1	0.0	0.2	0.2	3.0	1.7	0.4	0.3	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	1.0	0.7	0.0	0.8	0.1	1.2	8.6	0.0	1.0	0.2	1.3	1.1	0.0	0.0	2.4	0.3	2.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.2	2.1	1.6	2.9	1.6	1.9	3.3	2.4	2.4	1.8	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PCIF1	"bA465L10.1, C20orf67, CAPAM, PPP1R121"	ENSG00000100982	"Phosphorylated CTD interacting factor 1"	Q9H4Z3	20	45934683-45948023	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: AB_2680801"	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	28.7	28.0	20.7	18.6	23.0	33.9	28.7	30.2	24.2	36.1	17.6	30.7	16.5	39.7	10.8	24.4	35.3	16.3	31.9	20.4	20.2	23.4	19.5	28.2	27.3	22.7	21.6	41.7	29.5	22.8	26.0	17.0	22.1	26.2	11.7	15.9	23.6	21.3	41.7	36.7	27.2	21.3	20.9	34.7	25.4	18.1	21.7	34.4	32.0	27.6	19.6	28.6	29.3	24.9	21.2	29.0	22.0	27.2	15.3	18.2	24.2	8.3	25.1	24.9	24.2	49.3	27.7	22.7	27.4	22.6	28.7	23.4	15.8	29.0	10.8	14.1	11.4	29.1	23.1	33.4	28.2	26.4	28.1	25.5	29.9	15.3	24.5	22.3	21.0	37.1	20.8	30.9	17.9	44.6	52.3	48.3	7.8	25.5	24.9	32.2	20.4	28.0	20.1	21.8	30.2	30.0	31.5	29.5	16.1	11.6	31.0	30.7	18.1	30.7	24.1	27.3	16.8	35.4	22.1	21.0	37.7	23.8	18.2	75.5	47.5	80.2	54.5	47.2	43.0	51.6	47.3	50.2	50.3	56.2	48.6	43.0	74.6	74.3	48.0	40.4	54.4	64.0	20.7	23.0	30.2	24.2	20.4	20.2	22.7	21.6	22.1	20.9	21.7	24.9	19.7	3.2	14.2	4.6	33.7	8.7	26.4	7.9	26.2	9.9	17.0	19.7	21.9	20.0	7.1	11.0	2.1	19.5	32.4	14.6	15.6	21.4	9.6	13.3	10.7	16.1	26.5	25.4	2.5	38.6	22.6	15.4	17.3	13.5	14.5	14.9	9.7	12.4	16.9	13.5	3.6	14.0	4.1	16.0	8.7	8.1	11.5	21.5	17.8	1.0	24.9	12.0	33.0	3.0	3.9	28.3	13.1	12.8	35.5	25.4	14.8	23.2	11.0	13.4	0.0	20.2	19.3	14.4	11.9	23.8	10.7	27.8	30.8	15.1	12.0	38.8
PDCD2	"RP8, ZMYND7"	ENSG00000071994	"Programmed cell death 2"	Q16342	6	170575295-170584692	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026713, HPA075534"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Cytokinetic bridge"	"HPA026713: AB_1855103, HPA075534: AB_2686754"	"unprognostic (3.80e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	26.3	25.6	18.9	30.0	19.1	35.4	43.0	20.2	23.7	27.1	18.4	31.1	32.4	25.9	39.9	32.6	33.7	23.4	22.8	19.3	20.2	33.2	32.7	23.4	43.2	19.2	20.0	29.8	45.4	29.6	16.9	28.4	19.3	25.9	38.4	17.7	31.7	30.3	36.4	25.8	25.9	28.7	19.0	27.5	30.6	19.9	19.5	42.3	34.6	27.0	50.6	32.8	21.6	19.3	50.5	36.2	53.8	126.7	75.8	82.6	59.3	58.6	66.7	67.9	75.3	65.2	43.1	90.6	46.6	64.8	90.8	70.5	116.5	97.1	98.9	74.7	127.2	128.6	46.2	119.3	91.9	161.6	83.3	75.6	93.4	86.2	138.7	71.2	95.8	123.9	260.3	57.7	84.1	109.5	113.0	116.6	77.5	161.6	54.9	79.4	41.5	117.8	103.7	29.3	98.4	102.4	66.7	107.8	71.6	58.1	54.8	162.8	73.0	33.3	71.4	80.1	105.1	76.5	96.4	97.9	62.1	154.9	87.0	4.1	12.4	11.5	14.1	12.0	16.5	14.2	15.9	14.9	17.3	13.8	15.5	14.8	5.3	18.8	15.2	15.9	20.3	12.0	18.9	19.1	20.2	23.7	19.3	20.2	19.2	20.0	19.3	19.0	19.5	19.3	47.2	12.8	15.3	9.4	54.1	49.5	76.4	14.6	40.5	36.9	58.0	59.7	27.4	52.9	14.0	29.5	12.5	63.9	82.2	29.2	78.2	55.3	17.0	36.1	38.5	38.8	47.2	64.1	13.2	74.1	71.6	32.2	32.1	33.5	15.9	59.8	44.6	28.2	49.2	16.8	12.7	44.0	22.4	41.9	33.2	15.0	49.0	40.9	35.6	8.4	62.8	34.7	84.5	8.0	12.4	58.6	36.4	40.6	58.0	103.9	47.8	83.6	16.0	35.3	19.7	43.8	55.5	33.0	85.8	58.7	46.0	46.7	60.7	60.8	68.0	84.1
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 255.9;Gastric mucus-secreting cells: 141.2;Paneth cells: 251.4;Proximal enterocytes: 73.0;Skeletal myocytes: 106.5;Undifferentiated cells: 103.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.2;cerebral cortex: 1.1"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.0;U-87 MG: 4.4"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	1.4	0.6	0.2	0.1	1.2	0.5	0.7	0.0	1.1	3.2	0.0	4.3	0.7	3.4	3.4	0.7	3.0	1.1	4.4	0.2	0.0	4.8	1.3	3.4	0.2	0.0	0.0	1.8	0.7	0.2	2.8	3.7	0.0	2.3	0.6	0.2	0.5	2.7	8.3	0.3	2.4	1.8	0.0	2.1	3.8	2.5	0.0	0.0	1.1	21.3	0.1	1.0	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.2	0.3	0.0	1.2	0.0	0.2	0.0	0.1	0.4	0.9	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.7	0.2	0.2	0.0	0.1	0.0	0.3	0.0	0.6	0.3	0.1	4.4	0.1	0.0	1.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.0	0.2	1.2	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.2	10.6	2.0	0.8	5.5	5.8	8.6	5.2	3.9	0.2	0.4	35.3	4.3	22.4	0.0	6.2	2.1	0.0	255.9	0.0	0.0	32.9	0.1	0.1	4.6	7.2	0.0	8.2	0.0	4.3	6.3	141.2	0.1	4.5	0.0	1.1	0.3	0.5	0.0	2.1	55.2	4.1	1.4	4.5	38.4	0.6	2.1	1.8	0.0	0.4	1.9	1.0	0.5	0.9	0.0	251.4	4.1	1.6	1.8	73.0	0.0	9.4	3.0	46.0	106.5	17.2	1.9	2.2	28.6	3.8	1.1	1.2	0.0	103.3	17.3
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	33.3	41.0	26.3	29.2	28.6	35.5	32.2	26.7	30.5	31.8	27.1	29.6	21.7	35.5	21.2	43.6	29.4	20.2	28.8	26.9	26.2	38.7	48.2	26.2	32.3	27.1	27.2	34.2	57.3	30.1	21.8	21.5	27.6	32.9	19.6	9.2	29.3	21.5	48.8	45.3	28.2	22.5	25.8	34.4	35.7	40.0	27.0	23.8	27.1	20.0	27.3	35.0	31.9	30.0	132.2	146.6	53.0	113.7	59.9	58.4	81.6	84.7	69.6	141.6	110.0	170.6	55.2	177.2	74.4	97.0	110.3	89.4	163.9	153.5	103.1	76.4	159.8	85.9	80.8	149.0	149.3	209.6	86.8	82.7	94.7	148.3	147.3	68.3	93.0	62.4	144.6	69.9	87.7	164.3	102.6	209.8	103.1	128.3	106.7	129.0	91.7	173.3	78.9	88.7	91.4	94.6	84.2	94.6	117.8	42.0	66.8	106.1	74.2	165.9	126.1	85.3	145.1	88.1	81.0	178.6	116.2	94.9	109.0	7.5	24.9	6.4	18.9	29.8	23.2	20.2	17.4	18.1	26.8	20.0	19.4	18.0	0.9	20.0	22.3	23.2	14.3	29.3	26.3	28.6	26.7	30.5	26.9	26.2	27.1	27.2	27.6	25.8	27.0	30.0	23.6	3.2	18.9	4.9	17.4	22.6	23.4	32.7	22.2	6.5	14.1	12.2	3.8	24.3	22.1	25.8	8.4	34.9	7.8	19.6	25.4	48.0	44.4	11.7	13.8	23.2	23.4	24.6	4.3	43.9	40.0	15.4	22.4	10.6	18.3	24.4	27.8	22.8	38.4	3.3	4.3	22.4	22.4	27.8	12.6	14.3	19.9	21.2	21.4	2.8	29.0	13.5	16.5	6.6	5.1	38.7	16.2	20.3	28.3	26.4	31.3	55.1	24.6	8.9	19.7	23.2	20.7	28.7	20.9	25.9	22.9	28.5	13.5	19.9	29.7	15.1
PGAP6	"M83, TMEM6, TMEM8, TMEM8A"	ENSG00000129925	"Post-glycosylphosphatidylinositol attachment to proteins 6"	Q9HCN3	16	370788-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 129.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	23.5	25.5	13.5	18.0	15.1	30.0	20.1	11.8	17.7	17.7	14.5	39.6	31.4	19.2	24.8	31.9	17.7	16.4	37.7	12.8	11.0	59.4	57.6	36.2	17.0	14.6	12.6	12.2	102.8	19.3	28.8	34.8	13.5	30.3	10.3	5.6	40.8	12.5	36.1	11.3	38.5	8.8	11.9	36.0	53.9	63.3	16.0	11.7	28.0	10.1	7.9	23.4	14.3	14.6	12.7	32.8	18.4	33.9	24.7	22.1	36.7	35.5	36.6	17.7	25.3	129.2	57.9	13.4	47.1	34.5	27.3	17.8	8.4	39.2	4.9	38.5	31.1	22.1	23.1	74.8	56.9	16.9	40.4	25.7	11.6	27.4	7.9	18.0	41.4	14.8	36.2	20.1	22.6	78.2	23.9	33.2	29.2	20.1	12.9	51.0	21.0	31.2	28.8	32.0	21.9	25.2	19.8	19.7	106.3	9.6	35.7	33.4	61.1	50.2	53.6	35.2	19.2	40.3	21.6	27.0	25.5	17.8	32.5	7.1	7.6	10.1	10.7	8.6	8.3	2.5	8.1	8.3	3.9	2.6	10.7	8.0	36.0	1.5	6.1	4.2	6.6	5.7	13.5	15.1	11.8	17.7	12.8	11.0	14.6	12.6	13.5	11.9	16.0	14.6	11.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	63.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	7.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	100.2	1.4	0.0	0.0	0.0
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.0;retina: 32.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 104.3;Distal enterocytes: 75.5;Excitatory neurons: 69.5;Proximal enterocytes: 73.7;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	4.2	2.8	6.6	2.8	7.5	6.5	2.7	5.8	7.4	3.5	0.1	11.7	11.1	3.7	2.9	1.4	3.2	2.4	2.8	7.8	4.8	3.4	3.0	3.1	3.5	4.6	3.9	4.2	3.1	4.5	4.0	2.7	4.7	2.7	12.2	32.2	1.7	3.4	1.9	1.8	22.0	4.5	0.6	2.5	2.4	6.8	5.3	1.9	6.6	2.6	3.2	3.3	2.4	5.1	6.0	7.8	8.3	9.3	6.5	7.8	4.8	8.8	8.0	12.5	10.1	7.2	1.9	11.8	3.4	14.6	9.0	12.4	12.1	4.5	16.1	4.2	6.5	3.3	7.3	4.8	5.1	2.9	5.0	5.8	2.5	17.7	5.7	5.2	4.7	4.1	3.0	3.2	8.7	12.7	3.9	2.3	6.5	1.9	2.1	6.3	7.3	3.9	5.9	4.5	7.2	3.8	18.9	5.1	3.1	6.4	6.3	1.6	6.5	12.5	9.0	5.3	7.4	7.1	5.4	11.9	7.7	2.3	2.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.7	0.1	0.5	0.3	0.1	6.6	7.5	5.8	7.4	7.8	4.8	4.6	3.9	4.7	0.6	5.3	5.1	4.0	9.6	2.2	26.1	7.4	9.3	5.1	3.5	7.4	20.6	6.9	5.6	3.3	0.0	3.6	3.7	104.3	4.3	3.8	75.5	0.0	2.7	12.0	2.9	6.1	5.3	6.0	22.9	69.5	2.3	0.4	7.7	1.1	5.1	10.2	11.3	2.9	4.1	1.5	23.5	45.9	6.7	4.1	7.0	12.7	6.3	5.3	2.7	14.2	10.3	3.2	6.5	1.0	30.7	32.7	2.5	31.4	5.3	4.0	8.2	73.7	5.1	3.1	68.6	6.6	7.8	7.9	31.6	20.4	1.9	9.1	1.4	4.9	1.7	9.2	2.2
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652698-138834928	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 115.2;HMC-1: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	11.6	7.4	4.3	12.4	5.0	23.7	11.9	8.6	8.6	12.4	14.4	17.8	17.8	8.2	7.0	18.0	12.1	10.3	15.8	5.4	4.4	26.4	11.0	11.2	12.3	5.1	3.3	9.2	22.3	19.3	2.7	18.6	6.1	15.0	18.1	23.0	19.8	12.0	19.5	23.7	17.9	9.1	3.5	10.8	13.0	8.0	4.0	17.0	43.2	13.2	13.2	9.9	5.4	7.9	64.1	21.9	11.7	9.4	10.6	13.0	79.2	14.2	14.5	15.1	16.7	26.0	25.2	25.0	38.0	13.7	29.1	27.5	15.1	24.1	27.3	31.8	12.5	115.2	14.8	17.3	11.8	30.1	185.1	12.4	17.6	10.2	21.9	26.4	21.5	12.3	43.0	19.0	18.1	28.6	17.8	20.7	16.6	49.2	19.5	11.5	12.2	19.6	24.5	35.5	9.8	7.4	37.6	18.0	56.2	34.7	44.8	73.0	20.3	8.4	11.7	21.2	21.1	30.3	22.1	23.7	22.8	27.7	14.0	4.4	5.1	6.9	2.4	2.8	1.6	2.8	2.8	1.8	5.9	2.6	3.5	2.4	6.4	0.8	2.8	1.0	1.5	2.0	4.3	5.0	8.6	8.6	5.4	4.4	5.1	3.3	6.1	3.5	4.0	7.9	19.7	9.6	21.3	40.1	12.1	19.1	18.7	12.5	14.2	16.2	13.1	7.7	37.3	12.8	18.3	18.4	25.0	35.5	6.9	30.3	5.9	11.1	1.1	18.3	4.0	13.9	16.3	8.0	96.5	19.4	61.1	7.3	21.4	18.8	14.5	6.7	9.7	19.1	14.4	21.9	92.4	17.1	4.1	33.3	23.1	1.7	3.7	28.1	7.2	37.5	29.5	8.9	11.3	48.2	88.2	20.0	25.9	6.8	10.2	25.8	21.9	23.4	17.4	19.5	6.6	8.6	5.9	16.0	19.9	22.1	23.3	47.9	11.6	4.2	15.1	17.5
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651731-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 60.9;lymphoid tissue: 50.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.0;granulocytes: 25.3;Kupffer cells: 35.2;Microglial cells: 29.0;NK-cells: 29.9;T-cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 153.3;NB-4: 65.9;REH: 68.9;THP-1: 65.4;U-937: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	7.2	3.1	6.8	33.4	6.3	60.9	3.9	6.1	7.5	6.2	6.4	5.4	5.2	4.9	1.7	4.9	6.1	7.0	3.3	7.0	5.3	6.4	3.5	12.0	46.9	7.3	6.6	7.0	3.0	2.9	2.8	4.2	7.8	4.6	3.4	0.6	5.1	2.7	1.2	3.0	17.2	4.7	6.6	50.4	5.7	4.0	9.3	24.3	5.5	3.5	32.0	7.4	5.1	8.5	8.1	5.2	0.4	1.4	1.3	1.1	0.7	12.1	24.5	26.0	21.1	0.3	3.3	21.5	4.9	9.8	12.4	2.4	2.0	11.0	16.2	153.3	0.4	2.4	1.3	9.0	5.1	56.0	18.7	4.3	4.5	29.2	9.8	11.4	3.8	14.9	8.0	0.1	15.0	0.6	5.4	65.9	2.2	0.3	1.4	68.9	13.0	0.7	10.9	0.0	1.7	1.5	2.7	4.9	11.9	6.8	0.8	65.4	9.8	7.7	7.9	0.2	11.5	4.9	4.9	30.1	16.7	78.6	4.4	18.0	23.5	40.2	21.6	23.0	22.6	12.8	16.3	19.9	22.5	13.6	20.9	23.1	63.2	25.9	29.2	25.7	13.3	38.3	6.8	6.3	6.1	7.5	7.0	5.3	7.3	6.6	7.8	6.6	9.3	8.5	1.7	9.6	13.4	2.0	22.2	1.5	2.2	1.8	4.0	0.7	2.0	1.7	3.1	0.0	1.1	0.0	2.1	0.3	44.0	0.1	1.9	3.9	3.0	2.0	1.7	2.7	0.0	10.3	6.7	2.0	0.5	2.9	0.0	1.0	25.3	4.2	3.6	0.0	14.7	0.0	13.4	0.1	0.0	35.2	6.0	2.8	1.2	23.1	3.6	29.0	19.3	2.5	29.9	1.0	1.1	11.3	0.0	1.5	8.2	4.1	0.2	3.8	3.3	1.3	6.6	2.0	4.7	1.5	3.4	2.9	1.1	0.3	37.1	1.5	0.2	2.1
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.1	14.8	23.5	10.4	24.0	8.7	16.9	25.2	36.3	15.2	24.0	16.2	11.5	14.7	21.5	14.4	12.9	7.3	19.0	23.6	24.8	19.7	28.6	10.6	10.5	24.4	24.2	16.1	13.1	20.4	13.9	11.8	24.2	15.6	12.7	18.3	16.1	10.1	19.4	10.6	12.7	10.8	24.0	13.9	15.8	5.7	23.8	17.5	16.5	20.4	11.1	13.2	14.9	25.4	36.8	41.2	42.5	29.9	28.1	23.4	23.1	24.6	26.8	28.7	29.1	20.8	26.4	11.2	68.6	25.2	39.2	25.8	38.6	43.0	35.6	26.9	83.3	18.8	51.1	55.3	14.9	29.9	14.8	15.7	22.5	32.0	11.1	32.4	29.1	32.5	32.1	46.6	20.4	43.4	25.3	49.9	30.3	42.4	36.7	25.8	34.7	32.3	37.1	24.7	27.0	48.1	28.5	13.3	27.0	32.0	20.3	25.9	30.7	13.4	19.9	36.8	17.7	15.4	18.5	17.9	38.5	28.3	14.7	42.7	37.1	40.6	41.8	41.1	41.7	49.2	43.7	40.3	38.0	45.6	44.1	44.8	15.7	41.1	39.4	44.6	58.1	39.6	23.5	24.0	25.2	36.3	23.6	24.8	24.4	24.2	24.2	24.0	23.8	25.4	68.3	67.3	48.2	14.0	44.4	43.2	63.3	167.9	36.5	26.7	67.2	94.5	84.9	78.6	89.4	119.5	8.4	162.8	44.5	99.2	181.9	125.0	13.5	78.6	66.7	71.5	92.7	71.7	17.8	117.9	89.0	59.9	45.3	56.6	57.6	46.3	92.4	288.5	110.3	28.6	17.8	93.7	128.1	72.9	44.9	9.3	74.6	50.7	60.5	7.5	69.6	90.7	80.3	16.6	27.3	136.3	114.9	81.3	38.7	51.5	162.0	296.1	95.9	42.9	85.5	65.9	94.6	19.6	42.6	51.3	46.9	120.7	44.8	53.9	88.5	54.8
PKN1	"DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1"	ENSG00000123143	"Protein kinase N1"	Q16512	19	14433053-14471867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 102.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003982, CAB010278"	Approved		Approved	"Plasma membrane,Cytokinetic bridge"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Cytokinetic bridge"	"CAB010278: AB_2163965, HPA003982: AB_1855440"	"unprognostic (3.83e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.24e-2)"	59.2	45.1	47.1	40.4	50.3	66.8	49.0	44.6	52.4	46.6	44.2	72.4	14.5	61.0	13.6	16.2	48.7	23.9	89.0	40.9	46.3	43.1	25.0	71.1	49.4	53.6	48.4	38.7	52.5	32.8	44.9	33.3	49.8	43.8	9.3	11.5	41.3	30.6	81.7	20.1	45.2	33.0	49.8	90.4	51.4	50.2	49.2	35.6	39.6	53.8	25.8	60.3	32.8	48.5	152.8	88.9	32.3	67.8	51.3	59.8	53.0	53.5	63.5	55.2	52.5	34.9	84.2	144.4	135.0	92.2	68.9	34.4	52.1	23.8	21.2	117.6	67.7	172.8	55.4	75.2	169.1	68.2	103.9	43.3	17.0	33.5	52.2	62.5	129.8	74.9	78.0	96.7	41.4	62.5	104.1	63.2	59.2	54.7	100.0	138.5	43.9	104.7	27.3	24.2	117.3	166.0	33.2	41.7	88.9	15.5	37.8	117.7	196.6	108.8	46.1	133.2	82.8	126.5	123.6	78.9	71.5	135.7	87.4	27.6	27.9	40.6	30.4	38.5	23.3	15.9	20.5	21.1	26.8	16.9	18.6	21.0	32.6	22.1	52.3	17.0	25.7	29.0	47.1	50.3	44.6	52.4	40.9	46.3	53.6	48.4	49.8	49.8	49.2	48.5	78.1	3.2	2.2	17.3	35.3	3.7	6.4	1.9	1.8	37.2	17.6	14.7	4.0	27.1	3.1	35.0	16.7	2.8	77.9	4.9	1.9	28.2	4.9	27.0	25.4	49.4	40.2	17.7	3.6	30.1	14.5	20.8	30.1	20.7	2.5	80.9	53.2	11.3	59.8	48.8	8.6	10.9	8.2	69.0	17.0	8.4	19.9	56.2	17.8	17.8	48.2	61.2	102.0	7.5	11.9	64.2	10.6	23.0	27.1	12.7	1.1	15.2	12.4	29.2	26.3	21.7	29.2	9.3	42.2	1.3	2.7	3.7	55.5	34.3	4.8	4.9
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	3.6	3.3	2.6	2.0	5.8	0.0	1.2	1.4	12.7	3.2	8.1	2.8	0.9	3.3	2.7	1.4	6.1	1.8	7.3	4.8	0.6	3.0	0.5	10.0	1.4	3.0	0.3	14.9	3.9	0.9	5.6	8.4	1.3	6.3	1.4	2.8	2.5	5.1	15.0	2.4	1.7	2.6	2.6	2.3	2.3	4.8	0.8	3.1	12.1	36.3	1.1	3.1	2.7	3.1	0.0	0.0	39.1	9.6	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	3.9	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	6.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.8	1.4	12.7	4.8	0.6	3.0	0.3	1.3	2.6	0.8	3.1	0.6	0.0	0.0	31.3	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	1.4	46.8	0.0	1.1	0.5	0.0	0.0	132.9	0.2	0.0	3.1	0.0	0.0	0.0	12.2	1.8	0.0	0.3	8.4	137.4	0.0	0.0	0.0	0.3	9.6	5.0	0.0	8.8	22.5	0.0	2.9	0.0	85.5	3.8	0.1	0.0	17.7	0.0	1.9	0.0	0.1	0.0	0.3	6.6	8.8	2.9	1.2	0.4	0.0	0.4	0.1	0.0	6.9	0.0	0.0
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 53.4;Smooth muscle cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 63.4;BJ hTERT+ SV40 Large T+ RasG12V: 49.5;SK-MEL-30: 77.0"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"spinal cord: 45.0"	"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: AB_2678249, HPA048473: AB_2680409"	"prognostic favorable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	34.0	24.6	8.8	12.1	8.8	0.7	31.7	8.0	9.5	28.7	10.9	43.0	5.6	34.6	5.0	14.3	30.5	11.1	41.4	8.7	10.6	32.4	32.8	25.7	5.8	16.9	14.7	47.5	13.2	9.5	29.9	5.6	10.4	28.3	3.9	2.5	15.1	8.4	19.3	17.2	16.0	10.7	10.8	16.2	21.1	11.0	12.4	5.5	31.0	13.1	3.3	34.4	21.7	10.3	9.0	0.5	9.9	63.4	14.2	41.7	8.0	7.0	24.7	26.8	49.5	5.9	2.5	0.4	11.8	9.8	10.4	2.7	3.5	3.6	4.2	0.0	3.4	2.3	1.7	6.6	11.0	0.0	14.2	21.5	2.2	15.6	1.0	11.1	8.0	11.2	9.5	5.3	7.4	5.4	3.2	0.5	1.5	6.0	0.8	0.3	31.5	0.6	8.3	0.1	0.0	11.0	3.0	2.6	77.0	2.5	3.9	3.0	1.3	8.5	6.8	11.2	1.8	28.3	25.4	5.3	10.2	0.7	23.0	0.0	0.3	0.9	1.8	0.3	1.3	1.7	1.7	1.1	0.1	3.9	2.8	2.6	0.1	0.8	0.3	1.2	0.6	0.9	8.8	8.8	8.0	9.5	8.7	10.6	16.9	14.7	10.4	10.8	12.4	10.3	6.4	0.0	18.7	2.3	1.4	9.6	31.3	17.6	12.0	0.7	11.4	18.3	37.1	17.2	27.2	7.3	0.0	3.3	2.9	3.2	1.9	23.3	0.8	11.6	34.1	7.0	1.2	3.2	0.4	5.1	6.8	41.7	7.7	11.6	0.0	18.8	6.4	13.3	2.9	0.0	0.5	2.5	4.1	0.8	9.2	2.0	41.3	1.9	12.4	1.9	1.3	9.9	2.1	0.5	0.2	6.9	0.5	53.4	0.7	29.8	0.7	14.6	20.5	1.0	6.6	33.0	48.4	4.0	3.7	5.7	9.8	2.9	2.4	16.0	3.3	21.4
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 24.0;NK-cells: 9.4;T-cells: 16.2"	"Cell line enhanced"	"Detected in many"		"A-431: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favorable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	25.2	3.5	44.0	10.7	92.5	16.3	23.4	47.2	74.1	33.9	53.0	39.0	13.0	67.5	5.0	45.8	38.1	22.6	17.2	44.5	46.7	36.0	36.3	14.3	5.6	65.8	66.3	33.8	33.0	17.0	6.8	29.3	60.9	24.2	15.5	2.9	29.2	37.5	9.7	44.9	13.2	26.4	37.9	26.6	22.3	5.7	74.1	4.6	23.7	7.4	4.9	32.2	39.1	179.2	78.4	36.5	29.8	45.3	3.1	0.0	49.0	8.7	10.4	13.8	11.0	38.9	34.3	0.0	15.3	8.6	4.8	74.6	20.3	69.7	4.7	0.2	16.7	35.1	48.3	9.2	4.0	1.3	16.1	3.9	39.6	2.9	24.4	22.9	9.1	0.3	0.0	0.4	4.6	37.5	0.1	32.0	10.0	21.2	37.0	0.4	14.7	5.5	37.0	58.0	9.9	18.0	17.7	26.7	25.1	27.5	29.0	8.0	16.6	6.0	59.8	0.3	12.3	0.1	0.2	0.1	0.6	3.7	10.7	9.0	3.0	18.2	16.2	1.5	11.1	0.0	5.0	7.3	1.0	0.0	0.5	3.6	24.0	9.4	1.0	0.0	1.7	5.3	44.0	92.5	47.2	74.1	44.5	46.7	65.8	66.3	60.9	37.9	74.1	179.2	3.1	3.2	6.2	15.0	0.7	19.4	19.4	15.1	21.6	5.5	16.0	9.8	7.8	12.8	6.0	47.8	0.0	7.9	14.5	24.7	11.7	26.7	0.9	18.6	18.5	4.0	34.7	0.4	1.0	20.6	9.5	7.4	14.3	23.6	1.3	1.9	3.6	10.1	5.5	0.0	3.2	26.9	18.3	6.5	8.0	1.5	7.5	2.7	5.4	6.5	4.6	9.1	45.3	10.6	90.9	35.3	16.7	25.6	2.8	16.1	2.3	9.5	4.0	0.8	26.3	5.1	25.3	0.2	1.6	25.6	21.5	2.6	9.0	10.5	13.2	32.2
PPAT	"GPAT, PRAT"	ENSG00000128059	"Phosphoribosyl pyrophosphate amidotransferase"	Q06203	4	56393362-56435615	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036091, HPA036092"	Approved		Approved	"Midbody ring"		Yes	No		11000	"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Midbody ring"		"HPA036091: AB_2674936, HPA036092: AB_10603132"	"unprognostic (5.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (1.38e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (1.14e-8)"	"unprognostic (6.74e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.09e-1)"	2.8	6.1	3.8	5.4	4.0	5.6	7.1	3.7	4.7	4.3	3.6	3.9	4.0	4.6	3.4	4.5	4.4	3.0	2.3	4.1	4.0	6.0	6.1	2.2	8.4	3.4	4.0	7.4	5.9	3.9	2.5	6.7	4.3	3.9	4.8	4.4	5.6	3.1	2.9	4.3	3.2	3.6	3.7	4.3	3.5	8.6	4.1	8.3	5.9	2.9	8.0	6.7	2.6	4.2	23.1	19.0	38.0	18.7	12.2	15.7	31.0	25.2	11.1	20.4	21.6	38.1	27.5	80.6	33.4	11.9	19.0	16.8	74.0	25.4	40.7	21.1	32.8	32.6	22.6	42.2	18.4	65.0	19.5	13.6	19.4	29.0	32.4	12.6	21.8	32.5	83.5	43.3	23.2	20.9	80.6	49.1	50.6	52.0	22.4	67.2	24.9	56.9	34.2	16.2	64.0	31.2	20.1	36.3	23.0	35.4	24.5	13.8	15.3	21.2	36.6	21.4	45.0	32.2	34.5	82.9	23.6	40.7	20.1	4.7	1.8	0.9	3.8	2.7	5.9	7.4	5.1	5.2	2.5	6.1	7.7	7.1	0.5	10.2	3.9	3.2	4.3	3.5	3.8	4.0	3.7	4.7	4.1	4.0	3.4	4.0	4.3	3.7	4.1	4.2	4.8	0.0	5.5	16.6	10.7	31.0	16.0	5.6	28.5	8.4	10.1	9.7	3.8	4.3	8.0	3.7	2.1	29.7	10.3	1.5	9.8	3.7	2.6	5.5	14.1	7.8	4.2	14.9	22.9	2.7	25.2	9.4	4.1	6.9	7.0	66.2	5.3	7.1	7.9	38.7	15.8	4.3	4.1	1.6	6.0	2.6	7.8	5.2	8.8	5.6	3.1	6.4	2.1	5.5	9.1	3.3	2.7	5.7	15.3	15.0	0.8	12.7	6.2	4.7	0.0	9.3	10.8	16.4	27.5	18.3	31.8	7.7	10.7	21.9	9.0	8.7
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.8;testis: 14.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 64.0;Late spermatids: 139.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;HeLa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.2	1.3	0.0	2.0	1.0	2.3	1.8	2.6	0.1	0.8	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.3	1.6	1.4	0.2	0.1	0.3	0.1	3.5	2.1	0.2	0.1	0.0	0.5	0.6	2.4	0.4	0.0	1.4	0.1	0.3	0.1	0.4	0.1	0.0	1.8	0.2	0.1	14.6	1.5	0.1	0.2	0.0	0.1	0.2	0.1	5.8	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.0	1.8	2.6	1.6	1.4	3.5	2.1	2.4	1.8	1.5	5.8	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.0	0.0	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	4.7	0.0	0.0	0.0	0.3	139.0	0.6	0.0	3.6	1.0	0.1	0.6	0.0	0.5	2.2	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	1.2	1.2	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1
PPP1R3E	FLJ00089	ENSG00000235194	"Protein phosphatase 1 regulatory subunit 3E"	Q9H7J1	14	23295652-23302859	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 47.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 111.9;Late spermatids: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 41.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061600	Approved		Approved	"Microtubules,Mitotic spindle,Mitochondria"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Microtubules, Mitochondria"	"Mitotic spindle"	"HPA061600: AB_2684566"	"unprognostic (3.45e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.89e-5)"	"unprognostic (4.05e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.12e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.67e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (8.12e-2)"	"unprognostic (5.46e-2)"	5.8	8.0	15.2	5.7	17.9	3.9	6.4	17.9	23.8	10.2	9.7	7.4	6.3	6.4	10.1	6.0	9.5	3.3	6.2	15.0	15.3	11.6	11.2	5.7	9.5	18.5	16.5	12.5	10.6	5.7	19.3	2.7	19.4	12.1	5.9	47.0	8.5	6.2	14.9	10.9	13.3	3.4	13.8	15.1	9.0	14.7	17.7	8.2	14.9	5.4	8.2	7.9	8.5	23.3	1.1	3.0	3.6	2.5	6.9	2.9	1.7	1.2	2.2	2.0	1.7	1.7	5.8	11.2	0.8	1.6	2.2	7.6	2.1	1.2	2.5	4.0	2.1	2.0	6.9	4.0	1.8	2.3	4.4	2.5	4.5	1.2	6.1	3.3	0.9	6.0	1.9	9.8	1.7	2.6	2.1	3.6	0.9	3.6	2.8	3.4	2.5	7.2	1.1	2.5	4.5	1.2	1.8	1.6	1.2	1.8	1.9	0.8	1.7	2.4	1.3	4.1	0.9	41.1	4.6	5.1	1.9	4.0	1.5	0.2	0.4	0.2	0.5	1.4	0.6	1.0	0.1	0.2	0.3	0.6	0.5	0.3	0.4	0.2	1.8	0.3	0.4	0.3	15.2	17.9	17.9	23.8	15.0	15.3	18.5	16.5	19.4	13.8	17.7	23.3	5.8	3.2	4.8	30.0	25.4	5.6	9.0	5.3	11.4	59.4	7.8	11.6	8.8	7.2	5.0	20.2	37.5	8.2	12.8	8.0	5.9	2.1	111.9	3.7	6.6	7.2	8.4	7.2	25.0	3.3	2.0	6.1	20.4	4.3	3.8	9.4	7.5	7.2	7.4	32.0	33.0	7.7	4.1	9.5	9.6	62.9	27.4	9.2	10.6	15.9	8.1	20.4	26.8	16.1	56.1	2.4	11.6	25.9	11.9	6.7	19.5	9.5	4.8	38.1	13.1	3.5	5.4	36.5	13.9	8.4	9.1	5.2	15.7	7.2	9.6	8.6
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966040-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.9;testis: 55.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 34.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 34.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	7.4	6.2	6.4	10.0	6.1	89.9	6.4	10.3	8.4	8.1	5.0	16.3	10.6	5.7	2.3	37.6	6.0	3.0	6.9	5.6	4.9	5.6	4.8	9.0	16.9	4.8	5.2	8.1	8.9	2.6	3.6	15.3	5.2	4.9	16.5	4.9	9.5	1.5	4.1	20.1	13.0	9.4	4.9	12.5	11.7	55.0	4.2	43.0	4.3	2.3	24.9	4.8	13.7	5.6	167.9	199.9	164.8	113.6	16.8	28.7	87.5	237.8	139.3	257.2	195.3	134.6	158.5	65.5	91.4	151.9	156.9	220.9	188.8	101.2	240.6	118.7	206.4	135.6	263.5	123.5	4.1	71.4	109.0	7.7	12.8	145.8	146.9	56.6	146.4	100.5	114.0	132.4	241.1	144.4	66.9	98.5	66.6	216.4	84.9	69.7	205.1	86.3	115.3	123.6	151.2	118.9	225.4	121.9	82.7	112.3	149.1	127.1	91.2	168.2	146.0	140.5	345.1	43.5	127.7	80.0	74.5	162.0	265.3	34.4	0.6	2.9	0.6	0.1	0.4	1.1	1.3	1.3	2.4	0.5	1.2	0.4	0.4	3.0	0.3	2.6	8.0	1.0	6.4	6.1	10.3	8.4	5.6	4.9	4.8	5.2	5.2	4.9	4.2	5.6	2.5	0.0	3.1	1.3	6.8	16.6	6.6	8.0	2.2	6.4	3.4	4.3	3.2	0.0	7.6	3.7	0.0	45.5	2.8	16.5	0.0	3.2	41.5	4.5	4.0	4.7	5.4	142.9	5.0	2.9	68.3	7.2	16.3	6.8	8.9	13.2	9.3	2.1	21.5	3.3	5.2	17.0	10.2	8.7	15.0	15.4	3.7	5.2	3.6	1.9	5.5	3.8	4.1	2.0	1.7	2.3	3.2	1.9	17.5	5.9	2.0	0.1	3.2	4.6	6.6	7.4	10.9	136.4	74.2	38.0	14.2	14.6	6.8	0.4	24.1	6.7
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780782-41787452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 15.0;Basal squamous epithelial cells: 30.7;Erythroid cells: 17.7;Gastric mucus-secreting cells: 17.3;Plasma cells: 36.8;Squamous epithelial cells: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.0;HeLa: 4.6;hTERT-RPE1: 9.7"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		Yes	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	1.8	1.2	1.3	0.3	1.2	0.1	1.9	1.3	1.2	2.2	0.0	1.6	1.1	2.4	0.0	3.8	2.3	1.0	1.9	0.7	1.0	1.3	2.0	2.1	0.1	1.1	0.7	1.3	1.2	0.4	1.0	0.6	1.0	2.3	0.5	0.6	1.7	0.4	1.6	0.8	1.2	1.5	0.3	4.5	2.6	0.8	1.0	0.0	2.5	1.5	0.3	2.6	2.9	1.3	0.2	0.6	1.3	1.2	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.7	0.9	0.4	1.5	0.0	0.1	2.1	0.0	0.1	0.0	0.3	0.3	0.2	4.6	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.5	1.2	0.2	0.0	0.6	0.0	0.7	0.2	1.8	0.2	1.3	0.3	0.0	0.2	1.4	0.1	0.4	0.0	2.4	0.2	1.2	0.6	0.7	0.6	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.3	1.2	0.7	1.0	1.1	0.7	1.0	0.3	1.0	1.3	0.0	0.0	0.0	1.6	15.0	1.5	1.4	2.4	30.7	2.3	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.7	2.6	0.0	0.0	0.3	0.0	0.0	2.8	3.5	17.7	0.2	0.0	0.0	4.8	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	1.5	0.6	1.2	8.4	0.0	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.5	2.6	36.8	1.7	2.2	0.0	0.7	4.1	0.0	1.9	3.7	1.9	1.4	49.4	2.0	0.0	10.9	0.0	3.0	1.4
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 310.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 116.8;Theca cells: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		170000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	62.7	126.5	46.6	27.6	47.6	18.9	53.9	39.9	64.2	53.2	29.5	59.0	20.9	56.9	28.5	41.8	53.7	14.2	204.8	49.2	53.3	35.4	78.4	46.1	15.9	56.8	54.5	94.1	34.0	21.6	71.2	17.3	55.3	41.2	13.0	25.2	42.3	20.8	310.9	42.3	36.3	21.8	40.7	71.6	40.2	57.2	50.3	18.2	39.6	122.1	13.4	50.6	44.2	46.6	37.5	16.3	40.3	74.4	36.2	30.8	9.9	30.5	23.6	32.7	27.5	21.6	15.0	13.8	26.2	49.2	22.9	25.4	26.7	26.6	32.3	23.1	17.7	27.7	20.6	24.4	36.8	21.9	33.5	33.8	18.1	30.0	11.1	26.6	29.7	19.0	29.1	47.3	36.7	48.1	46.3	31.9	21.5	38.7	45.0	38.0	47.8	36.7	41.7	13.5	36.5	24.2	34.2	31.3	23.8	18.1	37.2	26.5	37.7	71.7	20.3	100.7	39.6	31.9	24.9	23.6	49.6	28.0	32.7	0.1	1.5	0.2	0.8	2.7	0.3	0.8	0.3	0.5	1.1	0.5	0.5	0.7	3.2	0.4	2.5	0.6	0.3	0.6	46.6	47.6	39.9	64.2	49.2	53.3	56.8	54.5	55.3	40.7	50.3	46.6	39.5	6.4	3.4	9.4	7.0	8.8	6.8	6.4	2.2	42.2	19.2	19.0	116.8	22.8	4.7	14.7	27.1	6.9	9.0	24.6	7.9	12.4	32.4	11.7	22.9	26.7	17.5	2.5	16.9	19.1	5.7	22.6	8.6	12.9	0.0	15.9	26.4	39.7	34.5	3.3	21.6	11.8	2.0	49.4	50.8	15.7	49.0	37.1	14.2	9.4	37.8	26.1	9.2	10.1	10.7	15.6	11.6	51.9	3.3	6.4	20.7	11.8	7.0	23.9	19.7	23.3	23.5	26.4	6.9	10.1	11.2	8.1	10.0	100.6	14.4	6.6
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 334.4;Inhibitory neurons: 348.8;Oligodendrocyte precursor cells: 302.6;Oligodendrocytes: 499.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	NA		130000	"Cluster 48: NK-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	16.5	47.7	79.4	26.1	101.6	16.0	17.7	70.0	113.3	19.8	0.0	55.9	10.8	19.2	38.8	17.8	10.0	26.2	23.8	100.7	107.5	23.8	20.8	15.8	41.8	53.5	44.4	17.8	27.8	23.5	24.7	11.5	65.4	30.6	51.7	71.6	83.7	27.3	4.9	4.1	12.7	28.8	59.9	36.0	34.1	8.1	91.0	63.5	25.2	13.5	36.8	27.6	7.7	110.0	8.6	16.9	26.4	31.8	29.9	26.1	12.3	41.7	31.4	20.8	19.4	0.4	7.5	45.1	28.0	32.8	38.0	5.8	12.6	13.6	22.0	44.1	6.8	99.3	21.3	3.2	29.4	39.8	2.2	15.6	6.0	20.2	11.2	30.2	97.2	16.7	3.2	25.2	34.3	1.6	51.8	21.0	26.1	0.1	11.8	39.6	41.2	27.3	50.5	30.2	8.6	33.4	23.0	8.8	25.6	19.7	8.1	8.2	86.8	28.7	22.4	29.4	31.9	18.6	24.2	45.3	13.7	41.5	36.5	56.3	7.5	16.4	59.3	10.2	47.7	35.2	43.4	52.9	19.4	28.4	65.0	69.5	3.8	73.1	16.2	11.1	44.2	66.8	79.4	101.6	70.0	113.3	100.7	107.5	53.5	44.4	65.4	59.9	91.0	110.0	9.5	0.0	1.5	118.8	56.6	5.1	7.2	3.5	11.4	44.9	11.5	9.1	44.4	21.5	5.2	14.7	35.5	1.9	103.0	115.5	33.2	6.2	2.9	11.4	27.0	13.4	21.7	52.3	334.4	11.9	1.2	17.0	16.3	14.0	58.9	15.2	28.5	17.0	27.1	47.1	348.8	58.1	4.1	62.3	24.4	3.6	14.9	51.6	16.0	95.5	14.6	35.6	96.8	302.6	499.0	20.6	42.2	21.8	53.9	10.0	4.5	25.6	6.3	34.4	13.1	14.1	20.3	13.9	8.0	8.1	2.8	0.7	87.6	11.4	51.1	9.1
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012504-69014113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	152	"testis: 24.6"	"Group enriched"	"Detected in some"	27	"Early spermatids: 71.0;Late spermatids: 88.4;Spermatocytes: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222424-170305977	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	6.7	5.0	2.0	6.9	2.4	2.6	10.4	2.0	3.2	12.7	0.3	12.4	11.6	11.0	8.2	15.1	15.9	11.4	6.9	3.4	1.1	13.5	7.3	16.6	4.6	0.4	0.2	13.6	7.0	13.0	3.1	10.9	0.5	17.3	13.1	6.2	17.5	12.7	6.2	6.9	10.8	11.0	0.2	5.2	34.5	12.5	0.9	10.9	24.5	9.8	10.4	16.1	6.2	1.1	81.6	20.2	20.0	21.6	17.3	23.9	32.2	20.4	29.9	26.4	28.3	29.7	38.6	24.7	65.3	28.8	36.4	37.3	37.9	40.0	44.8	18.2	23.5	22.9	24.3	16.6	27.9	20.9	10.0	21.8	27.5	22.6	35.1	42.8	20.9	13.3	25.8	19.8	27.4	28.0	30.5	8.5	42.3	86.4	22.1	21.8	30.7	41.2	42.3	24.4	31.5	25.8	44.1	57.7	20.0	29.5	63.0	14.5	22.4	27.5	21.1	26.0	34.3	33.9	34.9	35.2	19.8	16.4	11.0	0.0	0.6	0.4	1.1	0.6	1.7	0.9	1.5	2.0	0.8	1.2	1.6	0.9	0.3	2.6	0.5	0.8	1.1	0.7	2.0	2.4	2.0	3.2	3.4	1.1	0.4	0.2	0.5	0.2	0.9	1.1	17.6	73.7	82.1	23.2	5.8	57.1	49.5	39.8	30.7	16.4	29.0	19.7	16.2	24.3	45.3	49.7	14.6	30.2	15.0	29.0	25.4	16.5	8.4	42.0	29.7	20.5	29.3	10.5	77.2	22.0	26.6	32.2	59.7	72.3	8.8	20.4	17.5	17.7	10.0	15.2	55.2	28.3	50.8	18.6	26.8	6.8	23.3	11.6	17.8	22.5	12.7	8.8	6.2	33.2	33.5	55.2	18.6	28.6	29.4	99.4	18.7	20.4	31.9	9.4	19.7	23.7	18.7	15.8	20.6	38.5	63.6	20.7	14.8	14.3	28.5	80.1
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464300-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 30.4"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 171.6;Inhibitory neurons: 188.9"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.3;BJ hTERT+: 83.9;fHDF/TERT166: 102.1;HSkMC: 62.5;hTERT-RPE1: 103.0;LHCN-M2: 97.9;U-138 MG: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Midbody, Cytosol"	"HPA049254: AB_2680693"	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.0	2.8	2.0	5.2	2.1	0.2	7.9	6.1	3.5	14.9	0.0	5.1	1.7	11.8	1.5	1.8	7.0	5.7	12.7	2.2	5.1	3.0	0.9	9.8	1.1	3.4	1.8	5.6	2.0	1.1	1.7	9.7	3.2	9.3	4.5	7.0	2.6	2.4	26.4	4.0	5.0	8.2	0.7	2.5	4.0	2.4	2.3	0.7	4.4	30.4	0.9	9.5	10.0	1.4	3.7	0.0	8.0	0.0	22.2	77.3	0.0	37.0	83.9	51.5	39.1	0.0	0.2	0.0	0.0	102.1	9.3	0.0	8.1	0.9	53.8	0.0	1.9	0.0	1.2	0.0	21.5	0.2	0.1	62.5	8.9	15.4	48.0	103.0	1.7	0.0	0.1	0.1	97.9	0.0	0.0	0.0	0.9	0.0	1.4	0.0	6.2	0.0	4.3	0.0	0.3	16.1	0.1	0.0	1.1	6.1	0.1	0.1	0.5	117.9	13.3	3.8	19.4	0.3	0.0	0.0	6.7	0.2	4.1	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.3	2.0	2.1	6.1	3.5	2.2	5.1	3.4	1.8	3.2	0.7	2.3	1.4	1.4	0.0	0.0	14.0	0.4	1.3	6.2	0.0	0.0	7.5	1.5	1.9	3.2	0.0	0.0	0.0	14.6	0.1	0.1	0.0	0.0	0.1	16.8	0.9	18.9	0.8	0.0	0.0	171.6	0.0	0.0	13.5	0.0	0.8	0.0	0.2	0.4	0.0	0.5	15.2	188.9	0.0	0.0	1.8	2.7	11.6	2.8	1.0	1.8	9.4	0.1	2.6	0.0	7.5	3.9	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.7	0.0	1.4	9.6	0.9	1.4	0.5	0.6	0.5	0.4	3.1	0.0	0.7
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 21.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 26.7;Late spermatids: 60.1;Spermatocytes: 37.9;Spermatogonia: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: AB_2686259"	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.4	1.1	1.9	0.7	2.5	2.3	0.5	2.1	2.4	0.7	1.3	0.4	0.4	0.6	0.4	1.1	0.5	0.5	0.2	1.9	1.7	0.7	0.6	0.3	0.5	1.8	1.5	0.5	0.4	0.4	0.9	0.4	1.9	0.7	0.2	0.5	0.7	0.4	0.3	0.7	0.5	0.3	1.4	0.5	0.4	21.6	2.0	0.6	0.4	0.1	0.5	0.4	0.7	2.0	2.7	3.9	2.2	2.9	0.1	0.2	2.2	1.2	1.2	3.5	3.5	1.6	2.5	0.5	4.5	1.3	2.6	0.8	1.0	1.0	0.7	1.8	1.0	2.8	2.0	1.0	0.8	0.7	1.6	1.1	1.6	2.3	0.4	0.7	0.6	2.9	1.5	1.3	1.6	6.2	2.7	1.3	2.3	2.5	0.0	1.0	0.4	0.2	1.1	2.1	4.9	1.9	2.1	1.5	0.6	0.6	2.0	1.0	0.8	2.3	3.4	0.5	2.1	0.2	1.0	0.8	2.4	2.0	2.4	0.4	0.4	0.1	0.4	0.4	0.1	0.6	0.3	0.5	0.5	0.4	0.4	0.2	0.4	0.5	0.1	0.3	0.5	0.2	1.9	2.5	2.1	2.4	1.9	1.7	1.8	1.5	1.9	1.4	2.0	2.0	1.2	0.0	0.5	0.0	0.7	0.6	0.9	1.9	4.0	0.4	2.7	2.8	0.5	0.0	0.6	0.0	0.0	0.9	0.3	0.8	1.9	0.9	26.7	1.0	0.7	1.2	0.0	0.0	0.4	1.2	0.6	0.6	1.1	1.5	0.0	0.3	0.0	0.4	0.8	1.7	0.4	0.1	0.0	0.0	0.3	60.1	1.2	0.4	0.0	1.0	0.1	0.0	1.0	1.0	0.3	0.4	1.2	1.2	0.6	0.4	0.6	0.6	2.3	0.2	0.0	0.8	0.7	37.9	22.5	2.1	0.9	0.5	0.4	0.6	0.4	0.7
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139003962-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 1.3"	"Group enriched"	"Detected in some"	8	"Spermatocytes: 6.4;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"											HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"			"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.00e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PRR35	C16orf11	ENSG00000161992	"Proline rich 35"	P0CG20	16	560394-565529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 46.5;kidney: 17.2"	"Cell type enriched"	"Detected in some"	9	"Collecting duct cells: 36.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	20	"cerebellum: 46.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.5"	"Not detected"	"Not detected"			HPA069297	Uncertain		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli	"Cytokinetic bridge, Cytosol"	"HPA069297: AB_2686113"		"unprognostic (6.96e-2)"		"unprognostic (3.08e-2)"	"unprognostic (5.25e-1)"	"unprognostic (8.11e-2)"				"unprognostic (2.56e-1)"				"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"			0.0	0.1	0.1	0.0	0.2	0.0	0.0	46.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	17.2	0.0	0.0	0.0	0.2	1.5	0.0	1.1	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	46.5	1.8	0.3	0.1	0.2	1.5	2.3	0.3	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.3	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.9;intestine: 34.7;lymphoid tissue: 36.4"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 302.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 35.5;HMC-1: 55.7;hTERT-HME1: 57.9;SiHa: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cytokinetic bridge, Cytosol"		"HPA070174: AB_2686231"	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.71e-8)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	3.6	1.5	10.1	8.9	27.8	4.7	2.7	21.7	16.7	11.4	2.2	34.7	3.3	2.8	2.0	1.4	6.3	7.1	2.0	9.6	21.1	7.7	2.9	13.6	9.3	36.6	23.8	12.8	1.2	0.9	2.7	3.6	33.9	2.4	27.8	0.7	7.8	2.0	0.9	1.7	12.2	5.9	24.1	36.4	3.4	1.5	23.9	3.4	3.2	0.7	3.3	4.3	3.8	46.9	0.0	5.5	10.3	0.2	1.4	0.0	0.1	13.2	8.9	25.7	27.2	0.0	0.2	0.1	4.4	15.7	5.9	0.5	2.1	5.9	12.9	5.0	3.7	1.5	35.5	0.0	3.5	0.0	55.7	3.8	9.0	2.3	57.9	25.2	9.4	0.0	0.0	0.1	13.6	3.3	0.7	0.1	0.8	0.1	2.3	4.1	1.1	1.1	27.0	6.9	0.0	0.4	40.1	0.0	2.2	6.5	0.0	0.6	7.8	22.3	6.8	0.0	16.4	0.2	0.0	0.0	9.7	1.5	6.7	36.1	2.0	24.9	34.6	21.4	8.2	0.0	12.2	29.7	2.5	1.6	2.6	18.0	11.8	9.6	24.6	7.7	0.0	15.4	10.1	27.8	21.7	16.7	9.6	21.1	36.6	23.8	33.9	24.1	23.9	46.9	2.1	19.2	4.2	17.6	0.7	0.4	0.2	5.0	0.0	0.1	1.9	0.9	0.9	1.5	6.8	7.3	0.0	0.2	25.9	44.3	1.9	1.3	17.6	1.5	0.8	7.7	1.8	7.0	1.8	2.2	0.1	2.1	1.1	2.5	5.1	0.5	22.5	0.4	8.8	0.0	1.1	22.7	10.2	11.7	0.7	54.9	0.6	5.4	0.0	16.9	4.7	1.2	58.7	31.7	302.0	3.9	37.0	0.4	4.2	0.7	13.2	0.5	9.0	0.2	6.6	1.8	2.6	0.3	0.6	0.4	0.6	0.3	14.5	0.9	17.5	0.5
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No		2700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	62.7	76.9	3.3	11.2	3.4	9.8	56.5	3.3	7.3	42.7	3.4	79.9	12.9	41.3	3.2	59.5	41.6	5.8	34.2	3.4	3.5	63.7	99.2	78.2	18.2	4.3	3.4	32.1	29.5	8.2	26.6	4.4	3.7	45.2	20.4	0.7	44.2	6.4	14.4	58.0	93.9	8.9	4.0	150.4	57.0	5.9	3.6	13.5	40.8	0.1	17.2	41.3	48.1	4.1	15.1	3.9	0.3	0.0	5.1	13.1	11.2	4.9	22.9	29.1	39.3	0.0	20.9	45.7	9.4	10.5	25.5	8.1	6.8	16.6	8.0	19.2	0.0	27.6	5.9	0.3	30.3	5.2	7.5	14.9	10.3	12.9	6.8	1.9	18.1	11.8	1.1	8.1	6.1	0.1	12.9	11.7	0.1	0.0	7.3	29.3	1.3	24.1	21.3	4.9	0.8	0.2	8.6	10.4	8.5	0.1	7.0	41.0	4.3	8.8	7.6	7.8	0.6	21.0	15.9	11.2	2.2	27.7	9.0	56.8	70.3	94.6	58.1	88.0	51.2	73.4	49.1	61.1	67.5	71.1	34.8	49.6	90.2	63.0	78.2	58.5	81.2	156.0	3.3	3.4	3.3	7.3	3.4	3.5	4.3	3.4	3.7	4.0	3.6	4.1	237.0	38.5	55.8	2.9	162.0	84.4	64.1	183.7	54.7	1.8	85.3	92.5	8.7	71.4	103.2	62.5	0.0	2.7	211.2	219.9	86.1	219.4	0.6	63.2	74.9	158.5	65.7	45.0	0.1	247.6	18.3	60.7	93.8	81.5	50.7	51.4	114.5	75.0	165.9	6.7	0.5	243.8	120.1	143.5	94.9	1.9	39.1	128.2	56.9	10.3	214.3	39.9	279.1	3.0	0.7	179.6	287.9	30.5	153.2	100.1	319.8	78.9	103.2	3.0	39.5	33.2	56.8	0.4	1.2	60.5	79.6	2.7	181.6	110.9	222.6	121.6
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Cell line enhanced"	"Detected in some"		"HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	1.3	4.2	0.6	10.2	9.8	39.7	0.7	1.0	1.8	0.8	0.5	2.2	4.5	1.1	0.0	1.5	0.6	3.2	0.5	0.6	1.2	1.3	1.1	2.5	20.8	2.3	1.5	0.3	0.4	0.1	0.3	0.5	1.8	0.8	2.7	0.0	1.3	0.6	0.1	1.2	5.6	1.5	1.4	9.9	2.4	8.3	2.9	31.1	0.8	0.5	20.8	3.2	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.6	0.0	54.1	0.0	0.0	0.0	118.6	150.8	0.0	0.0	0.0	0.0	0.0	0.1	40.0	2.3	5.0	0.0	0.0	16.3	51.4	0.0	0.0	0.0	2.4	0.0	39.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	53.7	0.3	0.0	0.5	0.0	0.1	22.8	6.3	33.7	0.1	84.0	0.1	17.9	1.5	24.9	13.7	1.5	12.5	2.6	9.2	14.0	2.9	3.2	6.7	8.2	9.9	14.9	0.6	3.8	12.8	4.5	0.6	9.8	1.0	1.8	0.6	1.2	2.3	1.5	1.8	1.4	2.9	2.5	3.2	3.2	5.1	3.3	46.8	2.3	1.3	0.1	0.0	2.7	1.5	1.8	0.7	1.5	0.7	0.0	0.0	0.5	112.7	0.5	0.0	0.5	0.6	0.9	0.8	5.6	0.0	35.5	0.7	0.0	0.2	2.2	1.5	0.7	140.7	6.7	3.6	0.4	15.4	0.0	0.7	0.1	0.0	11.2	31.2	2.4	5.3	21.3	8.8	1.0	10.4	3.8	99.9	1.0	4.6	0.1	0.1	2.2	63.9	0.6	0.2	0.7	0.1	3.7	0.0	0.9	1.1	0.8	0.7	0.5	2.4	0.8	127.2	54.6	0.5	0.6
PYCR3	"FLJ13852, PYCRL"	ENSG00000104524	"Pyrroline-5-carboxylate reductase 3"	Q53H96	8	143603210-143609773	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 14.7;Ductal cells: 10.2;Exocrine glandular cells: 9.1;Extravillous trophoblasts: 11.8;Proximal tubular cells: 12.4;Theca cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053776, HPA063416, HPA069706"	Uncertain		Supported	"Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Cytokinetic bridge, Mitotic spindle"	"HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178"	"unprognostic (2.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.54e-1)"	5.0	9.7	2.8	0.4	2.9	0.6	5.2	2.7	3.3	5.1	1.0	4.2	0.5	5.2	1.1	7.1	6.0	0.8	3.9	2.9	1.6	9.7	17.2	3.8	0.9	2.3	2.2	5.1	9.2	0.6	10.0	0.4	2.7	8.7	0.6	0.7	5.8	0.5	3.0	4.0	4.1	0.4	1.5	5.9	5.5	7.0	2.7	0.4	8.4	0.3	0.7	4.4	3.8	2.1	3.2	4.0	1.6	2.5	1.8	0.6	2.0	3.0	1.4	2.9	1.9	2.9	2.6	6.2	2.1	2.0	1.1	2.6	2.0	4.0	1.1	3.0	5.3	3.7	2.2	2.0	0.6	1.9	1.0	0.8	1.9	3.1	1.9	1.2	0.7	3.7	4.3	3.1	1.9	7.2	3.0	1.7	2.1	4.5	10.4	2.8	1.8	4.3	3.4	2.2	5.3	1.4	3.6	4.9	1.6	0.8	6.4	2.0	0.9	2.9	4.0	3.4	3.1	2.5	0.8	4.2	2.6	2.0	1.9	0.2	0.9	0.0	1.1	0.6	1.2	1.3	0.8	0.8	0.6	4.7	1.1	1.0	0.1	1.3	0.7	3.0	0.9	0.6	2.8	2.9	2.7	3.3	2.9	1.6	2.3	2.2	2.7	1.5	2.7	2.1	2.9	3.2	3.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	8.8	7.7	0.0	0.0	0.6	14.7	0.0	5.1	1.6	0.0	3.9	10.2	0.0	6.8	6.6	1.9	0.0	0.0	0.0	9.1	11.8	2.9	0.0	5.2	0.0	5.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.8	0.0	0.0	12.4	4.4	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.5	1.2	14.7	0.0	0.0
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 151.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	27.9	32.3	18.0	5.3	18.9	7.0	19.5	21.3	22.6	29.6	7.6	35.1	9.0	31.3	5.5	12.3	27.5	7.4	31.4	21.7	14.0	151.1	37.3	25.2	5.8	14.4	15.8	33.8	47.4	15.9	41.5	6.5	15.2	29.9	3.1	6.1	19.3	7.8	52.2	19.5	27.5	7.1	12.7	26.4	22.2	34.6	16.8	5.3	24.8	15.8	3.2	31.7	19.9	19.0	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	18.0	18.9	21.3	22.6	21.7	14.0	14.4	15.8	15.2	12.7	16.8	19.0	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 199.1;skin 1: 237.7;vagina: 113.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Microtubules"	"Cytokinetic bridge"	"HPA022895: AB_1856071"	"prognostic favorable (8.43e-4)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	6.3	4.4	38.4	6.8	36.1	4.4	9.1	12.1	58.3	48.7	1.8	53.8	48.3	4.6	9.9	199.1	6.6	8.8	6.8	55.1	12.9	3.8	10.5	8.0	2.2	12.0	11.4	3.7	7.9	1.1	14.2	2.3	10.9	17.7	44.5	6.1	27.4	6.9	12.6	237.7	40.6	4.0	8.3	7.3	31.8	10.2	15.2	3.3	4.5	2.8	20.7	21.9	113.2	30.6	5.3	2.6	13.7	10.2	1.5	3.3	6.6	1.9	1.4	2.7	3.2	6.0	7.6	4.2	1.9	2.7	2.4	92.4	2.7	3.3	3.8	7.7	6.9	2.5	3.6	6.0	1.7	5.2	8.5	3.9	45.8	2.8	1.3	4.0	4.1	13.9	1.9	2.8	2.1	14.6	4.9	6.3	4.3	26.1	2.6	8.8	1.6	2.6	1.7	27.6	26.2	5.3	3.3	31.2	1.3	11.5	80.7	3.9	7.9	3.3	6.8	3.5	3.2	4.6	4.7	3.4	7.8	3.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	38.4	36.1	12.1	58.3	55.1	12.9	12.0	11.4	10.9	8.3	15.2	30.6	1.9	0.0	1.1	7.5	1.0	45.5	9.7	14.0	13.1	5.7	2.6	3.7	2.4	11.5	10.9	1.8	6.2	0.2	0.7	87.7	0.0	0.9	2.7	5.9	2.1	2.2	4.9	2.7	47.8	0.8	0.3	1.4	32.6	9.4	5.7	1.7	3.9	4.4	0.5	1.7	32.1	31.9	6.1	1.2	5.2	2.2	3.4	1.9	5.4	1.0	2.4	2.9	1.0	8.0	5.0	1.6	44.6	3.8	0.1	10.9	55.3	0.1	6.5	4.4	0.0	2.1	1.9	12.0	15.0	95.4	97.0	0.7	1.1	1.8	44.1	39.2
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 77.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 84.2;monocytes: 84.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	35.3	7.1	57.4	21.7	67.9	8.3	22.7	64.3	58.6	6.5	43.8	18.5	13.6	3.0	8.6	4.7	6.0	10.8	44.8	53.9	58.9	77.3	17.1	11.9	19.7	63.4	64.0	3.6	39.5	5.0	13.0	12.7	65.9	7.9	6.0	26.9	16.7	10.9	14.8	4.8	13.8	8.7	55.8	20.1	9.4	9.0	65.3	10.4	40.7	17.6	9.1	11.4	7.0	69.7	1.4	0.3	6.0	11.4	17.9	1.0	4.1	0.7	1.1	2.0	3.5	5.0	0.6	0.1	2.3	0.8	3.9	0.0	2.6	2.8	2.8	37.8	0.0	0.1	0.2	39.7	19.0	2.6	0.0	13.1	0.0	1.9	0.2	10.9	3.0	1.6	0.0	64.3	2.9	0.0	3.0	43.1	1.2	0.2	1.2	8.1	162.7	54.9	0.4	1.2	1.0	0.8	0.0	0.5	2.0	10.7	1.1	32.4	0.0	0.4	3.6	3.0	6.5	0.7	0.7	0.1	18.9	85.4	54.8	0.0	84.8	0.1	8.7	63.9	0.2	0.0	0.6	3.7	84.2	0.0	0.6	2.6	3.0	6.9	37.9	2.2	0.3	48.9	57.4	67.9	64.3	58.6	53.9	58.9	63.4	64.0	65.9	55.8	65.3	69.7	8.9	19.2	17.2	77.4	3.7	3.7	1.4	3.2	1.2	22.5	9.7	7.0	47.9	37.1	13.1	16.5	4.2	1.2	20.3	10.1	17.6	45.3	1.4	6.4	13.7	9.2	11.5	0.0	17.0	3.8	1.2	28.6	1.5	14.8	1.3	4.2	6.1	20.1	157.0	37.0	33.6	7.4	12.2	84.7	94.3	4.4	10.5	91.0	8.8	35.6	258.7	260.3	54.6	37.7	38.2	4.0	11.3	2.2	4.1	1.0	45.0	128.0	5.9	13.3	26.3	186.4	25.9	0.6	1.9	0.8	1.7	2.6	8.0	4.9	15.0	0.7
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491648	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 468.3;Late spermatids: 209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	32.5	25.4	11.1	32.3	13.6	19.1	31.7	12.5	10.4	33.5	14.8	26.6	23.3	32.2	20.2	25.0	31.8	27.7	25.6	8.7	10.5	39.2	59.5	38.9	49.7	12.3	12.0	37.8	39.0	62.7	17.7	19.3	13.0	42.9	29.3	23.1	34.2	39.9	32.4	26.3	26.1	30.7	11.7	41.0	32.6	48.4	11.4	66.6	40.2	37.7	51.2	30.9	28.9	16.9	25.9	18.1	20.7	20.6	61.2	57.9	9.4	17.8	26.4	23.1	7.9	10.1	30.9	39.0	28.4	32.8	22.3	29.6	17.9	30.1	36.0	12.5	22.4	15.9	14.7	22.0	27.3	23.4	49.0	35.6	34.0	15.3	22.4	43.0	36.3	39.6	12.7	23.2	26.6	7.1	48.6	22.0	7.8	30.8	15.0	33.6	41.8	46.1	25.4	25.3	16.9	14.3	42.2	17.2	19.1	16.8	22.7	30.0	28.3	27.5	14.3	24.1	13.7	35.7	22.9	42.4	34.4	28.2	19.0	53.9	22.5	56.5	53.4	16.2	60.5	22.5	59.7	62.8	21.7	22.0	85.5	75.3	41.8	74.4	28.8	13.1	48.2	76.2	11.1	13.6	12.5	10.4	8.7	10.5	12.3	12.0	13.0	11.7	11.4	16.9	37.9	41.7	101.1	51.2	49.5	23.1	30.1	15.3	40.9	27.8	27.0	15.5	13.5	45.8	32.5	27.6	20.9	6.0	77.0	26.3	17.6	13.4	468.3	38.9	25.8	31.4	19.8	26.5	55.1	10.2	13.0	35.8	24.5	45.9	55.1	27.9	40.7	46.1	11.2	35.3	54.1	30.0	34.6	43.6	23.7	209.1	42.0	35.4	10.6	58.1	44.9	38.3	79.3	63.3	85.7	10.8	19.0	42.9	48.7	31.4	29.2	25.3	38.3	22.5	39.5	36.2	26.1	161.4	61.3	33.7	27.6	4.1	118.9	25.2	21.7	35.6
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237622-122264840	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA057281: AB_2683394, HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favorable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	9.0	9.5	7.4	6.4	7.9	11.7	16.4	8.0	10.1	8.9	7.3	7.5	7.0	8.8	10.3	7.7	7.4	7.6	13.5	7.8	8.8	11.4	8.4	7.2	8.1	8.2	7.9	9.5	6.9	11.9	5.7	10.4	8.6	11.1	8.1	11.5	7.9	8.3	20.7	6.8	6.1	8.7	8.0	8.0	8.5	3.6	8.0	9.5	10.0	23.1	7.6	8.7	5.4	8.4	8.1	8.3	11.2	12.4	16.1	19.8	9.7	18.0	14.7	12.1	11.2	9.6	7.8	14.1	7.7	11.8	13.3	18.5	17.6	18.7	15.1	14.5	8.0	10.5	12.6	8.2	18.1	21.1	14.0	17.0	20.8	12.7	25.8	12.1	17.6	11.3	14.6	10.7	18.3	8.8	11.1	13.0	8.7	27.2	13.7	9.7	23.2	19.3	16.9	9.0	23.3	12.3	13.6	18.9	21.3	8.8	11.0	11.8	9.8	11.3	6.4	18.3	18.0	15.5	30.7	11.7	18.6	12.9	13.8	4.5	6.2	11.4	6.3	7.2	6.1	5.8	5.5	6.2	6.5	4.0	5.7	6.0	6.5	5.4	9.7	4.6	6.4	5.8	7.4	7.9	8.0	10.1	7.8	8.8	8.2	7.9	8.6	8.0	8.0	8.4	19.7	32.1	12.8	2.0	18.3	21.7	11.7	28.5	19.9	12.4	27.2	20.7	51.6	10.0	23.1	25.8	2.1	32.8	23.3	17.2	27.4	23.2	75.0	14.7	19.9	21.6	19.7	28.4	9.1	16.2	44.7	15.9	13.3	16.4	17.7	14.1	13.6	13.7	27.7	3.3	12.9	16.5	34.6	21.0	17.2	76.9	13.4	18.4	19.6	4.7	20.6	16.9	27.8	6.0	10.7	23.0	18.7	17.0	16.4	20.8	14.8	26.6	19.8	14.7	19.7	15.2	25.4	19.7	22.1	16.5	25.9	56.9	23.5	16.7	14.2	20.7
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644336-110839468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;pancreas: 20.2"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.0;HEL: 5.2;K-562: 5.0;RH-30: 16.2;SH-SY5Y: 15.0;SuSa: 4.9;T-47d: 9.2"	"Low region specificity"	"Detected in single"							"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"		Yes	No				"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus"	"Nucleoli, Cytokinetic bridge"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.5	0.1	0.8	0.2	2.6	0.1	2.5	0.4	0.8	1.5	1.8	4.1	0.1	2.9	0.6	5.6	2.6	0.4	40.8	0.8	0.4	0.7	0.1	0.9	0.1	0.8	0.9	2.7	20.2	1.2	1.7	1.6	0.6	1.3	0.4	1.2	7.3	0.7	15.6	1.2	0.8	2.2	0.5	0.1	1.0	0.8	0.8	0.5	1.0	3.8	0.6	1.0	5.5	0.7	0.0	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	2.5	6.0	5.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	16.2	0.0	0.0	0.0	0.1	15.0	0.1	0.0	0.6	4.9	9.2	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.4	0.8	0.8	0.4	0.8	0.9	0.6	0.5	0.8	0.7	0.3	0.0	0.0	0.7	0.2	0.1	0.2	0.4	1.2	1.4	0.8	0.5	151.5	0.0	0.1	0.0	2.1	1.6	0.0	0.7	1.9	0.0	0.8	0.5	1.2	1.5	0.0	0.0	14.8	0.2	0.2	3.3	0.0	0.1	0.0	14.6	1.4	0.0	0.1	0.0	15.4	0.7	2.0	0.0	0.0	0.8	4.4	0.0	0.0	17.8	0.0	0.1	0.0	1.5	0.6	0.0	0.1	13.5	1.0	0.0	2.0	1.5	12.4	2.7	6.6	3.7	5.4	0.5	0.8	3.7	0.0	3.1	0.2	1.7	0.2	0.3
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161283	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoli	"Nucleoplasm, Mitotic chromosome"	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	12.2	10.3	11.7	15.0	12.5	35.5	17.0	12.1	13.7	10.0	12.3	12.4	17.9	11.5	15.6	13.9	10.9	12.2	15.5	11.8	12.6	17.1	14.8	11.9	23.2	13.3	12.5	12.8	13.1	9.2	8.7	13.2	13.1	12.0	14.1	6.3	19.9	7.4	19.7	18.2	15.8	11.6	13.1	12.7	14.3	21.3	12.5	16.3	15.6	12.3	20.6	15.7	9.6	13.5	28.6	20.9	23.8	28.8	17.9	33.3	52.8	29.3	24.6	29.4	30.1	26.9	33.7	49.4	29.9	21.0	22.1	40.5	29.0	28.9	28.2	44.4	47.8	35.7	17.0	20.1	35.1	60.4	34.5	28.0	33.2	26.5	19.6	26.5	26.8	50.5	54.5	23.7	38.7	18.0	49.9	48.3	65.3	43.8	15.8	48.0	23.2	57.3	29.5	22.7	26.2	47.1	39.2	27.0	66.4	17.0	55.2	63.5	21.0	26.2	23.0	36.1	59.9	27.8	47.5	47.4	30.8	38.0	40.8	113.9	36.0	44.1	46.1	42.5	55.6	74.1	53.0	59.8	37.2	54.5	49.0	57.4	18.3	58.2	46.4	59.5	77.5	51.5	11.7	12.5	12.1	13.7	11.8	12.6	13.3	12.5	13.1	13.1	12.5	13.5	4.3	19.2	12.8	12.1	11.9	3.2	10.0	7.3	10.2	2.6	6.3	3.7	3.4	7.2	9.1	3.7	10.4	6.2	19.3	4.1	5.9	6.6	7.2	3.2	5.1	6.9	7.8	3.8	10.6	6.2	4.5	10.3	4.6	6.0	23.4	8.0	6.1	3.6	3.3	0.0	11.5	2.7	8.2	5.4	3.2	7.9	4.1	7.1	3.6	15.9	9.4	4.0	23.7	10.1	11.9	8.6	9.6	5.7	10.2	5.3	5.3	12.8	10.7	5.7	0.0	5.0	4.4	7.1	5.3	8.0	3.8	6.2	16.2	3.3	4.5	7.7
RCOR2		ENSG00000167771	"REST corepressor 2"	Q8IZ40	11	63911230-63917164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 20.7;Excitatory neurons: 5.9;Extravillous trophoblasts: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.7;NTERA-2: 47.0;SCLC-21H: 72.6;SH-SY5Y: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021638	Uncertain		Approved	Nucleoplasm,Vesicles,Midbody		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Vesicles, Midbody"	"HPA021638: AB_10960885"	"unprognostic (1.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.33e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.06e-3)"	0.3	0.5	1.8	0.2	3.2	0.0	0.4	1.3	3.7	1.4	0.1	1.1	0.8	2.7	1.0	0.4	1.5	0.4	2.8	2.5	1.1	0.6	0.1	0.3	0.0	1.2	1.0	1.2	0.5	1.4	3.5	0.7	0.8	0.9	0.6	3.4	0.9	0.6	1.5	0.3	0.6	1.0	1.1	0.1	0.7	3.2	1.0	0.9	0.2	0.7	0.0	1.2	0.6	2.4	0.0	1.0	35.7	2.5	0.5	2.9	10.9	0.2	0.6	0.5	1.2	1.4	0.3	0.3	0.4	0.8	0.7	0.4	15.8	0.0	0.3	0.6	2.0	0.5	0.3	11.9	5.9	0.0	0.3	3.5	0.0	0.6	0.0	0.0	0.3	4.8	2.0	0.0	0.0	3.3	3.4	13.2	47.0	4.8	0.1	12.4	2.1	1.0	0.1	0.1	72.6	48.7	0.3	3.2	1.8	8.7	2.7	4.5	0.3	0.1	2.3	0.1	0.1	0.3	0.1	0.4	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	1.3	3.7	2.5	1.1	1.2	1.0	0.8	1.1	1.0	2.4	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	20.7	0.6	0.4	2.2	0.0	0.1	0.0	0.0	0.5	0.0	1.0	0.0	0.1	0.1	0.3	3.3	0.6	1.2	0.0	5.9	0.2	4.4	1.1	0.0	0.6	0.0	1.2	0.0	0.0	0.2	3.3	1.5	1.2	2.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	2.1	1.0	1.0	1.5	0.2	0.2	0.4	0.0	0.0	0.3	0.1	0.2	2.2	0.0	0.3	0.7	0.7	2.9	0.0	0.3	0.8	0.1	1.2	0.8	0.1
RDH8	"PRRDH, SDR28C2"	ENSG00000080511	"Retinol dehydrogenase 8"	Q9NYR8	19	10013249-10022279	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"retina: 114.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.3;Cone photoreceptor cells: 54.2;Early spermatids: 72.6;Muller glia cells: 22.1;Rod photoreceptor cells: 203.4"	"Cancer enriched"	"Detected in some"	4	"melanoma: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064473			Approved	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Midbody ring, Cytosol"	"HPA064473: "			"unprognostic (4.12e-1)"		"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.98e-3)"		"unprognostic (4.58e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-1)"			"unprognostic (1.02e-1)"	"unprognostic (3.86e-1)"		"unprognostic (2.63e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	114.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.2	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	0.0	72.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	203.4	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RMDN2	"FAM82A, FAM82A1, FLJ32954, RMD2"	ENSG00000115841	"Regulator of microtubule dynamics 2"	Q96LZ7	2	37923187-38067142	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 42.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 270.4;Late spermatids: 163.5;Theca cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034705, HPA034706"	Enhanced		Supported	"Golgi apparatus,Mitotic spindle,Cytosol"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Mitotic spindle, Cytosol"	"Golgi apparatus"	"HPA034705: AB_2674292, HPA034706: AB_10696362"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.34e-1)"	4.6	42.5	3.8	4.1	3.5	3.4	5.3	4.8	4.5	7.7	2.9	12.4	8.4	5.1	9.2	3.4	3.9	6.2	4.4	4.1	2.6	7.8	29.2	11.3	4.6	3.9	2.6	2.8	4.1	3.2	3.0	3.9	2.6	7.2	10.6	4.2	3.7	12.8	5.1	2.9	13.9	5.8	3.0	20.0	4.4	21.7	3.6	5.9	5.4	3.2	2.9	4.3	3.5	3.7	3.3	4.7	2.6	1.8	10.4	11.4	1.5	7.0	9.3	3.6	3.2	1.1	10.9	2.2	2.8	9.9	2.2	3.5	0.8	5.1	4.9	5.0	3.0	3.6	1.6	3.1	5.3	0.0	3.8	16.2	4.6	4.5	0.7	5.4	2.0	1.8	4.4	2.1	6.8	1.3	0.9	4.5	5.1	6.5	3.8	0.0	0.8	0.6	9.0	2.7	2.1	7.5	5.7	0.7	7.3	2.2	1.1	5.9	3.8	4.4	5.1	2.5	2.6	3.8	7.7	4.6	5.4	1.1	4.6	0.0	2.8	0.7	2.0	4.6	3.1	4.1	1.0	1.3	1.8	2.3	1.0	2.2	2.7	3.7	3.5	3.4	0.1	1.4	3.8	3.5	4.8	4.5	4.1	2.6	3.9	2.6	2.6	3.0	3.6	3.7	3.4	28.9	29.6	25.1	6.5	2.4	6.8	16.3	8.6	3.5	1.9	4.2	5.3	11.5	20.0	5.5	2.1	2.1	6.0	20.9	7.9	5.4	270.4	3.7	11.8	4.6	4.8	3.0	33.8	3.8	1.0	9.2	2.6	3.1	15.8	13.1	5.3	15.5	4.7	5.0	24.5	11.4	6.1	6.3	1.7	163.5	9.3	4.8	5.4	19.7	4.4	4.7	6.2	39.2	7.1	2.5	6.1	6.0	1.8	2.2	29.6	6.7	10.2	2.6	6.6	6.4	5.1	9.4	4.8	1.7	2.4	0.8	3.9	77.6	15.2	2.3
RMDN3	"FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3"	ENSG00000137824	"Regulator of microtubule dynamics 3"	Q96TC7	15	40735884-40755851	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009975, HPA074840"	Supported		Enhanced	"Cytokinetic bridge,Mitochondria"		Yes	No		42000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria	"Cytokinetic bridge"	"HPA009975: AB_1078811, HPA074840: "	"unprognostic (2.54e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.94e-3)"	"prognostic favorable (6.70e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.04e-3)"	30.1	22.7	37.2	16.2	40.2	24.1	26.7	38.4	48.6	18.0	31.2	18.1	43.8	15.9	5.4	22.6	18.8	16.7	16.4	36.3	36.1	18.4	37.0	36.5	15.6	40.2	38.6	17.2	27.2	36.3	10.9	19.4	36.0	17.2	9.0	6.7	33.3	15.4	20.7	21.1	51.7	11.2	37.7	13.0	21.5	13.8	42.9	15.0	19.9	14.1	8.4	20.3	17.6	41.2	19.7	17.7	21.0	35.9	19.2	17.2	36.3	50.2	19.8	34.9	25.6	63.7	21.7	16.7	65.0	27.0	26.0	66.3	26.9	37.3	3.7	44.2	33.1	53.6	51.4	31.6	62.9	36.4	41.1	30.9	34.0	25.2	23.9	16.3	24.8	32.6	57.4	44.9	15.1	40.0	27.7	23.6	16.7	52.7	34.6	42.6	25.1	38.9	28.8	32.7	49.8	18.1	39.9	53.4	19.5	8.2	41.6	39.1	37.3	37.8	27.0	51.1	42.5	34.0	42.7	26.7	26.8	38.2	42.2	4.0	13.2	5.5	28.2	17.8	25.0	16.0	20.6	26.0	14.4	13.7	15.9	17.3	2.1	65.1	22.3	54.2	20.3	26.6	37.2	40.2	38.4	48.6	36.3	36.1	40.2	38.6	36.0	37.7	42.9	41.2	20.1	32.1	28.1	18.6	11.0	15.7	16.4	26.9	15.9	20.0	21.0	13.6	8.1	15.7	27.8	18.4	4.2	44.4	22.4	17.2	1.9	27.7	2.8	20.7	17.8	18.1	4.9	42.7	23.5	22.0	28.5	17.8	13.7	22.0	19.0	8.6	17.5	36.4	110.7	18.5	18.2	12.3	26.4	14.7	10.4	3.4	16.8	21.0	19.6	8.4	11.7	21.6	43.3	16.1	21.8	21.8	16.7	14.3	18.0	17.3	77.6	14.5	29.3	17.3	6.6	22.2	16.0	40.4	40.4	21.9	11.9	62.8	18.3	16.7	21.4	23.1
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049810	Approved		Approved	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"	"Mitotic spindle, Centriolar satellite"	"HPA049810: AB_2680894"	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	75.0	110.6	141.9	53.0	146.7	69.0	73.1	146.4	179.9	93.2	138.6	111.5	66.6	94.9	76.4	122.1	84.3	45.3	131.8	141.5	146.4	106.7	184.2	77.5	64.5	146.3	145.4	87.4	115.1	105.8	96.8	50.7	146.3	95.0	65.7	98.1	92.5	70.5	152.9	127.8	100.5	52.8	142.4	113.8	111.8	110.6	150.3	98.1	93.4	94.2	71.6	106.7	90.4	153.3	102.6	143.1	61.1	73.7	132.8	68.7	92.7	63.4	76.1	119.7	93.4	96.2	43.3	71.5	120.3	93.5	63.9	147.5	103.2	114.8	86.1	74.5	166.1	121.9	164.4	94.9	100.6	59.0	245.0	79.6	176.5	129.8	116.2	74.6	77.2	101.0	49.9	237.5	96.2	66.3	92.8	70.6	75.4	102.0	86.8	62.8	61.9	91.5	137.3	77.4	49.2	61.1	56.0	92.9	81.9	83.1	87.3	55.9	49.5	76.6	48.3	66.8	119.3	79.5	88.0	23.7	98.4	80.6	77.9	108.4	88.8	236.9	195.3	94.0	153.4	100.4	148.0	195.7	73.9	98.7	103.2	152.2	219.8	118.8	117.7	75.9	153.0	177.0	141.9	146.7	146.4	179.9	141.5	146.4	146.3	145.4	146.3	142.4	150.3	153.3	36.9	0.0	3.9	12.4	54.3	68.6	44.4	65.8	51.8	43.2	56.6	44.7	15.8	77.2	38.9	49.7	20.9	120.1	64.7	65.2	56.7	78.5	59.6	29.8	25.1	36.4	31.8	60.6	11.3	66.7	139.7	36.3	36.2	32.2	14.0	26.3	45.7	95.1	58.4	18.5	11.2	45.7	65.1	41.3	43.6	86.5	48.7	36.1	39.2	6.5	53.1	46.9	114.4	10.1	17.9	60.7	44.9	53.8	59.1	32.6	108.2	64.0	31.1	32.3	39.5	28.4	35.1	127.1	106.7	61.4	83.3	125.2	82.5	37.2	59.6	48.0
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202179-56221933	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	32.2	24.6	22.5	18.0	23.3	19.6	21.4	15.7	23.8	21.2	13.0	23.8	12.4	22.3	13.2	23.1	24.3	25.5	32.7	24.6	24.8	19.7	15.1	23.8	23.4	16.8	19.1	22.9	23.0	27.4	22.8	21.3	21.2	33.9	19.0	23.8	15.0	20.7	34.0	15.0	16.1	28.5	15.3	20.6	17.0	15.9	23.5	26.5	28.6	40.8	25.1	28.2	17.0	19.2	21.6	32.6	34.7	55.2	71.0	51.3	25.8	70.8	69.5	62.2	50.2	40.0	27.6	41.6	36.7	60.2	20.6	24.3	47.4	34.1	44.9	43.8	25.7	55.8	22.3	23.2	148.3	61.6	58.3	66.0	78.6	52.0	91.0	81.7	61.3	34.5	40.4	41.3	35.1	34.9	35.6	27.6	41.9	21.6	37.8	38.2	24.9	25.3	33.3	31.3	62.9	38.1	61.9	35.0	55.4	34.3	49.2	71.3	37.3	31.3	32.9	40.6	27.8	29.6	36.6	37.5	37.2	36.4	38.0	59.1	27.2	99.9	27.6	26.7	24.9	50.3	23.0	24.3	30.6	55.1	23.4	24.0	36.2	33.1	28.3	23.7	29.4	31.0	22.5	23.3	15.7	23.8	24.6	24.8	16.8	19.1	21.2	15.3	23.5	19.2	18.9	44.8	22.6	11.1	42.2	12.0	19.9	8.6	19.9	30.7	22.2	21.1	24.6	24.3	18.8	16.5	22.9	15.2	17.0	10.2	17.6	15.3	92.8	13.9	14.2	20.7	20.4	11.1	15.0	21.3	18.5	22.7	9.7	14.2	25.9	16.8	30.0	16.7	19.3	28.6	15.7	13.9	8.2	34.9	22.7	58.0	23.0	25.0	7.2	9.4	33.5	26.2	15.5	14.6	12.3	20.8	20.3	25.9	14.6	33.5	12.3	19.6	18.0	18.3	26.3	23.2	27.4	10.4	14.2	14.4	16.6	16.8	16.6	17.1	14.3	23.1
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 234.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	16.4	12.2	6.6	9.5	7.4	10.8	14.9	7.3	8.7	12.9	7.2	11.9	6.6	11.2	5.4	15.2	12.5	9.1	15.3	7.0	7.1	15.8	17.2	9.7	10.4	6.9	6.9	13.2	19.9	9.7	8.1	10.2	7.0	11.4	8.8	5.6	9.9	7.1	22.2	13.9	8.1	8.1	6.9	9.3	11.7	13.5	7.1	7.6	13.0	14.0	10.9	15.3	12.5	7.9	23.3	16.6	12.7	50.5	26.4	34.7	32.6	32.5	23.6	32.3	32.6	39.2	18.5	50.2	29.4	22.8	38.8	27.0	51.5	37.6	84.2	19.4	38.7	29.5	14.2	27.4	35.9	45.9	16.6	26.5	31.4	46.5	83.5	20.3	24.9	22.1	99.0	29.9	52.2	23.4	39.2	45.5	45.2	37.7	20.2	40.2	22.4	43.6	37.4	22.9	20.3	28.7	14.1	23.7	61.3	16.8	18.8	47.3	17.5	24.7	21.2	234.1	81.4	13.4	22.0	65.0	36.4	60.8	55.2	0.2	4.4	0.7	4.1	5.5	8.5	6.6	6.1	5.0	5.8	5.7	6.8	7.0	0.3	8.8	3.5	5.8	5.0	4.0	6.6	7.4	7.3	8.7	7.0	7.1	6.9	6.9	7.0	6.9	7.1	7.9	40.0	19.2	26.9	6.5	25.0	78.4	119.6	90.1	35.9	14.1	33.6	52.3	71.9	47.1	67.6	18.4	0.0	44.9	18.0	15.8	68.4	48.2	105.7	49.8	57.6	35.2	11.4	26.1	15.7	47.4	53.8	50.0	17.3	60.9	46.2	18.9	23.6	83.6	56.0	18.5	14.0	30.3	36.7	27.7	19.5	32.1	34.5	28.2	37.4	5.6	21.8	21.0	19.6	9.0	13.5	42.2	18.7	27.1	18.8	80.4	15.2	87.2	55.0	8.9	13.1	61.7	49.9	76.8	28.4	33.0	66.2	34.6	22.9	29.8	44.0	70.2
RPL6	"L6, TAXREB107, TXREB1"	ENSG00000089009	"Ribosomal protein L6"	Q02878	12	112405189-112418838	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060903, HPA068418"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No		620000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Microtubules, Cytokinetic bridge"		"HPA060903: AB_2732653, HPA068418: AB_2685987"	"unprognostic (5.95e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.90e-2)"	1199.2	1080.7	788.0	937.3	801.7	2387.8	1856.5	776.8	1063.3	1357.1	828.3	1249.1	789.1	1236.7	1570.4	1485.5	1241.3	734.2	856.8	756.3	814.1	985.6	1026.1	803.0	1847.2	805.2	807.2	2777.7	1984.2	1103.8	1049.8	763.3	801.3	1017.4	1222.4	531.8	1632.2	850.0	1451.0	1598.1	946.0	1018.7	822.2	1015.0	1214.8	279.2	808.0	1815.8	1223.2	1298.0	2204.7	1349.1	1216.0	818.0	1973.8	1887.6	2227.1	2264.4	2725.6	4486.8	2932.4	1843.2	2670.8	2471.8	1408.6	2975.9	1213.3	4225.2	1547.6	2008.9	962.8	1881.4	2395.5	3288.1	2456.2	1682.6	3199.4	2274.7	1590.4	2693.3	2854.8	4103.6	1708.4	4171.2	4542.3	1876.9	4294.7	4571.2	2818.5	2754.1	3060.8	1134.5	2888.4	2727.7	3013.0	6699.3	3096.5	4209.0	2233.7	2731.0	2375.5	4144.9	3118.1	3283.8	2050.1	2651.9	1297.5	3446.9	3342.3	2007.3	3621.2	4189.6	1657.8	1215.8	1484.2	1572.8	2110.7	1542.6	2549.7	3377.6	1573.3	2948.5	1861.4	730.3	2260.1	463.1	2285.0	1851.6	3814.8	3463.8	3465.4	2972.5	2896.3	3116.2	3751.8	3251.5	262.6	2839.0	1688.0	3372.7	3027.9	7777.8	788.0	801.7	776.8	1063.3	756.3	814.1	805.2	807.2	801.3	822.2	808.0	818.0	1483.8	798.0	1587.2	31.0	3121.1	3145.3	3907.2	3373.8	2996.4	271.4	3790.3	6493.7	262.3	1818.7	1733.0	636.4	137.6	3077.0	2809.4	731.3	3502.2	2270.2	414.6	1133.8	2774.3	1661.9	1388.1	1929.0	42.6	3043.9	4721.2	1695.5	1135.6	1287.6	1290.2	1743.7	1854.3	1727.8	1880.0	121.1	48.2	2036.2	1112.9	2566.7	2790.5	714.3	2849.7	1964.8	1899.7	30.9	3399.6	854.8	2699.3	34.7	48.9	2582.7	1646.1	1589.9	2173.6	3165.2	1095.4	3376.3	776.7	412.3	927.0	2550.9	1835.3	376.5	461.6	3977.5	3650.1	3068.7	2710.6	2783.0	2512.8	3577.6
RPLP2	"D11S2243E, LP2, MGC71408, P2, RPP2"	ENSG00000177600	"Ribosomal protein lateral stalk subunit P2"	P05387	11	809965-812880	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053635, HPA075365"	Approved		Approved	"Nuclear speckles,Mitotic spindle,Cytosol"	"Intracellular and membrane"	Yes	NA		2900000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear speckles, Cytosol"	"Mitotic spindle"	"HPA053635: AB_2682212, HPA075365: "	"unprognostic (6.98e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-2)"	2013.7	831.3	1119.2	993.1	1162.5	2166.9	1656.6	1099.7	1368.9	1256.2	1084.1	1277.1	1016.8	930.2	701.6	1241.3	1240.4	564.0	869.3	1057.5	1116.3	885.0	657.0	851.0	1924.7	1138.0	1095.8	2092.8	2087.8	545.7	595.5	830.9	1154.3	925.8	887.8	180.9	1908.3	775.7	1802.7	1760.4	1191.7	624.4	1204.8	1543.8	1006.0	377.6	1167.5	1545.7	785.0	936.1	1715.4	1075.5	1137.9	1217.7	2773.5	2229.6	1070.4	1864.1	2343.2	2458.2	2389.5	1728.2	1285.0	2090.8	1638.4	3307.6	2218.5	3851.6	1225.0	1629.9	1107.9	2546.7	1786.2	2778.3	836.3	1713.6	8117.9	1901.7	1416.9	3996.4	2837.3	3540.8	1905.4	3393.9	4684.6	764.1	2182.7	1860.8	2111.9	2798.2	3432.2	2040.5	1317.9	2656.6	2969.5	6002.3	3188.8	3394.5	6045.3	3345.1	1465.6	4369.9	1759.0	1281.0	2222.2	3142.1	1118.5	2825.8	3582.4	885.1	1198.9	3577.2	1881.2	1142.3	1393.9	964.1	1981.6	3838.4	3778.8	3419.3	1790.5	2952.3	1340.6	1565.3	3908.1	1299.1	4402.2	3129.1	6208.3	10718.3	8296.0	6323.4	4273.6	9867.1	10158.6	8083.9	529.9	4310.4	2525.7	5882.9	5140.5	13330.7	1119.2	1162.5	1099.7	1368.9	1057.5	1116.3	1138.0	1095.8	1154.3	1204.8	1167.5	1217.7	1311.8	1067.3	1685.0	16.3	5889.9	6113.3	6658.4	2808.0	2619.1	206.2	5955.7	4736.9	638.4	2505.0	1972.2	1601.9	79.2	5046.4	3469.2	2296.4	2592.4	3688.3	1403.0	1105.9	2434.1	2724.8	2370.2	3482.2	18.6	7413.9	8045.8	2074.3	1401.2	1787.6	1721.9	1543.2	4028.6	3068.9	4514.0	146.4	17.8	5925.5	870.8	5458.4	6404.8	3133.4	6393.4	3169.4	2986.4	27.2	5854.8	1052.2	5787.9	6.0	19.0	5201.1	4547.7	2821.7	2403.4	6640.3	4473.8	4234.1	900.4	235.5	1991.9	3688.9	2346.3	1123.1	2093.1	4264.4	7887.4	5841.1	4889.3	1629.7	6189.1	7014.0
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	8.0	8.2	8.0	6.5	8.7	5.3	7.3	7.4	10.2	6.9	4.8	6.4	5.0	7.1	3.3	16.0	6.4	4.0	7.0	9.2	7.2	7.6	13.0	5.3	8.1	8.9	8.1	8.0	9.7	4.8	5.5	4.9	8.0	7.2	3.0	1.7	8.1	4.2	12.9	11.9	5.9	3.4	6.6	8.2	7.5	7.9	7.6	5.0	6.0	5.3	6.1	7.3	7.9	10.8	37.6	19.6	13.5	22.6	7.3	8.2	25.6	18.5	10.9	25.7	18.1	52.1	21.6	35.5	14.9	10.4	23.8	18.8	25.2	18.5	11.7	17.7	47.9	50.4	18.8	32.1	14.9	32.6	17.5	11.0	17.0	26.0	20.6	6.7	13.7	32.9	67.3	26.9	12.2	43.2	28.7	44.7	44.8	26.1	28.7	52.0	10.7	66.4	13.4	20.5	31.6	18.8	19.3	21.0	25.3	3.8	21.5	22.1	15.6	17.2	19.1	18.2	33.0	32.1	29.8	37.1	25.7	53.7	22.6	0.1	5.0	1.7	10.7	4.8	13.4	11.0	11.0	11.1	10.2	13.0	11.9	8.0	1.1	13.1	2.3	8.8	6.8	7.0	8.0	8.7	7.4	10.2	9.2	7.2	8.9	8.1	8.0	6.6	7.6	10.8	12.9	16.0	19.4	9.4	17.3	72.3	40.2	55.9	23.3	18.7	14.4	12.7	6.1	18.6	45.3	7.3	20.9	31.4	12.7	18.6	7.9	40.0	4.2	14.9	15.5	18.8	20.9	19.0	6.2	33.1	39.0	24.5	18.8	16.1	20.3	20.1	9.3	16.0	32.7	8.4	6.3	19.3	32.6	8.4	35.0	2.7	19.3	13.6	42.7	2.8	15.3	12.3	13.4	2.5	11.6	41.4	9.1	20.7	19.2	59.4	10.5	21.0	24.3	17.6	32.9	23.8	20.6	21.4	30.0	32.2	70.2	30.4	15.0	21.4	29.5	46.1
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285293-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Mitochondria"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	4.0	2.6	1.7	3.3	1.7	4.1	4.7	2.5	2.4	3.0	1.4	3.0	2.1	3.7	2.7	3.0	2.9	1.9	4.9	1.8	1.9	3.4	3.5	2.8	3.7	1.4	2.0	3.8	2.9	4.5	1.8	3.6	1.6	3.1	2.9	2.2	2.6	2.4	9.6	3.5	2.4	3.4	1.5	2.9	2.6	2.4	1.8	2.6	3.5	7.7	3.5	3.9	2.8	1.9	9.8	7.2	7.9	5.7	5.6	7.8	6.7	9.8	7.3	10.0	7.2	14.1	8.8	14.0	13.1	7.6	6.7	8.7	13.5	13.0	16.6	5.7	10.1	10.9	6.6	7.8	11.6	17.0	5.6	5.4	7.8	13.1	17.4	4.4	6.6	6.5	22.7	4.4	11.4	8.9	11.3	8.3	15.7	7.8	14.8	7.8	4.9	13.8	8.0	8.9	9.0	13.1	8.3	15.3	15.0	9.3	11.0	12.1	9.3	8.0	7.6	14.3	18.3	5.4	8.9	14.4	9.1	8.1	13.1	0.3	0.8	0.1	1.6	1.3	2.3	2.4	2.0	1.4	1.2	2.3	2.6	2.6	0.2	1.6	1.1	1.7	1.3	0.7	1.7	1.7	2.5	2.4	1.8	1.9	1.4	2.0	1.6	1.5	1.8	1.9	33.7	32.1	28.1	7.5	36.0	65.3	33.6	28.7	24.5	31.1	32.6	31.0	68.4	22.8	25.0	36.8	10.4	38.1	32.7	13.5	27.4	39.7	17.0	22.6	47.3	27.9	12.1	41.0	18.4	52.2	59.1	32.2	19.9	28.5	31.0	18.6	21.8	44.2	33.6	26.9	16.1	20.8	6.1	17.3	18.5	4.6	37.6	17.4	21.4	7.5	20.8	21.2	24.7	7.5	9.0	36.8	9.0	24.8	13.0	34.9	5.2	37.2	11.7	23.6	26.3	72.1	33.0	59.7	69.1	24.3	47.6	18.1	26.4	20.4	32.1	23.0
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659560-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 131.3;Early spermatids: 213.2;Late spermatids: 222.8;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	8.8	5.9	7.9	12.2	8.9	6.2	9.1	7.0	7.8	7.2	5.9	7.2	6.7	9.1	5.5	8.6	9.1	6.1	4.9	7.4	7.2	4.9	8.7	6.7	17.4	7.8	7.9	13.1	10.2	7.2	4.3	5.8	7.2	7.5	7.3	28.4	10.2	6.8	12.1	8.8	6.4	8.8	7.4	11.0	7.8	12.0	7.8	16.1	6.5	8.8	14.8	9.8	6.5	8.6	52.5	30.4	31.8	48.1	20.2	21.5	26.0	27.0	19.3	29.3	24.0	69.4	22.2	101.9	17.2	21.5	33.9	22.8	78.9	46.5	34.6	34.6	62.8	60.3	34.8	43.9	27.9	95.0	22.9	22.4	29.2	35.1	40.3	18.1	33.1	43.2	96.0	29.1	26.1	27.4	76.1	28.9	108.4	33.7	33.4	98.7	32.1	71.2	21.2	24.8	62.7	33.6	50.6	36.9	37.9	11.7	24.2	29.4	29.7	9.0	28.3	24.0	49.8	39.1	53.8	119.3	28.5	100.7	30.1	2.0	2.5	0.7	6.2	2.5	7.3	5.6	7.9	7.5	3.0	4.3	7.2	8.6	0.1	5.8	2.2	2.4	6.6	5.5	7.9	8.9	7.0	7.8	7.4	7.2	7.8	7.9	7.2	7.4	7.8	8.6	15.5	32.1	16.4	8.8	32.7	22.8	17.7	15.0	28.5	30.3	13.8	11.0	13.4	17.2	21.0	5.5	131.3	8.6	27.1	5.7	1.9	17.0	213.2	10.5	28.8	19.1	5.4	23.7	19.0	15.6	17.0	18.9	14.8	10.8	36.0	25.5	12.8	18.4	18.7	25.2	20.0	9.2	6.1	13.9	12.7	222.8	22.4	13.4	8.8	21.5	17.0	17.9	35.0	18.6	22.2	20.9	3.7	26.7	48.5	23.6	6.8	9.9	16.7	143.5	0.0	29.9	18.1	26.3	33.6	32.0	31.7	4.4	35.7	32.6	16.5	17.4
RSAD1	"FLJ11164, HemW"	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478860-50485974	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967, HPA024459"	Approved		Approved	"Mitotic chromosome,Mitochondria"		Yes	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Mitochondria	"Mitotic chromosome"	"HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: "	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	23.9	41.4	34.7	16.4	37.8	12.8	23.5	37.5	43.4	36.9	32.9	24.3	17.1	24.2	17.5	17.3	24.5	12.5	43.3	34.4	33.9	40.9	44.0	21.1	19.8	34.5	34.9	31.8	48.9	27.5	23.6	12.4	35.1	25.2	17.6	21.2	27.3	14.9	66.0	22.2	23.9	14.4	34.2	31.8	32.5	14.2	35.4	18.4	29.1	57.0	17.8	26.1	23.6	37.0	13.0	43.2	20.3	33.7	34.0	27.6	7.2	22.2	21.6	27.9	23.5	43.0	16.1	34.9	48.0	15.6	27.6	12.1	23.2	31.0	23.9	38.9	42.0	47.0	20.5	42.4	23.7	28.6	31.7	20.2	33.7	18.6	35.7	23.0	27.5	84.1	36.9	32.3	23.7	30.3	48.1	20.9	8.2	54.6	45.9	19.6	23.2	31.6	34.0	19.4	11.1	37.9	5.7	26.3	29.7	25.6	39.6	28.7	19.6	29.0	30.8	22.3	26.4	50.0	37.6	13.5	21.8	40.3	20.6	1.1	4.2	3.8	8.5	4.4	8.5	4.5	7.3	8.4	4.9	6.9	9.4	9.5	0.0	6.6	4.2	5.4	6.2	5.7	34.7	37.8	37.5	43.4	34.4	33.9	34.5	34.9	35.1	34.2	35.4	37.0	15.1	3.2	13.1	18.3	16.0	10.1	4.4	7.2	19.4	14.8	12.1	12.8	29.4	12.8	7.7	16.5	2.1	21.4	24.1	10.8	23.5	14.4	8.8	5.3	10.4	12.4	25.2	12.0	24.0	29.5	11.1	13.1	12.2	7.4	3.8	15.8	10.0	18.5	16.1	8.4	21.5	11.7	8.2	7.2	6.1	7.4	15.5	9.6	17.8	16.9	12.5	32.1	19.6	13.6	12.4	11.8	6.2	10.9	18.7	6.5	11.1	11.1	3.8	7.8	13.1	16.0	11.3	11.5	21.9	10.6	9.9	10.1	18.7	43.6	12.9	3.4
RSL1D1	"CSIG, DKFZP564M182, L12, PBK1, UTP30"	ENSG00000171490	"Ribosomal L1 domain containing 1"	O76021	16	11833850-11851580	"Predicted intracellular proteins, Ribosomal proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043483	Supported		Enhanced	"Nucleoli rim,Mitotic chromosome"		Yes	No		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim, Mitotic chromosome"		"HPA043483: AB_2678504"	"unprognostic (4.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.95e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.68e-2)"	39.3	32.2	11.1	36.9	11.7	46.7	78.8	13.4	14.1	47.6	12.2	35.7	32.6	44.0	28.8	38.2	44.5	30.5	33.7	11.9	12.5	33.0	39.1	26.4	48.2	11.6	11.4	118.5	43.6	28.8	13.2	30.0	12.2	33.3	37.9	15.1	42.0	34.0	87.3	34.1	29.2	36.6	13.3	26.9	25.1	22.4	13.3	41.8	34.8	51.7	65.1	48.0	26.4	15.4	90.7	84.3	69.1	87.1	88.6	157.9	81.9	82.1	91.4	104.0	105.9	82.6	83.1	225.6	133.1	68.6	72.1	62.5	186.7	124.4	168.4	88.8	100.7	111.6	75.9	188.0	165.4	159.5	71.3	116.6	173.2	107.6	248.2	77.8	102.4	87.0	198.6	101.5	129.3	100.8	125.7	92.6	177.7	108.1	86.1	129.2	127.3	240.1	92.9	78.0	96.4	79.2	155.0	116.6	110.0	70.9	100.5	122.2	63.2	69.0	77.3	66.0	120.0	81.3	126.2	261.7	75.0	164.9	94.1	14.1	123.2	12.6	69.7	119.1	129.6	132.6	129.5	91.7	130.8	117.3	185.4	136.8	7.1	124.6	120.7	80.2	100.9	253.0	11.1	11.7	13.4	14.1	11.9	12.5	11.6	11.4	12.2	13.3	13.3	15.4	111.2	141.1	156.6	5.5	198.1	330.9	338.6	251.0	299.3	39.9	241.1	344.4	188.4	74.4	198.1	49.7	22.9	186.4	118.7	41.2	135.0	134.5	22.8	76.0	181.1	118.1	94.5	104.5	11.0	186.2	286.8	180.9	88.2	100.0	152.6	106.6	64.2	78.5	147.6	38.7	11.6	126.4	107.8	153.0	177.3	18.5	199.4	141.0	92.5	3.7	276.5	52.8	113.3	3.5	7.3	135.4	75.1	126.0	104.6	226.5	110.5	155.0	81.3	30.8	59.2	245.4	151.5	111.2	136.0	203.5	290.2	160.6	166.5	162.8	184.3	225.1
RTN4RL1	"DKFZp547J144, NgR3, NGRH2"	ENSG00000185924	"Reticulon 4 receptor like 1"	Q86UN2	17	1934677-2025334	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 20.6;Cone photoreceptor cells: 37.5;Excitatory neurons: 43.5;Horizontal cells: 33.7;Inhibitory neurons: 18.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 12.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.9;HaCaT: 10.8;hTCEpi: 10.1;T-47d: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044428	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Midbody"	"Intracellular and membrane"	Yes	NA		35000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Midbody"	"HPA044428: AB_10963229"	"unprognostic (5.23e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.97e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.32e-3)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.15e-2)"	4.0	3.1	4.6	0.3	4.0	0.0	6.4	0.0	9.2	2.1	0.0	0.4	0.1	0.8	0.2	1.3	1.5	0.6	2.3	12.3	0.3	1.6	2.6	1.6	0.1	0.0	0.5	0.9	1.8	1.3	5.9	0.3	0.0	3.4	0.1	8.5	4.4	2.0	1.8	9.6	0.5	0.3	0.0	1.1	0.7	0.8	1.9	0.2	1.4	0.4	0.1	1.5	2.2	0.0	1.4	1.6	1.8	2.5	2.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.1	10.9	0.2	10.8	4.6	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.1	0.0	3.6	0.0	0.0	2.5	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.3	0.8	0.3	1.2	0.0	0.0	2.2	0.0	0.3	0.8	1.7	0.2	13.3	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	0.0	9.2	12.3	0.3	0.0	0.5	0.0	0.0	1.9	0.0	1.0	0.0	2.2	1.6	0.1	2.7	0.2	0.0	1.8	20.6	5.4	4.3	3.0	1.5	1.3	3.7	37.5	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.7	0.0	0.0	43.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.1	3.3	1.8	33.7	18.6	0.0	0.0	0.3	0.4	1.1	0.0	0.1	3.6	7.5	0.0	1.8	0.0	8.5	1.7	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.5	10.0	0.0	0.0	0.6	0.0	0.2	0.5	2.8	0.0	0.2	0.0	0.0	0.3
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	NA		67000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	43.4	40.1	27.9	34.5	31.6	55.6	44.2	37.1	33.8	52.5	24.0	50.4	28.8	49.7	14.0	45.2	45.2	17.3	46.0	27.6	31.4	39.3	42.6	45.8	39.0	32.0	29.2	54.4	44.3	22.7	43.4	27.7	31.0	46.4	17.7	32.1	42.8	19.6	85.3	60.9	48.4	20.6	23.9	58.9	43.2	43.4	32.4	43.4	42.6	30.2	29.4	43.4	47.6	44.6	94.1	81.8	95.3	62.0	41.6	36.4	111.5	68.0	43.7	56.8	47.4	124.2	52.0	149.7	52.9	33.8	48.3	86.4	92.7	55.7	58.1	101.6	94.6	109.9	75.1	118.0	39.4	136.7	93.6	33.6	50.9	50.8	53.2	40.4	45.5	65.9	156.7	75.0	43.5	84.7	146.2	109.9	128.3	63.7	81.1	144.4	105.1	104.8	44.4	76.6	88.2	76.4	76.3	61.2	76.2	54.3	56.3	74.4	71.4	57.6	71.6	72.2	106.2	121.5	112.0	133.3	55.4	112.6	77.7	65.4	47.4	84.1	55.9	47.8	57.1	53.1	55.1	54.9	53.2	47.6	56.8	55.1	53.1	54.6	79.8	44.6	58.6	55.4	27.9	31.6	37.1	33.8	27.6	31.4	32.0	29.2	31.0	23.9	32.4	44.6	34.8	32.1	21.0	33.3	59.1	65.6	50.2	41.0	51.2	41.3	28.9	30.2	43.4	17.2	47.6	16.5	35.5	53.6	47.7	41.0	25.4	44.0	10.0	56.6	55.6	38.9	29.8	29.6	28.6	35.0	55.2	42.6	33.1	46.4	50.6	52.6	23.2	28.1	38.0	50.5	29.8	43.4	32.6	23.0	52.6	8.2	35.8	37.0	30.2	30.9	55.6	30.0	50.4	34.2	41.5	32.3	29.9	25.9	50.9	44.8	33.7	28.1	72.9	47.2	19.7	44.5	45.1	89.7	94.3	37.2	65.4	62.5	52.2	44.0	40.5	38.9
SELENOO	SELO	ENSG00000073169	"Selenoprotein O"	Q9BVL4	22	50200979-50217616	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 21.1;Granulosa cells: 34.7;Proximal tubular cells: 41.7;Theca cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071795, HPA079100"	Approved		Supported	"Mitotic chromosome,Mitochondria"	"Intracellular and membrane"	Yes	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Mitotic chromosome"	"HPA071795: , HPA079100: "	"unprognostic (1.79e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.91e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (8.32e-4)"	6.7	6.7	2.3	4.5	3.4	13.9	4.8	11.7	6.8	5.6	2.5	5.3	8.0	5.9	2.8	8.2	5.7	4.1	5.3	3.0	1.1	6.6	27.9	4.7	6.4	4.6	2.7	5.0	13.1	3.0	4.1	3.0	3.7	5.6	2.0	2.9	7.7	4.1	12.3	8.2	6.5	2.4	2.3	6.5	7.0	3.7	3.1	4.4	5.1	4.1	3.9	5.1	6.1	6.0	12.0	7.7	4.2	4.7	5.6	4.1	8.6	11.8	5.6	7.0	5.5	10.6	7.5	7.9	9.2	4.7	3.9	26.2	6.5	10.7	1.4	2.3	29.9	5.7	17.4	6.4	2.8	10.6	6.9	5.4	7.2	4.5	3.5	4.5	5.8	5.3	7.8	5.6	2.9	18.6	5.7	16.4	3.7	2.8	15.6	17.6	5.9	11.8	4.3	15.3	8.4	9.3	12.8	11.3	7.5	2.1	8.7	7.5	9.5	6.0	8.3	6.5	7.1	13.8	3.6	4.7	6.8	6.9	3.5	0.0	1.1	1.3	0.2	0.4	0.5	0.0	0.2	0.5	1.1	0.2	0.1	0.4	0.5	0.0	0.4	0.4	0.2	0.3	2.3	3.4	11.7	6.8	3.0	1.1	4.6	2.7	3.7	2.3	3.1	6.0	11.8	0.0	21.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	13.3	13.2	0.0	0.0	5.6	9.2	0.0	3.1	12.2	0.0	15.6	3.6	0.0	11.8	10.9	3.0	0.0	0.0	0.0	4.6	2.4	6.0	0.0	15.2	3.8	34.7	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	4.5	0.0	0.0	41.7	3.6	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	1.9	5.5	29.6	0.0	0.0
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN7	"CDC10, CDC3, SEPT7, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 570.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Approved	"Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol"		Yes	No		4300000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoli, Plasma membrane, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	127.1	95.1	352.6	98.8	386.1	131.0	99.5	334.3	570.9	111.5	289.5	116.4	55.7	126.5	121.5	106.6	84.1	117.5	172.1	344.1	341.6	82.9	76.9	98.6	150.9	337.4	355.9	138.2	37.0	81.1	62.6	143.5	339.1	93.9	94.8	119.5	50.3	95.5	82.9	105.0	74.9	145.2	345.1	108.3	59.4	70.3	367.7	159.0	78.2	104.3	149.7	125.0	86.9	411.9	198.1	94.3	232.0	153.2	256.7	263.1	119.3	248.6	228.6	206.7	177.0	147.7	148.9	186.2	164.2	254.9	274.9	146.3	166.3	166.4	294.0	127.8	88.4	149.8	123.4	80.8	149.4	182.7	157.7	171.7	127.1	163.8	159.4	215.6	221.0	143.3	120.1	141.9	341.6	92.8	185.6	304.3	249.7	183.1	132.6	188.3	220.9	107.6	202.6	146.1	124.3	217.4	173.5	220.1	151.8	377.1	163.1	198.7	187.3	207.2	246.7	129.9	278.5	165.9	163.4	470.2	132.4	301.2	449.3	266.8	86.0	150.1	214.8	100.1	220.7	165.6	151.5	199.6	100.8	155.5	134.4	171.2	160.9	298.7	110.5	71.0	147.4	241.7	352.6	386.1	334.3	570.9	344.1	341.6	337.4	355.9	339.1	345.1	367.7	411.9	192.1	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.0	0.0	0.0	0.0	0.0	171.4	196.6	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	198.2	153.5	0.0	0.0	0.0	0.0	0.0	0.0	191.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.0	0.0	0.0	0.0	0.0	124.2	30.4	0.0	0.0	0.0
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing 7, histone lysine methyltransferase"	Q8WTS6	4	139495941-139606699	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	44.7	18.5	17.8	15.1	17.7	9.7	27.3	19.3	17.3	40.5	21.2	23.5	7.3	33.0	12.6	28.1	18.8	26.7	41.0	16.6	19.4	10.1	50.1	19.2	11.7	25.0	20.3	19.6	21.9	34.7	8.8	19.1	24.7	35.1	15.3	11.5	16.2	20.6	106.6	22.7	12.1	34.8	24.6	17.0	20.1	14.4	24.5	10.1	14.1	73.7	15.9	23.4	18.2	29.2	28.4	37.2	13.0	7.8	77.1	65.9	29.6	65.7	67.3	32.4	27.1	22.7	37.2	68.0	25.5	110.5	22.4	13.9	44.3	51.3	52.4	32.8	33.0	8.9	45.5	0.8	38.4	31.9	12.9	57.7	58.6	52.1	54.6	41.2	41.7	27.8	5.5	96.1	42.3	46.8	21.0	4.6	6.4	40.8	23.9	19.7	48.4	37.3	31.5	25.3	55.3	18.5	44.7	63.5	15.3	12.6	25.3	28.0	68.8	57.1	40.7	68.6	55.2	89.6	86.8	42.2	65.9	31.1	28.0	0.5	3.9	0.2	0.3	2.0	2.7	1.0	1.1	1.1	4.4	1.2	0.4	0.2	0.9	0.2	3.2	2.1	3.7	1.2	17.8	17.7	19.3	17.3	16.6	19.4	25.0	20.3	24.7	24.6	24.5	29.2	28.7	6.4	18.8	17.3	8.9	17.2	14.5	14.1	12.5	5.4	24.0	14.7	43.1	20.0	15.0	9.2	12.5	26.2	4.2	4.1	0.0	22.7	1.3	3.5	35.9	29.4	1.2	3.6	21.1	21.2	16.7	39.8	16.8	7.5	2.5	2.9	37.1	70.6	20.4	8.4	42.4	13.6	18.3	31.0	20.9	4.3	23.0	19.5	10.6	19.7	19.0	15.0	0.0	36.2	29.2	22.4	4.1	28.2	13.2	38.4	1.3	4.5	14.0	12.9	19.7	35.2	23.3	3.7	2.7	17.9	22.0	46.1	9.8	9.5	11.7	20.4
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354986	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	13.7	9.5	6.2	19.9	8.8	16.8	13.9	9.8	6.3	13.2	7.7	13.1	10.6	12.7	11.1	10.6	10.9	12.7	10.5	5.1	7.8	11.9	16.7	15.4	27.4	8.7	7.0	13.0	9.2	18.3	6.0	14.3	9.6	13.0	12.8	13.2	9.0	12.7	12.9	12.3	13.2	12.8	8.0	27.6	12.9	31.9	7.7	25.4	33.0	12.8	26.3	15.7	8.5	13.2	15.1	19.9	22.5	24.4	28.3	34.1	13.5	19.6	21.9	15.6	14.6	21.1	16.8	25.6	9.4	36.9	38.3	30.2	22.8	17.0	17.0	24.6	9.9	26.9	22.7	18.4	26.5	41.8	31.2	24.0	26.2	26.6	23.6	19.1	25.4	17.8	31.7	20.0	18.3	21.8	25.9	15.8	24.2	25.4	15.4	24.2	32.6	17.2	17.1	19.5	14.0	21.4	32.4	14.2	18.2	29.7	19.7	21.2	29.3	32.5	14.0	22.1	19.0	12.2	22.0	38.6	14.9	16.3	17.8	10.5	4.4	4.7	5.3	4.1	5.6	5.5	3.9	4.1	3.3	6.9	4.2	3.7	15.1	5.2	4.9	5.0	3.2	2.3	6.2	8.8	9.8	6.3	5.1	7.8	8.7	7.0	9.6	8.0	7.7	13.2	76.2	60.9	45.7	75.1	85.6	30.2	34.6	26.6	38.7	31.2	24.1	22.7	61.3	17.2	43.9	20.2	29.2	13.7	96.8	37.6	3.9	20.0	7.6	62.7	68.0	58.7	14.5	25.5	73.7	14.7	10.6	52.9	44.4	89.7	58.2	38.3	51.4	33.0	28.8	67.3	64.8	30.6	16.2	73.1	37.6	13.8	30.7	75.5	12.4	131.2	75.8	20.7	87.6	65.9	113.0	23.2	31.9	36.1	61.8	49.3	25.6	18.5	54.4	28.7	13.1	44.9	42.5	145.2	38.5	35.1	33.5	9.4	65.9	53.7	26.9	46.4
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SH2D3A	NSP1	ENSG00000125731	"SH2 domain containing 3A"	Q9BRG2	19	6752160-6767463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 117.9;Pancreatic endocrine cells: 81.3;Urothelial cells: 87.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 43.2;HaCaT: 34.2;HBEC3-KT: 67.4"					"Not detected"	"Not detected"			"HPA035722, HPA064382"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA035722: AB_10670024, HPA064382: AB_2685251"	"unprognostic (3.32e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.63e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.21e-4)"	"prognostic favorable (1.42e-4)"	"unprognostic (7.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.81e-3)"	0.9	0.4	0.2	4.6	0.2	3.4	7.5	0.1	0.6	8.0	0.5	12.8	14.3	1.2	1.0	32.5	4.3	3.5	0.6	0.1	0.1	19.6	2.6	10.8	5.2	0.4	0.2	0.8	19.7	5.9	2.8	5.9	0.2	18.1	5.4	0.9	18.7	4.1	1.5	27.6	14.4	0.3	0.2	5.7	14.2	4.4	0.3	3.3	13.0	0.0	4.1	9.1	17.0	0.5	43.2	6.2	0.1	0.2	0.0	0.0	22.6	0.3	0.0	0.0	0.0	20.3	30.8	6.6	19.6	0.0	0.0	34.2	2.3	67.4	0.0	3.6	6.6	0.3	6.9	2.6	0.1	0.6	8.6	0.0	30.3	0.0	5.9	0.8	0.0	14.8	7.3	14.3	0.0	15.3	3.2	0.2	1.6	21.5	12.0	1.2	0.1	24.8	11.5	31.4	0.0	0.2	2.3	31.7	0.1	1.0	22.0	0.4	0.7	0.7	2.2	0.5	0.4	14.1	15.8	9.2	0.2	4.8	0.3	0.1	0.0	0.0	2.6	0.1	4.2	3.6	5.9	5.2	0.1	5.6	7.7	4.2	0.1	1.8	0.1	0.4	3.2	0.9	0.2	0.2	0.1	0.6	0.1	0.1	0.4	0.2	0.2	0.2	0.3	0.5	0.7	19.2	14.2	0.3	25.8	30.7	117.9	51.4	25.0	4.1	13.6	11.4	1.9	40.0	43.9	40.5	10.4	23.8	7.7	46.6	1.9	54.1	1.6	15.4	2.9	2.8	12.1	7.8	0.1	37.1	52.8	2.6	50.0	24.9	5.7	0.3	1.8	2.9	3.6	0.0	0.2	37.9	28.5	0.6	10.3	0.8	0.6	2.2	3.6	0.0	4.2	0.8	14.4	0.0	0.1	81.3	69.7	0.0	8.0	58.6	53.9	13.1	27.0	4.6	0.0	2.2	3.5	8.7	11.4	17.6	39.9	10.8	18.0	1.1	32.0	87.9
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579066-17797124	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 123.8;retina: 75.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	0.3	0.2	63.0	0.1	69.0	0.0	0.1	92.3	123.8	2.3	1.9	0.5	0.2	2.2	1.2	0.5	2.0	0.0	4.3	77.7	26.6	16.8	0.2	1.1	0.0	27.9	28.5	1.8	3.0	0.3	26.2	0.0	25.9	1.8	0.6	75.0	0.1	0.1	0.1	0.1	0.5	1.7	29.3	0.1	8.7	6.5	41.1	0.7	1.5	0.0	0.0	4.3	0.4	55.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	7.5	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	9.3	0.0	21.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.1	0.2	2.5	0.0	2.4	0.0	0.0	0.0	0.0	41.8	26.5	0.0	0.3	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.2	0.0	1.5	0.0	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	69.0	92.3	123.8	77.7	26.6	27.9	28.5	25.9	29.3	41.1	55.5	0.0	0.0	0.0	16.3	0.0	0.1	0.4	0.0	0.0	89.4	0.1	0.0	1.8	0.0	0.0	7.3	22.9	0.0	0.0	0.1	11.7	0.0	16.7	0.2	0.1	0.3	5.3	0.0	390.8	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	13.5	140.9	0.7	0.0	0.0	0.3	47.4	1.2	0.1	0.0	13.1	0.1	9.0	0.0	41.7	10.2	0.2	0.1	0.4	0.0	2.2	0.0	22.2	0.0	28.0	0.0	0.0	0.1	2.4	6.1	0.0	0.0	0.1	0.0	1.2	0.7	0.4
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46578591-46621379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.4;lymphoid tissue: 10.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	0.7	0.5	0.5	5.1	0.5	17.4	0.9	1.2	0.6	0.6	0.4	1.9	1.2	0.6	0.6	3.5	0.2	0.6	1.0	0.4	0.2	5.4	0.2	1.0	9.8	0.4	0.3	0.3	0.2	0.2	0.2	2.4	0.4	0.3	2.2	0.2	0.8	0.2	1.5	3.3	1.5	1.7	0.1	4.4	0.9	5.2	0.5	8.8	0.3	0.2	10.6	1.2	1.2	0.7	33.8	30.8	11.9	15.3	3.1	6.2	16.2	60.7	24.6	59.2	26.8	14.6	20.8	28.0	30.2	28.8	26.8	21.0	29.3	21.7	73.8	17.7	17.2	28.2	25.8	30.3	0.1	28.5	35.4	1.2	1.6	45.9	18.1	5.9	33.0	14.9	12.7	28.3	69.7	21.5	24.0	23.7	10.0	17.2	31.6	45.4	89.9	44.8	13.7	9.4	5.0	7.2	46.0	23.7	11.1	11.4	13.0	23.4	16.1	43.9	28.7	43.5	54.0	24.9	36.7	46.7	21.4	31.3	45.8	0.2	0.3	0.6	0.2	0.5	0.0	1.7	0.3	0.1	0.3	1.2	0.0	0.1	0.4	0.1	2.4	0.7	1.2	1.1	0.5	0.5	1.2	0.6	0.4	0.2	0.4	0.3	0.4	0.1	0.5	0.7	0.2	0.0	1.1	1.3	7.1	1.7	0.7	1.2	0.0	0.3	0.6	1.1	1.9	1.5	1.4	0.0	0.0	11.3	0.8	1.9	0.0	0.2	8.4	0.7	1.7	1.7	0.0	36.2	2.1	0.0	28.7	3.7	4.1	1.5	0.0	7.6	1.8	0.3	12.6	0.0	0.7	2.2	2.0	4.5	3.3	2.3	0.6	4.0	1.8	2.8	2.8	0.8	0.0	1.0	0.5	0.1	0.1	0.4	38.3	0.5	0.4	0.1	0.1	0.3	0.0	0.5	6.3	33.7	23.7	3.6	0.6	3.7	2.2	0.8	3.4	1.1
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176552	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.1;testis: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle"	"Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.2	2.5	0.2	4.7	0.8	0.1	0.3	0.2	0.0	1.7	1.0	0.5	0.0	1.9	0.2	0.4	0.0	0.5	0.2	0.1	0.2	0.2	4.3	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.0	3.0	0.0	0.2	0.0	0.0	1.8	2.1	1.1	0.2	0.7	1.0	6.3	0.3	12.1	0.1	0.1	3.7	0.4	0.5	0.2	26.1	13.0	25.8	20.5	0.9	5.1	19.1	35.0	14.8	42.1	28.7	23.4	27.8	35.6	10.0	19.3	18.5	24.4	34.4	15.2	54.7	30.3	15.9	47.3	7.7	12.7	0.0	39.5	17.7	1.5	1.0	34.9	15.4	4.2	20.7	30.6	26.3	14.2	33.9	21.0	60.7	37.8	27.9	42.8	23.8	36.5	50.3	15.8	12.2	9.9	30.1	11.1	11.8	17.1	8.1	17.9	15.3	33.5	8.7	16.0	23.8	17.0	43.9	9.0	19.7	34.5	4.4	31.1	51.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.2	0.2	0.1	0.3	0.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.4	0.0	0.0	0.0	2.6	2.0	0.7	2.4	0.0	0.1	0.9	0.8	0.8	0.0	1.8	0.0	0.0	8.7	1.0	2.1	0.0	1.2	6.3	2.8	0.9	1.4	0.0	12.8	0.8	1.3	21.0	2.1	1.5	1.6	0.0	5.8	1.8	0.4	5.5	0.0	0.6	1.8	2.0	1.9	2.9	7.7	1.5	1.6	0.0	1.9	0.8	0.3	3.1	0.0	0.2	1.0	1.6	1.2	8.5	0.3	0.4	0.6	2.0	0.4	0.0	0.3	2.3	21.7	18.2	5.8	2.8	2.2	1.2	0.5	5.0	0.7
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959117-31969751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	21.9	33.1	0.0	5.2	0.3	4.1	21.6	0.0	0.4	26.5	0.0	25.1	10.5	22.6	9.4	23.0	25.0	0.0	22.0	0.0	0.1	24.0	54.7	22.2	3.4	0.0	0.5	24.6	25.7	2.4	39.7	2.6	0.0	31.9	2.4	2.1	22.4	3.2	20.4	20.2	31.2	5.7	0.0	40.6	27.6	16.6	0.1	4.3	27.7	5.3	2.7	23.6	20.9	0.0	0.2	12.7	13.3	0.0	16.5	11.8	27.1	10.9	11.7	13.6	13.2	0.4	0.0	0.0	26.0	25.5	13.2	11.9	0.0	30.8	9.9	14.8	15.7	0.0	0.0	0.2	0.0	0.1	0.2	28.3	17.9	0.1	0.0	12.7	0.0	19.3	0.0	13.6	0.0	0.0	0.0	0.3	20.6	0.0	0.0	0.3	0.0	0.0	11.2	0.0	0.0	0.0	23.6	0.0	17.6	11.5	0.0	15.7	12.8	16.0	7.2	18.7	0.2	42.2	35.7	12.0	20.4	0.1	0.0	0.3	0.5	0.2	1.5	1.4	1.1	0.2	0.7	0.3	1.1	0.9	0.8	0.8	0.1	0.0	2.2	0.5	0.2	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	6.4	16.0	11.3	10.1	13.3	2.8	5.0	7.9	11.4	5.0	9.3	5.1	8.5	10.0	8.8	7.3	8.4	12.6	12.7	19.7	1.9	9.5	3.1	7.7	7.9	7.9	12.6	6.5	7.2	8.6	7.9	7.4	28.1	6.3	8.2	10.8	8.6	19.4	9.2	0.0	5.0	13.2	8.2	6.3	4.1	1.5	9.3	7.8	7.2	2.8	10.2	4.9	18.6	3.0	4.8	9.4	16.0	6.0	20.2	5.9	25.5	6.9	16.5	8.3	0.0	4.1	10.2	4.7	7.5	6.6	3.7	12.4	14.4	12.3	11.0	5.2
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306912	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 43.3;choroid plexus: 55.5"	"Group enriched"	"Detected in many"	5	"Enteroendocrine cells: 103.2;Horizontal cells: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 49.2;SH-SY5Y: 70.7;U-2 OS: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Microtubules, Cytokinetic bridge"		"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	43.3	8.2	13.2	0.7	16.2	0.6	13.3	16.0	20.0	4.9	55.5	3.1	4.6	5.4	5.0	1.1	4.0	1.6	3.7	26.3	28.5	7.9	9.2	0.9	0.2	23.2	26.1	2.2	15.4	1.7	3.6	0.6	23.6	5.8	1.8	4.1	1.3	0.7	2.6	3.0	5.5	1.8	17.2	1.6	6.5	2.6	30.0	0.3	9.7	0.4	0.1	2.4	2.0	7.4	0.0	21.7	12.6	49.2	0.6	0.2	2.4	1.8	0.1	1.6	0.9	12.3	0.4	0.0	2.4	1.9	8.1	0.3	4.8	0.4	0.5	0.1	2.8	0.2	0.7	18.3	3.8	0.2	3.0	1.5	16.2	0.3	0.9	2.9	1.5	4.5	3.6	0.1	1.2	10.8	2.0	0.9	16.0	1.5	1.3	8.3	2.1	1.9	3.2	0.5	8.4	70.7	1.3	4.4	0.9	10.7	5.5	5.9	0.7	17.3	23.4	1.6	0.5	1.1	0.0	0.1	2.2	0.7	8.0	0.8	0.3	0.2	0.2	0.1	0.4	0.2	0.1	0.2	0.1	0.4	0.2	0.2	1.3	1.6	0.1	0.3	0.1	0.1	13.2	16.2	16.0	20.0	26.3	28.5	23.2	26.1	23.6	17.2	30.0	7.4	0.5	3.2	0.5	8.8	0.0	0.1	0.2	0.1	0.0	6.9	0.7	0.6	2.5	0.0	0.2	0.0	16.7	0.3	0.2	6.3	0.0	5.3	0.1	3.3	3.0	0.6	103.2	0.0	2.4	0.2	0.4	2.2	2.0	0.7	0.0	25.7	0.0	1.0	0.4	168.2	14.3	4.4	0.0	0.3	0.7	0.7	0.3	0.3	0.0	0.0	0.1	4.8	0.0	4.0	0.6	1.4	0.5	0.4	0.1	2.3	0.8	0.2	1.4	1.6	0.0	0.5	2.2	0.4	4.2	0.1	0.3	0.3	0.3	1.7	1.0	0.2
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLFN13	FLJ31952	ENSG00000154760	"Schlafen family member 13"	Q68D06	17	35435096-35448837	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.6;salivary gland: 32.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.3;Endometrial ciliated cells: 59.9;NK-cells: 60.8;Plasma cells: 38.2;Respiratory ciliated cells: 75.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 5.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.5;NK-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 38.9;HL-60: 131.9;REH: 75.0;U-266/70: 63.2"									"HPA022532, HPA023064"	Uncertain		Approved	"Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Cytokinetic bridge"		"HPA022532: AB_1856615, HPA023064: AB_1856616"	"unprognostic (1.11e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	3.1	0.9	1.5	9.1	1.1	25.6	9.9	1.2	0.9	6.2	5.7	5.8	8.5	4.8	2.9	3.5	16.9	6.6	1.8	1.0	1.2	2.6	2.1	6.4	10.5	1.3	1.4	1.1	3.2	14.5	0.5	1.9	1.2	2.1	6.5	0.1	32.5	4.2	0.7	2.3	4.5	4.2	1.0	13.7	11.3	0.6	1.2	10.0	7.9	0.8	11.6	2.5	1.5	1.7	0.2	7.0	13.7	0.1	0.4	1.4	0.2	1.7	0.5	6.7	10.6	0.0	0.1	0.0	38.9	1.3	0.3	11.7	1.4	4.9	7.6	3.9	2.2	37.2	6.5	0.1	0.6	131.9	1.0	0.4	0.6	3.6	0.1	0.0	2.2	0.4	0.1	36.8	0.2	0.1	0.9	28.4	6.8	0.0	0.0	75.0	0.5	3.8	11.6	34.1	0.0	0.0	0.0	6.2	0.3	0.9	9.8	20.9	0.3	0.1	2.0	10.1	0.5	63.2	9.5	0.2	0.2	20.9	1.0	3.7	0.2	4.5	1.2	0.3	1.0	0.9	0.5	0.6	0.2	0.9	0.4	0.3	0.8	5.3	0.1	0.1	0.5	0.4	1.5	1.1	1.2	0.9	1.0	1.2	1.3	1.4	1.2	1.0	1.2	1.7	6.2	0.0	3.7	0.0	7.3	1.0	3.1	4.7	5.7	0.2	14.5	9.1	0.8	27.1	12.5	5.5	0.0	0.8	56.3	2.1	1.9	1.2	0.1	59.9	3.6	3.4	3.0	19.1	0.1	0.4	0.4	1.6	8.2	11.7	3.8	3.8	1.8	0.6	1.6	0.0	0.1	4.5	12.2	1.0	1.7	0.0	0.9	3.2	0.0	2.8	1.8	0.2	60.8	0.0	0.1	1.3	0.6	0.4	38.2	1.0	0.5	1.3	75.4	0.2	0.0	0.4	3.8	0.2	0.6	6.7	1.1	0.0	16.6	3.3	4.2	1.4
SNPH	bA314N13.5	ENSG00000101298	Syntaphilin	O15079	20	1266280-1309328	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 75.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Bipolar cells: 24.3;Excitatory neurons: 60.6;Horizontal cells: 30.3;Inhibitory neurons: 71.7;Oligodendrocyte precursor cells: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049393	Approved		Uncertain	"Cytokinetic bridge,Mitochondria"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Cytokinetic bridge"	"HPA049393: AB_2680744"	"unprognostic (1.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	1.6	3.7	47.2	1.5	49.6	0.6	1.6	7.5	75.5	4.0	0.0	8.4	1.5	6.4	1.9	1.8	6.5	2.6	7.1	54.0	19.0	2.7	0.3	2.4	1.6	38.0	19.0	2.1	3.5	4.4	12.5	0.6	38.1	5.9	0.8	12.9	6.1	11.1	7.2	1.2	4.6	4.8	7.1	1.7	5.1	3.9	33.3	0.9	5.0	1.6	0.8	4.7	3.0	44.3	2.3	7.6	0.1	6.5	7.6	4.0	0.0	4.1	5.2	4.4	2.0	0.3	0.7	0.4	2.4	4.9	10.9	1.2	1.0	5.7	0.8	1.6	1.8	4.7	1.2	0.1	4.0	0.0	7.1	2.7	2.7	4.5	0.9	4.3	5.6	4.5	0.9	0.2	4.0	0.0	0.4	0.2	2.4	0.0	5.7	0.0	1.5	0.1	5.8	3.4	0.4	2.0	4.1	0.2	5.8	0.6	0.3	0.1	9.6	7.1	5.3	6.4	1.2	0.6	1.4	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.1	0.5	47.2	49.6	7.5	75.5	54.0	19.0	38.0	19.0	38.1	7.1	33.3	44.3	0.5	0.0	0.0	45.7	0.6	0.1	0.1	2.2	1.2	24.3	2.4	0.9	4.7	4.3	1.2	3.7	6.2	0.0	2.3	0.9	0.0	0.4	10.4	0.2	0.7	1.0	8.4	0.0	60.6	0.6	0.1	1.3	5.6	0.5	0.0	2.1	2.2	0.0	0.3	30.3	71.7	1.0	2.0	0.0	0.3	5.4	1.5	0.2	0.0	9.4	0.2	2.7	1.0	38.2	1.7	1.1	1.0	4.1	0.4	1.6	0.1	1.7	1.2	20.3	6.6	2.6	1.7	1.3	0.5	0.2	0.1	0.0	1.6	1.2	1.8	0.1
SNRNP25	"C16orf33, U11/U12-25K"	ENSG00000161981	"Small nuclear ribonucleoprotein U11/U12 subunit 25"	Q9BV90	16	53828-57669	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 131.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 156.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 219.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041183, HPA044248"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041183: AB_2677353, HPA044248: AB_2678873"	"unprognostic (7.87e-2)"	"prognostic favorable (1.95e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.03e-3)"	15.2	29.3	80.7	20.6	81.4	32.7	16.1	95.2	98.3	14.0	74.4	27.2	12.9	15.9	16.3	20.1	16.0	10.4	85.3	81.7	81.0	25.0	39.2	10.8	32.6	86.3	82.7	19.8	19.7	24.6	30.7	8.7	87.0	19.8	17.5	12.4	22.9	13.8	131.6	10.9	16.5	15.1	81.8	19.0	27.6	11.0	88.0	22.5	17.7	84.5	31.2	17.2	11.9	80.1	50.1	111.2	60.7	70.8	21.2	24.9	29.5	41.4	26.5	90.7	76.1	150.4	47.5	157.3	48.3	34.2	48.6	50.4	111.8	76.2	69.2	57.3	87.8	91.6	155.3	152.9	22.4	168.9	103.9	32.1	27.0	80.8	22.4	19.6	49.6	93.5	139.2	36.5	52.2	236.5	89.5	70.0	72.8	88.4	54.5	141.9	64.6	186.9	48.6	34.7	66.2	42.9	93.4	119.8	20.7	59.0	77.5	80.8	39.3	40.0	49.6	51.8	67.2	37.6	96.9	248.2	21.3	89.5	62.3	15.1	25.5	93.3	14.9	40.3	17.9	74.3	15.1	17.9	49.6	75.1	15.9	16.3	17.2	22.5	35.9	219.7	26.1	23.2	80.7	81.4	95.2	98.3	81.7	81.0	86.3	82.7	87.0	81.8	88.0	80.1	16.5	12.8	14.3	6.8	53.4	18.6	27.2	39.5	14.8	17.9	48.1	51.9	113.0	18.6	29.3	33.1	4.2	54.6	62.3	30.9	156.5	41.6	3.0	27.3	23.8	18.9	44.0	58.5	9.9	51.4	63.3	29.3	30.1	36.9	4.5	62.3	16.4	67.5	114.5	11.8	9.8	34.5	69.2	26.4	59.8	6.5	21.5	36.2	62.2	5.6	94.3	89.0	32.0	4.5	6.5	31.0	44.8	29.7	65.9	31.5	24.0	87.6	53.2	14.5	6.6	29.4	35.7	33.7	44.8	35.8	21.9	26.1	22.4	105.0	53.5	27.7
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.8;skin 1: 14.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 57.5;Syncytiotrophoblasts: 98.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 11.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 92.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"		Yes	No				"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.72e-4)"	0.9	0.9	0.1	0.6	0.1	0.0	3.9	0.4	0.1	1.3	0.1	1.4	1.6	0.3	3.9	5.5	1.1	0.1	0.3	0.1	0.2	1.0	0.0	3.1	0.6	0.7	0.4	0.9	0.4	6.2	0.2	22.8	1.0	1.8	0.7	0.1	0.9	10.2	0.1	14.6	4.7	0.3	0.5	0.8	0.3	0.2	0.2	1.1	1.1	0.1	1.9	2.7	3.9	0.1	6.8	0.8	0.0	0.0	0.0	0.0	92.3	0.4	0.4	1.8	0.4	20.1	1.9	0.0	0.6	0.0	1.3	2.8	0.1	3.4	0.5	0.2	0.7	0.1	1.5	0.6	0.1	0.0	0.0	0.1	1.8	0.0	1.8	0.2	0.2	0.2	4.7	0.1	0.1	1.8	0.0	0.1	0.0	8.2	1.6	0.0	0.0	0.2	0.5	11.9	2.9	0.1	0.1	11.9	0.0	16.8	4.8	0.0	6.3	0.4	2.6	0.0	0.5	0.8	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.2	0.7	0.4	1.0	0.5	0.2	0.1	1.3	0.0	0.0	1.0	0.2	0.1	2.6	4.6	4.0	0.0	6.0	6.1	0.5	0.0	0.8	1.8	0.0	57.5	0.3	5.2	0.0	0.7	0.1	0.4	0.1	2.7	1.8	0.0	0.2	0.8	3.9	0.7	0.0	0.7	0.0	0.2	0.7	0.1	4.1	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	3.2	0.0	0.1	3.8	13.4	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.6	1.1	0.9	98.8	0.3	0.1	3.3	6.3
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599025	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;kidney: 37.8;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 11.7;T-reg: 4.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.7;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.2	3.3	7.8	7.8	7.6	37.9	2.4	5.8	9.1	2.6	3.4	8.3	7.9	1.9	2.4	8.3	1.7	1.8	1.4	7.6	7.7	37.8	14.8	3.4	14.5	6.7	6.8	2.7	1.5	1.1	4.3	5.7	6.7	2.2	10.7	10.8	2.4	0.8	1.0	5.5	9.1	3.4	5.0	7.4	3.6	74.0	7.7	22.4	8.7	0.7	17.3	2.6	3.6	7.5	84.7	87.7	103.3	78.4	5.2	8.6	42.4	65.9	42.4	98.1	78.3	69.2	25.5	59.8	34.2	46.8	91.7	70.2	114.5	42.7	103.8	108.6	72.9	62.9	87.9	80.2	0.6	83.1	76.1	2.9	3.8	78.6	40.4	14.5	52.1	90.6	69.7	101.5	80.7	52.6	109.4	92.9	54.2	68.3	44.5	72.1	144.4	70.9	29.0	43.0	78.6	45.8	96.4	114.9	31.6	84.9	82.2	70.6	25.7	56.4	91.3	46.6	114.6	46.7	72.9	87.3	37.8	60.6	91.8	11.7	0.0	0.0	0.4	0.4	0.7	0.6	1.2	0.9	0.1	1.4	1.1	0.9	0.2	0.8	0.3	0.3	4.9	0.9	7.8	7.6	5.8	9.1	7.6	7.7	6.7	6.8	6.7	5.0	7.7	7.5	0.5	3.2	1.7	0.7	3.3	2.0	0.9	1.3	1.2	5.0	1.1	1.0	0.7	0.0	1.9	0.0	0.0	9.0	1.3	4.7	1.9	0.5	126.0	6.0	1.1	1.5	13.1	37.2	5.2	0.4	12.2	2.6	5.1	1.8	1.3	12.6	3.3	6.3	6.5	3.3	6.0	4.6	4.1	2.7	4.0	25.2	0.9	6.1	0.0	1.9	0.9	0.7	0.0	2.0	1.7	0.4	4.7	0.0	13.1	0.8	8.1	12.5	7.7	3.9	6.6	2.0	2.2	72.6	21.0	5.2	1.0	3.8	2.8	0.9	5.1	1.1
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 101.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.2	16.9	25.8	18.6	33.7	0.1	19.5	26.3	22.3	43.8	7.8	31.8	31.6	36.5	15.2	17.3	63.1	101.4	30.6	28.2	28.3	12.2	2.0	49.2	1.6	25.6	33.6	23.9	4.6	0.8	10.0	41.3	26.4	16.9	46.6	63.8	7.0	8.8	0.8	8.8	28.4	46.9	14.9	8.3	28.8	2.5	34.0	1.7	5.2	1.6	1.2	51.5	12.5	21.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.8	33.7	26.3	22.3	28.2	28.3	25.6	33.6	26.4	14.9	34.0	21.8	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
SRA1	"SRA, STRAA1"	ENSG00000213523	"Steroid receptor RNA activator 1"	Q9HD15	5	140537340-140558252	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Receptor, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044598, HPA050153"	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA044598: AB_2679013, HPA050153: AB_2681033"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (8.01e-6)"	"unprognostic (9.32e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-1)"	12.2	34.0	8.7	7.7	9.0	9.6	9.7	15.8	12.3	10.0	9.2	12.5	5.1	8.2	6.0	9.3	9.4	5.6	12.0	9.9	9.3	12.4	25.8	15.0	6.3	8.4	8.2	14.9	7.5	4.7	22.2	5.8	8.8	12.5	4.7	7.2	14.8	6.2	14.5	9.4	11.9	5.4	8.6	17.6	14.0	22.6	8.9	5.6	12.9	2.5	5.2	9.4	8.8	9.2	9.7	22.7	11.8	12.3	5.6	7.6	16.4	16.1	9.1	10.3	10.8	41.8	5.9	8.2	11.7	6.2	5.5	6.4	2.1	12.0	4.1	12.7	13.9	7.2	25.0	16.1	12.0	13.1	9.4	14.7	6.1	5.5	2.8	9.1	4.7	13.8	7.4	12.1	6.9	29.5	10.7	20.4	3.6	5.2	18.0	11.7	10.0	7.9	5.4	11.3	8.3	9.8	9.4	8.5	11.6	4.1	10.5	14.7	7.5	9.7	5.1	8.5	13.2	15.1	10.9	8.6	12.0	16.8	6.5	16.1	26.0	20.3	10.7	23.8	9.9	15.8	10.2	10.4	25.2	14.0	8.2	9.4	43.0	13.6	23.6	15.2	19.5	26.8	8.7	9.0	15.8	12.3	9.9	9.3	8.4	8.2	8.8	8.6	8.9	9.2	43.3	6.4	49.4	13.4	46.7	52.4	68.5	126.1	38.7	23.6	57.8	48.9	71.7	57.2	86.4	33.1	8.4	103.7	56.9	87.8	113.5	102.7	104.6	59.5	33.4	39.8	38.4	35.1	15.5	148.2	117.9	48.6	64.7	43.1	68.4	21.8	42.1	69.7	93.1	15.2	17.2	71.6	107.8	61.2	71.5	150.0	25.1	82.0	67.6	7.5	90.4	59.5	42.2	9.0	11.5	186.0	78.7	29.7	113.7	82.9	83.7	131.0	84.1	23.7	26.3	26.7	76.1	77.2	30.7	62.3	45.9	179.0	47.4	66.8	49.2	142.6
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.2;brain: 17.0;parathyroid gland: 6.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 106.1;Inhibitory neurons: 75.5;Oligodendrocyte precursor cells: 32.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		Yes	NA		24000		"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.1	12.2	4.0	0.0	12.9	0.2	0.0	17.0	11.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	6.2	0.0	1.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	6.2	0.5	0.0	1.4	0.1	0.0	0.7	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.2	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	87.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	12.9	17.0	11.4	6.2	0.0	0.4	0.1	1.4	0.0	0.0	7.7	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	7.8	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.9	0.0	3.1	0.0	0.1	0.2	0.0	0.0	106.1	0.0	0.0	0.2	0.0	0.0	0.0	12.9	0.0	0.0	0.1	0.0	75.5	0.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.7	0.0	1.1	0.0	32.2	9.1	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.6	0.0	0.6	0.2	0.8	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.1
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328776-133336188	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	10.4	11.7	8.1	4.1	7.8	4.9	10.3	8.7	7.5	12.4	5.9	13.6	6.2	11.9	2.6	12.5	11.2	2.5	10.5	7.2	7.5	11.7	12.3	8.5	5.5	7.7	7.8	13.1	11.2	3.9	8.1	3.3	7.8	11.5	3.4	3.3	9.7	4.0	17.9	13.2	12.1	2.7	7.5	11.4	9.9	7.9	7.9	4.6	10.6	3.9	3.7	12.2	11.1	8.1	5.6	8.7	6.5	9.8	4.0	3.7	10.8	8.8	5.1	7.7	4.8	13.8	9.2	16.2	6.7	4.9	5.6	16.7	8.4	9.3	2.8	10.8	9.6	11.2	10.5	8.3	7.2	19.1	9.3	5.3	8.0	8.0	7.4	6.8	4.0	15.6	25.1	8.4	6.8	14.7	15.5	15.7	19.1	22.7	15.6	16.1	9.1	16.7	6.7	5.3	13.7	11.6	8.6	13.7	7.8	3.9	12.2	10.6	8.4	17.3	9.3	8.9	12.0	6.2	9.6	21.0	6.5	12.9	10.4	3.3	3.0	1.4	4.3	2.9	4.5	4.6	3.9	3.9	3.3	5.1	5.2	4.4	0.8	3.2	2.7	6.0	3.6	2.5	8.1	7.8	8.7	7.5	7.2	7.5	7.7	7.8	7.8	7.5	7.9	8.1	25.7	44.8	27.3	4.6	20.9	23.7	15.7	11.0	24.5	26.5	33.4	32.3	30.0	28.6	24.5	22.0	6.2	32.2	20.3	36.8	21.5	29.2	1.3	21.1	42.2	23.6	33.6	14.1	4.3	19.6	25.2	21.2	18.8	25.1	25.3	25.4	16.4	35.2	21.2	21.9	4.8	40.3	6.1	14.7	10.2	4.1	27.7	13.7	7.2	5.6	18.6	15.2	29.9	5.0	4.1	29.0	33.3	27.8	14.4	24.8	50.6	26.1	13.2	19.6	0.0	15.8	20.3	19.2	23.6	26.3	27.6	19.0	18.1	91.1	57.7	13.3
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: AB_2682974, HPA060385: AB_2684271"	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	10.0	9.3	2.5	18.2	3.0	16.4	12.6	5.0	6.7	7.7	1.2	9.5	13.7	14.1	9.0	9.5	7.7	15.4	7.1	2.9	3.5	6.8	6.9	8.1	20.6	2.3	0.6	13.8	20.9	5.3	4.9	18.0	2.3	9.9	12.5	8.2	10.1	7.3	8.0	11.4	13.3	9.1	0.5	11.9	11.9	5.5	1.7	10.9	10.1	7.1	13.1	13.8	7.2	7.8	18.2	8.6	17.5	17.9	14.0	47.8	29.2	27.0	11.5	18.4	13.8	28.6	38.8	32.6	34.0	15.6	12.6	44.3	21.5	25.9	21.2	10.6	7.8	34.8	55.6	20.2	16.4	31.9	25.1	19.5	25.8	16.0	35.7	35.0	23.7	22.7	24.2	50.4	22.8	5.0	25.8	66.4	12.1	16.7	9.6	23.3	19.1	30.9	22.7	17.4	10.7	19.5	10.8	38.2	16.5	19.3	32.7	12.4	28.7	26.9	30.5	44.2	28.7	22.9	26.2	32.5	11.2	36.9	10.3	44.2	16.7	28.8	17.3	12.5	17.7	39.1	24.9	19.8	12.0	39.8	28.4	24.1	42.7	18.1	10.8	26.1	18.2	5.2	2.5	3.0	5.0	6.7	2.9	3.5	2.3	0.6	2.3	0.5	1.7	7.8	106.7	89.8	95.5	20.9	246.1	244.2	252.4	66.6	255.0	86.6	129.4	130.9	26.2	134.4	105.3	29.5	39.6	176.0	162.5	94.5	45.0	95.2	19.9	144.9	184.9	121.3	110.2	98.4	41.6	146.3	170.2	147.1	125.4	245.6	104.4	257.2	63.1	54.2	69.3	69.0	38.2	148.0	24.4	103.7	153.6	16.5	128.6	112.0	80.0	24.4	102.1	34.8	89.6	35.2	44.0	110.4	87.5	67.7	162.2	269.2	71.1	101.5	67.7	78.2	72.3	187.4	123.1	49.0	71.5	251.4	203.0	160.9	182.3	119.7	174.1	356.8
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 224.8;Spermatocytes: 82.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA075923, HPA077353"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Vesicles	"HPA075923: , HPA077353: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.7	3.3	3.0	5.1	0.2	0.8	7.8	5.4	1.2	1.8	1.0	0.7	0.9	3.4	0.6	0.8	2.2	1.6	4.1	2.6	2.1	2.5	0.7	4.0	3.9	3.2	1.1	1.1	0.4	3.0	1.6	4.1	2.0	0.3	8.9	1.3	0.6	2.3	3.5	0.7	0.4	2.7	2.5	0.8	30.3	3.7	0.0	5.6	0.1	0.1	1.1	0.8	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.1	7.8	5.4	4.1	2.6	3.9	3.2	4.1	2.7	3.7	4.0	0.8	9.6	0.5	3.9	0.0	0.5	0.4	0.1	1.2	11.3	0.4	0.8	3.4	0.0	3.8	7.3	6.2	0.0	0.0	0.0	1.9	0.3	224.8	1.0	2.2	1.2	4.2	0.0	13.6	0.2	0.0	1.0	0.0	0.7	0.0	0.4	0.7	3.0	0.1	5.0	14.7	0.3	0.0	0.3	0.0	33.8	4.1	0.5	3.6	6.5	0.0	1.1	0.0	14.6	17.8	0.1	0.0	4.5	0.0	0.6	0.4	0.4	0.2	7.5	13.1	3.0	0.5	82.7	34.7	0.0	1.6	0.0	0.0	1.4	0.5	0.2
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 986.1;Late spermatids: 397.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 216.4;MOLT-4: 423.3;REH: 222.7;U-698: 366.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	18.8	15.1	7.8	9.2	8.9	50.3	18.9	21.2	12.7	12.1	8.2	14.8	22.7	15.3	15.9	13.7	14.7	19.4	26.0	9.0	7.0	29.5	17.3	11.8	10.5	12.5	10.6	23.3	12.4	16.7	13.0	28.4	12.4	19.4	14.0	13.2	12.3	13.7	28.5	11.9	21.3	14.4	7.4	9.5	12.4	69.9	8.2	169.7	21.6	21.3	10.6	11.2	10.2	10.0	32.8	14.7	61.6	49.4	20.3	21.9	134.0	16.3	18.8	25.5	40.2	19.2	32.2	115.8	73.7	18.7	44.6	19.5	15.8	31.2	35.8	46.9	28.5	140.4	21.5	26.0	19.6	43.1	47.8	20.6	22.8	27.8	26.9	23.5	18.3	216.4	53.5	6.8	44.3	25.4	423.3	16.1	49.6	17.2	20.0	222.7	42.2	27.0	29.4	16.5	26.9	25.0	54.5	19.5	29.0	45.3	46.7	21.9	12.0	24.2	21.9	19.8	20.7	20.7	20.5	366.5	19.4	11.4	11.6	69.3	4.0	48.0	28.0	6.9	10.9	14.7	12.8	14.9	9.8	18.7	18.6	22.2	4.4	37.4	10.0	33.7	12.8	12.5	7.8	8.9	21.2	12.7	9.0	7.0	12.5	10.6	12.4	7.4	8.2	10.0	29.7	32.1	30.6	64.0	24.2	25.1	52.1	30.4	43.3	33.0	45.1	36.8	87.6	45.8	30.7	47.8	33.3	235.4	98.5	23.1	93.9	36.8	986.1	63.9	51.1	26.8	38.6	171.9	194.6	26.4	125.2	44.0	15.8	35.8	33.5	84.8	27.8	39.8	27.8	37.0	166.7	27.1	40.7	13.5	15.4	397.5	77.0	27.0	5.4	51.5	14.9	26.1	128.8	61.9	116.6	27.2	25.7	75.2	25.2	36.3	87.5	98.4	43.1	34.5	26.3	96.7	38.6	75.4	75.6	31.3	20.0	99.2	42.9	72.4	42.0	36.0
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TIGD1	EEYORE	ENSG00000221944	"Tigger transposable element derived 1"	Q96MW7	2	232543883-232550557	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041717	Approved		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoli rim, Mitotic chromosome"	"Nucleoplasm, Nuclear bodies"	"HPA041717: AB_2677636"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.40e-2)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (3.77e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-3)"	1.8	2.3	6.3	2.3	5.3	6.5	2.7	13.4	7.8	3.2	5.4	2.8	1.9	2.6	2.9	2.8	3.8	1.9	2.4	5.0	4.5	7.4	2.7	2.5	3.4	3.2	2.4	5.7	2.9	1.6	5.0	2.0	4.1	4.4	2.1	10.4	2.7	1.7	4.0	4.2	3.6	1.3	1.5	6.1	3.3	5.2	4.5	3.3	4.7	1.4	2.2	2.8	3.0	9.7	3.1	2.3	4.7	7.5	1.7	2.3	3.6	2.1	1.2	2.6	2.9	2.8	3.6	5.0	1.5	1.6	2.8	3.2	4.1	1.3	3.8	3.0	3.9	4.5	7.7	3.5	1.1	3.6	2.9	2.6	1.2	2.6	1.6	2.5	1.5	6.5	3.6	5.0	2.1	5.3	4.9	8.3	2.8	1.9	2.7	4.7	6.3	2.3	1.5	3.5	6.1	6.0	2.2	2.1	2.3	3.3	3.1	3.9	2.5	4.3	4.5	2.7	2.1	4.8	3.4	4.5	2.5	3.6	2.6	1.6	1.7	1.8	1.9	1.4	1.9	1.7	2.0	1.5	1.1	2.1	3.1	2.5	2.3	1.8	1.5	1.2	1.6	0.7	6.3	5.3	13.4	7.8	5.0	4.5	3.2	2.4	4.1	1.5	4.5	9.7	2.4	9.6	3.9	4.2	5.3	1.3	4.5	2.3	1.8	4.9	2.5	2.2	2.0	1.5	2.9	3.7	8.4	2.2	3.1	1.7	0.0	3.6	4.2	1.0	3.6	1.7	1.2	6.5	4.5	1.5	1.3	3.1	7.7	1.5	0.0	6.4	1.4	0.7	1.4	6.7	5.7	1.5	2.0	1.6	1.7	0.7	4.7	2.4	1.8	1.0	2.8	7.5	5.2	5.0	8.1	2.0	2.4	1.9	5.6	2.6	3.5	1.4	1.7	7.0	6.6	3.7	2.0	3.9	5.7	3.7	2.0	1.4	4.1	4.0	3.0	2.9
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TMEM107	"JBTS29, MGC10744, MKS13"	ENSG00000179029	"Transmembrane protein 107"	Q6UX40	17	8172457-8176399	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease variant, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 110.8;Respiratory ciliated cells: 164.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052555, HPA059653"	Approved		Approved	"Nucleoplasm,Plasma membrane,Midbody ring"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Plasma membrane"	"Midbody ring"	"HPA052555: AB_2681870, HPA059653: AB_2684096"	"unprognostic (2.87e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.49e-1)"	9.6	13.4	11.1	6.6	12.0	15.0	9.8	12.2	13.3	10.6	19.3	9.0	3.5	11.3	20.7	10.5	27.0	7.2	9.2	11.9	12.8	14.7	4.4	11.3	7.4	13.0	12.6	7.8	11.2	16.9	23.5	6.8	12.2	7.3	5.0	29.6	10.7	6.5	1.6	12.0	7.6	6.6	12.1	13.7	8.0	17.1	12.3	8.9	16.1	1.8	7.6	8.4	9.6	12.5	45.0	16.9	21.8	11.3	12.2	17.8	4.8	11.1	8.2	8.2	10.9	2.0	26.6	10.5	14.6	9.7	7.4	30.5	8.3	16.9	13.6	18.1	11.5	7.6	29.0	4.7	4.9	2.6	8.3	7.9	11.2	20.7	9.4	18.4	13.1	17.7	5.9	23.5	18.0	12.2	6.8	7.7	2.2	6.3	7.2	13.1	6.5	19.1	15.8	3.5	7.3	10.7	13.5	2.4	9.1	5.1	8.1	8.8	10.6	4.8	9.6	7.6	6.1	9.5	5.5	4.9	27.3	10.0	8.7	21.0	22.1	51.6	28.2	27.9	24.3	45.4	27.6	30.3	19.7	59.2	30.9	32.2	20.0	26.4	56.8	31.6	24.8	21.0	11.1	12.0	12.2	13.3	11.9	12.8	13.0	12.6	12.2	12.1	12.3	12.5	30.8	9.6	9.8	2.9	38.1	19.2	19.5	35.2	11.4	17.3	31.1	43.3	7.9	35.8	25.1	33.1	45.9	17.3	30.0	12.9	13.7	21.7	12.2	99.9	22.9	25.1	9.1	15.4	5.1	11.1	21.3	18.2	48.9	26.9	36.7	12.7	27.1	24.0	45.5	11.8	3.6	14.1	16.2	45.6	31.6	10.1	12.8	55.9	33.8	3.7	22.0	37.7	28.8	1.5	1.7	11.0	12.7	15.1	110.8	16.3	26.0	21.7	164.3	63.2	0.0	15.3	16.8	69.4	50.3	13.0	28.6	13.3	34.8	13.2	17.6	11.1
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269983-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 75.7;pancreas: 89.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 121.8;Alveolar cells type 2: 136.9;Distal enterocytes: 72.7;Proximal enterocytes: 164.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.8;BEWO: 21.8;CACO-2: 20.6;CAPAN-2: 48.3;OE19: 31.3;SK-BR-3: 41.2;T-47d: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol		Yes	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favorable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.3	0.7	17.4	3.2	32.2	0.2	11.5	27.6	29.9	16.4	12.8	21.2	35.4	1.6	18.3	10.9	15.5	11.3	0.9	17.0	20.7	16.4	1.1	75.7	0.3	31.5	28.5	1.4	89.6	22.2	31.0	4.4	29.0	22.0	21.0	0.1	31.8	7.1	0.0	12.9	27.5	0.8	22.6	0.3	27.4	1.5	26.8	0.4	44.9	0.0	2.5	2.9	3.4	42.8	26.8	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	20.6	48.3	0.1	1.2	0.0	0.0	11.7	0.0	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.1	0.1	0.1	1.1	31.3	0.0	0.0	0.0	0.7	0.4	8.5	12.4	0.1	0.0	41.2	0.0	3.6	33.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	17.4	32.2	27.6	29.9	17.0	20.7	31.5	28.5	29.0	22.6	26.8	42.8	0.2	121.8	136.9	0.0	0.9	0.0	2.3	18.0	0.6	0.0	30.4	15.2	0.5	42.9	56.0	16.5	0.0	33.5	0.1	72.7	17.6	39.1	3.7	20.1	1.4	0.6	21.7	0.0	0.2	38.5	2.2	0.6	45.3	13.1	1.3	4.9	0.0	0.0	2.4	0.0	0.2	63.0	34.6	0.0	0.2	7.9	0.3	0.6	0.0	0.0	0.6	1.7	1.0	0.0	55.3	22.7	40.1	1.2	0.6	12.2	164.2	33.9	43.8	0.0	0.0	0.0	2.3	1.4	0.3	2.1	0.4	7.3	1.0	0.1	38.6	9.1
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226638-55228784	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 11.0;liver: 16.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Erythroid cells: 66.5;Hepatocytes: 33.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.6;RPMI-8226: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	0.9	2.1	4.6	2.4	5.1	6.9	0.9	4.7	6.8	1.4	3.8	1.8	9.7	1.5	0.1	1.0	1.8	11.0	0.8	4.6	3.9	1.3	16.9	1.2	1.7	4.4	3.7	1.2	0.6	0.5	2.9	0.6	4.3	1.8	0.3	0.7	0.9	0.6	1.5	1.6	10.2	0.3	3.4	3.6	4.1	3.0	4.2	1.6	2.3	0.4	1.2	1.2	1.0	4.2	1.7	0.0	0.9	1.1	0.1	0.0	3.0	1.2	0.3	0.9	0.9	5.4	1.4	2.4	0.4	0.4	0.3	0.7	0.1	0.2	0.0	0.3	4.0	1.9	0.4	7.6	0.9	1.6	0.9	0.7	1.5	0.5	0.0	0.4	0.0	3.8	3.8	1.4	0.4	1.0	3.8	5.3	0.2	0.6	1.7	3.8	0.5	8.1	0.8	1.6	0.7	1.7	0.0	0.9	4.4	0.7	1.0	1.9	1.2	1.9	1.1	1.1	0.9	1.4	1.5	4.1	1.0	5.2	0.4	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.3	0.2	0.0	0.6	0.0	0.2	4.6	5.1	4.7	6.8	4.6	3.9	4.4	3.7	4.3	3.4	4.2	4.2	1.5	6.4	2.7	4.9	1.3	3.3	0.4	1.0	1.8	6.0	1.9	1.1	0.6	37.1	1.5	0.0	2.1	0.4	1.9	2.0	0.0	1.1	3.0	2.5	1.0	1.9	10.7	66.5	5.2	0.2	0.3	0.9	12.8	1.8	0.0	2.5	1.4	33.3	1.0	10.1	4.5	2.8	4.1	5.9	2.8	4.5	0.9	2.5	3.6	0.0	3.1	1.2	2.1	2.5	3.3	1.1	0.3	0.4	2.9	1.2	14.5	1.0	3.8	3.9	0.0	0.8	1.3	1.8	1.2	0.8	2.3	0.3	3.3	1.9	2.7	2.4
TMEM9	TMEM9A	ENSG00000116857	"Transmembrane protein 9"	Q9P0T7	1	201134772-201171574	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008483			Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA008483: "	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.90e-2)"	34.1	102.3	103.1	20.8	104.4	27.8	45.0	93.5	126.6	76.8	122.7	45.0	25.4	70.9	65.4	31.1	75.4	39.5	51.3	107.8	113.2	73.8	73.8	44.5	23.5	99.4	111.5	81.4	73.9	92.2	63.4	28.5	102.8	60.3	25.4	43.9	60.7	45.9	44.9	35.5	30.4	37.5	100.2	31.2	49.8	67.0	112.5	26.3	68.5	24.9	17.7	45.7	51.8	100.2	63.1	117.0	72.6	168.9	38.5	54.5	128.5	48.6	51.5	76.0	68.2	115.7	99.8	33.2	69.2	73.4	70.1	123.3	76.5	80.1	37.3	21.3	131.9	58.1	182.4	76.6	73.8	28.2	51.9	65.0	87.0	71.2	43.0	91.3	47.7	46.2	105.6	35.5	66.2	81.0	34.1	46.1	111.0	57.3	285.3	60.7	108.4	44.0	87.9	48.0	67.6	137.7	86.7	146.9	91.8	107.4	180.3	48.5	35.7	84.8	70.0	68.5	59.8	143.9	135.2	26.1	64.4	30.1	42.0	49.8	59.8	33.7	45.7	41.8	52.2	54.5	44.0	37.8	51.5	49.2	64.6	42.7	41.0	32.9	38.5	56.1	43.0	75.5	103.1	104.4	93.5	126.6	107.8	113.2	99.4	111.5	102.8	100.2	112.5	100.2	20.9	51.3	49.5	17.0	13.4	12.9	31.4	65.6	27.3	61.0	56.2	65.7	39.3	40.0	48.0	36.8	31.3	44.4	9.3	7.9	17.6	88.8	58.0	37.3	58.6	26.3	31.8	43.6	15.7	74.7	52.1	59.9	20.9	46.4	13.3	46.3	30.0	40.4	28.1	8.4	22.1	26.9	36.7	13.4	11.9	60.9	70.8	15.6	23.2	8.4	11.8	102.3	25.7	15.6	10.1	40.3	18.8	53.0	18.8	28.5	8.3	56.9	54.5	32.8	13.1	33.3	42.1	54.8	76.7	14.5	13.9	13.0	13.0	130.7	28.4	27.8
TP53BP1	"53BP1, p202, TDRD30"	ENSG00000067369	"Tumor protein p53 binding protein 1"	Q12888	15	43403061-43510728	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004083, HPA008788, HPA022133, CAB079980"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"	"Nucleoplasm, Mitotic chromosome, Vesicles"	"CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382"	"unprognostic (2.12e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.07e-1)"	"unprognostic (8.06e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.38e-2)"	6.9	11.5	17.4	10.1	16.6	11.5	10.7	19.9	14.5	17.7	21.5	9.7	6.4	16.0	15.9	6.1	14.7	10.7	8.8	15.4	26.3	9.1	4.1	8.3	8.6	13.5	16.7	16.8	7.4	22.3	24.1	12.2	15.7	12.1	10.2	22.0	10.1	12.8	7.2	9.2	6.4	16.3	9.6	8.7	7.6	21.6	23.0	15.3	17.9	11.0	12.6	11.2	8.7	12.1	13.5	22.3	63.8	40.1	25.8	31.9	15.8	22.8	33.8	31.0	39.1	19.4	15.8	14.5	19.2	39.0	66.9	32.4	46.3	27.5	36.8	38.9	15.8	27.1	40.1	11.7	16.8	30.2	37.4	24.9	19.0	41.8	31.2	51.7	37.4	24.2	26.9	12.3	36.5	9.6	23.7	14.1	41.1	24.2	13.9	25.1	23.9	9.3	22.9	31.8	57.3	26.8	33.8	14.3	8.5	48.6	29.9	16.9	27.5	33.7	22.3	27.0	20.5	9.8	22.4	33.0	27.6	14.6	17.5	1.4	0.5	1.0	1.6	0.7	1.3	1.9	1.6	1.6	1.2	1.8	1.8	1.6	0.6	0.9	0.5	1.3	1.4	0.7	17.4	16.6	19.9	14.5	15.4	26.3	13.5	16.7	15.7	9.6	23.0	12.1	11.5	22.4	22.3	53.2	17.8	6.4	10.2	10.0	13.6	32.4	17.4	13.2	14.9	5.7	20.8	29.5	47.9	13.4	11.1	7.4	9.8	14.5	38.8	47.0	44.8	16.8	41.9	8.4	66.2	7.1	11.2	23.9	14.8	26.8	26.6	47.0	15.0	3.3	10.8	47.1	81.9	15.7	12.2	3.8	6.9	17.8	23.6	9.3	1.8	17.8	4.0	11.9	7.2	62.8	50.4	7.5	5.8	17.7	17.1	11.0	2.6	8.8	60.7	51.7	13.1	35.2	20.5	33.1	36.2	14.7	5.3	18.5	17.0	29.9	13.4	8.9
TP53TG5	"C20orf10, CLG01, dJ453C12.5"	ENSG00000124251	"TP53 target 5"	Q9Y2B4	20	45372557-45407889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 17.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 671.5;Late spermatids: 254.4;Oligodendrocytes: 157.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041979, HPA058510, HPA077455"	Enhanced		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA041979: AB_2677778, HPA058510: , HPA077455: "	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-3)"	"unprognostic (3.10e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.72e-5)"	"unprognostic (2.09e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.41e-1)"	0.1	0.1	1.1	0.2	1.8	0.7	0.1	0.9	2.6	0.1	1.4	0.3	0.1	0.2	0.4	0.1	0.2	0.2	0.2	1.1	1.5	0.1	0.1	0.2	0.4	1.8	1.5	0.1	0.1	0.0	0.2	0.1	2.0	0.1	0.0	0.8	0.2	0.0	0.2	0.2	0.2	0.0	0.7	0.2	0.2	17.8	1.7	0.0	0.2	0.0	0.0	0.2	0.1	3.5	0.3	0.7	0.4	1.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.3	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.3	0.4	1.0	0.6	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.1	0.0	0.5	0.4	0.3	0.1	0.3	0.3	0.0	0.2	0.2	0.0	0.4	0.4	0.3	1.0	0.4	0.2	0.1	1.1	0.1	0.6	1.4	0.4	0.9	0.2	0.3	0.4	0.0	0.7	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.8	0.9	2.6	1.1	1.5	1.8	1.5	2.0	0.7	1.7	3.5	0.1	0.0	0.0	2.9	0.0	0.1	0.4	0.0	0.0	0.8	0.5	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	671.5	0.5	0.2	0.3	0.0	0.0	7.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	7.8	0.5	0.0	0.0	1.1	254.4	4.7	0.1	0.0	1.9	0.0	0.1	0.0	2.5	157.5	0.0	1.2	4.5	0.0	0.2	0.2	0.1	0.3	1.0	0.0	0.4	1.2	2.1	1.8	0.0	1.1	0.0	0.1	0.0	0.3	0.9
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2 microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.9	1.4	0.9	13.0	0.9	48.0	2.7	0.8	1.0	2.3	0.5	11.6	9.4	2.4	0.2	13.2	0.9	1.8	0.8	1.1	0.6	0.7	4.2	1.9	26.6	0.6	1.0	0.5	0.4	0.4	0.2	8.3	0.7	0.7	14.2	0.5	2.0	0.5	1.4	9.8	9.4	6.8	0.6	5.2	6.2	30.7	1.3	70.3	1.0	0.8	32.3	3.4	4.1	0.9	455.1	149.1	176.4	139.1	13.8	25.2	169.8	186.1	104.5	264.0	197.7	319.1	190.4	212.4	106.7	104.5	196.8	232.7	203.7	169.0	298.8	92.3	78.8	416.3	139.7	219.6	4.2	161.9	102.8	8.7	9.1	166.0	120.0	37.9	144.6	157.1	313.8	187.8	209.7	186.2	272.2	125.3	197.1	174.0	159.3	152.5	475.5	128.2	71.2	72.8	127.5	85.7	284.6	106.3	82.0	120.9	185.1	97.3	98.3	294.1	179.7	136.5	290.0	74.4	138.6	187.3	92.2	565.1	195.8	5.1	0.0	0.4	0.4	0.0	0.2	0.6	1.4	1.7	0.5	0.2	0.3	0.5	0.2	3.6	0.1	1.0	8.1	1.0	0.9	0.9	0.8	1.0	1.1	0.6	0.6	1.0	0.7	0.6	1.3	0.9	1.0	0.0	4.2	0.0	5.9	6.9	1.5	4.3	1.2	0.9	3.0	3.4	0.9	4.3	3.8	0.0	0.0	23.3	3.8	6.4	0.0	1.2	9.3	7.3	6.6	3.9	1.2	90.7	2.9	0.4	68.5	9.2	16.3	8.4	0.0	46.6	8.9	3.0	19.5	1.7	0.9	9.8	10.2	8.0	5.5	13.1	0.9	7.6	0.0	1.0	2.1	0.4	3.1	0.5	0.5	1.8	1.4	0.0	30.8	2.5	0.9	0.0	0.7	0.4	0.0	1.1	15.4	114.5	63.1	31.2	6.1	4.7	8.2	4.2	18.4	2.9
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 79.8"	"Cell type enriched"	"Detected in some"	10	"T-cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Group enriched"	"Detected in some"	25	"JURKAT: 29.9;MOLT-4: 76.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	1.1	0.6	0.0	11.0	0.0	2.7	0.8	0.0	0.0	0.4	0.0	1.3	1.4	0.4	0.4	1.0	0.3	2.5	0.4	0.1	0.0	0.3	1.3	2.1	23.9	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	1.5	0.0	0.6	0.1	0.1	0.6	3.0	0.5	0.0	8.5	2.4	0.4	0.0	79.8	0.4	0.4	12.4	2.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	2.1	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	395.1	0.6	0.2	57.0	0.2	116.4	1.0	229.5	119.6	0.3	0.4	313.1	77.7	3.5	2.2	0.7	0.8	111.1	139.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.0	3.3	8.4	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	1.8	0.0	0.0	8.9	0.1	0.0	0.0	2.3	0.1	0.1	1.1	0.0	2.7	0.1	0.0	0.0	1.7	7.7	0.1	2.5	0.0	1.8	0.6	0.2	0.0	0.2	0.0	0.0	1.0	12.2	2.2	0.0	1.8	3.6	0.0	3.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	5.1	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.0	8.0	0.1	129.3	0.6	0.0	0.2
TRIM45	"FLJ13181, RNF99"	ENSG00000134253	"Tripartite motif containing 45"	Q9H8W5	1	117111060-117122587	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 29.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cardiomyocytes: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030266, HPA054308"	Uncertain		Supported	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Cytokinetic bridge"	"HPA030266: AB_10795476, HPA054308: AB_2682445"	"prognostic favorable (1.58e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.70e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.27e-2)"	2.9	7.1	3.9	1.2	3.6	2.1	5.4	2.9	3.9	7.3	3.1	6.2	3.7	8.7	6.6	2.2	10.0	2.9	12.6	3.4	3.1	6.7	1.7	2.4	0.9	3.3	3.2	9.1	11.4	5.6	10.5	2.0	3.0	10.7	2.1	3.6	4.7	5.7	29.1	5.8	3.1	4.9	3.2	3.2	5.7	7.6	3.7	0.8	12.0	10.5	0.6	8.1	5.3	3.8	4.3	3.6	16.0	7.5	1.3	3.6	11.9	4.8	2.0	3.3	3.3	1.8	3.9	0.1	3.5	2.2	3.5	3.9	3.7	3.9	4.4	2.5	3.8	2.6	13.9	2.1	2.3	2.4	3.6	4.6	3.8	5.5	3.9	6.2	4.1	4.7	3.2	3.2	3.1	19.3	1.4	2.7	8.7	2.5	3.5	6.1	31.4	0.9	4.5	3.9	11.9	3.1	3.9	3.6	3.1	15.0	6.2	3.1	1.4	4.6	6.6	2.8	4.3	8.7	3.5	0.3	6.0	2.2	12.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5	0.0	3.9	3.6	2.9	3.9	3.4	3.1	3.3	3.2	3.0	3.2	3.7	3.8	1.1	9.6	2.7	4.9	0.1	1.1	1.8	1.5	1.2	1.4	5.0	3.4	12.2	4.3	2.2	1.8	4.2	2.7	0.1	0.3	1.9	1.9	5.7	2.8	2.6	1.5	1.8	2.5	2.5	3.2	1.2	2.1	3.6	2.8	0.0	4.0	2.2	0.2	0.8	1.7	1.9	1.6	0.0	0.3	0.3	2.7	1.8	0.4	0.0	3.7	0.0	1.4	0.0	3.5	2.3	2.1	0.0	1.9	0.6	0.5	0.4	0.4	1.9	1.4	0.0	3.1	2.1	6.1	5.3	1.3	1.6	1.1	0.4	5.5	1.6	1.3
TSPAN31	SAS	ENSG00000135452	"Tetraspanin 31"	Q12999	12	57738013-57750219	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	4	"glioma: 54.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030758, HPA057489"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA030758: , HPA057489: AB_2683447"	"unprognostic (2.66e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (4.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (9.91e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.58e-1)"	24.5	29.7	9.0	11.2	10.8	5.5	23.1	10.8	15.6	26.2	11.8	20.5	16.4	26.2	13.2	20.4	25.8	20.9	26.7	9.5	10.3	26.7	20.9	22.8	11.8	11.2	10.2	25.6	25.2	32.7	24.4	12.5	11.0	22.1	10.7	29.7	25.6	13.5	21.0	18.6	18.5	8.4	11.1	20.8	23.0	8.0	9.9	9.8	30.2	21.2	8.7	21.0	20.1	13.0	9.5	23.4	21.1	5.4	44.3	24.0	13.5	15.8	11.7	4.6	5.1	16.7	46.4	7.6	32.7	29.0	9.4	17.5	5.7	26.7	10.7	23.1	15.4	10.7	18.7	6.6	45.2	10.6	17.9	29.6	30.2	13.7	30.3	22.1	14.6	4.6	7.5	19.9	19.6	19.4	9.2	5.9	4.3	18.3	7.0	10.5	139.8	20.0	15.7	19.0	6.6	16.7	15.6	21.3	10.5	4.5	41.1	15.8	27.6	11.3	9.5	5.6	7.4	28.9	8.1	4.1	32.7	6.3	19.2	25.4	26.3	16.4	35.8	28.6	34.8	31.1	28.5	30.7	27.6	31.0	28.3	26.2	5.8	35.4	42.0	58.3	22.1	33.0	9.0	10.8	10.8	15.6	9.5	10.3	11.2	10.2	11.0	11.1	9.9	13.0	37.1	48.1	32.4	8.1	23.8	11.2	46.4	37.4	22.2	43.2	32.0	27.4	5.1	20.0	31.4	31.3	41.7	20.9	29.8	19.9	9.8	37.6	1.2	18.5	32.5	26.7	26.5	8.2	9.1	39.0	15.2	31.7	11.7	20.4	45.0	28.9	22.1	21.6	22.4	21.9	9.1	21.6	32.6	18.0	16.4	1.8	25.7	24.2	32.0	8.4	21.6	62.7	35.0	11.1	13.3	37.6	20.3	17.3	18.4	30.5	30.6	18.1	27.9	60.4	19.7	22.3	31.9	9.2	7.7	16.1	12.6	24.5	20.4	35.3	19.4	31.8
TTC28	KIAA1043	ENSG00000100154	"Tetratricopeptide repeat domain 28"	Q96AY4	22	27978014-28679865	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 291.5;Excitatory neurons: 169.6;Inhibitory neurons: 289.8;Microglial cells: 332.6;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001080			Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Cytosol	"HPA001080: "	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.25e-1)"	"prognostic favorable (4.30e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (4.36e-1)"	7.2	4.6	4.3	2.9	3.0	0.8	6.3	0.4	3.4	8.8	2.6	6.9	3.1	10.2	9.8	5.2	8.7	6.4	4.9	3.9	1.8	4.9	3.5	7.2	2.0	2.4	2.0	16.8	5.0	3.8	3.8	8.8	1.4	5.1	2.9	3.4	6.8	6.9	5.4	3.0	3.8	8.5	1.8	3.5	4.8	8.1	2.1	2.7	6.8	5.1	1.4	6.3	5.0	2.1	0.0	6.8	17.1	7.4	10.0	14.8	0.3	5.1	9.4	7.1	6.1	0.5	0.0	0.1	6.9	14.9	2.3	1.0	11.1	0.3	3.8	0.7	7.5	1.1	8.6	6.5	4.5	0.2	6.8	14.9	0.3	4.6	3.2	4.8	13.0	4.5	4.5	0.6	1.6	2.5	0.1	0.6	3.1	0.0	4.3	7.0	4.3	0.1	3.3	0.2	4.8	10.6	7.1	0.2	4.5	4.7	3.5	0.6	12.2	8.4	4.0	5.5	3.8	2.2	0.2	0.1	3.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.3	3.0	0.4	3.4	3.9	1.8	2.4	2.0	1.4	1.8	2.1	2.1	29.4	3.2	12.5	291.5	3.2	6.0	5.8	1.7	11.4	34.1	8.7	8.0	9.7	8.6	1.6	12.9	18.8	6.0	2.3	2.1	0.0	6.2	10.8	7.9	28.9	30.9	9.0	7.0	169.6	6.0	1.5	27.3	4.1	12.4	1.3	32.3	36.8	15.3	3.7	28.6	289.8	5.8	0.0	9.4	7.2	9.1	31.4	4.3	10.6	332.6	0.7	11.5	5.2	318.7	116.3	3.9	4.4	45.5	3.1	5.0	4.8	18.6	1.9	24.9	13.1	27.2	19.7	23.8	11.6	6.7	3.8	2.5	3.2	27.4	6.9	4.0
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;lymphoid tissue: 4.3"	"Cell type enriched"	"Detected in some"	10	"Macrophages: 191.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"basophil: 63.5;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.5"	"Cell line enriched"	"Detected in some"	19	"HEL: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		87000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.2	0.2	0.2	0.3	0.2	8.5	0.1	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.3	2.4	0.2	0.3	0.2	0.1	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.1	4.3	0.1	0.9	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	29.5	0.8	1.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.2	0.6	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.1	0.2	0.4	63.5	2.4	1.9	0.5	0.6	0.4	0.9	0.2	0.0	1.1	0.5	0.4	0.0	26.0	0.2	0.3	2.6	0.5	281.6	0.2	0.2	0.5	0.5	0.1	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.1	0.0	1.1	0.3	1.4	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.1	0.0	0.6	0.0	4.2	0.0	3.1	0.0	0.0	0.0	16.0	0.3	0.2	1.5	0.0	19.0	0.2	0.0	0.1	0.1	0.0	0.7	1.3	0.0	3.6	0.2	0.3	0.0	0.2	0.0	0.0	2.8	0.0	5.9	0.3	191.2	0.0	0.0	13.8	0.2	13.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.1	0.1	0.1
TUBB2A	"dJ40E16.7, TUBB, TUBB2"	ENSG00000137267	"Tubulin beta 2A class IIa"	Q13885	6	3153497-3157544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 364.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 516.5;Suprabasal keratinocytes: 368.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.2;monocytes: 1.6;T-cells: 3.2"	"Cell line enhanced"	"Detected in all"		"AF22: 241.1;CACO-2: 247.6;SuSa: 365.5;WM-115: 280.1"	"Low region specificity"	"Detected in all"							"CAB015339, HPA043640, HPA046280"	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.57e-1)"	"unprognostic (9.86e-3)"	"unprognostic (5.90e-3)"	"unprognostic (7.98e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (1.61e-4)"	58.8	17.8	266.1	19.3	251.1	67.5	47.8	130.1	287.5	32.7	10.0	78.0	24.2	50.8	28.0	90.6	23.5	21.5	29.4	248.3	364.3	31.1	67.0	16.4	11.0	292.6	212.2	15.5	39.4	2.2	56.3	23.9	334.3	17.5	8.2	49.9	52.2	15.6	22.3	151.4	34.9	41.7	131.6	7.7	41.0	9.5	204.4	6.4	10.0	11.8	9.6	23.6	51.2	169.4	55.9	45.3	241.1	53.6	30.6	34.0	14.5	119.8	44.7	80.6	115.7	247.6	18.4	27.4	72.9	115.5	80.2	26.0	86.6	26.8	28.0	134.1	57.7	9.4	11.4	77.0	31.6	1.5	8.4	35.1	31.1	85.1	5.3	28.9	37.3	10.6	33.7	8.8	74.2	25.1	14.9	2.8	207.2	16.0	58.3	12.4	22.6	18.9	28.0	27.4	57.6	52.9	30.5	8.5	179.7	365.5	19.1	2.0	76.0	53.9	56.7	117.3	65.8	3.2	4.6	18.8	19.7	7.0	280.1	0.0	1.1	0.0	2.2	1.6	2.4	3.2	2.1	3.1	0.5	0.6	1.0	2.0	0.3	0.4	1.3	0.2	3.2	1.2	266.1	251.1	130.1	287.5	248.3	364.3	292.6	212.2	334.3	131.6	204.4	169.4	125.3	16.0	13.1	43.1	31.6	311.4	63.3	87.0	132.6	105.6	32.0	134.6	20.4	42.9	62.7	12.9	16.7	6.0	53.4	87.0	217.2	54.0	60.9	46.7	29.6	40.6	73.1	322.3	59.9	182.4	50.4	96.2	185.0	57.9	34.9	10.1	12.5	55.6	50.8	516.5	73.0	103.9	73.2	6.3	164.4	32.9	20.8	36.7	129.9	24.4	72.7	261.0	0.0	18.1	23.0	103.4	181.8	15.4	15.8	34.9	126.3	40.4	50.3	86.2	6.6	95.6	87.9	32.4	14.9	140.6	368.5	6.2	58.9	6.4	60.0	54.7
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3223324-3231730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 387.9;choroid plexus: 154.0"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 414.8;Horizontal cells: 430.7;Muller glia cells: 847.3;Skeletal myocytes: 350.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 541.9;CACO-2: 415.3;NTERA-2: 268.0;RPMI-8226: 277.7;SCLC-21H: 797.7;SH-SY5Y: 390.2;SuSa: 245.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	4.0	7.2	298.1	8.1	324.5	1.0	5.0	348.4	387.9	9.9	154.0	17.0	2.4	4.2	45.5	2.4	3.3	3.8	4.6	258.8	356.9	11.6	1.0	1.4	8.1	363.3	349.9	1.1	5.7	0.0	35.1	4.4	354.5	3.7	2.6	65.3	10.8	4.6	6.2	3.9	6.1	7.3	337.2	0.7	4.5	1.0	369.1	2.3	0.9	1.6	5.7	2.6	5.6	383.9	0.0	8.2	541.9	164.2	0.6	0.2	0.9	5.1	7.4	20.8	45.0	415.3	2.0	0.9	5.6	5.7	0.0	1.3	212.8	0.7	12.0	1.6	98.3	0.2	0.0	33.2	1.1	0.1	6.1	3.1	0.0	2.3	0.0	7.6	1.4	0.5	6.8	1.2	7.6	0.3	1.5	0.4	268.0	1.0	17.6	0.6	26.3	277.7	2.9	0.8	797.7	390.2	0.3	1.7	4.3	245.9	3.2	0.0	0.0	1.9	89.9	6.3	2.2	51.6	0.1	0.0	0.8	0.1	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	298.1	324.5	348.4	387.9	258.8	356.9	363.3	349.9	354.5	337.2	369.1	383.9	3.6	0.0	0.0	109.4	1.9	8.7	2.3	1.8	4.6	63.5	3.9	31.9	40.1	5.7	0.3	7.3	16.7	0.7	1.0	0.9	414.8	15.4	5.8	2.7	3.3	7.6	66.7	0.0	2.4	3.5	1.2	18.7	7.1	3.9	0.0	0.5	0.7	0.6	3.0	430.7	19.4	1.0	24.4	0.0	12.4	7.1	0.3	1.0	92.5	9.4	3.6	847.3	0.0	37.2	21.6	12.0	0.1	0.0	8.4	3.9	0.2	2.0	0.0	43.1	0.0	350.1	19.1	1.3	6.2	3.1	2.7	0.8	0.6	0.0	0.6	1.1
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 313.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8"					"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		89000000	"Cluster 24: B-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.91e-2)"	5.7	24.8	99.4	12.1	93.3	3.4	2.1	100.5	127.6	3.3	0.0	18.4	3.7	9.7	0.2	3.6	2.3	8.8	5.5	88.6	313.3	13.3	0.9	4.1	7.1	208.8	132.7	3.9	3.2	0.4	55.1	1.8	266.2	3.0	2.6	24.8	10.6	0.4	0.6	5.2	8.0	12.7	74.2	1.3	7.2	38.0	183.4	1.0	2.5	0.3	5.2	7.3	5.3	82.5	30.1	421.3	152.6	173.9	17.9	170.8	6.8	181.0	31.0	105.8	48.2	57.2	53.5	89.6	93.6	136.8	74.3	112.1	148.9	26.7	26.3	22.7	15.5	0.7	32.5	383.7	6.0	0.0	67.6	98.4	7.9	161.9	14.0	136.8	88.4	5.9	9.2	2.5	122.3	288.6	1.2	31.5	274.3	11.2	237.3	0.1	54.1	9.5	131.8	8.1	424.9	433.8	251.2	4.4	137.1	27.5	15.0	1.9	110.9	142.8	156.9	197.3	185.3	1.4	19.6	35.2	150.2	11.5	260.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	99.4	93.3	100.5	127.6	88.6	313.3	208.8	132.7	266.2	74.2	183.4	82.5	0.4	0.0	0.0	20.2	0.0	0.0	0.0	0.0	3.4	1.8	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	28.7	8.2	0.5	2.6	3.8	4.9	0.0	37.9	21.4	0.7	6.1	27.0	0.7	0.0	0.0	0.0	0.0	0.2	5.0	45.1	0.1	0.0	0.0	0.0	16.8	0.3	0.2	0.0	9.4	0.0	0.3	0.0	16.1	9.2	49.2	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.1	0.2	0.4	3.0	0.0	1.0	0.1	0.0	0.2	0.0
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 828.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 3.8;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		110000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	0.9	203.4	209.7	1.7	404.6	0.2	0.6	452.3	388.7	0.6	0.0	6.3	1.1	0.6	0.3	0.7	0.9	0.6	2.5	249.2	229.1	2.2	1.2	0.6	1.1	425.9	254.4	1.5	3.0	0.6	4.0	0.7	440.0	0.8	0.8	22.6	1.2	0.4	4.4	5.2	3.0	0.8	221.4	9.5	2.1	76.0	373.5	0.3	0.6	1.0	0.7	0.6	1.8	828.2	0.2	28.3	0.1	100.7	0.2	0.0	0.2	0.7	0.0	0.1	0.0	1.4	0.4	0.1	30.3	0.0	3.5	0.7	58.3	0.0	0.6	0.0	10.7	91.7	1.9	0.9	0.0	0.0	5.5	0.0	0.0	2.3	0.0	1.0	0.0	17.1	8.6	0.8	0.0	3.0	18.1	4.1	7.5	0.0	49.6	43.4	0.1	20.3	10.9	0.1	0.2	36.6	0.3	0.2	30.9	2.7	0.8	1.9	0.0	0.2	12.2	0.1	0.4	2.4	1.7	11.7	1.1	0.1	0.5	0.0	0.0	0.0	5.4	0.0	3.3	3.8	0.7	5.0	0.0	1.1	1.6	3.8	0.1	0.3	0.0	0.0	0.0	1.4	209.7	404.6	452.3	388.7	249.2	229.1	425.9	254.4	440.0	221.4	373.5	828.2	0.1	0.0	0.0	6.8	3.2	1.9	0.7	0.3	0.0	2.8	0.1	0.1	9.8	1.5	0.0	0.0	0.0	0.2	1.6	0.1	5.9	1.6	2.9	0.1	0.2	1.2	0.0	2.1	22.2	0.0	0.2	1.8	0.0	0.1	0.0	16.3	1.4	0.3	0.4	10.1	15.0	0.0	0.0	0.0	1.2	9.4	5.3	0.3	14.2	13.1	0.0	33.0	1.0	8.5	94.1	0.1	0.0	0.4	0.9	0.2	0.0	1.8	0.5	2.3	6.6	0.4	4.6	1.9	1.1	0.0	1.6	0.1	3.8	81.7	0.0	0.2
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241287-137243707	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (1.69e-1)"	134.5	112.6	162.0	97.2	163.4	423.9	94.4	149.4	182.7	88.1	482.7	198.3	142.0	107.7	209.1	343.3	507.2	106.0	435.8	174.0	185.2	122.5	140.1	130.5	95.5	184.1	233.6	72.9	123.8	87.8	118.0	86.3	213.9	120.2	111.9	261.8	177.9	121.5	202.5	240.0	166.4	119.8	162.9	85.6	161.4	765.7	192.6	162.9	115.7	96.6	119.7	188.3	139.4	133.9	706.2	1032.5	431.7	314.2	213.2	223.6	600.5	643.7	536.0	872.4	598.6	1101.0	840.2	429.0	480.2	631.2	848.2	1305.1	539.5	1039.2	330.2	307.9	458.5	311.2	789.6	877.8	134.5	370.0	331.5	145.0	291.5	667.5	183.1	215.7	631.7	300.6	443.0	239.7	731.2	1936.4	337.4	504.2	457.8	1234.8	1778.1	423.5	822.2	394.2	666.8	647.8	301.5	323.6	853.9	485.8	173.2	244.2	699.0	397.6	495.6	618.1	685.0	710.0	863.6	92.4	274.9	475.1	503.6	286.9	549.8	95.7	30.0	43.2	40.5	30.1	38.2	32.6	31.3	34.4	34.9	30.8	19.7	26.7	56.4	24.4	30.5	36.3	44.7	32.6	162.0	163.4	149.4	182.7	174.0	185.2	184.1	233.6	213.9	162.9	192.6	133.9	478.5	221.2	146.3	21.5	315.8	326.2	945.7	458.7	327.2	508.1	286.9	389.5	91.9	143.0	284.1	143.5	300.3	346.6	640.9	744.1	221.1	348.6	2190.0	1191.6	224.8	203.9	391.5	419.9	30.1	446.8	545.5	247.8	274.7	415.0	189.2	200.9	142.5	139.2	265.9	244.0	24.3	503.6	323.5	59.9	214.9	2907.1	254.2	299.3	138.7	22.5	224.0	299.3	49.4	15.6	19.7	477.4	697.2	153.1	264.0	475.1	540.7	345.5	1558.7	763.3	111.7	261.8	416.0	1717.5	740.9	419.1	297.6	321.1	362.9	89.8	487.3	592.7
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 190.2;Extravillous trophoblasts: 494.3;Pancreatic endocrine cells: 221.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 157.3"	"Group enriched"	"Detected in many"	6	"B-cells: 58.7;dendritic cells: 157.3"	"Cell line enhanced"	"Detected in many"		"TIME: 821.6"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 19.9"	"Region enhanced"	"Detected in all"		"spinal cord: 10.3"	"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		52000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (9.69e-4)"	197.9	37.9	12.3	82.1	11.7	34.8	134.6	14.7	14.6	106.5	28.6	193.6	31.4	173.5	24.9	217.5	121.2	66.4	166.2	11.8	13.7	66.0	40.8	92.9	31.6	19.2	16.3	81.2	52.7	5.6	33.1	59.7	15.1	84.2	28.8	3.6	69.6	91.3	37.3	78.2	75.8	151.9	14.1	34.0	89.1	28.3	18.4	12.2	52.2	20.2	31.3	129.9	124.2	12.5	211.8	142.3	149.5	76.1	149.0	208.8	108.1	648.5	424.2	492.0	459.1	113.0	65.2	1.3	281.7	440.8	148.6	99.5	84.7	653.6	380.6	1.8	46.1	32.3	159.2	73.6	151.0	2.7	59.5	219.1	146.0	429.4	222.7	148.8	366.1	12.5	159.7	2.5	432.5	216.1	0.8	162.4	79.1	3.3	70.0	1.6	260.0	2.2	99.7	5.8	19.3	27.2	360.3	34.8	113.9	153.7	76.5	203.8	821.6	600.0	510.6	565.7	574.2	11.5	3.8	3.8	458.9	46.9	219.8	2.0	19.4	0.3	0.6	7.6	0.3	42.0	0.1	0.2	25.5	58.7	0.2	0.3	0.4	0.9	7.5	157.3	0.2	13.2	12.3	11.7	14.7	14.6	11.8	13.7	19.2	16.3	15.1	14.1	18.4	12.5	67.0	83.3	7.9	0.7	16.1	69.6	42.7	151.4	16.5	1.2	30.4	44.8	54.3	8.6	37.4	7.3	0.0	53.8	23.6	0.6	1.9	167.6	190.2	6.4	76.9	128.9	0.0	12.2	0.8	104.9	494.3	112.8	1.5	7.1	45.6	7.4	82.5	0.4	69.4	0.0	0.6	0.4	42.7	13.2	85.2	114.9	70.2	36.5	33.8	12.2	65.9	0.2	0.0	0.5	0.4	221.1	0.1	91.4	1.0	51.5	0.1	1.2	18.2	1.6	26.3	89.2	130.5	4.3	6.3	55.7	66.9	22.2	3.6	9.5	0.5	65.2
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46888-74163	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"									"HPA043640, HPA046280"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.1	0.1	0.4	0.1	0.4	0.0	0.2	0.3	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.3	0.7	0.0	0.1	0.1	0.3	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	2.4	0.3	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.4	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	13.0	15.9	0.0	0.0	0.0	0.0	0.4	0.0	0.6
TUBB8B	TUBB8P12	ENSG00000173213	"Tubulin beta 8B"	A6NNZ2	18	47390-49557	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 2.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043640, HPA046280"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA							Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.42e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 36.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	12.7	8.2	5.8	5.4	7.0	21.4	11.2	36.4	5.9	11.7	15.4	13.4	6.5	12.9	4.7	10.9	10.9	5.4	6.0	5.3	6.3	10.1	8.2	13.2	6.5	6.9	6.9	16.2	18.9	3.1	6.2	2.7	7.6	10.4	5.6	6.3	12.4	6.0	10.0	14.6	13.9	4.5	5.3	17.6	15.7	5.3	8.6	7.4	9.1	3.6	6.4	12.4	11.9	7.5	10.4	21.0	12.1	8.1	5.5	7.6	8.2	6.7	9.6	7.1	5.8	6.6	13.1	8.7	15.3	9.3	3.6	12.0	11.6	11.1	5.6	12.2	5.8	10.4	8.6	9.8	6.8	6.4	11.4	11.3	7.8	7.7	10.6	8.9	12.4	17.3	9.5	9.0	3.3	5.2	11.0	8.8	16.2	13.7	5.3	22.2	8.4	11.3	4.5	23.8	9.6	9.5	3.3	13.0	6.7	7.8	5.5	9.5	13.4	7.2	16.9	3.3	10.3	9.3	24.4	18.2	7.4	13.8	7.5	120.0	84.7	12.7	24.8	66.0	28.4	34.1	34.3	26.0	59.8	34.8	34.0	25.2	169.1	19.8	65.4	13.1	28.1	45.2	5.8	7.0	36.4	5.9	5.3	6.3	6.9	6.9	7.6	5.3	8.6	7.5	23.6	38.5	69.2	76.7	63.4	52.6	34.3	24.8	23.3	31.4	27.9	20.3	9.2	25.8	41.4	16.5	12.5	19.8	48.4	37.6	41.1	41.0	21.6	37.8	32.8	26.0	43.8	15.8	11.2	37.2	57.3	28.3	39.8	74.6	27.1	64.5	11.4	24.0	24.8	13.5	40.0	35.4	30.5	78.4	109.6	77.4	15.8	74.5	42.7	75.9	101.8	25.9	41.2	80.4	40.6	39.8	35.6	18.4	69.7	40.6	33.2	28.3	33.3	17.9	13.1	25.3	34.5	14.8	40.3	33.9	59.0	34.1	64.6	40.1	40.6	37.6
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6 small subunit processome component"	Q9NYH9	17	31860904-31901708	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	"Mitotic chromosome"	"HPA025936: AB_1845588, HPA055806: AB_2682930"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	17.7	14.3	24.2	7.8	24.3	9.5	15.8	24.9	39.8	21.5	25.4	17.0	4.4	15.3	12.9	17.7	17.1	4.3	17.2	24.2	24.1	21.1	24.4	14.5	11.4	24.0	24.3	20.5	19.1	5.1	19.7	6.4	24.0	22.3	6.4	10.2	13.1	5.7	16.2	17.4	17.1	6.9	23.6	25.7	15.1	18.7	24.5	9.1	18.0	6.3	12.5	16.7	17.0	24.7	14.4	9.0	12.3	7.4	11.9	8.0	15.3	11.8	6.7	17.6	13.6	32.8	7.8	20.9	14.0	11.3	16.7	18.6	16.7	14.1	16.0	4.6	26.4	13.1	21.2	31.6	14.1	19.8	13.5	13.2	15.1	16.7	12.5	16.3	11.4	13.2	23.1	11.9	13.8	11.6	19.4	56.4	16.9	17.2	14.6	20.6	17.8	21.4	19.0	12.9	8.4	12.8	12.5	9.3	22.7	19.4	22.7	39.0	11.5	27.8	20.5	14.3	24.3	13.0	25.9	31.8	18.9	14.4	15.4	15.5	10.6	7.4	7.1	11.3	7.0	12.6	7.7	7.7	14.7	15.2	6.6	7.7	13.7	5.9	11.1	21.3	8.1	7.8	24.2	24.3	24.9	39.8	24.2	24.1	24.0	24.3	24.0	23.6	24.5	24.7	22.5	19.2	24.3	17.9	32.7	25.7	30.7	29.1	12.5	16.7	13.5	16.3	15.6	14.3	31.7	5.5	8.4	42.4	34.3	10.6	9.8	29.7	35.6	23.4	29.0	21.1	5.4	29.5	23.0	24.0	50.3	26.2	16.3	33.5	36.2	20.5	12.1	15.6	35.8	11.8	21.4	16.3	20.3	21.0	17.6	5.4	18.6	29.4	8.8	18.7	43.4	16.4	7.2	17.6	16.2	26.3	8.4	17.0	17.4	31.9	12.7	18.5	30.3	16.4	6.6	28.2	23.7	102.9	66.2	17.2	26.0	38.3	19.9	21.0	16.7	31.2
VLDLR	"CARMQ1, CHRMQ1, VLDLRCH"	ENSG00000147852	"Very low density lipoprotein receptor"	P98155	9	2621182-2660056	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 77.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 78.1;Cone photoreceptor cells: 104.3;Oligodendrocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 6.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.3;JURKAT: 20.5;THP-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032462, HPA051312"	Uncertain		Uncertain	"Vesicles,Cytokinetic bridge,Centriolar satellite"		Yes	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Cytokinetic bridge, Centriolar satellite"	"CAB032462: AB_2216805, HPA051312: "	"unprognostic (5.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.34e-2)"	15.7	16.3	2.7	2.2	6.4	0.8	8.5	5.3	4.2	10.3	6.4	6.6	0.5	9.6	3.2	19.2	13.8	2.9	43.7	3.2	5.3	10.6	3.1	10.7	0.7	7.7	5.6	77.5	27.4	19.5	6.5	5.9	5.9	6.6	2.0	12.3	11.6	2.0	26.2	5.3	1.9	6.8	4.0	5.5	9.0	6.0	4.9	0.8	11.6	11.7	1.7	12.5	10.4	9.8	0.1	0.8	14.3	0.4	1.5	0.5	22.3	7.0	2.2	1.7	4.3	3.6	0.3	0.0	6.4	2.8	0.6	0.3	3.4	5.6	4.5	9.7	2.4	0.1	1.6	1.8	1.9	9.2	1.7	1.5	3.3	0.7	0.1	7.6	0.7	20.5	0.0	17.4	1.1	0.9	1.1	1.1	9.9	1.5	0.9	0.1	0.4	0.0	6.4	0.4	2.5	2.4	0.6	0.6	10.4	7.5	0.3	33.3	0.3	2.8	4.5	0.1	3.3	14.1	6.1	2.6	14.7	8.2	0.6	0.0	0.0	6.3	0.2	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	2.7	6.4	5.3	4.2	3.2	5.3	7.7	5.6	5.9	4.0	4.9	9.8	4.2	16.0	8.8	1.0	0.1	2.7	1.2	18.7	4.6	23.8	4.3	3.9	78.1	1.5	9.7	5.5	104.3	13.2	1.6	9.8	1.9	11.3	5.7	8.6	6.1	3.6	10.9	0.0	8.3	10.3	29.0	17.2	3.1	19.3	0.0	5.7	2.2	2.8	2.3	11.8	10.9	1.4	24.4	1.0	1.1	2.8	7.8	0.6	10.6	2.8	1.0	3.9	0.0	8.0	39.1	8.6	4.3	10.9	0.5	5.1	0.0	8.0	11.9	32.5	0.0	2.7	9.4	8.2	6.4	5.0	2.0	3.4	1.7	15.9	1.3	6.0
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311350-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203"	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	13.2	15.3	15.7	8.9	16.9	8.8	12.8	16.1	17.1	10.4	11.0	13.5	13.5	11.7	8.1	16.0	10.3	9.4	20.6	15.5	14.9	18.0	11.6	9.9	11.8	16.4	16.8	12.2	27.8	20.6	7.6	10.0	16.7	10.4	7.6	10.2	19.9	8.4	54.0	15.3	12.8	8.4	15.4	9.2	17.6	6.8	16.7	6.2	16.7	33.6	7.3	11.4	11.3	18.2	21.1	34.9	23.2	30.7	21.2	18.8	20.5	27.9	25.2	36.4	24.3	33.4	19.0	35.0	27.3	28.0	17.5	30.3	23.9	28.2	21.8	14.8	30.8	22.0	20.7	26.3	32.6	27.5	19.6	21.7	36.3	31.6	28.7	21.4	27.4	27.3	37.0	10.3	27.2	46.8	36.4	20.5	26.7	20.6	24.5	47.8	19.0	41.3	18.5	16.8	39.1	24.7	59.3	18.1	21.4	15.4	31.4	20.6	32.8	33.2	20.8	30.4	22.1	36.9	31.3	62.6	30.4	18.2	37.1	8.8	9.9	13.3	11.2	8.7	10.0	8.5	9.3	13.9	9.4	7.4	10.5	9.9	7.5	8.0	11.5	5.5	11.8	13.8	15.7	16.9	16.1	17.1	15.5	14.9	16.4	16.8	16.7	15.4	16.7	18.2	39.8	25.6	19.0	14.7	33.8	30.7	37.3	22.2	22.8	51.4	30.2	28.2	31.0	22.8	16.7	23.9	22.9	59.8	48.4	48.9	74.3	51.7	11.2	14.9	27.0	34.9	31.3	43.6	14.5	82.5	66.5	32.9	29.0	25.6	29.2	36.3	31.8	21.6	45.1	74.0	14.9	34.2	20.3	33.7	24.6	11.9	29.5	30.2	44.4	5.6	40.9	66.0	38.1	4.5	16.8	67.4	42.2	30.5	31.9	67.6	76.4	57.7	6.4	41.8	52.6	36.0	38.9	28.7	38.3	27.1	31.3	70.1	35.6	26.0	41.4	41.2
WIZ	ZNF803	ENSG00000011451	"WIZ zinc finger"	O95785	19	15419978-15449956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	13.9	13.7	22.2	10.2	18.0	7.5	13.2	11.1	28.2	13.5	8.3	15.8	9.6	18.7	3.6	12.2	13.4	6.6	18.7	21.4	12.2	13.3	12.3	9.9	6.6	14.0	15.4	14.0	19.7	9.3	7.9	6.7	13.7	12.0	3.5	3.6	10.4	10.3	14.4	13.7	10.2	8.3	12.2	9.5	15.8	21.3	17.7	6.6	9.1	7.3	4.0	16.0	11.6	15.7	23.0	13.1	22.6	28.0	32.2	13.4	17.0	23.2	10.8	19.8	13.4	14.1	43.0	18.8	36.7	22.9	12.1	20.3	12.5	17.3	5.0	13.8	21.3	14.6	13.5	11.3	21.2	15.2	19.9	23.8	22.9	14.7	16.4	12.3	18.3	14.4	22.5	16.8	13.8	48.4	30.2	15.9	28.7	23.8	38.2	27.7	10.4	19.9	13.2	18.5	31.0	36.4	20.2	19.5	15.7	8.3	21.4	16.0	29.2	45.4	16.7	36.0	32.0	22.8	15.6	21.2	18.0	19.1	31.5	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.5	1.0	0.3	0.2	0.1	22.2	18.0	11.1	28.2	21.4	12.2	14.0	15.4	13.7	12.2	17.7	15.7	11.3	12.8	6.9	6.5	4.1	15.8	7.2	7.8	5.7	9.4	16.2	17.8	10.9	8.6	5.6	12.9	0.0	7.1	8.4	8.4	3.9	14.9	9.0	6.3	15.3	14.9	6.7	3.0	3.2	20.0	9.9	10.3	9.2	12.1	1.3	17.3	14.3	14.7	7.8	6.7	3.2	9.0	4.1	11.3	7.2	10.0	15.8	8.7	7.2	3.7	6.7	8.5	2.1	2.0	2.8	19.1	3.9	19.2	3.1	14.1	6.2	5.3	2.5	7.4	13.1	9.5	12.7	34.8	21.9	9.3	20.3	7.4	5.4	16.8	10.0	12.8
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA056856"	Supported		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Cytokinetic bridge"	"CAB000155: , HPA056856: AB_2683258"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.55e-3)"	"prognostic favorable (4.28e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.17e-1)"	15.1	13.4	9.9	9.5	10.3	9.1	13.4	12.0	15.4	13.9	10.8	23.0	15.8	14.0	11.0	14.9	13.1	9.7	9.9	9.7	10.8	18.4	18.8	11.3	14.0	10.2	10.0	13.0	11.8	18.7	9.9	9.7	9.8	14.8	9.9	10.6	12.5	12.7	19.5	12.5	13.1	12.0	9.7	12.5	21.6	5.2	10.7	11.0	23.6	8.6	17.2	15.4	13.5	10.6	35.5	8.2	11.9	14.8	14.3	13.7	8.2	9.4	14.9	16.9	11.4	21.4	28.9	19.9	8.9	10.5	11.3	17.4	9.6	11.4	14.1	13.7	19.2	15.7	17.7	12.0	15.5	18.7	18.2	12.0	12.0	7.9	8.0	11.4	19.1	16.1	22.0	15.2	9.4	11.0	24.4	22.5	8.2	33.5	13.5	24.6	25.4	17.0	27.0	13.7	16.7	16.7	13.4	10.3	12.7	9.0	14.9	11.1	12.0	5.9	14.8	23.4	20.6	26.5	22.7	12.3	14.6	13.2	11.8	12.8	21.6	22.6	25.5	23.0	30.1	34.4	27.9	25.0	23.0	40.5	33.5	29.0	2.6	35.2	29.7	39.8	33.1	19.6	9.9	10.3	12.0	15.4	9.7	10.8	10.2	10.0	9.8	9.7	10.7	10.6	32.4	25.6	37.8	49.0	36.1	17.3	23.3	39.3	31.9	101.4	24.8	31.9	36.2	45.8	39.7	22.0	81.3	32.1	47.2	10.6	121.3	36.3	1.7	22.5	29.1	30.4	22.3	11.1	49.3	38.3	9.7	31.3	22.4	17.2	30.9	28.0	28.2	48.7	36.0	84.1	63.5	24.6	30.5	27.7	20.7	4.0	44.1	24.5	14.2	40.3	49.6	87.0	64.9	74.9	96.0	29.3	19.2	47.4	26.2	18.9	32.1	55.5	28.6	97.5	32.9	38.3	39.4	18.2	17.9	28.5	18.8	14.0	34.9	36.4	24.2	23.5
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483219	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: AB_2669673, HPA049003: AB_2680596"	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	3.1	2.2	1.5	5.4	2.4	8.9	4.6	2.4	2.4	4.0	1.0	3.5	3.6	3.1	3.2	3.0	2.9	2.5	2.2	1.6	1.9	3.9	2.6	3.9	8.7	1.5	1.2	3.4	3.5	7.4	1.8	3.2	1.6	3.5	3.8	10.1	4.4	3.3	3.2	4.7	3.7	2.8	1.3	5.5	4.1	4.3	1.6	6.9	4.9	2.9	7.3	3.5	2.7	2.9	4.7	4.8	4.3	10.8	6.8	6.9	7.0	5.3	7.3	6.5	7.4	6.7	3.6	20.0	6.7	6.7	7.8	6.0	10.9	8.3	9.8	12.4	10.7	16.2	6.5	5.1	5.0	13.3	8.0	7.0	6.7	6.6	11.4	4.6	5.5	9.3	13.8	11.0	6.8	8.0	19.2	9.0	10.7	4.7	5.3	11.9	6.1	8.3	8.0	8.0	7.3	6.4	6.8	7.1	16.9	5.9	5.0	14.5	5.4	5.3	5.3	4.4	11.5	5.3	4.4	20.2	7.0	10.4	9.0	0.1	0.6	0.9	0.7	0.6	0.4	3.4	1.5	0.9	0.7	2.8	1.9	1.1	0.4	1.3	0.8	1.1	2.9	0.5	1.5	2.4	2.4	2.4	1.6	1.9	1.5	1.2	1.6	1.3	1.6	2.9	8.4	12.8	9.1	2.6	32.8	10.1	11.2	5.3	7.4	21.7	8.6	7.4	3.8	7.2	5.2	3.7	31.3	8.5	16.8	4.5	3.9	6.6	1.4	7.3	14.3	6.6	9.6	12.0	3.3	9.1	9.9	8.6	12.8	10.7	9.5	14.1	3.6	7.3	7.7	10.1	2.8	11.0	6.1	12.5	12.1	1.8	7.2	10.3	8.8	5.6	20.5	10.0	14.4	1.0	5.4	6.4	5.1	6.4	16.8	8.2	7.4	6.4	6.0	65.2	0.0	13.2	7.4	6.2	27.8	9.3	9.7	7.8	17.8	15.0	8.5	7.3
ZNF202	"ZKSCAN10, ZSCAN42"	ENSG00000166261	"Zinc finger protein 202"	O95125	11	123723914-123741675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.7;Spermatogonia: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059229			Approved	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli rim, Mitotic chromosome"	"Nuclear bodies"	"HPA059229: "	"unprognostic (3.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (9.93e-7)"	"unprognostic (2.61e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	5.7	4.7	5.9	6.7	5.9	5.2	7.6	5.9	6.5	8.1	5.7	6.3	4.4	9.7	9.3	6.0	6.8	4.6	4.5	5.7	5.9	6.2	5.1	5.1	8.9	5.4	5.8	10.4	9.7	5.2	5.9	6.2	5.4	7.2	7.9	6.1	6.0	5.3	6.2	8.4	6.5	7.3	4.8	9.9	6.2	9.8	5.8	6.7	6.9	3.9	8.7	6.9	6.4	6.8	6.0	9.3	15.3	18.5	6.6	10.1	11.9	9.3	7.4	8.5	7.6	10.5	15.7	17.7	8.6	7.2	13.7	14.3	15.9	10.6	11.7	7.3	8.9	31.5	6.6	10.2	9.0	18.5	8.9	7.2	21.0	9.7	28.7	7.3	10.0	14.8	17.1	11.8	11.2	6.3	16.0	25.3	25.2	21.0	12.8	19.2	9.5	6.5	8.3	11.4	11.3	12.6	7.8	9.4	6.2	12.5	17.8	12.8	8.7	16.3	10.5	11.8	9.5	7.6	5.9	12.1	4.3	20.2	10.8	0.0	1.2	0.0	1.7	1.8	1.6	1.6	2.3	2.5	1.9	1.9	2.6	2.4	0.0	1.6	0.7	1.2	2.2	1.7	5.9	5.9	5.9	6.5	5.7	5.9	5.4	5.8	5.4	4.8	5.8	6.8	3.1	6.4	0.5	7.8	3.8	2.9	3.8	1.9	0.6	3.1	3.4	3.2	3.1	2.8	9.7	3.7	0.0	2.2	2.1	1.5	1.9	2.2	5.1	1.4	3.3	3.1	3.0	1.7	8.9	3.5	1.7	2.8	4.6	2.0	3.8	6.0	2.2	1.9	1.8	6.7	8.3	3.9	0.0	2.0	2.0	5.0	1.8	3.1	0.0	3.7	1.6	2.4	1.0	6.6	11.0	3.2	2.4	1.2	3.6	2.5	1.0	1.4	1.3	3.1	6.6	5.0	2.2	14.7	14.5	3.6	3.0	0.8	3.0	3.1	3.2	2.9
ZNF214		ENSG00000149050	"Zinc finger protein 214"	Q9UL59	11	6997085-7020346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 6.6;Endometrial ciliated cells: 6.6;Excitatory neurons: 10.5;Respiratory ciliated cells: 10.4;Spermatocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 3.5"									HPA055391	Uncertain		Approved	Nucleoplasm,Midbody		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Midbody	"HPA055391: AB_2682804"	"unprognostic (3.01e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.77e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.53e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-2)"	0.6	1.0	1.0	0.2	1.2	0.0	2.1	0.8	1.5	2.3	1.8	1.2	0.5	2.3	2.7	0.5	3.9	0.8	0.8	0.9	1.1	2.4	1.2	1.2	0.2	1.8	1.7	4.2	1.0	2.5	1.3	0.1	1.1	2.0	1.1	5.3	0.9	2.1	0.4	0.4	0.6	1.7	1.2	0.2	0.7	3.1	1.0	0.2	3.4	0.5	0.2	1.4	1.3	1.4	0.4	0.8	3.3	0.0	0.6	2.2	0.8	1.3	3.5	1.7	1.9	0.0	2.4	0.1	0.4	0.9	1.1	0.5	0.3	0.9	1.9	0.0	0.9	0.0	0.5	0.2	1.2	0.0	0.1	0.6	2.2	0.0	1.9	2.3	1.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	2.6	1.3	0.1	0.1	1.3	0.5	0.0	0.2	1.1	1.4	3.0	0.0	0.0	0.0	0.0	1.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.5	0.9	1.1	1.8	1.7	1.1	1.2	1.0	1.4	0.5	0.0	1.5	4.6	0.1	0.0	2.0	1.6	0.6	2.5	1.1	1.5	0.9	1.5	2.7	0.0	0.0	0.1	0.0	0.4	1.9	2.1	6.6	6.6	2.0	0.6	2.4	0.0	10.5	0.9	0.4	1.5	0.0	0.9	0.0	1.2	0.0	0.4	0.1	3.3	5.5	1.7	0.0	0.0	0.5	1.0	0.6	0.2	0.0	2.8	0.0	3.0	0.0	4.0	2.9	1.1	0.1	0.4	0.0	0.6	0.8	3.3	10.4	3.6	0.0	0.8	0.9	10.4	3.3	0.9	0.1	0.0	0.2	0.8	0.9	0.4
ZNF263	"FPM315, ZKSCAN12, ZSCAN44"	ENSG00000006194	"Zinc finger protein 263"	O14978	16	3263800-3301401	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035085, HPA035086"	Approved		Supported	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Mitotic spindle"	"HPA035085: AB_10671099, HPA035086: AB_10603244"	"unprognostic (2.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.98e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.66e-1)"	20.8	18.3	18.3	16.8	18.1	19.1	24.1	20.4	22.5	20.2	20.3	20.1	14.5	22.9	23.2	15.4	24.5	16.7	15.1	19.1	17.7	20.4	17.6	19.4	22.6	20.1	17.6	29.2	21.5	30.7	23.4	20.4	17.2	21.4	17.0	24.6	20.2	20.2	17.3	24.0	19.3	18.7	16.6	23.2	22.0	18.1	18.2	22.3	20.0	13.7	21.5	19.5	17.5	20.5	19.7	25.1	27.6	40.8	22.7	28.8	36.6	26.1	38.6	30.0	32.2	27.5	30.3	74.2	26.5	33.6	28.6	25.7	38.6	26.4	29.9	41.6	41.3	31.4	35.6	25.6	25.7	48.8	38.5	34.0	53.3	27.6	40.0	33.5	26.2	44.5	37.9	47.4	24.8	25.5	43.9	37.2	55.7	23.2	19.2	70.4	29.8	57.6	20.7	18.4	40.6	43.8	27.9	30.0	30.9	32.5	32.8	57.7	30.1	31.4	30.9	23.3	25.4	50.8	60.8	88.0	12.9	23.6	23.8	1.4	2.5	6.4	3.5	2.4	4.0	2.5	4.2	4.7	3.5	4.4	5.4	3.8	3.0	4.5	3.4	2.9	3.1	1.9	18.3	18.1	20.4	22.5	19.1	17.7	20.1	17.6	17.2	16.6	18.2	20.5	15.9	0.0	11.5	8.8	16.6	17.5	17.1	3.7	16.5	12.5	13.9	12.8	4.6	15.7	5.0	1.8	0.0	11.5	16.1	8.7	7.9	10.2	60.9	10.5	8.8	12.8	13.2	6.3	7.9	10.0	11.1	11.9	11.2	13.5	7.0	14.3	10.0	7.1	9.1	3.3	6.7	12.1	10.2	9.4	14.3	35.1	8.1	9.5	16.0	7.5	8.4	9.8	19.6	8.0	7.8	10.3	6.0	7.9	11.8	16.3	7.5	6.3	5.7	9.0	13.1	17.5	17.3	13.0	11.1	14.3	20.6	11.1	15.0	15.2	12.3	13.6
ZNF302	"ZNF135L, ZNF140L, ZNF327"	ENSG00000089335	"Zinc finger protein 302"	Q9NR11	19	34677639-34686397	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 203.2;choroid plexus: 142.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA059503			Approved	"Vesicles,Cytokinetic bridge"		Yes	No			"Cluster 6: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytokinetic bridge"		"HPA059503: AB_2684043"	"unprognostic (3.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (9.85e-5)"	13.7	18.1	139.4	10.2	142.4	4.6	24.0	142.8	203.2	17.5	142.3	20.0	12.4	19.5	21.6	9.1	18.5	11.1	25.4	139.0	140.3	19.8	19.0	14.6	17.8	140.2	141.5	28.0	24.4	21.5	16.7	11.9	141.4	18.0	15.4	45.2	13.5	18.8	37.2	12.8	15.7	14.8	140.7	19.4	14.9	15.5	140.7	17.2	19.1	30.4	16.7	18.0	12.1	147.3	10.5	16.0	33.3	13.2	30.8	23.6	11.6	17.8	21.8	16.0	17.3	11.9	9.5	16.3	21.7	13.5	12.0	8.5	16.3	10.4	17.1	1.3	13.6	31.2	18.0	0.3	16.5	0.3	2.4	22.3	15.0	9.9	1.8	20.0	13.8	11.4	0.3	0.9	25.2	5.5	16.9	16.7	15.1	18.9	10.6	12.5	27.0	9.1	16.9	14.0	14.8	24.1	16.2	6.0	21.9	17.7	12.7	24.8	13.6	7.4	17.6	6.8	8.9	18.6	35.1	5.1	6.8	2.4	33.9	28.1	10.1	17.2	14.9	10.0	20.7	23.3	17.0	14.0	8.8	25.0	28.0	22.3	7.5	19.4	13.4	20.3	14.9	9.1	139.4	142.4	142.8	203.2	139.0	140.3	140.2	141.5	141.4	140.7	140.7	147.3	32.2	28.9	27.6	41.8	33.2	26.8	34.0	16.0	19.9	56.5	24.4	30.9	58.9	25.8	22.1	22.0	52.1	16.8	26.6	10.4	45.0	17.5	31.3	12.7	29.7	34.3	19.9	20.8	41.5	11.4	6.8	41.0	21.4	11.8	29.1	63.0	28.5	11.8	10.1	48.8	42.4	13.4	14.2	14.5	44.9	6.3	59.4	15.7	24.9	29.0	17.8	73.5	42.2	54.8	76.1	10.0	16.4	51.1	14.8	40.1	20.6	14.3	25.6	88.8	52.6	73.5	40.5	67.0	40.2	15.7	21.5	5.5	29.3	44.8	11.6	30.8
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"		3	88059255-88144660	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364"	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavorable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	5.0	3.7	2.6	4.1	2.7	8.1	5.5	4.9	3.3	5.1	1.8	4.4	4.5	4.6	4.7	5.6	3.4	4.8	3.4	2.4	3.2	4.8	7.0	4.5	6.1	2.8	3.1	6.4	4.1	4.3	1.2	5.0	3.3	5.5	4.2	11.7	4.6	4.1	3.0	6.5	4.8	4.1	3.2	4.9	4.7	6.0	2.7	7.6	5.9	4.9	5.7	5.1	2.3	3.9	7.2	3.0	5.0	6.9	9.9	8.6	4.6	9.3	8.4	6.1	8.4	4.4	4.3	11.3	6.2	7.4	4.4	4.7	5.3	8.6	11.8	7.0	3.0	7.0	3.9	3.2	7.5	8.0	7.6	8.4	7.4	6.7	7.8	12.1	8.1	6.6	4.9	9.0	13.6	5.3	8.0	6.5	2.7	5.7	4.8	5.7	3.4	5.4	5.4	9.0	3.7	3.3	6.8	5.2	17.0	6.0	7.3	5.7	9.5	13.6	8.7	51.8	6.6	10.1	7.6	7.9	10.8	7.5	8.6	9.7	1.2	1.8	1.7	1.2	2.0	1.1	1.8	2.4	1.5	1.7	2.2	1.5	1.7	4.0	1.0	0.7	1.4	1.0	2.6	2.7	4.9	3.3	2.4	3.2	2.8	3.1	3.3	3.2	2.7	3.9	18.2	9.6	13.1	10.1	12.8	22.4	10.1	7.9	9.1	14.0	17.4	10.2	11.8	5.7	10.8	5.5	12.5	4.8	14.5	11.9	1.9	7.6	1.4	9.4	16.0	12.4	5.3	5.2	11.7	5.3	4.2	11.7	5.1	12.2	15.8	14.5	8.9	14.0	6.3	16.8	11.3	7.1	10.2	12.3	19.5	1.5	7.5	14.8	8.8	7.5	10.9	9.9	9.2	9.0	13.3	8.4	8.2	12.4	9.2	12.0	9.0	6.0	10.7	14.3	6.6	13.9	11.5	12.1	10.4	11.4	18.6	8.2	14.0	9.0	7.8	14.4